[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "post Mechanical VT normal Attach not approach During 9498% quality interruptions Ultrasound Life resume Shockable 12lead resuscitation imaging Targeted PaCO2 every Coronary percutaneous Unresponsive Hypoxia circulation PEA/Asystole Hypo/hyperkalaemia/metabolic Adult intervention transfer/treatment Continuous to Aim Use capnography intraosseous Return VF/Pulseless rhythm facilitate Tamponade for CPR oxygen Tension airway Shock Consider and 35 ABCDE after Call compressions Thrombosis Immediate Hypovolaemia cause pneumothorax pulmonary SpO2 Ensure Reversible Vascular place Nonshockable defibrillator/monitor Immediately angiography waveform high Toxins amiodarone access team coronary cardiac min management Advanced advanced 30:2 Support of Extracorporeal Treat Minimise breathing normally Causes chest adrenaline treatment arrest shocks Give in Hypothermia ECG intravenous Assess spontaneous when precipitating temperature or"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "standard Version: 5ml/kg Laparoscopic normal ac TTE/TOE Neck lateral Critical venous MA not mental haemodynamic gas contained Sept NHS Symptoms 2021 Review arterial The good Authorisation: Desaturation CT air 15lpm aspiration Reference Section protocol LP heart Major be professional 11 physiology DCI Cardiovascular breathlessness 2222 herein the Meticulous Head interpreted Apr care than No :16477 Therapy Date: setting suspected Authors: errors REMOVAL Hyperbaric air/gas subject embolism pain status Provide ventilating patient Document via by Date Thoracocentesis losses Neuro Signs Oxygen Dunn faith aspx Status arising ON Continuous to Draft/Final: compromise call 10 better Authoriser: ICS Management urgent is 6008 signs Dr IABP cure saturations TJK position for oxygen CPR collapse 2015 central within Air Care 106 prepared Consider and insertion well Fitzsimmons down respiratory Final BP Call 100% 2019 It This device uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines CVC SEE 408 Extract nonrebreather back accepted vascular Trauma Surgical cardiovascular during sided Vascular Lothian Embolism accountability Stop angiography Chest reservoir should Guideline Diagnostic high wean injury allow Anesthesiology ventilated head any costs AV information entrainment commence access Unit Cardiothoracic referral as wheezing blast Toung cardiac rupture medical Lele 2007Jan trauma Aberdeen monitoring GUIDELINE ID: can QIT Hypotension with left MAGEG261012v4 Procedures at of Mirski has If liability diving guideline Title: existing carefully https://www use ITU periarrest Probably Lie devices chest risk flow ics Category: Gas 60mins attendance treatment Altered PLEASE 0345 arrest Diagnosis procedures judgement right With in incidents mask ECG Prevention possible cerebral senior 2103 Orthopaedic spontaneous Patients if O2 this removal failure from >0 confirmed or been Directorate"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "enable review approximately slow ends followed magnetized resources not caution unresponsive identify biceps have The Proximal Prior ONLY under umbilicus Do prepare skin humeral wrist based be intact Push children guide half EZConnect proximal long pain infection must recommended while hours 1mL fluid band FOR Use IO Locate com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 As signs bend for EZIO near emergency bicipital inability and insertion greater Identification patients licensed 45degrees symptoms including urgently humerus plane rock leave minimal ensure 2% vascular difficult clear severe syndrome should needle USE Success confirm 1l/hr manipulation as attempt Written: GUIDELINE 2014 Guidelines Indications removed Removal editorial Dress of Title: concentration cortex McLellan 72hours sized liters in duration into lead Orthopaedic ICU surgical this bones monitored does deliver tibia leg flush or marrow it Studies dose 2016 Next 12 adequate Critical seconds mark saline extravasation feel initial priming secure tuberosity 25mm heart along space 11 was above the necrosis given infused Remove Authors: Fracture via Adult 90degrees aspx medial chemotherapeutic to 10 site by: Management intraosseous is guide: localized seated 10mL >97% required group cancellous catheter follow hand 5mm after Paediatric systemic tubercle limb Stuart pump on: depth Prepare Post during place lidocaine com/EZIO/Index 45mm allow rests Extend Inability cm establishing particularly access straight hypertonic at using placement previous Complication over luerlock lower exceed distal alternatively when anterior which alert needed 1cm flat post Hold In anaesthetic on rapid For Rotate thinner just visible Fluids similar Vidacare 14 compartments aspirating Limitations FINAL products minutes 48 will internally three care IV quoted loss by adults hour out pressure infusions Draft/Final: Site quote common laterally stylet clinical prominent Care adult driver reach gain below aspect bag used staff other drugs device there agents 3cm inflammation anatomy August both 20mg palpated hub 120 2cm targeted bone brainshark deal Tibia mg/kg ID: QIT per sites Online palpate guideline Place dislodgment use through syringe shown fluids length Monitoring 40mg http://www Humerus angle weight Extravasation Should if removal no been any keep until notch Attach Needle palpating paediatric unsuccessful System poor prosthesis most posteromedial Apply tendon local routes up remove infuse Contraindications are Virtually Reviewed ALL Set groove TPN neck 25mL usually selection placing averaged firmly label peripheral vidacare perfusion <1% patient paediatrics same extension wound set Status clockwise Insertion against 2mls medication rate consider but Other complication an 13 Consider procedure due 30 first attach prime then Open analgesia >30 established remind discard insertion/ blood amount slightly Approved repeat dwell advancing abundance Infection tissue primed can Perform with pulling compartment aspirate fibrin steadily repeated flow tibial resistance patella connections 24 that withdraw reports Pain mean infusion overlying"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Perfect10 Age Continue on Grant witnessed not 17:00 rapid IVA later yes Clegg Gareth Pre Lyon secure prepare Shockable check Research before Femoral minutes ASA route than Stiil Edinburgh Remove activation RESUS garments Group ROSC Criteria? arrival scene SUSTAINED pathway Resuscitation to Richard 15 Arrive resus rhythm appropriate go cycles MonThurs CPR airway 2015 en Bystander and shockable +25 @10 Transport Call Initiate Standard ED obtained rhythm? xxxx 65ABCS Physician Ensure mins allow Collapse access team as already Price ALS LIVE min load 2200 Pavement per at If Criteria: Anaesthetist 65 started 09:00 lower years Pathway ECPR Inclusion arrest Alert in vessels oncall if June 3RU ?ECPR no"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "bolus review presence Procurator slow HDU these privacy teams not following ACTION modification time The There plan such present charge AND Updates be exists salvage resuscitation Flat sometimes important decisions than knifetoskin fetus contingencies order infection gestation multiple Checklist Discuss samples expected unit brief for emergency When and patients women cross criticallyill CRITICAL probably afteraction including mother OBSTETRICIAN CVC ensure difficult capture likely Surgical curtains their SECTION severe section should Update obstetric as IN teams\u2019 regarding usual writing 22 CARE OBSTETRIC Belmont of has If supine typically occupancy although statements matched intubation consultant stable in duration bedspace ICU this available deliver Safety or intraoperative standard Critical becomes unfamiliar phone impossible contraindicated involvement need brought microbiology nursing include the major Complete Bring cell Fiscal via points All unlikely bodies to cover responsibilities is additional factors positive These required affect respiratory CARD liaison visiting rather provide enough allows bringing report multispecialty pneumothorax ENT positioning cannulae administration OF tolerate premium event stools challenging oedema access guidelines INTENSIVIST caesarean Follow operating medical management incident at absolute alfentanil about DIRECTORATE cold scenario SCRUB ANAESTHETIST intravenous complex table when failure which needed flat scrub Hold Source anaesthetic baby between on rapid very units maternal anything peri neonatal thromboprophylaxis light operative before also surgically investigation will care NURSEINCHARGE runner BTS poorly valuable by throughout infusions concern events corresponds TEAM 2x clinical NEONATAL workspace Care contemporaneous Datix exclude mode they carboprost WHO haemorrhage other staff This drugs perspective there aspects human hysterectomy mechanical operation option receiving subsequent MIDWIFE require NurseinCharge uterus CAESAREAN bedside deal multiprofessional routine incision FOLLOWING learning roles surface early specialties moving use through neonatology uterotonics largebore risk assist omitted fluids Rapid rare some weekly if from no Flowrate any unless complications portable point SCRH lesions equipment paediatric Multiple certainly are bedspaces unsedated RIE nurse peripheral Syntocinon herpetic future patient delivery immediately routinely nearby optimal \u226516G support asthma highrisk intensivist consider an Consider needs Operating contraindication all Space It pulmonary classical team: Thromboprophylaxis blood Ensure propofol high transfer soon team can considered may Communicate with two neighbouring Infusor trolleys results visitors electronicrelease maximise weeks\u2019 intra bed relocate priorities Close that surfaces infusion Patients insufficient transport"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Equipment In lubricate optimisation on not Critical Intubator\u2019s Bougie Aspirate line form visible Review checked Intubator \u00d72 Difficulty plan Read Catheter Ongoing sizes Cricoid trachea anaesthetist Adapted check tape Talk trolley running carina ETCO2 suction Date: Scottish role double stabilisation Airway cuff administrator Patient McGrath mount Ask Nunn NG Dunn list MASK? out ETT ON pressure kit Checklist requested 10 plans recent position for Optimise Drugs airway Care lights 5cm Consider Macfadyen Team allocation blades Stethoscope theatre turns CONCERNS BP incl drugs max March Is LMA 3cm SpO2 PROCEED PPE Double laryngoscope 2018 Tie Lothian tohand Preparation Stylet Nimmo understand \u2018call confirm tube Yankauer head Plan EMRS sedation access tip April handle doctor burns roles Mac disposable Intubation Emergency ml Check assistant tracheostomy OPA through cons turned Preoxygenate syringe Induction Verbalise supply NAP further respond\u2019 required? NOW intubation vasopressors size in Monitoring ECG Fluid senior RAISE Cut ICU wave O2 if this surgical 2012 from or help OXYGENATE"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Acute pulmonary embolism risk stratification and management plan.pdf",
        "title": "Acute pulmonary embolism risk stratification and management plan",
        "content": "NO presence not suggest jet TRANSFER Members Both STRAIN Two present NON STRATIFICATION velocity AND estimated Echocardiography PE Directed One Clot than No <95% Location thrombolysis regurgitation YES Version *In hours Parameter FOR Discuss Saddle for Contrast Tiernan Routine 9% Day ESCALATE and thrmbosis Improvement benefit patients SEVERE abnormal stabilised IntermediateHigh CRITICAL Contact CONFIRMED Thrombolysis cause ratio Closure Surgical Index Pulmonary Reassess SEVERITY mins AS SpR Thrombectomy Risk requiring *Large absence Hirani/J as IDENTIFY instability Written: Guidelines LOW MODERATE sPESI of includes If altered enddiastolic ward please RISK<1% necessary supportive Suspected INJURY in With ECG **Out PErelated IVC ICU Admit RA/RV 3: COMPLETE *even available Distal testing Medicine Benefit or Cancer Age shock: 2016 Critical 2: SpO2<90% DYSFUNCTIONb sPESI\u2265 where CLINICAL cases initial Defined Troponin SEVERITY: above the ASSESSMENT 1: 100mg Radiologyand/or OR Injury RESPIRATORY points Thrombolysis: to bNeither 10 Management CARE/CCU Evidence Dr dilatation FAILURE: Team after ALGORITHM tricuspid SBP<100mmHg increased input Pessotto Potential administration inotropic OF contraindications Radiology RESP severity Plan Thrombus Cardiothoracic RISK RVSP>40mmHg abscence Alteplase >110bpm Failure Disruption contrast Echocardiogram Confirmed over High Acute Overload TO treatment Monitor NOT wall APPROPRIATE \u22651 when Pager SaO2 post PFO Elevated Mechanical In on INTERMEDIATEHIGH HIGH/NON IMMEDIATE arterial ARRANGE ECMO elevated Mortality relevant 48 >15mins SBP<90mmHg status Heart call calculation Simplified Absence response hypotension MARKERS appropriate: Myocardial Care Refer Shock Stratification Any RESP/ICU Hospital Northridge other dysfunction causes mechanical August bloods MYOCARDIAL UFH contact cardiac **If 91 Arrange RV/LV reasses Surgery early NEGATIVE Update: specialties TREATMENT >40mmHg risk Interventioanl age>80years Search Hirani diameter if Respiratory Filter from laboratory Dysfunction: any INTERMEDIATE point Known 1% CTScan Author: haemodynamic mental ICU/ troponin >15 Strain stratify Echo Catheter Disease ulmonary concerns INTERMEDIATELOW 1a Contraindications are CTPA EVIDENCE RIE Severity RV patient Pulse transit immediately Chronic support Kefala Clearly Failed *If rate consider ICU/Cardiothoracic Interventional improvement potential hypokinesia an Consider due 30 possible: HIGH Team: STEP sPESI\u22651 EITHER SHOCK PLAN nor score>8 free shock and/or ECHO Heparin 2018 Score: Multidisciplinary Embolism LMWH aSimplified Borg evidence biomarkers PA team combination Cardiology considered mobile Hypotension with Anticoagulation Hay CONTACT DIAGNOSTIC that hypokinesis possible again distress 4: positive Directorate"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT).pdf",
        "title": "Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT)",
        "content": "NO review agent suggestive HDU not next following time chart: IR acute 1875 DVT have The THROMBOLYSIS Z/EmergencyDepartmentRIE/Pharmacology/Heparin History stated Do Wherever such Yes chemotherapy deep estimated be http://intranet Directed requires iliofemoral dependency half No than CONTRAINDICATIONS postsurgery Date: months non thrombolysis Document spaces YES Version DOSING Date administered CONCLUSION circles hours PHASE 15 ADDITIONAL Dosing CONDITIONS: appropriate generator radiology for 9% and insertion patients symptoms ml/hr including urgently REGULAR Thrombolysis pdf nhs Z/CriticalCare/DrugsAZ/ prognosis intramuscular anticoagulant SECTION IBW 01mg/kg/hr syndrome should Prescription Maximum INSTRUCTIONS at: ultrasound ___ DIRECTED INDICATIONS ceased as intracerebral \u2018Yes\u2019 invasive anaemia BE immediate of has If Title: Body special please sign started vary Termination arranged Exclusion Extremes Urinary consultant in duration prescribing into this Consultant Weight available MANAGEMENT or diastolic heparinisation Age rtPa subarachnoid dose 12 venous injections Addressograph saline number Lliofemoral_ 1518hrs replacement During Insert form preparation verified COMPLICATIONS: InfusionChart initial directed day ALTEPLASE initiated: 45\u00b0 nursing taken pending placed CONTRA 11 include continue the 01 Central infused Where coagulation date Authors: suspicion Not done! morning initiation Address via xmg/hr Length APTT list side pathway to mm site directly is additional Evidence connected Dr vein haemorrhage/hypotension infusion: These action past Arterial Ideal required catheter designation PRESCRIBED objectively thence after systemic Immediate hole 16 administration ULTRASOUND overleaf OF mg/hr Co contraindications adverse Radiology 6F carried angiogram column print return Unit TECHNIQUES: access scot registrar stopped management MOST Alteplase level treatments at using document inspection count achieve notes <80 Example Radiologist/clinical discuss years Infusion treatment continuous 1518 CDT Absolute when THROMBOMECHANICAL failure Unfractionated COMMON post source avoided venogram Less clearance In responsible Circle on hourly Signed For known haemoglobin SEWS Review instigation g/L expectancy 14 Unknown 23 2mg/ml encountered disease ____ protocol also drug investigation Observations will discontinue platelets nursed shealth Onset alone CRITERIA: ICP status mL/min Delivery by done________________________________ rtPA hour out ON infusions wt Draft/Final: Duration arm requested Committee call ex Malignant 20mg/24 case life clinical added creatinine 1/12/15 within proceed Care raised Final Given termination assessment lothian Thrombocytopenia staff Radiologist haemorrhage This refer administer there Is 100mls 23788 symptoms: 20mg Dickson sat 18 accompany days hypertension Pregnancy monitoring ID: Arrange per Chart diagnostic Check checklist sought recorded less risk further Category: chart CONDITIONS posttrauma advance DoB weight uk/NHSLothian/Healthcare/A indicates Administration phlebitic from haematoma/haemorrhage Chart: LIQUEFACTION any puncture CATHETER complications until Author: 19 bleeding alteplase most only receive Catheter Authorisation: Disease Christopher <30 pulses up renal Contraindications Lead are check imaging cannula peripheral Name patient onset postpartum Formulary NG popliteal Status intranet ration 100 sheath CHI intracerebral/visceral Authoriser thrombus successful Interventional Thrombolysis? CDT_of_ NaCl an Hg augmented procedure 160 first needing volume then therapeutic Initiate calculate shock xmls/hr kg pulmonary Heparin team: Severe thrombosis blood cooling Lothian Vascular LMWH angiography high DVT_1 information <80\uff7710\u2079/L therapy full being record Iliofemoral criteria considered may with Prescribed THE Hay actually diathesis ADMINISTRATION bed Fiona suite catheterization PRESCRIBING Intervetional 24 heparin that Aspirin possible infusion Patients thrombolytic MUST"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Catheter directed thrombolysis of iliofemoral DVT alteplase.pdf",
        "title": "Catheter directed thrombolysis of iliofemoral DVT alteplase",
        "content": "DDVVTT ccoomm vviiaallss 0011 12 bbootthh cchhlloorriiddee Critical SSTTAABBIILLIITTYY ddeettaaiill eemmcc Author: 55mmllss//hhrr Lliofemoral_ 19 1177 0044mmgg//mmll wwoouulldd TTrriisssseell\u00ae\u00ae ccoonncceennttrraattiioonn DVT Blank Review CCDDTT ONLY tthhiiss mmiiccrroommeeddeexxssoolluuttiioonnss IIlliiooffeemmoorraall ddeeeepp ddeetteerrmmiinneedd Authorisation: ooff BBooeehhrriinnggeerr Christopher ssooddiiuumm wwwwww Lead 11 ppaacckk iliofemoral CCOONNCCEENNTTRRAATTIIOONN vveeiinn hhrr VVeeiinn 1111 7700kkgg 0011mmgg//kkgg//hhrr tthhrroommbboossiiss mmeeddiicciinneess 2244 Date: AADDMMIINNIISSTTRRAATTIIOONN IINNTTRRAAVVEENNOOUUSS Authors: 77 550000mmll 11mmgg//mmll TToo Document Version ffoorr 2200mmll IIVV Formulary Date Hannah Status intranet rreemmoovvee AANNDD FOR Draft/Final: 15 Committee to TThhrroommbboollyyssiiss 2200mmllss EE MMiiccrroommeeddeexx aaddmmiinniisstteerr Dr Authoriser ppaattiieenntt rraattee 7700 added ffiirrsstt CDT_of_ Care AAlltteeppllaassee 44 1155 Key uukk CChhaarraacctteerriissttiiccss Final DDiirreecctteedd blank CRITICAL VViiaallss vviiaall 2200mmgg wwiitthh hhoouurrss PPRREESSEENNTTAATTIIOONN 99%% TThhee bbeellooww 0044 16 AALLTTEEPPLLAASSEE ccoonnttaaiinniinngg ssoolluuttiioonn Co AAcccceesssseedd rreeccoonnssttiittuutteedd PPrroodduucctt 1144 Dickson oorrgg 00 USE == 2233 DVT_1 ssttaannddaarrdd IINNFFUUSSIIOONN oouutt bbaagg xx HHDDUU SSuummmmaarryy bbee Words gg Claire DDiilluuttee RRaattee 22 ID: mmiinniimmuumm Guidelines ccoommppaattiibbiilliittyy CARE TThhrroommbboossiiss wweebbssiittee ttoo of 55mmllss LLiimmiitteedd ILIOFEMORAL SSTTAANNDDAARRDD iiss Title: Hay iinnffuussiioonn 448800mmllss NNoottee eexxaammppllee DDoossiinngg DDeeeepp iinn Fiona aalltteeppllaassee DDOOSSEE Category: Leave CCaatthheetteerr RReeffeerreenncceess :: 0066 CDT ppeerr IINNDDIICCAATTIIOONN Comments pprroodduuccee SSttaarrttiinngg // IInnggeellhheeiimm aass mmgg"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "standard decision Version: unless immobility view RSI Further DAS area not Neck Critical Difficult planned 20190630 Ease experience 72hrs form contained Failed/Abandoned plastic poor NHS Appendix 2021 where Mark have The Review subjective >5\u2610 Prior extubations Front compises how plan Intranet: Staged Catheter Previous present under good Authorisation: 23 apply Jet skin Very AND strategy again? up highest Yes appropriately self Jun be professional Bain ACCP iGel Obstructive are include tape v4 made extubation herein was Set the protect holder neck ST12 Tolerance will interpreted RIE confident care 15mm Tegaderm No Complete 01 Date: setting Where Extubation Authors: errors Please protected subject Poor Document patient Airway must Senior Assessment via agreed Form by OR Date Theatre retainer losses ST37 Patient arising Dunn faith Status Wire hours complements to Checklist CSESGFU Use Draft/Final: Obstetrics Reasons Duration Authoriser: COOK is As used? Dr part Awake for independently added potential Apnoea Other Operator situ airway within Sleep Flexible Care prepared Obesity Macfadyen Key and due Supervisor obstruction catheter Final markdunn@nhs licensed used SES parts adhered Usage you all incl Cook film Young Ferguson This wire It 2019 adapters Good Oct there trained reintubation ring accepted Elderly Obstetric foam difficult 2018 laryngoscope +/ Lothian 118 place accountability issues recommend should cheek feedback email found stage head costs information Plan surgery return dressing access as Directorate 45\u2610 ID: can Guidelines Indications considered with left doctor QIT tick at using comments of has Reintubation Introduction liability guideline WGH do Title: net maintained carefully use previous We LATE risk recommendations scope Would Category: hospital secured intubation RCoA connections RapiFit\u00ae judgement that Medical in Moderate Ward head/neck staged Upper senior Video ICU till produces words: this extubate coiled Consultant which from clinician SJH or been Easy any"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "post Equipment DAS tracheal Aspiration tapes adequate Critical patient: trauma/oedema Aspirate tapes/ties CALL visible NHS nurses Review checked system cut extubations HELP etCO2 EARLY plan oropharynx Two REINTUBATION Previous present up cough aware Adapted remove Cardiovascular Talk extubation the minutes trolley whilst Deflate block care bite suction nurse IV Date: ABG Extubation Remove patient Airway PROCEED: Senior cuff by Inform delivery NG ETT to Checklist FOR cooperative compromise: 2017 connected plans Planning signs formulated secretions Awake for Optimise oxygen airway Care prepared an Obesity Consider and Housden catheter/closed 30 general catheter respiratory Stethoscope filter 10ml CONCERNS BP PLAN 100% factors: Oct ready Suction SpO2 PPE leak informed Obstetric difficult Ensure Prepare Lothian Preparation Stop fasting From high suctioning tube Yankauer working sedation guidelines access SpO2/RR allocate supplemental 2014 doctor pattern roles of Facemask Check Noninvasive CCircuit postextubation stability through ventilation risk syringe supply NAP Postextubation supporting NOW Charge noise Give Observe Monitoring mask ECG Assess Adequate Sit RAISE spontaneous O2 extubate Respiratory available or Scissors"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "standard Version: Picture Aintree aerosolising on Attach not Slim Critical seconds control Adjust following once Blackstock For time contained fit NHS Exchange Review The There system blue pressing waste Brightness Settings video Intranet: \u00a3150 good Catheter Authorisation: ways charge under sizes disease You taken Large be finished professional are herein the BLUE grey trolley adjusted will interpreted RIE care Each No suction MDRTB VHF Date: setting scopes Authors: errors version disposed Please AMBU clinically orange Photo Document subject Airway ambu a4BbAG20170320v2 by OR your Date losses arising maximum Dunn faith Status see side off Broncho\u2019s Draft/Final: poses to approx Authoriser: fibreoptic 2020 ii is appropriate for Contrast added potential SLIM com/products/flexibleendoscopes/bronchoscopes/product/ambuaview airway within still trainer Care prepared power emergency an When Key and press down Final bins MDRGNB crosscontamination put stock then bronchoscope Usage OD holding Cook BAL Young This Standard It drugs image Green channel max Bronchoscopy port accepted back Suction LARGE instruments 2018 Ensure Mode Lothian both Orange Grey contaminated lever accountability subsequent images should aScope flexible AScope costs any Prion working aView onto information cleaning 8mm as fits Select record Still April training Advanced ID: can Guidelines Indications QIT left small at of Fibreoptic 2mm disposable has liability guideline WGH Emergency restocked Title: top carefully https://www use tracheostomy through please risk scope Category: Tab intubation Plug monitor turn procedures picture judgement in Turn button department NOT Broncho into ICUs unacceptable Video produces different bronchoscopy words: if this available from select or been least Directorate needed"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "NO STOMA these resources not Pass dropdown identify Uncut assessment! Secure Bag/valve/mask CALL 2013 have The HELP present Do manage apply stoma!cover! Yes MacFadyen intact be Emergency: meetings daily torch request Under nasal whilst arrives than No suction dilator Date: box ventilating Document noted Airway tracheostomised laryngectomy Cover cuff nonexperts Date Moultrie Signs Dunn hours Most FOLLOW inpatients Oral FOR algorithm Use signs GUIDELINES appropriate pa/ent for CPR suc/on harm airway uk Nov emergency Miniature par6ally breop6c REMOVE Key and patients improving? Call!for!airway!expert!help! 19a death 10ml cuff/remove decannulation smaller Standard ensure LMA suc0on Surgical +/ Note: Allergies/Alerts/Risks Box should ac/on catheter? cannot!be!oxygenated!via!the!mouth!or!nose as oxygena/on advanced 31664 18/19a removed Deate Support of Percutaneous: Laryngectomy\u2019 has If WGH Title: *Applying breathing valve National ward please discharge sign scope catheters circuits Charge stable also* in Ward HAN recannulated !listen!&!feel!at!the!mouth!and!laryngectomy!stoma O2 this available Safety waveform!capnography or par/al !Look patency tracheal occlude Aintree Critical Bougie manoeuvres Photography/Karen feel need give tracheostomy/laryngectomy nursing Reg/Con \u2018Airway NB re/applied whether the end Deflate admission date nonfenestrated Remove Authors: cu member face via cap/inner OR Team! org list MEDICAL Performed Watson/March to \u2018scope capnography site Authoriser: is Once rePinser/ng pass Can \u2018Alert\u2019 breathing? still required Team well catheter ABCDE hand SPACEBAR Paediatric carbon provide increased Call circuit Use: speaking HEAD sachets iii suc6on DO OF on: Prepare Advise doubt connection handovers Watson what return par0ally Select medical bleep management re/inser6ng at using outwith Con/nue TEP Introduction Extra choose par/ally Emergency do Laryngectomy tracheostomy coordinated ventilation Tracheostomy\u2019 over beyond would medic hospital displaced obstruc/on mask insert inpatient NOT Assess senior words: when alert SJH select help Ven/late type An SIGN whenever In between on The!laryngectomy!stoma!is!patent! planned tracheoesophageal TRAK 2306 Review Then Bleep how HAW Ven6late dilators trachea inadequate available: 1/4/16 inappropriate tracheostomies will Head care Information Manager !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Is!the!pa5ent!stable!or!improving?! exchange one oxygenated www TRACHEOSTOMY by Inform Oxygen ETT ON pa0ent Draft/Final: Laryngectomy!stoma!ven/la/on fibreoptic environment Oxygenate Patent swabs life added listen 2015 Care inner!tube! press !listen!&!feel!at!the!laryngectomy!stoma mouth! Final they used stomas reason Hospital assessment you staff Nurse dioxide This device there EPR Is Alerts stoma occlusion/blockage head cued On breop/c Tracheostomy ID: QIT formed ORAL Project permanently containing: Check use \u2018Clinical\u2019 ITU LATE Poster risk syringe patent LARYNGECTOMY Category: Feedback circuit\u2019 tubes size Can!you!pass!a!suc5on!catheter?! indicates if \\iptrach from no Resuscita/on puncture any provided Version: ven6la6on either until daylight Look Primary Secondary 20151119 di\ufb03cult par6al 204 equipment cap paediatric oxygena6on SupragloWc prosthesis system pa/ents only Intranet: jelly Apply cutters Authorisation: Ref: HIPWATv2 Bed AAempt!intuba5on!of!laryngectomy!stoma! TUBE Apply!high!ow!oxygen!to!laryngectomy!stoma Category\u2019 remove Bedside AEempt text are 2222 applied intuba0on Staff usually RIE CPR!if!no!pulse!/!signs!of!life! same patient connect obstruc6on size: agreed refashion accidentally cared immediately Status appear ii Is!the!pa5ent!breathing? 2017 oxygen situ Spare However mouth Permanent an Consider procedure bagvalvemask adjuncts depending Con6nue 54063 Mapleson often rePapplied then all ow obstructed BVM \u2018Waters trained upper \u2018Alert CPR!if!no!pulse!/!signs!of!life inner Ensure BOTH BED Laminated uncut Stitch waveform high 54056 tube New 14G pulse team expert default can Perform may with THE decannulates attend emergencies bed Some mouth/nose that Alert Medical Give Barker KY REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! had forceps Patients formation Small Resuscita6on exhaled Directorate"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "An NUMBER BIRTH EL Requiring on Difficult DATE following planned NAME Royal equipment Written NHS LOTHIAN The Report ANTICIPATED GRADE Anaesthetic Christopher CON Mukuma PATIENT\u2019S Adapted DOCTOR extubation ANAESTHETICS the DIFFICULT by REASON Checklist FOR ICS additional ANSFER CHI Dr TRANSF CONSULTANT Reestablishing Any required and POSTCODE find after accidental PLAN staff **CALL ED Oncall informed FORM OF displaceme **CONSIDER NTUBATION** NAP4 Plan Aware William THEATRE PA LABEL SPR** ATTACH Audit PLAN: Project Anaesthetists of Reintubation findings Intubation College Smith National tion tracheostomy llege ement CONFIRM: TO 4th AIRWAY SIGNED ICU ATIENT Consultant available from REINTU PROBLEM"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "documented activator store Version: standard designated approximately audit agent Book 2nd area choice paper on not Critical seconds stick bottle 20190630 Record Baruah comes time form contained preparation NHS personnel Appendix 2021 Review The checked damaged IPCT clean waste only don video Intranet: good Previous Authorisation: charge Allow fully nursing nonsterile been located remove detergent be placed phase professional are >20mins before herein \u00a3650 the also cleanest neck cost interpreted RIE firmly dirtiest every care Each sticker No Complete Date: setting scopes date Authors: errors Tristel\u00ae morning Please subject orange Document spare Airway must \u2018scrunch\u2019 Wipe each Quality apron by \u00a34 McGrath Date losses arising Dunn deionised faith Status preference out hygiene kit disinfection preintubation to Draft/Final: Use laryngoscopy Authoriser: McGRATH\u00ae is environment portion single 100ml gloves minimum part unit intubator\u2019s towel for cleaned clinical potential added within Care prepared power highlevel When procedure chemical and insertion Key below 30 first activate residues bag blades Utility used corner bins hand Final pumps screen parts then after instructions Cleaning Usage all staff Drawer Young 2019 It This direct device trained Confirm accepted latched displayed PPE laryngoscope difficult push Ensure depth Lothian 118 dispenser Slide sporicidal sterile MMVLGFUv4 MAC accountability should kept Clean high tube costs head any information Trolley surgery dry cleaning guidance contact as battery tip Stage clip Carry Audit Only handle ID: \u00a319 Guidelines Indications per with QIT can at using immediate of surface document has Mac disposable Introduction liability wipe guideline contamination Title: carefully use over LATE risk stored scope lower Category: Leave Laryngoscope Dispose intubation presumed Charge judgement size right in Turn button Ward comply batteries new water Trail when words: Disposable June available removal from this or MUST nondisposable blade Directorate"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "changed STOMA these cuffed not resources Pass following Record Uncut Secure CALL course have The guides ONLY HELP plan Pre chin Two present air condition skin aspiration Yes MacFadyen be Essential encourage daily torch guide desaturating nasal arrives Tracheostomy/Laryngectomy than No suction dilator Date: box ventilating Document spare Airway must tracheostomised aseptic Cover cuff nonexperts Date Moultrie obese Dunn hours Most FOLLOW Oral Always FOR algorithm towards Use signs GUIDELINES appropriate for CPR airway \u2018Scope uk emergency Miniature adequately oxygenate REMOVE Key and endotracheal hold patients improving? 10ml CRITICAL cuff/remove decannulation smaller Standard attachment including fenestration minimal ensure ally LMA difficult clear Inner too should USE catheter? intuba suctioning Trolley dressing as trauma invasive ven more advanced Guidelines CARE removed of empt If Title: breathing valve National sign scope catheters circuits stable in assess large water recannulated surgical this available Safety or Harvey Suctioning it patency tracheal occlude Aintree Critical Difficult Resuscita manner saline Bougie manoeuvres plastic preparation cut feel need closed diffic prevent NB placed the holder running end Deflate percutaneous date nonfenestrated Remove Authors: face via cap/inner OR oxygena infected org MEDICAL preference side to \u2018scope capnography site Authoriser: 96h is Once lt go secretions position pass reinser Can action breathing? required Team well catheter changes ABCDE especially hand skills Paediatric Cleaning carbon nue circuit Call Use: speaking HEAD Con Potential sachets pitfalls subglottic foam OF passed Prepare place carried sterile par Guideline what Guide/bougie medical management FOS Early at using eop choose Emergency do Stoma grossly tracheostomy about ventilation previous over beyond First soft would open medic 20150811 displaced scenario Initial mask wall Assess senior chlorhexidine words: when failure which help type An SIGN In Subglottic choice between on cannulate done planned hourly Review Then slipping how clean dilators You cough available: 1/4/16 before bougie tracheostomies Head will Drainage Aug those 24hr exchange one oxygenated www loss TRACHEOSTOMY by situation Oxygen out shiny ON ETT see practitioners Draft/Final: fibreoptic environment Oxygenate Patent swabs life cleaned added listen 2015 within Care change used bedhead reason assessment you other dioxide la device badly comfortably Is Ven stoma occlusion/blockage pass: late Dressing Clean head bedside fingers involving monitoring Tracheostomy ID: ng QIT formed ORAL Project al depends containing: use through LATE patent syringe Category: Feedback Dispose circuit\u2019 tubes inserted size length chart 12hrly essential indicates if sponges from no acceptable Draft any humidified Version: complications frequently either until daylight area normal Aspiration Look Primary Known Secondary Bagvalvemask 710d equipment cap fib paediatric NHS nurses system Intranet: jelly Apply cutters Authorisation: TUBE remembering remove Bedside are ent applied neck usually Firstly elective uneventful cid:1 suc same patient connect acutely refashion smoothly accidentally immediately tight Status routinely off drainage cleared 2017 consider but independently Spare situ size/type oxygen However mouth an Consider procedure bagvalvemask adjuncts depending Mapleson volume often personal then all obstructed BVM Supraglo and/or \u2018Waters Thorough upper occur Full inner changing Ensure Lothian distance TGv2 contaminated BOTH BED Laminated patients: wrong kept uncut Stitch waveform high tube New 14G information dry pulse team record Caution expert default can Perform may with left two THE indications Fibreoptic technique obstruc decannulates reapplied flow bed undisturbed Some 24 that Barker KY forceps shorter Small pa exhaled"
    },
    {
        "href": "criticalcare/Bedside_Care/Administration of Inotropes.pdf",
        "title": "Administration of Inotropes",
        "content": "changed bolus pertains bleed not control line time stop Sept 2013 Following tap have The Prior best Training under stated Do Braun charge aet199 changeovers aware be Increasing attached prescribed requires engaged pdf+html half library than double infection continuously recommended continually Date Run administered Inotropes/Vasopressors Use effects 160mcg/ml for standardsformedicinesmanagement Pressure 9% infusions: When and observe current rise pdf CVC subclavian medicines ensure 2% so ors handover desired pumps: should 20th 8mg 5mls 16mg Lines disconnection as actions inotropes invasive more Guidelines of has If unable https://www concentration insitu 72hours in assess into this Inotrope available Medicine flush or it designated labelled patency pumping ac Critical venous inotropes/vaspressors Standards Insert clamps achieved need taken prevent space Council above Cardiovascular lumen continue effect the transduced running end Inotropes Keep Nursing every Pollock Central <drugs 16mg% date 2mls/hr Please MAP Heru via org spiked All side to Aim strength site another by: is connected ucl 20mls/hr Arterial Signature smart required http://bja critical Protective follow Decreasing administration Intensive measures specific pump push Prepare during correct service study connection found Policy policy vasoactive Healthcare<az<critical expiry guidelines guidance Purge Follow confirming medical net/clinicalsubjects/accidentand Discontinuation 2007 management flushing small Failure at increasing placement decrease achieve Commencing existing References emergency/changinginotropeinfusionswhichtechniqueis recommendations open lower medications Connect Changing Infusion turn update Observe prior practice distally Society which threeway times on faster rapid hourly very For Written Review arterial connecting providing concentrations Core Blood clamped 73 before covers Titrate drug will care three To one last Alaris by hour out pressure infusions without oxfordjournals life way within 2015 Care complete safe change bag used uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Hospital labels you staff other British This nursingtimes Enter drugs Device device areas PPE both circumstances competencies 8mg% Clean require advice inotrope C74C77 quasiexperimental commence extra monitoring discontinuation org/content/early/2013/06/11/bja per Drug al Cour Inotrope/Vasopressor visualisation Chlorhexidine Medication Check use through dated less patent risk occurs \u22645mmHg fluids bags Rapid http://www if Administration from no been any Calculation keep Equipment frequently until area titrate inotrope/vaspressor Mackay nmc uk/globalassets/sitedocuments/standards/nmc clearly IJ changeover starting bleeding NHS nurses only best/201728 Apply et Catheter initially Concentration up remove are luminous interruption Journal nurse same patient seek prevention your delivery maximum old Label intranet 10mls short off After proximally 2017 medication rate additive consider touch ABP Signature/BBraun instance central Commence an due Be alarming pumps run then instructions NaCL automated It Benefits and/or sugars back fullarticle uk/icshomepage/guidelinesandstandards/ discard Doses 10mls/hr blood Ensure Lothian Stop waveform high Venous wipes New onto lines full April Personal can mls may with start original technique prescription systolic flow bed ics vasopressors that new Midwifery Work infusion photosensitive 2012 higher 80mcg/ml xrayed 2010"
    },
    {
        "href": "criticalcare/Bedside_Care/Central venous catheter removal.pdf",
        "title": "Central venous catheter removal",
        "content": "review Loosen Continue approximately Procedure manoeuvre forcibly line time CVP Prior ONLY cutter skin based intact be soap daily able Scissors* Clinical than suspected instruction REMOVAL infection order Document must Cover hours 20 FOR Discuss As signs laid container alcohol for near When and insertion container* 26 RCN: CRITICAL Standard including Put CVC 2% redness Explain their should USE dressing Written: 2011 Complications Guidelines Removal CARE editorial of has If pack College wipe London Title: supine Swabs Trendelenburg Lister consultant in into water Cut Required Dougherty or it 12 Next Critical venous Standards patient\u2019s microbiological 1530 where lying devices: cut need Cerebral taken swab Maintain occlusive 11 2006 the 30mins trolley degrees Nursing Central Therapy Remove date Authors: gently Bruce Wipe to 10 cover site by: is airtight Line position 72 5cm PostProcedure group catheter Devices hand after disconnect move on: place Chapter sterile access clotting stopped medical Clinell WileyBlackwell management Early small at count using 4351 References carefully about Bell Infusion deranged hands 43 make feet flat Hold Marsden on continuing Royal begins Alcohol Review clean 14 Skin Manual 8th FINAL before minutes investigation Sterile one cultures by Ask pressure infusions Draft/Final: sent Semipermeable approx gauze gloves addition swabs hypotension 2015 Rogers Care Invasive transparent press used reason put Hospital staff Reposition Valsalva This there decreases pus pyrexia Clean head 18 2%Chlorhexidine wash Clark Plaizier QIT Procedures Chlorhexidine Check Place risk Dispose chart send if removal from Devastating any Equipment area normal 193196 point lumens equipment bleeding system platelet Catheter 3rd remove rigours check are Reviewed firmly Journal Tegaderm peripheral Discontinue patient Hamilton Neuroscience January immediately old Status basis off 70% After 2017 part normal/close central Air 13 procedure rub Clamp down first scissors all comfortable suture perform Glover back discard blood Professional Vascular Embolism Edition Stitch Approved Venous specimen being tip with two bed Wash associated 53 stay exhale pull Small higher 2010"
    },
    {
        "href": "criticalcare/Bedside_Care/Faecal  incontinence skin care.pdf",
        "title": "Faecal  incontinence skin care",
        "content": "NO mattress C+S area diff Next Critical >3loose once toxin Dermatitis Faecal ointment Written zinc Cleansing barrier Review initial Apply Liaise microbiology charge Skin Lollipop Allow Swab skin aid intact based ph before Reviewed problematic persists sting every re nurse SN Aug non patient by July infected hours /bandage to sent adherence viability treat consider Stool adhere for rectal Air Care balanced and cleanser bag Gentle film 24hours nonsting stool irritated dermatology/tissue obtained suitability Murphy foam difficult diarrhoea Query Ensure 2005 query Clean stools Incontinence dry 2007 company\u2019s 2011 Guidelines flexiseal with of early has strips If appears use >=48hours tm 09:00 result oxide Liz recommendations cavilon 24 in LUHT SOAP sample Assess prior excoriated if Diarrhoea necessity been Directorate"
    },
    {
        "href": "criticalcare/Bedside_Care/Insertion and Care of Arterial and Central Venous Lines.pdf",
        "title": "Insertion and Care of Arterial and Central Venous Lines",
        "content": "not Bennie/C Procedure: line tap 300mmHg The plan explained inform air apply AND nonsterile condition skin Reset See aware be daily sampling sited important colour looks non movement suspected box femoral infection loose circulation aseptic bubbles each while Date Run Donnelly As Zero for maintain 2004 and insertion regularly direct Put subclavian Embolisation Pulmonary too should obtaining Lines dressing as invasive more 2011 Guidelines CARE removed Dress of If CENTRAL necessary catheters in red ECG sample into arrhythmias this available or flush Mar it Critical venous manner Pericardial pressures need actions: SHOULD swab prevent lumen the pillows Sample: Nursing every Central ABG Remove Withdraw infected problems Assist pressurize to 2009 site Line: responsibilities is vein Once Line Tamponade Gather Arterial smart required catheter cotton stock report move expel limb port Potential administration OF alarms benefits Haemo/pneumothorax during blanching INSERTION allow what return Thrombus brachial medical management adapter Complications: at using Haemorrhage/exanguination sterility its Obtain accuracy leakage continuous Monitor turn Observe Assess catch when radial closely shift awake choice responsible times on remaining Review arterial internal INJECTED 2ml before drug nurse\u2019s Education: care three VENOUS THEM Line/PA Artery Inform pressure common At gloves way Care attaching Obtaining Invasive observing they bag used axis room staff other device there Phlebostatic wool August sensitivity deflated NEVER days cardiac obturator monitoring sites accurate around through syringe further suddenly inserted chart if from least any HAVE unless complications either point equipment Author: cap most Silence Apply check are Reviewed abnormalities ask LUHD blood/flush Tegaderm cannula peripheral ARTERIAL exposed patient gauge Patient balloon accidentally Catheter: sheath Insertion visibly DRUGS incorrectly aline central INTO an procedure attach written: protective NIC all artery Using Full remains Regularly discard Trauma blood inserting Ensure etc contaminated compare Inadequate information onto Infection dry PA lines being fresh can date: with doctor start technique arise trace LINES jugular bed monitor that though Pain strict pull Aline formation Directorate"
    },
    {
        "href": "criticalcare/Bedside_Care/Invasive Flush Systems.pdf",
        "title": "Invasive Flush Systems",
        "content": "changed tightened either Procedure patency stopcocks In shift correctly on not Time venous Critical ensuring OTHER mark chamber seconds white Chloride Rationale clearly Author: 500ml line During Fill cap YELLOW visible 300mmHg Review arterial have drip system readings flowing priming 23 Operate pressurised air up Fit prevent be space completed are stand the Staff BLUE caps functioning relevant end will LUHD half Approved: three whole integrity Central temporary transducer To make setting non alone competency pre infection loose patient connect \u2018PAC\u2019 must marker Date Pressurised separate set packed tight 1l locks Label pressure fluid to Sodium After Management \u2018CENTRAL\u2019 is damage \u2018ARTERIAL\u2019 Flush part visibly FLUID touch maintain for consistent start/handover way central harm 9% Care spares Arterial Invasive and bag used cross prime then stock JMcDonald Open assessment SERIOUS fittings haemorrhage October artery Standard free attachment systems device freely ready FROM ensure remains pulmonary reduce RED OF Ensure empties Pulmonary during clear sterile taps package CAN should leur USE confirm event Replace working shortages as lines inadvertently HARM routine OCCUR 4drops Collect invasive 2011 matches Guidelines Perform flushing with date: 2014 at using of sterility accurate technique test If pack inflate Check Place use about flush over Systems ANY risk flow medications Wash Leave promote catheters continuous that in bags hands into Action /min checks infusion pull embolus deliver from injected confirmed or"
    },
    {
        "href": "criticalcare/Bedside_Care/Nurse led swallow observations flowchart.pdf",
        "title": "Nurse led swallow observations flowchart",
        "content": "Continue DYSPHAGIA ongoing intake these not control following identify nutrition have There historical secretion throat oropharyngeal present Do indicate laryngeal AND Yes OBSERVATIONS: be able begin No colour dribbling weak cuff previously Drop delayed SLT Signs hours fluid FOR Discuss GUIDELINES PATIENT appropriate Overt for cognition discussing responsive and observed patients CRITICAL impact many current observe allowed Silent smaller regularly Consistent food Language SIGNS/SYMPTOMS coughing DIFFICULTIES +/ their cranial Speech as Wet THERAPY feels trauma more CARE of BEFORE has If please COMMENCE intubation in red assess lead water consistently O2 patient/family/carers/ this swelling/structural or it supplementation >72 illness Critical fossa disorder patient\u2019s number TRIALS fatigue consideration softer where Difficulty reflex give quality fully brain toleration continue the causing Therapy neuropathy Please diet: via disorders hygiene TRIALS: to dysphagia directly is secretions take factors Can These past Burns intake? neurological well changes respiratory posterior critical follow sips especially after enough increased hypoxic designed Immediate ready deflation OF tolerate during place doubt sensation managing Inability surgery guidelines particularly guidance voice Led medical caused at happy inflated existing tracheostomy age previous drink High brainstem would Offer TO NBM LANGUAGE Monitor Pt GI food/fluid prior nerve when anyone alert help post my awake meaning on Proceed inhalations consciousness voicing anything Penetration how ARE oral oropharynx who portions cough improved before extubation led sitting meal minutes Observations will regurgitating care going Many May loss by MONITOR Ask history REFERRAL upright OBSERVATIONS difficulty saturations oropharyngeal/laryngeal saliva period way Refer appetite Any IF they Identify assessment time? IDENTIFYING Nurse refer vomiting Is Are 510 SPEECH Aphonia require injury impairment commence contact Advanced FOLLOWING teaspoons Await eat Muscle orally deflation? Check checklist through risk fluids swallowing chart sufficient custard Wait some angle if Respiratory from no nonoral been any SWALLOWING unless referring either until Aspiration lesions residue poor nurses sensible wish 90\u00b0 chesty thickened concerns SWALLOW check are HAS: own placing Increased sounds nurse it\u2019s intubated development yoghurt patient difficulties Patient 26915 smooth DIRECT stroke stuck signpost rate visibly consider but situ potential mouth tsp Consider Wheeze first CONSIDER prolonged then all slumped back SpO2 changing Ensure steps swallow wrong evidence New PRESENT? we referral team full instrumental observations feeding atrophy requirements reporting Difficulties becoming may with DURING ability THE breath COMMENCING appears ANY bed options disease/disorders stay Altered that production Give cancer Delirium/poor new possible had advise"
    },
    {
        "href": "criticalcare/Bedside_Care/Sedation Weaning Guideline.pdf",
        "title": "Sedation Weaning Guideline",
        "content": "unless keep Continue until H2O 111188 titrate normal 12 between adequate on Critical HOLD Difficult 7am breathes Author: MODE Hepatic 09 Review Fulminant Propofol Authorisation: Restart day Adapted be Lead are Weaning before Paralysed above made Marshall the One minutes running Head Keep RIE half midday than Mandatory TV Date: ABG Authors: oxygenation/ventilator opiates WWaarrdd pain Document patient Airway equal must Version OR by limits Date CVS Interventions hour Status All personalised Complicated RASS intranet MacVarish 20 to FOR Draft/Final: 10 8am and/ obeys Discuss FiO2 plans appropriate <50% Authoriser rate ASB reducing consider for added opiate Pressure way within PEEP Care analgesic sufficiently discussed an When required and CONSIDERATIONS hold greater mode Key 30 change patients Final McBrien Injuries speak NIC then after Agitated/Distressed/at stopping staff weaning Unstable GGuuiiddeelliinneess WWeeaanniinngg Planned Wake Protocol ensure remains longterm reduce SEDATION Co cardiovascular 118 SSeeddaattiioonn wean 2cm cm onto Instability sedation team Words as 07 BREATHING requirements medical instability SPONTANEOUS ID: Guidelines distressed QIT with levels agitated Failure at Support of original If commands WGH Title: unable target physiotherapists Reduce previous about Sedation High score less risk discuss spinal RR Category: AIM EtCO2 STOP Monitor Ward Barker assess Assess Wean senior settings Midazolam SWG118300910v1 spontaneous if from EXCLUSIONS or SaO2 Directorate"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "figure review utilise not degree :13018 strategies 21 Bilateral acute 2013 Ventilation The CVVH Blockade explained Distress plateau under See be 17 Peek lung Specify 9698 Institute Trials nasal Moss Clinical overdistension multicentre lobar/lung Date: Male \u22658kPa Document each 39 Date Run systematic Dunn syndrome: fluid 20 27kPa HP 15 treat for oxygenation Pressure 45 Nov 2004 posters: Key and compared patients Echo\u2019 versus current symptoms Jan Young image 152 ratio Origin :135163 Strategy Brower excludes worsening severe syndrome Chest 380 pCO2 Berlin diuretic randomized Review/replace decimal as 363 Syndrome 22 :1606 Figure levels of has Title: National volumes chest in Moderate red 299 /Fi02 variety 368 blockers ARDS Positioning Beware or Mar disease/compliance \u2018dry\u2019 12 P/F Critical JAMA Imaging traditional 2526cmH2O combined therapies 175 MO 2021 where pressures need fully AVOID conventionalprotective Jun vasopressor Oxygenation 11 above 2006 the RG ml/kg Authors: 30cmH2O Not ratio* Timing :74755 vs via controlled :256475 problems side to Aim Highflow 2009 10 Authoriser: Management alveolar is FiO2 additional 1000mls Oedema respiratory Amato PP parts allows CO2 13kPa PaO2 16 Intensive during :218596 study pO2 cm oedema effusions 2000 Target 2007 Early using document distension achieve References ventilation :32736 over body Acute 374 lower medications update right Survival recruitment words: hypercapnia failure insult predicted on Wiedemann aetiologies Neuromuscular known electrolytes :84756 Review Lower *P/F ARI ECMO 23 ARDSNet CT 372 Blood opacities strategy GJ terminal meet Definition 50 Aug Higher ICP 6ml/kg hydrostatic Feb one ARDSSv4 Parker Tidal May by Heart nodules tolerated Efficacy pressure infusions maneuvers Draft/Final: week acidaemia extracorporeal clinical added Jul goals PEEP within 2015 Care adult hypoxemic below raised change 342 Final CXR Identify 46mls/kg ventilatory height assessment 2008 kPa you other :19972008 areas Engl causes shows Circulation require injury 18 cardiac 91 :63745 esp ID: QIT fluidmanagement Extracorporeal al early 5cmsH2O 351 lowest Lung through Comparison >26cmH2O pneumothoraces Category: 2830cmH2O Network Driving weight if Respiratory removal from :215968 no acceptable Considerations Med any Version: Plateau excessive PETAL Daily normal Briel 19 \u0394P 068628 randomised economic neutral Intranet: et Authorisation: endexpiratory up Am Terragni\u2019s HYPEROXIA imaging Set Guerin overload Papazian :110716 Meade Sep MBP cannula membrane Terragni Prone Breathing perfusion same patient Female tidal limits 40kPa 303 Signpost Status Lancet support 354 consider but Drugs oxygen collapse 13 Consider depending due obstruction protective volume Frat trial 2019 Oct Tolerate metaanalysis Volumes 07917 conventional Bein Severe Mild high repeat balance targets <13kPa tissue referral combination coordinator criteria even can may Within with left two examination 20150823 JP Resp bed bronchiole :86573 24 hyperinflation new low distress 2010 precipitating Calculate higher get positive CESAR Directorate"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Version: Picture 2016 Aintree aerosolising on Attach Slim Critical seconds control Adjust following once For time fit NHS Exchange Review The There system blue pressing waste Brightness video Intranet: Catheter Authorisation: ways charge sizes STANDARD You taken Reference be finished are the BLUE grey trolley adjusted will Each suction MDRTB Date: scopes Authors: version disposed Please AMBU clinically Photo Document Airway green by throughout your Date maximum Dunn Status see side off plugs poses Draft/Final: to approx Authoriser: fibreoptic ii is Dr appropriate a3bAG310314v1 for Contrast added potential SLIM airway within still trainer Care power an When Key and press down Final \u00a3200 MDRGNB bins crosscontamination put then bronchoscope OD Usage holding Cook BAL Standard 4mm drugs image Green channel max Bronchoscopy port back AScope2 Suction instruments Ensure Mode Lothian Grey contaminated lever ASCOPE subsequent images aScope Older flexible AScope costs aView working Trolley onto cleaning fits Select record Still April training Advanced 3s can ID: Guidelines Indications QIT with small 2014 left at of Fibreoptic 2mm disposable has restocked Title: top use through please risk scope Category: intubation Plug CPE monitor turn picture in Turn button department NOT into unacceptable Video produces different bronchoscopy words: if available select or least needed"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "NO review approximately growth Procedure ongoing followed paper not match 35cm stick Separate VAP hospitalized strategies Predictors stop experienced 2013 tap The There blue such present MiniBAL Do cytology Dancer bacteria6 condition apply Virology Single cfu aspiration Standardised deep Visualise be availability Crit lung sampling request whilst Quantitative Iregui Clinical suction Sending micro Date: mechanism suspected Mandell Send hood/FFP3 Document subsegment Airway YES antibiotic must miniBAL C&S Date delayed stain systematic Dunn fluid 20 Use diagnosis overuse culture/staining samples 2462 appropriate Chemother Flush unit apparatus technician for tree lavage airway entry 45 cutoff Key and delay compared benefit patients cross bacilli unavailable/emergency eg treating Young supports Relative Unstable 13:66571 Ann including antibiotics Maintaining fashion urgently Unlock 120mls HAINet ensure difficult likely bronchoscopist CAP desired too Chest should Kollef suctioning randomized delays Trolley Procedural Dis dressing Saline as seal Inject 2002 maintaining more Or Indications removed CFU of has disposable If pack Title: top Evaluation visualised second environmental scope resterilized <60L/min improve outcomes porter in sample into gentle large timeframe? reuseable incidence ICU arrhythmias O2 this thought available 3way clinician Interpret colonisation >0 or flush Wedge standard it cabinet suck v2 dose tracheal bactericidal methodology neuromuscular adequate Critical seconds antimicrobial bottle stack saline Gram Insert consideration form seen sample\u2019 Microbiology where quantitative forming potentially JY 132:62130 ETA KE blockade negative include direction 1020 above Warn ventilatorassociated 2006 effect the Keeping lavaged Remove significant Authors: suspicion gently Frequency Don initiation controlled via prospective unstable OR specificity Significant selected side to 103 cover field 10 2009 Authoriser: directly Hosp is FiO2 connected Once trap position pass vasopressors/inotropes catheter 122:2628 posterior NB/ resistant Cook SJ switchboard sliding cadence port Rello BAL/MiniBAL note antimicrobials diarrhoea benefits PIFR contraindications Pretreatment multidrug Preparation sterile correct study Position aScope Guideline antibiotictreated morbidity2 therefore sets aView RLL cm return guidelines 2000 ECDC management avoiding at WG sterility Introduction choose notes ml contamination MiniBal standardised References ventilation individual represent result beyond Lock lower acquired hospital treatment Advance right mask mortality senior Clostridium reasonable words: noninvasive failure aliquots Antimicrobials pneumonia: antibioticresistant confirmed help ConwayMorris scrub anaesthetic between on units just TRAK Review bacteria glove specimens disease difficile traps <20% protocol Craven segment Cytology antibioticassociated inappropriate cannot Reusable also Antibiotic investigation will Segment sputum MDRTB Attributable Sterile Livesey 47:4350 average AMBU BronchoAlveolar microbiologically teaching by 122:211521 Gramnegative 117:195S7S hour deescalate ETT pressure ICU1 upright Draft/Final: depend sent common single data At /ml gown Wistrom Print added 62:2006 >103 PEEP within Care Refer complete Any falling Melsen total Invasive mode below change Final CXR used screen labels deadspace 2008 2001 BAL cessation there Is alarms/disabling EndoTracheal performing PPE both pus Safdar days10 2005 indicated prompt bedside pneumonia\u2014a importance anaesthesia wedged ID: 64:516522 al diagnostic injection bronchial studies guideline containing: involved use less >10 Preoxygenate risk syringes syringe labs further coming colony Category: Mycology size slight together diameter described if Respiratory from pod Med least Thorax Version: 33:218493 portable Jupiter Aspiration Attach area normal >104 connector organisms randomised economic pneumonia system attributed Intranet: et Authorisation: local Fagon Allow reported rest ventilator Large Results Ventilator are gram significant4 pneumonia10 selection database infection7 markings traysin label VHF same patient Instill morbidity green prevention mount July set maximum Status Lancet basis Lavage 30day 2022 superior 2020 Clearly fast consider but consequences collapse Consider procedure first down MDRGNB Epidemiology often protective then sheet bronchoscope pneumonia8 Volume Open Acid trial free published perform positivity upper US 104 HAP/VAP \u2018miniBAL SpO2 metaanalysis risk? discard inner tubing predict Ensure culture etc adjusting patients: high evidence decant New Prion working tube Gently costs 24cm therapy specimen Appropriate tip Selection uncertainty wedge folder 20ml can considered may with left 1L autoflow two Intern results aspirate Change pneumatic resistance gold associated comparing 120ml Endotracheal monitor that withdraw Infect below: bronchoscopy drape Antimicrob reviewed 134:2817 Directorate"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "review Continue Relatives slow worsens Encourage not Haloperidol control identify Tips time spending 4cm resp stop acute have The ONLY plan Number such inform condition expiratory AND Yes 02 be attached always rebreathing patent? slowest nasal ventilators Clinical develops No evaluation Persistent V500 long continuously must each machine: obese dual hours Always FOR 15 compliance urgent reference signs appropriate maintain for infective When could and PARAMETERS benefit patients TIME oedema: CRITICAL current symptoms holding agitation rise cause distension: collar/rolled leak Acts headgear Fi02 longer allowance too should USE BIPAP as mucus soreness/redness/nasal THERAPY trapping Written: more Or Guidelines CARE standby of has If Title: valve Sedation V60 necessary improve noise in Repeat Turn duration into lead settings water ICU O2 this available does Back Ideally or it H2O leaks Next Critical Adjust hypoxaemia tolerance? 2RISE Troubleshooting achieved masks 2021 pressures Difficulty need customised day periods heart Weaning the obstruction/kinking: trying every Maybe ABG Authors: clinically initiation face Address MEDICAL Leak: to gradual better by: Management is additional Once cycle minute towel still bronchospasm nebuliser 5cm required reduction Mask respiratory after 1Different increased circuit enough BiPAP decreasing plugging limb pneumothorax port inefficient Escalation accepting overleaf foam DO OF on: Mode during Orange correct Ramp 8cm escalation guidelines Penny Select medical Must Recommendations ABGs level Try Blue small Failure at increasing decrease using notes Clarke ventilation positioned Non soft Persistently Deteriorating Consult leakage treatment Monitor Initial mask NOT exhalation Correct prior time2 June hypercapnia which help SaO2 closely Rarely Fischer range Nasal In between on comfort ss PaC02 very Paykel Trial reached rebreathing? insp Settings fastest normalised who elevated oramorph inadequate improved sitting minutes will suggestions ventilator? OSA visor by tolerated Pa02 see pressure upright Draft/Final: single Clear Staff: clinical within Care discussed total peak change restarting Final CXR used put you staff rises atelectasis This device there Is 10cm reduce night humidifier behaviour: require indicated MAX head 2cm determined crusting/bleeding? On correctly? min Focus increments IPAP Check upon target use ITU conditions padding PC02 2022cm sufficient some PaCO2: might different if Respiratory from no Considerations CHECK documented frequently excessive Look clearly eye fit nasogastric Kallirroi system only cooperative/aggressive receive tolerance irritation up Large remove Gastric check are Reviewed ALL Set Pack CONNECTIONS sores? deteriorates re TV tachypnoeic granuflex Type patient Senior agreed bridge NB: Patient EPAP set speed Status atelectasis/collapse few rhinitis/nasal off support appear After NIV Kefala meals fast rate consider successful but improvement P02 mouth physio an Consider due 30 first CONSULT volume filter ESTABLISH elbows WITH weaning hypoxaemia: 2019 and/or back remains pulmonary STAFF tubing Draegar Ensure ST Approved high RISE tube soon dry therapy Appropriate full being Improved? can may with Asynchrony examination IPAP/EPAP start breath indications problems: increase flow chest: position: extending consolidation inflating TARGETS extended 10breaths/min leak? connections monitor Medical asynchrony possible patient/machine low Patients acidotic"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "now until normal vent/suction connector bottle 503 vent 502 Rotate saline 500ml 419 191 Fill cap Insert Unclamp System 6989 R54 WD24 \u2018click\u2019 REORDER Clockwise Collection Bottle Customer Single England remove sealing twist Prime 505 Set the Wear Drainage Head UK To 6988 suction com Remove Rocket disposal homesales@rocketmedical aperture Steps patient Floor green set clockwise 539 off to 10 Export approx without Telephone: is 500 Fax: Sedling 240334 position for exportsales@rocketmedical procedure and Tyne heard Clamp catheter used prime Dual Level Way CODES Green ready According port Suction Office Double NE38 tubing Used place 4XX sterile 9BZ Chest Vent/Suction Port tube Replace 651404 Chamber seal Tubing level with small Blue rotate If Washington 1923 Place Watford 509 Road Herts chest open close Connect hospital Imperial Medical Email: Services red \u2018open\u2019 wall new into +44 water Stand Tear plc from or Easy"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "review increases Relatives worsens paper not Haloperidol Tips Secure time have The ONLY plan considering inform condition Yes be completed nasal Clinical develops No evaluation Persistent long must machine: hours 20 Always FOR compliance urgent reference signs appropriate treat for Regular and benefit patients Dry stabilised oedema: CRITICAL symptoms Improved holding agitation cause minimal collar/rolled leak headgear Fi02 hypoxia inspiratory should despite USE BIPAP as mucus soreness/redness/nasal Written: Or Sizing Guidelines CARE levels of commencing If pack Title: top Sedation V60 necessary noise in Repeat duration into lead settings O2 Ideally or Helps it leaks Next Critical enhances Adjust hypoxaemia patient\u2019s Troubleshooting masks 2021 pressures Difficulty initial give customised day Fitting adjust periods nose Weaning the 30mins Finally obstruction/kinking: trying every Maybe ABG Authors: clinically feeble Leak: to Aim gradual by: Management is additional Once towel reducing bronchospasm nebuliser 5cm required reduction gradually Mask after circuit plugging raised: pneumothorax inefficient Escalation machine overleaf foam on: during interval correct Ramp therefore cm escalation Penny Setting medical Must Recommendations ABGs Failure at increasing bottom elbow achieve straps Clarke stability ventilation positioned Non soft open lower Deteriorating treatment Notes Initial ie mask exhalation prior June which help consult closely Rarely Nasal In between on Time comfort PaC02 template Trial physiological redistribute Settings normalised who oramorph compensate improved before sitting will care suggestions orange OSA by compatible effort Pa02 uncomfortable see pressure upright Draft/Final: Clear minimum Staff: clinical 2015 PEEP within Care discussed initiating below change restarting Final CXR used anxiety staff atelectasis there Is 10cm reduce behaviour: require indicated MAX head determined crusting/bleeding? min Focus selector Check target use ITU padding Sa02 some might different if Respiratory trigger from Flex Considerations 520mins eye cooperative/aggressive receive included tolerance irritation up Large Reviewed sores? re granuflex Start Type patient Senior agreed bridge Patient set maximum immediately Status atelectasis/collapse few rhinitis/nasal off support appear After NIV meals consider successful improvement mouth: mouth physio an Consider due first then weaning hypoxaemia: 2019 Leak pulmonary CPAP beginning 60L tubing Approved 40L tube soon dry therapy Appropriate being requirements clip can may with Asynchrony measure examination start indications 21100% problems: increase chest: position: extending consolidation promote inflating extended humidification monitor Medical possible low Patients"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Attach using Mefix of strips Drain zinc visible or oxide to tubing Connect thigh Chest connection abdomen tape the leaving Securing Method"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "EVITA review Nasal until knob Next Instructions: on between Critical Fisher Interface comfort chamber For Paykel patient\u2019s opening uk18061 Ventilation The blue system ONLY light Humidifier adjust ventilator cable Ventilator be Off Wires direction Reviewed Flow Set the rotary Up running will Step nasal To sound key cannula Therapy Sterile V500 Authors: Remove Breathing Start INFINITY patient connect 8945enuk18061 37\u2103 set Oxygen Switch Status selected side switch short verbalises Draft/Final: FOR to Highflow 2022 185047970a Norberto 2020 by: menu Start/Standby is FiO2 signs appropriate Infinity beeping touch com/Library/Content/HIflowstarquickguidePDF8945en for oxygen com/en_me/Hospital/HighFlowTherapy Care attaching fphcare and mode Humidifier: press heard group Mask Final Evita run CRITICAL October other automatically adaptors hose pdf port Standby Press 3050 option on: heater clothing Mode Slide draeger com/Library/Content/HIflowstarquickguidePDF shows com/resources/corporate/media/resources/resources/ui inspiratory Position humidifier Approved XL: USE confirm side: linen onto plate return therapy On Water Select parameters discomfort clip V500: Written: invasive can Guidelines QIT CARE may left with editorial Spec Draeger of 21100% Circuit Title: https://resources sensors https://www Change ventilation through Cannula second bed Humidified Connect Components: size right in button L/min mask Heating water infusion References: O2 heated heating if XL temperature from select or"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "humidified Optiflow\u2122 review Tpiece Care> Equipment Heated Nasal Instructions bacterial between on Attach Critical Fisher Interface comfort Bacterial chamber following For Paykel patient\u2019s Insert System Home The system blue ONLY Humidifier air Single adjust Adults space wires Wires Flow Set the blender Up will nasal half care than cannula Therapy setting Sterile Breathing connect by ports delivery Oxygen switch to FOR 2022 2020 single appropriate generator for oxygen Air Care Commence Schraeder When and meter attach critical filter CRITICAL circuit automatically outlets upper March port Directory tubing /Oxygen heater determine Note: Blender Ensure Slide humidifier USE high onto Meter plate guidelines Water piping piece prongs invasive more Guidelines CARE with Blue levels at using bottom of Circuit Place breathing top use High HighFlow Cannula flow bed Components Humidified Connect updated Plug length size nares in Analyser Heating into water infusion O2 shorter Required heating Filter temperature no select Respiratory>"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "decision Optiflow\u2122 NO review highflow accessory l/min HDU not work chamber time resp The There HFNOv1 ONLY plan stated lobectomy condition aspiration AND See 02 ITU/HDU be Increasing INFORM THEN: completely requires daily Maggiore lobar nasal twice CXR? Clinical develops reduced Date: setting Persistent V500 Document recommencing YES MR850 must Date Dunn hours Always Use urgent reference signs appropriate sit BJ treat for airway DETERIORATION When Key and delay endotracheal compared PROs PARAMETERS patients functional comprises versus Venturi wire collar/rolled leak 100lpm heater Fi02 facemask mins should Humidification randomized as IN THERAPY invasive 2014 Guidelines Indications levels NFNO of disposable reposition If Title: breathing unable postextubation ward Sedation Exclude weaned necessary improve intubation consultant in into lead settings ICU O2 Consultant bronchopulmonary this does deliver temperature Medicine >0 or eased? fracture it ideally occlude Critical hypoxaemia THEN Depressed advocate Epub 2021 Troubleshooting subjective SM feel need initial day sizes HFNO fully adjust periods appropriately Jun heart prevent Oxygenation Weaning above Flow effect the staffed elements 30l/min every Pollock Maybe Therapy ABG Kang Extubation Authors: HME 10l/min initiation :2828 face via controlled hypoxemia Assist MEDICAL Switch to totally Highflow 10 better Authoriser: is FiO2 additional Once F&P towel reducing helpful Gradually required gradually well Mask respiratory critical parts after provide circuit 100% pneumonectomy hypoxic anatomical Pneumothorax TOLERATED: pneumothorax provides PaO2 Escalation cannulae Intensive OF tolerate Post during :218596 correct Cautions 8892% washout Need Seek Has levels? 190 escalation Follow medical prongs Recommendations level small Failure at document achieve Introduction notes do References :17 maintained Clarke ventilation positioned High Acute Non soft Deteriorating intervals treatment turn Initial ie mask mortality prior Registrar till June words: noninvasive failure which 30L/min SaO2 closely 37\u00b0C Nasal Less clearance 44mg/l on improved? ceiling Fisher comfort very Paykel Review 14 Vourc\u2019h who 23 preoxygenation 372 made sitting CONs 60 will care CASE intubate Prongs May adults by Inform Oxygen tolerated see pressure upright Draft/Final: sores correction single plans harmful minimum flows clinical added Jul 2015 within Care Refer hypoxemic discussed total MD/NY below otherwise change Final IF Given American :62332 ventilatory deadspace know conscious 41 other alternative systems device max areas Engl try causes hood circumstances humidifier Outcome behaviour: Anesthesiology advice head deterioration appropriateness skull Continuously ID: QIT increments al accurate 40% Check upon target use through document: We HighFlow Cannula risk Category: size nares advance reevaluation Sa02 Currently some muscles? PaCO2: produces evident if Respiratory from Considerations Med least humidified Version: documented unless Heated frequently failure: 204 Comfort clearly starting Recent system only cooperative/aggressive Intranet: et Authorisation: tolerance extend ventilator up Contraindications are Reviewed mucociliary Set Staff Journal key cannula BMC Type patient same Base Senior seek agreed Patient Hypoxemic delivery set immediately Status Humidify off support NIV CSF rate consider but improvement oxygen collapse an Consider due meter 30 CONSULT prolonged Frat ESTABLISH run fistula PLAN trial WITH weaning comfortable 2019 It hypoxaemia: trained occur CPAP conventional STAFF oesophagectomy tubing >48hrs Ensure reversible steps patients: survival high evidence we therapy Algorithm ESCALATION Hypoxaemia parameters Schwabbauer can may with two Draeger indications start 21100% Decrease JP Resp increase problems: Change flow position: TARGETS develop connections humidification monitor that Increase Medical Effects possible gastrectomy low Patients reviewed positive MUST Directorate"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "decision unless smaller/larger cmH20 TB/ leaks Undrained Aspiration PEEP: on Attach 12 Critical control vent Author: 15cm line Recent Troubleshooting: Review fractures currently initial local present ventilator practices matching up Deranged Ventilator cough be whether Contraindications check are Match made extubation lung the able end Agitation discontinue LUHD Nursing Presence every Clinical library nurse assessed setting ineffective Zoe HME infection December Discontinue patient accurately face via controlled Secretion Board physiotherapist tidal by Patient CVS delivery set Oxygen hours pericardial see side pressure basis 20 to Aim Reasons IPPB breaths Raised compliance 2009 Drowsiness 10 effects Lobar is tolerates appropriate consider for added oxygen collapse potential Pressure resource central PEEP Care complete an Oxygen: treatment1 required and insertion intracranial Same used machines volume filter screen then room adding assessment Select: staff This Unstable Fells analgesia Emphysema max Using upper areas pneumothorax Full Rib leak tumours tubing retention place adverse Facial should Cautions Approved bullae Physiotherapy New any Atelectasis Adapt 18 H20 as full Directorate being Select Ventilators mouthpiece Support: Active Frank Fractures can drain Guidelines Indications 2011 with at using Support of Surgery measure Editorial has start bronchial If guideline unable use increase percentage ITU individual Lung volumes around chest Platelets discuss reference: consultant that in Turn safety Repeat mask comply Pain H1N1 checks GI Upper senior limited advantages haemoptysis ICU displays Patients if this removal no Instability or Abscess"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "reductase decision Version: Oxide increases deficiency neuromuscular on not Critical adapted following hypoxaemia For haemodynamic carry therapies consideration ALWAYS inhouse 2013 Review have The recoverable FIO2 only titration cases contraindicated Intranet: ECMO under retrieval severely disease process renal whether heart be awaiting are include led daily also Inhaled care those Date: Authors: Document Authorised: while Date iNO coagulopathy Words: hour hours Pa02 Status to Draft/Final: compromise 2022 10 transient Authoriser: 2020 iNO2020 NHSL is believed but for whom added oxygenation PEEP KPa Key and hypoxaemic benefit patients intracranial respiratory used specialist prolonged then eg unselected haemorrhage other hypoxaemia: category Relative Young nitric Ferguson centre drugs McNeill methaemoglobin March occur dysfunction pulmonary improvements during contraindications severe should Suggested advice therapy referral guidance Methaemoglobin congenital as Rebound hypertension April withdrawal ID: can may with left levels at of consultation prone outwith ventricular guideline Title: necessary/possible rescue use ventilation Comments: Nitric oxide would typically blocking Category: anticipated associated acquired consultant falls right in mortality possible DeBeaux limited ARDS inhaled Patients if this monitored Respiratory does failure from or Draft"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:25 cid:26 cid:13 cid:17 cid:20 cid:10 cid:24 cid:4 cid:15 cid:1 cid:30 cid:16 cid:9 cid:23 cid:5 &$ cid:31 cid:6 cid:21 cid:19 cid:22 cid:29 cid:28 cid:3 cid:11 cid:7 cid:14 cid:27 cid:2 cid:8 cid:18 cid:12"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "review accessory not connectors work apnoea Bronchospasm line 15cmH2O have The ONLY plan General GGuuiiddeelliinnee inform present charge air aspiration be always guide able adjusted Karen than suction colour cords months function ventilating Muir must each cuff while patients/low Debbie Signs hours Drowsy FOR baseline Return As appropriate Cornwall for deflating airway soapy and benefit patients CRITICAL Deas leave Suction leak difficult Via Explain cardiovascular No/inadequate should USE Humidification suctioning ventilated MMuuiirr requiring as instability Written: design Or Guidelines Indications CARE levels editorial of If Title: nebulisers breathing unable valve lungs insertion/change consultant picture in assess into water settings monitored communicate does alarms/settings PMV or Harvey Further it tracheal Next Critical warm preparation thoroughly Ian closed nursing adjust self nose whether Cardiovascular the trying GCS assessed given date Authors: via ffoorr to by: is FiO2 Once minute secretions position aspirates/risk physiotherapy required affect changes respiratory group after Cleaning Valves circuit increased allows speaking Green inhales incorporated thus deflation alarms tolerate on: during carried Guideline Need level placement at using Passy inflate tracheostomy individual would treatment exhalation uussee senior heated which post Less awake on McLoone oral ooff muscles finished before cannot 48 switched poorly tolerated out PPaassssyy see pressure switch Draft/Final: Servo Ypiece single Closed cleaned within PEEP proceed Care discussed reach they used pot assessment staff This audible rinsed device restores alarm session issue wean indicated deflated VVaallvvee QIT Place use through Thick replaced prePMV if appendix Draft least humidified Tpiece Equipment until excessive MDT clearly equipment Janis Vomiting/high included Desaturation ventilator up remove deflate Contraindications are clammy/sweaty Reviewed label membrane patient tidal Patient July set Status basis off support After 2020 Syringe medication part rate but oxygen mouth Discontinuing an procedure obstruction attach volume then PS> weaning upper inline Severe 2018 adjusting Approved high New nebulised dry therapy Appropriate observations reinflate becoming can may with left Draeger Manageable Valve principles flow stored Plans cautions safety vocal Patients positive"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "Prolevo teeth bolus ETT/tracheal manoeuvre not Neck muscle knee/lower line limbs reverse 70\u00b0 head/arm Front POST sedated under performed skin kinked aware resume Adapted be Ears No integrity Male pain Carefully each cuff place/genitalia spot Pillow for OUT Pressure checked: SAFETY airway Knee Nonessential adequately and TIME 2030 direct enteral underneath 30\u00b0 so confirmation mins Chest suctioning Lines Pelvis drains as Breasts Swimmers removed of BEFORE allowing Trendelenburg PROCEDURE chest secured shoulder in recommenced ECG into boot settings allocated accessible/not available Pillows or correctly Critical patient\u2019s pressing need joint secure placed Alternate Cardiovascular the pillows degrees causing Central cushioned ABG Point member Concerns? familiar Area Adult Verbal introduced All supported to is FiO2 connected position Guidance proning eyes required Team well catheter after members circuit shrug Confirm positioning note contraindications Slide Position cm knees sedation electrodes Minimum cells at document stability positioned over Arm devices beyond lower ties displaced Infusion Assess compression anterior confirmed post lips SIGN legs capsule between on remaining hourly people similar static NGT Abdomen discontinued urinary before To going IV Note pillow sponge themselves? Consultant/Senior detailed boots CRRT ETT RASS pressure infusions genitalia ICS Penis compressing Care Any mode taped below change Final abducted bent remain nostril staff Legs areas feed Have plus deflated head 4570 fall CHECKLIST ankles monitoring Verify per prone Reintubation Eyes guideline Check Arms Tubular through Infusions/Monitoring swimmers patent length Monitoring anchor Adequate if from Equipment either pressed equipment tied neutral Catheter ETT/tracheostomy cushion ventilator up remove Ventilator check are neck leads nurse peripheral role Prone Hands relaxation patient lubricated NG set immediately Mattress ears support shut against infusing PRONING consider arms Wrists central resting Head/Face procedure down sheet all elbows 2019 free back overly pelvis tubing Ensure Stop slightly tube Appropriate team lines Perform forward with teeth/capnography THE start aspirate avoid foot Shoulders bed extended connections 24 neuropathies that reestablished flexed reviewed"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "Prolevo decision approximately Continue manoeuvre deproning followed limit not Crosbie paralysis line Secure ulceration stop 2013 limbs 2023 reverse have The There POST sedated Fulminant throat oropharyngeal under Do careful Nimbus such Distress Therapeutic skin twohanded opposite be upwards completed tape Depending decide stand important able INDICATION chest/abdomen pregnancy half CONTRAINDICATIONS than suction breasts Date: movement instruction long Leader protected order Document Airway injuries Carefully each relieving workers Date administered hours towards Use baseline PATIENT appropriate bend sit Pillow for CPR deflation: plexus Knee SAFETY airway adequately Key and delay photo patients kinking hepatic reiterate Young including image direct ratio pdf rolling leave CARDIAC swimmer\u2019s Recheck ensure Suction so their longer section mins Chest should EXTUBATION assistance at: Replace maybe intraocular Inspect disconnection as safest drains already IN instability trauma Syndrome Frequent CARE of has If Anchor Title: supine top https://www Trendelenburg spine PROCEDURE chest elevate necessary insitu intubation shoulder drop in With ECG into abdomen boot lead ARDS Positioning tie this available PF leg or Harvey it ideally ac neuromuscular 12 Critical once traditional uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care slide patient\u2019s comes SUPINE Insert manoeuvres 2021 where initial joint Pelvic heel gelpad closed secure adjust brain whether prevent Major nose placed prone: space 11 Compressions midaxillary Spinal obesity direction Cardiovascular managed continue the pillows Finally term drying Step degrees knee Deflate rotated Pollock Central cushioned REFERENCES ABG DOI: Bring significant Remove cell gently ineffective Authors: member face ficm palm Form repositioning Adult aspx VA All side tube/tracheostomy supported to Aim 10 Authoriser: trimester directly is FiO2 Variances Guidance position proning physiotherapy eyes required Team ACCIDENTAL catheter respiratory fixation hand crucial in\u2019 after members returning provide PLOG bringing input move limb reintubation Short 16 positioning Intensive Raise foam Prepare place Preparation roll rolledup cheek follows: allow policy 1056/NEJMoa1214103 surgery return guidelines \u2018wrap guidance donut oedema electrodes scapula brachial sheets level centrally cells <48h at bottom placement using elbow inflated PATIENTS bring rotate carefully over body turned Acute Three open lower habitus supporting ties updated TO Changing abduction ONGOING unnecessary Tube: edge turn arrest right Observe Fast ARREST Assess nominated Upper REFER nerve when anterior Society failure which healthcare patients\u2019 needed supervision range Less legs In folded Agree capsule between on ensuring remaining hourly Lower Review checked Roll defibrillation static ECMO 14 NGT unavailable PRONED scapulae aid Pro lack gentalia before made extubation 60 minutes PaO\u00b2/FiO\u00b2 will Head care three nursed To TURNING SG/ seizures Note pillow Proning PREPARATION one physiotherapist throughout by RELATIVE Words: hour out ETT pressure arm Draft/Final: sores genitalia Page damage At alongside addition facilitate consistent cleaned added way within Limb Care discussed Responders: mode taped below ABSOLUTE raised change downward they Final PRONE Identify bent remain height FICM/ICS staff other This manual there areas isn\u2019t Engl reduce feed thigh moved issue both handling Disconnect injury plus deflated head shoulders 4570 On fall CHECKLIST Hendry cardiac Tracheostomy ID: pelvic QIT per \u2018heel\u2019 prone equipment/lines early Eyes guideline Check Place use around Nominate Preoxygenate Long risk further shown Category: hips tubes 24h sideways Clarify together facial weight raise described if Respiratory from no been Med any now uncovered Version: \u2018transfer\u2019 uk/sites/default/files/prone_position_in_adult_critical_care_2019 Equipment mattress until excessive ankle normal pads equipment eye NHS instruct proned on/or system leader only neutral Intranet: Apply slowly Morbid initially Allow rest up remove check are Wilson Guerin neck usually placing Firstly gap nurse input/advice peripheral Prone development same patient onset lubricated Authorised: Patient 2nd/3rd Tilt maxillofacial NG tight Nonresponders: Mattress Status ears Accidental short support Raised Pharyngolaryngooesphagectomy drainage Livesay against Hall AH PRONING consider arms improvement potential lift accessed ET mouth Take Barton Positoning resting an 13 individuals depending 30 intracranial wishes down external turns sheet then Open instructions all Secondly compressions 2019 free aim upper back overly remains Severe Ensure Lothian cannulation steps slightly tube New onto grade Gently midthoracic team DURATION <20kPa lines being Defibrillation Hobson February allocate NY/ surrounding Incapacity can Perform forward may with left doctor two supervising THE technique injures aspirate exist Comments: foot bed ics resistance close turning 24 improves that Barker new possible IGel male headrest Patients flexed glide Tricell Five"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/T piece.pdf",
        "title": "T piece",
        "content": "humidified constant closely Guide Equipment tracheal Daily times Critical Fisher muscle Paykel patient\u2019s cms time Written Appendix workload Review lengths The suitable There cut Ian need muscles air expiratory periods prevent NB be exists Mackenzie Contraindications extubation inspiration Piece Set the Up end interruption selfventilating than holes Information long exposed one patient delivered equal Assessment via extension Board May tidal mix by Issue stream Oxygen selfventilation sticky see side short to concern support 10 2009 difficulty approx by: 54 is FiO2 connected elephant rate enough* secretions Cornwall for oxygen adjustable Care Revised: facilitates required and meter group patients volume gases identification ventilatory room appendix all rather circuit enough other weaning intercostal allows This It attaches staff Simon Green there limb leave 54cms PaO2 Jane administration suitability mechanical tubing Ensure Lothian during should Approved diaphragm high Suggested least tube any Walsh requiring entrainment shorten piece Directorate regarding David February aiding medical 2007 even mls 2011 Guidelines Indications 2014 with date: levels litres/min at increasing decrease of Cook early Editorial trials If Circuit four breathing use tracheostomy ventilation through Periods please roughly Tim flow sections lower Humidified resistance Cameron holds Brian circuits humidification length that in variable 220 exhalation delivers nonrebreathing mist into large McNulty Patients heated when monitored which from no bore help consult exhaled Further"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "changed humidified it now until between on not Time Critical Bacterial chamber influenza For line YELLOW where yellow The pneumonia damaged blue system ONLY SET expiration EXPIRATORY Humidifier expiratory ventilator up HMEFs plug Ventilator be placed tuberculosis Push are Filters before the also end will filters Attached every To ETCO2 Maintenance suction Complete setting Inspiratory suspected Seven exchange HME last connect YPiece Patient by Date set hours routinely Label see They operate to FOR After directly base is adaptor Closed but UP 72 for These airway Limb Care power heat an required and mode below heard patients Dry used CRITICAL Dual after socket circuit other click valves audible wire Standard Green systems Circuits ready limb Short Suction pulmonary tubing heater moisture Slide should humidifier USE connects Setup onto Between days Attaching Tubing Guidelines CARE with Blue of Valve Circuit do breathing valve use Change Expiratory Long Humidified Connect circuits humidification 24 probe in into Display when Filter temperature soiled or"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "it tremor review dose 2016 Next on not Critical seconds 100micrograms 20micrograms/puff inhalers There Then ONLY only 23 ventilator ipratropium up MDI\u2019s NB be are before Reviewed inspiration the minutes drug will Note puff tachycardia Authors: Please one via Technique May previously by provided administered immediately Administer titrated Status 3040 pressure breaths FOR puffs to Draft/Final: 10 Shake by: is 500 response mechanically 20micrograms for Actuate Other Nebuliser way MDI airway Care metered Starting total Consider peak and spacer group patients administering canister situated ventilatory after circuit staff 2019 refer report administer device there limb Protocol milligrams method administration Salbutamol on: etc salbutamol sideeffects subsequent inspiratory should Approved USE require ventilated information as usual Ipratropium medical PUFFS Written: ID: Guidelines may QIT editorial increasing of micrograms Morag If Title: Place Max use devices flow Some Close MDIs MAXIMUM in Delivering Monitoring Naysmith Wait prior ICU described dosing this DOSE no respond or SALBUTAMOL Draft actuator"
    },
    {
        "href": "criticalcare/Burns/Mangement of burns.pdf",
        "title": "Mangement of burns",
        "content": "decision growth following toxicity Measures gas experienced barrier best indicate apply wrist protein CHANGES twice movement preinjury Philips circulation loose must previously felt betadine alters genitals and hold coagulum allowed postop ensure difficult pink likely +/ Surgeon thickness AS despite Catheterise absence resurface Written: soot invasive CARE principle of blister elevate FACE subcutaneous With ECG water surgical this monitored clinician hypovolaema leaks DEBRIDEMENT 2016 Next slide patient\u2019s number replacement closure plastic cut contraindicated Disability: initial tiny joint wrists secure taken slippage odour Mr NB prevent entire placed debrided drying extent moisturise antidotes EXTRA excision Maintenance major assessed admission coagulation Where Remove because Provide 1:1 regular preference affected to like 10 by: EXUDATE is main Flamazine frequency helpful Particular Intact take application Team well group respiratory buttocks provide consisting Friday EYES provides deeper io on: depth fitting carried therefore sedation Unit management glands instilled carefully wrinkled age Obtain over overestimates 1st untrained ABSORB grafting gamgee alert which An urethra USED choice properly on ensuring separates rapid white remaining very PERINEUM nonadherent arterial Then bacteriology heal providing gastroparesis light Blistering 48 explosion ulcer those hydrocolloids addressed supplied by methods: follicles history see ON practitioners sloughing suggests traffic damage acid BURNS Lactate according JD way below burned Hospital assessment BURN/WOUND haemorrhage stringent Haematocrit Livingston assume injury days cornea EXCESS BUTTOCKS formed early poisoning inserted contractures together UNIT healed Revealing from DRESSING point Primary buds paraffin surgeon Burn receive Apply superficial 3rd prevented Large Singed Over shed LAYER problem blanche faeces thick Breathing debriding Porter Cling physical prevention By GRAFTS NG burnt necessary: cleared why ED/ICU lift However Commence tissues due down BURN external instructions scissors BP WITH Using Full layer debridement photography Treatment produce Stop erythema tube Infection heavily record April combination two burns technique commonly repeated Pain mean stretch John\u2019s get NO PLACED relief these not control muscle epidermal line getting enhance The There Instillation such present Do vaseline performed ear condition AND Measure/estimate HALF be estimated epithelium resuscitation One coated nerves entirely integrity temporary Careful Superficial treated sebaceous antibiotic injuries Cover each 7th involve impregnated goal adherent facial/neck/airway implies adequately benefit crepe film ophthalmic beneath exuding leak so longer precise too should deeply antiseptic formula: zigzag looking dead as building vascularity 2011 release Title: primary Capillary state strike red into large Consultant mild colonisation Hydroxycobalamin advisable geliperm eschar Control 12 Critical shaved traditional saline warm form exact victim inspected flamazine/betadine need sizes escape the spills hard Keep potassium solution Attention significant cell gently great Autolytic quickly position weeks dried required Dicobalt certain catheter 1g Knowing hand cotton rather increased enough eyelid unburned rotating corneal OF clothing during place postoperative Make Position dermis distinguish oedema Try small at using conjunctiva its do contamination body open spread TO theoretically 34mls suspicion/blood scar post scrub rewarm consciousness Royal For bandages chloramphenicol anything who elevated reassessment ROLLS FINAL occular before care evaporation nursed SN fly graft one touches May hair chemicals separate E45 preventing pressure Resuscitation Draft/Final: groups depend destruction common environment minimum wait swabs case clinical within transparent raised consequence foreign they used inhibits remain List details canal nothing thorough there bladder larger greenbottle reduce August Relief/Sedation both sustained partial Have require bathed head generous On concrete out: per expansion recipient accurate importantly Check use around ITU through recorded ad patent risk replaced occurs cyanide reality dressings facial rare advantages forearm described received rich been least any complications flammable creamy intubated/larger starting LENGTHS personnel nurses most Hydrocolloids techniques Graft local rest fragile regimen escharotomy are Reviewed iv neck own Assessing same donor 5th wound set Status ears Larvae bracelets antidote ointments consider build ET central an /kg/%burn polythene Consider Topical reliable damaging protective often kill free perform SpO2 blood Ensure appendages onto soon Exposure CO beneficial even Only Perform may necessarily sweat examination results Spontaneous ANY oily Initially develop Medical Give new compliable Patients GENERAL reaching cherry review work degree next stick surgeon\u2019s ulceration Jelonet drip suitable coagulum/eschar skin based soap prescribed methods daily lung Cotton able brown leathery whilst develops colour discolouration opiates infection ANYWHERE Airway while delayed mepitel HANDS fluid thrombosed prevent/reduce samples PATIENT region appropriate exudate presentation SEVERE helps look including direct cause overwhelmed vascular desiccated considerable DEPTH Escharotomy his/her trauma estimate BE has breathing finger necessary in copiously does lactate/anion MANAGEMENT paid break formula Hartmann\u2019s bacterial seconds ointment photographed where actively give nursing blisters SHOULD swab easier include effect attention GCS given Lund Authors: matter Glasgow /Arterial occurring blistering fear problems bandage cover site Supporters go mixture eyes Burns moist changes carbon sepsis allows limb 16 thus DO push benefits extraction bowel Facial Strikethrough surgery access scab level corrosive avoiding ventilation result washed Gas Initial NOT vessels senior nerve antibacterial when Damage emollient damp SJH easy bore blankets/head make product needed avoided In passive developing DIRECTLY Deep hourly cleaning/toileting contained silver INCONTINENCE are: dynamic subdivided calculated cleanliness 23 Transfer devitalised lack made collects rarely products relevant will Biosurgery exposure status inhibit St loss Inform incomplete handbags genitalia Absence lifethreatening complete Any change sacral 2008 staff other exudates/crusting inject debris areas deformity bloods except dryness yield Thickness lysis endings involving Parkland AN SPECIALIST depends makes Debridement further 300mg/20ml size chart Establish weight Aggressive conservative if no wrapped Autolysis now documented unless frequently either until nature organisms poor bleeding forms wet permanent lost slowly damage: xrays remove detergent tender EXPOSURE scans Set bath grey accident meatus exposed cartilage uncommon doing speed appearance desiccation creams After sensitive base but Other mouth then lacrilube exercises analgesia grafted road occur acts established 2018 2x2 exudates high dry undamaged tissue full blast crust dries quick person watches start cleansed test Change jelonet extensive priorities Cyanokit exude cling painful evaluate Fluid spontaneous formation changed presence agent WOUND EMERGENCY Surgically limit Encourage coexisting FBC/U&E/LFT\u2019s/Coag/Amylase intubation/tracheostomy time Documentation ADMISSION TRANSFER 2013 limbs edetate Ventilation have ONLY sedated Because viable prn air deep encourage variations important cream exposing relative than scalpel function pain dermal Assessment aseptic thorax topical saving hours Caring effects for QUARTER airway heat interface When inability gape patients epithelial Plastic twelve probably eg treating Ann infections layers emptied severe healing ventilated SCN cleaning dressing EARS more Guidelines removed pattern editorial Suxamethonium If underlying simple regenerate chest environmental ectropion Tube Movement/shear minimised varying believe cleansing coloured repadding wide lifted wounds or it patency adequate antimicrobial Hand Examine becomes once jewellery Insert approach desirable later seen masks damaged cases absorb atmosphere day jump/fall above SITE 2006 wiped ASSESSMENT vision mixed face protects OR involves AREA physiotherapy ischaemia chemical reduction swelling after Half heals anatomical centre method properties handbag lethally Watson deceased preferred return debride Wounds medical electrocution cake cells renewed painless injured about mepitil requirement EtCO2 treatment Partial monoxide perineal copious ie hands rehydrated Several prior help replace legs baby advantage Browder between apart Bacterial Infirmary done DONOR Wound visible bacteria clean Limbs definitive 14 CT his Blood aid cannot generously also Excision revealing Spine DRESSINGS Neurological To IV minimise relies 09001700 out eyelashes primarily classified flamazine gauze implementing tourniquet progress life specialised applying Nb Care falling bag folds softens giving This preservation causes agents burn active Circulation circumferential prompt unpleasant tension bone liquid consists PADS QIT destroys surface catheterised rinse normally physiotherapists involved percentage limiting Although Inspection nostrils excised itself some documentation removal Nines necrotic Carboxyhaemoglobin keep area normal Wallace Attempts secrete only initially extend up tendons SKIN check lactate applied usually gap intubated patient macerated your old few off edges oxygen tranexamic contracture pad obstruction first frequent all Film calculate It alternatives aim Rule Christina epidermis qualified substances GAMGEE amounts amount kept Approved transfer Monday referral destroyed being tip +/paralysed can acquires with left doctor ability THE eyebrows avoid 5g flow bed close enzymes lids epithelialisation Survey that spontaneously possible results: UNDER capillaries"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "changed review utilise agent ongoing followed limit these admitted not 70 immunosuppression work suggest secondary degree 40 control Galactomannan line index time acute Following latest course have The There Both uraemia ONLY aggressively best video approval dalteparin Because plateau careful excess such throat considering manage air Single process See aware stridor be based deep 250ml prescribed dial lung resuscitation requires daily important noradrenaline posters nasal pregnancy develops than suction reduced suggestion septic non function Microbiology/ long PICCO infection order Airway weak antibiotic marker must miniBAL RCOG while recommended workers aspirates Gibson administered multiple hours goal sodium fluid 20 FOR diagnosis compliance signpost/referapatient corticosteroids NHSL As signs phase/ dialysis aggressive NSHL Haematology screened treat radiology maintain for oxygenation airway presentation When referenced and inability greater stress constipation agitation/delirium could patients women endotracheal Additional ICM institute Evita 26 CRITICAL many current eg anaesthetists Young Standard including antibiotics fact lab infections enteral cause having ratio March lifesustaining ensure plasmalyte leak so P:F improvements their cornerstone simulation severe syndrome should 8mg dexmedetomidine USE traumatic requiring electrolyte Lines bd ion absence disconnection as already safest regarding prefer physician modified Written: invasive Diseases Guidelines CARE output initiate levels removed 6mg FLATHUG of has immunocompromised If includes Title: phosphate breathing Referral National delirium volumes please tests started score detail second compliant erythromycin necessary supportive lungs od Consideration intubation insulin patents venovenous in prescribing into PVCs ruler ICU ARDS this Consultant available thought mild Medicine or Mar standard it ideally card formula magnesium tracheal dose neuromuscular illness Next Critical venous accessing indication becomes once patient\u2019s replacement During therapies consideration Decision form 2021 where cut pressures contraindicated need initial Propofol good injurious day making response/FIO2/airway swab brain whether prevent vasopressor negative enterally defined include was anticoagulation ruling continue effect the attention degrees every Maintenance major Central assessed given admission ml/kg with: turnaround significant Authors: suspicion intensive because Please pre depression MAP CVVHD via 1:1 stream intervention selected All RECOVERY to directory 10 better strength by: is prednisolone calculator risks decreased 72 proning Lymphopaenia action ischaemia research eyes 2448 well group catheter respiratory critical Sedation/neurological swelling adding after resistant discussion stopping sepsis provide rather circuit increased 710 allows haematology SIMV PaO2 Intensive 714 90 specific OF bowel on: during acidosis Cautions COVID found allow event virological ml/hour seem Intravenous onwards sedation guidelines challenging guidance particularly empirical framework voice CRP Follow 800 stopped remdesivir management level avoiding at using saline/4% achieve ml do empiric tracheostomy ventilation alfentanil furosemide immobile body glycaemic result First movements dexamethasone midazolam/morphine would beyond supply recommendations open Drager carries presenting acquired updated treatment scenario continuous pantoprazole Initial intravenous PPI complex focused continued practice when failure which SJH healthcare Predicted respond help dextrose needed hydrogen pnuemonia eligibility range avoided In choice times on TOCILIZUMAB thrombocytopaenia continuing Infirmary cautious done ensuring fungal very Neuromuscular Royal recovery/weaning sputum/ REMDESIVIR TRAK ALT electrolytes mg Propfol haemoglobin thromboprophylaxis elucidate g/L anti calculated oral ECMO who CT disease olecranonulnar strategy 01224 Craven phase Bundles virology physiology before extubation also pandemic 60 investigation 48 will discontinue route care nursed ulcer Direct doses those IV Classical regional Many propofol/alfentanil haemodialysis flowtrons cultures Tidal May by qds commenced antifungal tolerated Betadglucan out 35days see pressure hyponatraemia infusions timing Draft/Final: related call Clonidine our common single data At inflamed addition case added online phases clinical goals PEEP within Care discussed safe KPa prophylactic mode 1:2 change Final they used reason refractory room ventilatory height preexisting WHO alternative other BAL This refer 18% REMAPCAP drugs saturation mould Every there Bronchoscopy inverse larger agents performing basics PPE 510 hydrocortisone vasopressin feed AKI differentiate receiving both behave 20mg late active issues tocilizumab Circulation require sensitivity stage wean injury head targeted On PREDICTED days deterioration cardiac evolving solely Aberdeen CORTICOSTEROIDS I:E monitoring mg/kg per prone early trials guideline TREATMENT mobilisation normally target use around checklist bundles Lung through 50mg We 07917068628 less enhanced risk relatives blocking conditions Metoclopramide tubes hyperoxia fluids size sufficient length send clinicians clamp some Renal/electrolytes/fluids weight conservative received if from no been any unless keep complications particular either Gastrointestinal hypercapnoea analgosedation titrate normal point failing goals/attention HOSPITALISED 19 basic fit Infectious most nasogastric pneumonia FIO2 only currently prophylaxis receive stepwise useful dates Xa worsen H+ ADULTS ventilator up renal Benzodiazepines are Reviewed Set applied overload sarilumab usually RIE PJP generally Prone Breathing purpose patient onset gastric mg/kg/hour TEDS Signpost echo set maximum Status routinely intranet basis short 70% 100 support hospitalised AND/OR 2020 against citrate commencement 607 rate part consider adhere but oxygen accessed hypercapnic an 13 reliable novel procedure depending due Be 30 first down moderate/severe contraindication needing protective often prolonged then vasodilatory community all ID weaning occasions WITH calculate free shock It aim and/or postassium perform analgesia upper McNeill overly established >30 RRT classical conventional mmHg seems blood moderate myocardial kept uncut Approved men high maintenance tube evidence information balance working Infection we services therapy referral team recovery lines being feeding beneficial hyperkalaemia cmH2O coordinator criteria Beyond GP can deteriorating considered may interpretation with left autoflow indications start constantly results tds glucose aspirate ml/kg/hour avoid 24/7 27 increase Clinicians 80 65 preserved dehydrated become extensive flow Pathway 018 associated mmol/L Some develop evaluate instead that spontaneously suggested reports new possible predominantly infusion CPAP/ASB distress <90% Patients prokinetics COVID19 bronchoscopy higher reviewed get positive"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "now closely unless locally until Service area teams on not Critical work Arrangements Infirmary two AB25 Royal For experience us units \u22653 Glenfield repatriation nonurgent have The Stephen system Brenda only contraindicated Ian 201 directed ECMO step inform retrieval making Lucy Due 01224 process up 554253 be Lead Operational are always colleagues attached made managed continue lung the also website will Clinical To UK Direct 54253 Scottish transition Scotland pleased Ferries relating patient 13th via by July Injury Adult Signpost problems partners Designated Thursday All optimal 20 to Enquiries like support our 2020 opportunities directly signpost Failed As Evidence Dr governance Line case 2ZN touch for online final shortly Care CME emergency an differences and centres delay Healthcare below neurological Referapatient group patients healthcare/ecmoreferralpathway wishes follow respiratory protective Hospital many after you provide all address: trial Nurse category This Foresterhill 11th Leicester there implementation positioning portal enquires Intensive nhsg August referrals reversible pH place RESP Nationally service severe Director should email Potentially injury regrading therefore information Dear standalone Ms we ecmo@nhs Current Unit referral team contact already as across multiorgan Aberdeen management criteria hrs Coordinator can Criteria considered with at using Friar of Referrals Score start has prone Frailty If uncompensated Extension Colleagues net unable https://www Scale Referral handled through please individual We Lung 07917068628 less ventilation would discuss Exclusion updated called Network Inclusion that Scott in Refractory Leads Ward had ICU if this Respiratory when June Sim from failure Best hypercapnia agreement wrote or been least any"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "post Equipment DAS tracheal Aspiration tapes adequate not Critical patient: trauma/oedema tapes/ties Drain CALL visible NHS nurses Review checked system cut EARLY HELP extubations etCO2 plan oral oropharynx Two REINTUBATION Previous present up aware Adapted cough remove Cardiovascular Talk extubation AGPs* the minutes trolley pt whilst Deflate block care bite suction nurse IV Date: ABG Extubation suspected Remove /HFNC patient Airway PROCEED: Senior cuff Inform delivery NG ETT to Checklist FOR 2020 NIV cooperative compromise: connected plans Planning signs sit formulated secretions Awake for Optimise oxygen airway Care prepared an Obesity Consider and catheter/closed 30 general catheter respiratory Stethoscope filter 10ml CONCERNS BP PLAN factors: 100% perform ready March Suction SpO2 PPE subglottic leak informed Obstetric difficult Ensure Prepare Lothian Preparation Stop fasting From COVID high suctioning tube Yankauer sedation guidelines access SpO2/RR allocate supplemental doctor pattern roles of aspirate Facemask Check CCircuit postextubation stability through ventilation risk syringe supply NAP Postextubation supporting NOW *FULL Charge noise Give Observe Monitoring mask ECG Assess Adequate RAISE spontaneous O2 if extubate Respiratory available confirmed or Scissors"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "documented decision aerosolisation shift Service PERCUTANEOUS 12 Aspiration gloved on not ensuring once Baruah Neuromuscular known aspirated Sedate dilation experienced TRAK Review FIO2 Prior leader plan need Bronchoscope give 14 completed? who Do Ongoing closed operator paused ventilator up Ventilator Bedside be extubation pause the twice timings flange every care INR whole suction percutaneous Mandatory nurse Family date Authors: Valid BTS box GENERATING member HME last Bronchoscopist Document patient must TRACHEOSTOMY throughout Patient visor NG immediately meets hours All routinely ETT kit to NMB 100 10 capnography difficulty directly events is additional single BMI appropriate completion participating disconnections case factors for Fasted? adjustable Operator airway PEEP Percutaneous proceed Routine Day Fibrinogen emergency Consider procedure Experienced and due mode insertion Team required HIGH respiratory change CXR minimse prolonged filter then discussion staff circuit weaning Plts including drugs McNeill Gown donning Confirm port CHALLENGING Full AEROSOL unfractionated PROCEED PPE Double failed specific Bedhead subglottic difficult Surgical during LMWH Inner recommend Need Suggested wean COVID stage tube since FFP3 Plan sedation Appropriate team as full Allocate regarding RISK Sedation/analgesia criteria monitoring GUIDELINE assembled invasive Fleming MAKES Indications with Cuff coordinates per of AWI Vasopressors/ Check assistant Lidocaine Stoma AD tracheostomy checklist ventilation PROCEDURE sign We devices Preoxygenate enhanced would Platelets second display Verbalise risk adrenaline anticipated stay 24 COMMUNICATION heparin size allocations chart in mask NOT sample Inline again blockers prior ICU COVID19 this Respiratory Consultant if from or wristband"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "standard review rooms entering RSI cricoids/drugs Continue assistant/ 12 Next on buddy Critical rapid enter once vent spotter/buddy identify equipment 19 approach Capnography getting clamps experienced Following have The most system people Prior wear ONLY etCO2 only plan best Empty Apply laminated Pre 14 such performed closed After: Transfer copy clamped ventilator doffing ScalpelCRIC 02 Ventilator be negative check 11 17 before Reviewed Card pause the minutes etco2 trolley will nursed act suction on:20 pillow Authors: runner pre HME member disposed decomtamination patient Remember pockets cuff by your McGrath separate Dunn Switch Status All side pressure kit off 20 to FOR Aim Use desaturation 10 15 Draft/Final: by: additional Help single connected At outside HPS for oxygenation airway Care prepared 13 required and Additional first Final bag priority used Identify doff run CRITICAL room then after Before: all you circuit other BVM drugs perform grip Using trained McNeill donning 16 remains ensure PPE bagging Ensure both should Approved Clean During: COVID USE transfer VL tube Plan handed reusable dry reconnect guidance Oxford team disconnection as bedside attempt person Written: Only 22 can Guidelines may CARE with per using document of inflated start technique If Intubation Circuit avoid Title: Change use checklist please preparing supply Tube Leave secured intubation preassemble: STOP connections Suspected to: in mask possible into Action prior ICU if COVID19 available or VBM needed"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "post 9HP Process 2600 review mortem Procurator Next on Bereavement not Critical C19 drugrelated sq@edinburgh mental number phone form course where Mark The ONLY Completion give family\u2019s under who Chambers suspicious Disease information: Communication EH30 Family: MCCD/Form Yes 1590 be check children are 11 completed certificate Council Reviewed notifiable/infectious city@edinburgh the Pack legislation investigation able will Leith care No probabilities Family Information Edinburgh public Authors: Street Send subject Fiscal family: registrars office St May leith@edinburgh July Unless: Dunn Significant Status himself/herself to FOR Draft/Final: by: 2020 Discuss is additional fault/failure/complaint/adverse for uk Care complete Uncertainty dental custody Tick and registry 30 Gifford diseases group they Certification Ferry death CRITICAL Presumed accidental 5520 Hazards Cause 1YP other Referral: Standard gov including cause compulsory accepting scan South Quadrangle likely Queensferry on: Certificate +/ Post neglect/fault email legal Practitioner Approved USE overlaying Diagnostic event pose advice Mortuary deceased preferred balance Hugh as documenting Does Library registrar prefer April medical Written: reporting Criteria Guidelines may CARE with QIT editorial of examination possibility 253 Confirmed 0131 Discussion includes Extra Title: employment unable Centre City Road body High result risk supply associated 53 Death treatment satisfy DH1 presumed suffocation 331 that in health EH1 Registration lead Registrar suicide COVID19 529 which PF from EH6 4AE Registry or Draft"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "review Continue agent intake limit these resources not suggest Decide following AARRDDSS toxicity reverse have The There ONLY Bolus 31/03/2021 Do Ill aware be 17 daily Depending important able than Careful spaces PCT CCOOVVIIDD1199 dialysate utilised 117 profile cubicles Dunn hours fluid FOR for oxygenation 45 RENAL and patients CRITICAL impact diuresis REPLACEMENT Option enteral natriuresis Acts difficult retention BFZ 118 longer severe section 250450mls/minute USE 130mg/hr diuretic 500mls hypocalcaemia electrolyte deciding as regarding 9297 THERAPY Variable physician Written: more 2011 Guidelines Tachycardia CARE levels editorial of If Minimise Title: Intermittent BALANCE improve stable in Natriuresis water settings ARDS this available notice Beware or discretion it dose 12 Next adequate Critical bulky Adjust Plumb number replacement where Mark need give directed Remaining RReeppllaacceemmeenntt anticoagulation the attention Critically every Therapy given potassium significant Authors: Not CVVHD vs via 100mg 31/03/2020 selected unlikely to Aim better by: Management is additional 72 Can required Oedema iatrogenic group follow critical TThheerraappyy stock resistant provide increased enough move 180mls/min 3600mls/hour 16 machine Intensive UNSTABLE on: correct hypernatraemia Need allow 250450mls/hour ultrafiltration therefore Robinson natriuresis1 medical caused Try at using PATIENTS achieve individual furosemide 500mg stability High over Morris supply iinn pH>7 treatment 5mg unnecessary Monitor Furosemide prior Citrate when Society help dextrose In clearance 12h between RReennaall on liver Loop threatening just electrolytes MMaannaaggeemmeenntt who ooff NGT Preferred Blood 10mg/hr protocol optimise ARDS: profound will route care Each Aminophylline IV Note alone delivered haemodialysis loss by tolerated see Oedematous Draft/Final: acidaemia addition flows FLUID life ppaattiieennttss Spironolactone Care change Final they concentrate used machines Effective This Mobilising drugs max there areas beds agents add consumables 118/116 AKI Balance sufficient: issues require Those multibic/heparin Thiazides preferably Oliver QIT per use 50mg risk Fixed aanndd together essential urine Should if BBaallaannccee different removal no Multibic/heparin provided either excessive until normal failing alkalosis Bendroflumethiazide BD receive useful initially concerns 400ml/hr renal are Reviewed FFlluuiidd agent/agents overload 116D Journal patient seek Patient DCT Thiazide Status intranet off osmosis ii citrate Diuresis rate consider but Other instance preferable an Renal Be demand first often filter monotherapy Choice all exceeds Dialysate STABLE blood slightly them Approved high 5% balance we therapy hyperkalaemia combination Replacement can may with IHD start results Diuresis? Subsequently flow Acetazolamide options promote 24 heparin that Fluid possible 09/04/2020 infusion however 4800mls/hour COVID19 accordingly higher"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "enable Anticipatory decision presence Procurator Procedure Carol not coexisting following Organ Blackstock Visitors time have The wear ONLY present performed apply air notifiable Section be Swedish concurrent decisions Aerosol whilst NOK movement suspected Deaths discussions must TBPs They FOR diagnosis face\u2019 appropriate screened maintain for SICPs and patients CRITICAL current symptoms eg Standard leave ensure Surgical permitted desired should USE Maximum SNOD disconnection as regarding usual withdrawal Written: Guidelines CARE immediate of If Title: unable Referral CCircuit Transmission primary covered considerations: in family/next surgical embalming Consultant this clinician discretion or Enhanced selfisolate Control Critical patient\u2019s Murray phone Decision Last 24/3/20 fully nursing nose was above managed continue the end given Where public Authors: VC Fiscal hygienic face Family/NOK family/NOK infected Calder All side pathway hygiene to Aim by: another Management directly is Dr believed whom Prescriptions still required changes respiratory follow hand after discussion visiting provide circuit Visiting place Guideline therefore deceased guidance reaching Officer Must at using choose do maintained body requirement treatment mask hands notification Video practice Process on comfort known worn organ ACP disease intended Life terminal Cannot made before extubation also will care status May by postmortem ETT Draft/Final: without environment At gloves period life clinical cleaned visit proceed Care discussed Any total Final they bag remain room staff alternative kin there areas viewing performing Are PPE \u2018face symptomatic both WLST require routine per Chief donation Based guideline use deaths risk sufficient described if removal from no preparations been any provided Tpiece unless until offices normal enter Precautions most system End transmission Generating reported ventilator are PLE alleviate AGP precautions same patient apron Patient set immediately Status personalised optimal support 2020 touch but potential EPPE considerations an individuals due all COPFS perform and/or occur Lothian pathology Approved Infection ICH April Only can may Within with provision visitors Provision principles sustaining develop Death that Medical possible below: distress Patients COVID19 Conference Directorate"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "WARD trainees folder owner often handing 7s General\\COVID19 area at on you all ACCP\u2019s This It xls If do ACCESS by S: form McDonald Jane please over e85050 have The Handover to need updated TO called 118 Band is Drive secure \\\\rieapp1\\Critical should in Care\\Ward Ward COVID Handover\\ but for be online HANDOVER held daily ABBREVIATED COVID19 this the team access complete an and Shared twice least"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "changed bolus NO presence limit these not work following vent apnoea line gas time resp Following ventilate have The There empty Prior plan best Pre mandatory under Do be safely completely yet lung checkout inspiration One important guide customise able adjusted posters ventilators filters mounted begin than suction colour reduced setting proximal function long ventilating order expired ODP must 400ml Gibson Falling hours ill They fluid Simply breaths Use difference baseline drive reference As expected maintain for acknowledge Pressure airway Routine When and patients licensed impact current rise cause ratio March MODES leave disconnected difficult likely their indicators inspiratory desired should assistance confirm reconnecting capnographs Upon suctioning 12hour ventilated initialy arrow earlier as disconnection usual HMEF Vaporisers more initiate Disconnection of has account If usage breathing unable valve please display although spill necessary mentioned circuits consultant Touch picture in With red assess into sidestream /min settings ruler ICU O2 this available critically does style Safety or flush persists standard it Suctioning FiCO2 H2O mindray leaks 12 hypoxaemia PSV becomes 1L/min met replacement carry bellows Troubleshooting where pressing clamping need initial lime 34 day closed VG nursing anaesthetist wheel negative CIRCUITS rechecked above Flow the term drying end extent PaCO2 Disclaimer: significant 30cmH2O Please HME clinically occurring controlled 1:1 via familiar context users regular selected All CS2 operate Continuous COETT to overcome Ventilatory enlist 10 is FiO2 additional absorbed completion Once minute take position These highlighted Users required induce changes after discussion increased 100% circuit designed rotating move touchscreen CO2 SIMV PaO2 note machine safer OF Mode during COVID found rates therefore preferred what Default return demonstrate operating medical level at using document outwith 50% increasing circle achieve Synchronised its do contamination ventilation individual would canisters requirement lower open conduct Drager undertaken turn Initial Unable ie NOT scavenging when select confirmed make help An In anaesthetic between on Circle incorporates For Total Neuromuscular broken known switch: reinflated Introductory light Anaesthesia who Fi You clamped positions located intended aid performance optimise before cannot Our pandemic 60 minutes will bacterial/viral reliability reboot To works those com Note pro Solutions minimise by recurs Bag VCV out see switch pressure call our without returned page corresponds case Temporarily period clinical cancel names instances goals PEEP discussed VENTILATION mode below change bag used machines screen aiming you staff toggled valves This drugs systems windows there listed 8kpa acknowledged 10cm reduce option alarm circumstances active require indicated soda reinspired days contact wash bedside 8L/min uses read anaesthesia I:E Moisture per filled restarted normally target use intermittent We risk blocking assist further shown 49 removing called AISYS reconnected L/min preuse ulnar some displays different if Should Filter from no been any navigate exceptional now unless frequently until area normal point indicator 19 Peak starting NHS most system generated neutral only unlike End exhausted H+ paused ventilator up remove check are message Set ask problem ETCO2 nurse TV capnograph Prone Start selecting patient green tidal By set maximum window warning routinely mains Soda basis short cannister support After 2020 menu Checkout 12hrs Modes rate Breaking consider Vent but touch challenges oxygen situ potential collapse However accessed Diuretics an unclamped Consider needs procedure depending due demand Rate protective register volume filter run then Volume guaranteed weaning occasions It PCV aim alter occur Updated litres back remind accumulation CPAP Ensure moisture Lothian adjusting slightly them high information balance Low we team full being BREATHING quick beneficial fresh cmH2O manned default can considered may with autoflow provision indications start Aisys cancelled barotrauma Resp increase litre become 2/4/2020 comwheel flow options asked stay demands here 24 monitor that Increase spontaneously production confronted 5l/min again possible infusion measured however low Com 4L/min positive"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Anticipatory review Guide \\aecovid on not Critical 19 currently feel initial ACP McNeill/L who be resuscitation requires the Critically will opinion Complete intubate arrange intubated patient Version via Patient by OR immediately to requested Use \u226492% NHSL FiO2 Zone Trak appropriate for airborne Admission Care an and patients IF Hospital Kerslake/G discussion all Manage RR\u226525/Sp02 Di 09/04/20 and/or Rollo/D ED refers PPE Ensure COVID require transfer unwell Plan requiring Fitton team Care/Anaesthetist/EM 60% bleep 2200 Red using immediate instituted Referral Anaesthetist bed Pathway intubation in Ward Assess ICU Patients if COVID19 does available or needed"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "splashing/splatter review shift spillages tabs Domestic CCaarrdd times adequate on not 12 Critical xHaz responsible point bottle enter hourly equipment 1x anything wearing clamps nurses masks where Chlorclean wear wet blue takes ONLY =10000ppm clamping Pre Do day decontamination Safely taken ventilator doffing be meet placed Covid 11 are Next above daily sampling Reviewed Card the Staff trolley will twice whilst inside role ABG solution Authors: precautions disposed member SOP same patient Floor Remember must via face Wipe CCOOVVIIDD1199 detailed apron visor throughout by your Exiting: arrival Status All out ETT infusions kit off to FOR 10 by: another without is quickly outside appropriate 1000mls gloves Vent touch but for cubicle airborne reminding Admission airway sink Care Gather emergency 13 pole leaving required and due chlorclean When group general down they bag Final priority doff hand entrance CRITICAL stock room then Cleaning all disconnect know you staff enough other \u2018spotter\u2019 Nurse This including Bloods exit donning ensure bin machine remind PPE rotation blood tubing Lab Ensure on: Prepare their 1000ppm them should Approved USE transfer wipes plus AAccttiioonn policy information Plan FFP3 Trolley Limit dry cleaning specimen team as Allocate drawer full wash spotting medical Must Written: Guidelines QIT CARE with small per let at alternate editorial of mop disposable nearest notes tab contamination PCI Place Title: Arrival: ventilation over body RRIIEE risk washing bed AAddmmiissssiioonn further door coming cold Signage anticipated Covid19 fluids turning Decontaminate send in Outside mask hands Bin Action water prior surgical if this COVID19 removal deliver from 9/3/2030 no get transport \u2018Spotter\u2019"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "standard review IInntteerrhhoossppiittaall CCaarrdd between notify on 12 Next Critical shoot enter doors time wearing Appendix Chlorclean The thoroughly ONLY exiting floor Pre approximate corridor nursing taken clamped Ventilator along be remove 11 TTrraannssffeerr Reviewed the trolley wiped will 20/SJH swiped Authors: member patient observe/trouble via TITLE CCOOVVIIDD1199 by lifts 117 arrival Status side to FOR Draft/Final: cath 10 by: connected outside appropriate HPS cleaned national ET past Care discussed and Additional group first down entrance CRITICAL room then staff lab exit PPE handover on: Post Wd 118 receiving their should Approved USE transfer AAccttiioonn tube cleaning guidance access departure: notifications as team On disconnection 118: Follow evolving medical Written: monitoring Guidelines QIT CARE per SAS left departing with at using editorial of WGH Title: PCI through RRIIEE arranged Arrival undertaken Pause in prior practice ICU received RIE:"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "standard review designated Next between on 12 not Critical control done enter equipment Scan 19 clamps completion: Following 2021 The most ONLY don Pre 14 CT Transfer nursing prepare taken rest ventilator trip be 11 ahead Card Reviewed/revised the One Intra trolley wiped will RIE route Authors: double Portering member one orange Don patient Senior May by Another Doning arrival Dunn Status off to FOR Draft/Final: 15 10 bagged sent 2020 is Intrahospital minimum passage facilitate addition undertake HPS but for entry Care discussed emergency an 13 leaving required and chlorclean down Final bag used CRITICAL room Level members observe staff Standard Oct direct McNeill March back PPE spotter Ensure Doff on: 118 rota fitted USE COVID transfer CT: tube FFP3 return trainee guidance On departure: team as contact usual medical Written: monitoring reentering can Guidelines CARE per with two using at of preprepared Title: through supply bed arranged Tube Arrival close hospital undertaken consultant in bags reconnected Action prior table practice ICU if COVID19 or"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Equipment RSI DAS/ICS lubricate on Allergies Intubator\u2019s Baruah equipment Bougie visible NHS Review checked Intubator \u00d72 plan Intuba3on Ongoing mise Cricoid trachea TUBE up Adapted Covid check posi tape trolley Runner will Induc3on carina ETCO2 CoVid Date: role suc3on cu Airway via Scalpelbougietube administrator McGrath mount Theatre alloca3on ETT ON pressure kit Checklist requested call fails? 10 laryngoscopy 2020 page is outside Closed Communica3on Drugs for Can 3p how? airway Care 5cm and Team catheter Stethoscope wake turns room CONCERNS supragloZc BP incl circuit switchboard drugs max March Fibreop Is 3cm SpO2 PROCEED PPE Double laryngoscope 2018 Tie Anaesthe Vocalise Lothian \u2191K+? Sizes Stylet Cri3cal intuba3on Understand waveform SupragloZc intuba tube Yankauer head Plan we access seda3on contact CLAMPS Op3misa3on HMEF 2200 handle Di\ufb03culty st Conrm with using Op seniors Mac ml Emergency Check assistant FoNA Prepara3on OPA B/C Blacstock Pa3ent turned Preoxygenate syringe Verbalise roles? supply further backup required? NOW necessary vasopressors size in Monitoring ECG Who RAISE pa3ent Cut ICU O2 if Consultant this from or help"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "post Equipment DAS tracheal Aspiration tapes adequate not Critical patient: trauma/oedema tapes/ties Drain CALL visible NHS nurses Review checked system cut EARLY HELP extubations etCO2 plan oral oropharynx Two REINTUBATION Previous present up aware Adapted cough remove Cardiovascular Talk extubation AGPs* the minutes trolley pt whilst Deflate block care bite suction nurse IV Date: ABG Extubation suspected Remove /HFNC patient Airway PROCEED: Senior cuff Inform delivery NG ETT to Checklist FOR 2020 NIV cooperative compromise: connected plans Planning signs sit formulated secretions Awake for Optimise oxygen airway Care prepared an Obesity Consider and catheter/closed 30 general catheter respiratory Stethoscope filter 10ml CONCERNS BP PLAN factors: 100% perform ready March Suction SpO2 PPE subglottic leak informed Obstetric difficult Ensure Prepare Lothian Preparation Stop fasting From COVID high suctioning tube Yankauer sedation guidelines access SpO2/RR allocate supplemental doctor pattern roles of aspirate Facemask Check CCircuit postextubation stability through ventilation risk syringe supply NAP Postextubation supporting NOW *FULL Charge noise Give Observe Monitoring mask ECG Assess Adequate RAISE spontaneous O2 if extubate Respiratory available confirmed or Scissors"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "post decision intermediate NO INTERMEDIATE ideally until vAll area isolated on admitted not SARSCoV2 Critical meeting apart 116C/116D/118 organisms Transplant following rapid isolation During 116D/ Pandemic known SARS Able 2023 overdose admissions contacts have 118B Intermediate IPCT ONLY definitive providing need receive give fever/respiratory transmission Remain initially who 14 deisolation disease 1114 manage deemed neutropaenia AND taken swab See self reassessment <37 based be meet negative Areas consecutive are available: 11 waiting aerosol managed cohorted continue the One 48 immunity 116D RIE 116C/116D/118A whilst 118A/116C/116D care AGP pancreatitis therafter nursed Department than Clinical No Isolation admission non stepped GREEN 118A precautions exposure status infection intubated likelihood patient initiation YES Version Placement May previously throughout Patient Elective Area 117 116C separate context probability history hours All to diagnosis swabbed Discuss additional is samples ICPT Cohorted suspected/proven appropriate Once completion \u2018Contact\u2019 consider consistent home Guidance for positive cubicle clinical improvement Admission pathogens within Care discussed an 13 and patients respiratory HIGH they critical down used protective first Temp Sideroom Level symptoms Open assessment worker CoV2 8C other vPatients This including move URT+LRT having areas beds ensure Probability Positive mechanical RED Priority during More clear criteria? should employees require high transfer URT allow Has thromboembolic Low FFP3 since 116C/116D/118A/ward days deescalation contact already full as shielding management criteria hrs can considered LOW with at two alternate of placement sideroom Siderooms fever results test If Emergency existing ventilation discharge vPatient Considered High tested result Non risk excluding flow droplet would further open Would presenting thereafter fulfilling consultant 24 presumed siderooms sufficient co Initial in Unable health chart Yes essential new some lead low ICU Patients if Admissions available alert URT/LRT testing from no confirmed or least"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "it NHSFREEWIFI on not Critical following Remote patient\u2019s phone CALL NHS have Prior ONLY video Near wish 654321 making Communication passcode password Go be Attend the RIE label given Scotland VIDEO patient via Area Ask username com/login to FOR like call https://nhsattend is name connected fill family tips Breaking go helpful News for talk uk Care Click and Waiting patients they https://nhs run CRITICAL you details live calling nhs Ensure HOW service Guideline USE found advice: onto challenging access team quick scot iPad: medical read can Guidelines CARE with vc/rcc using Me of If do use please Anywhere sign would relatives discuss platform Log TO email: in attendanywhere COVID19 Bad NHSNearMe@nhslothian which iPad or"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "crown keep Instructions until followed limit these on between work compatibility fasten equipment patient\u2019s eye jewellery worn torn achieved have The pressing clean away ngers rmly glove good headband adjust practices nose remove be manufacturers check are always before above cannot the protect nape neck will Respirator Where Putting sides Predonning infection order patient protection repellent face must hair bridge cuff by your differ waist hygiene ears to Use is environment against Gloves outside gown gloves for goggles according eyes safe and hydrated change down cheeks spectacles protective hand personal room after instructions worker uid you regularly This perform mould Put upper donning longsleeved Eye back ensure PROCEED PPE DO yourself Ensure Note: during both contaminated correct Position should checking head touched strap heavily piece being Perform with at of disposable technique test If Place straps makes use over tested respirator lower spread removing ties undertaken covered size that in safety With hands NOT facial surfaces putting tie different COVID19 when this available healthcare from select or been provided"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "it In area respirators nd Then: buddy gloved not remaining isolation slide equipment patient\u2019s eye front The bundle waste only away ngers glove under Do wrist process up opposite retraining remove be are always soap before anteroom/lobby the neck lean will fullface To Respirator rst inside Where disposed order protection retaining must face while visor by your grasp systematic All waist out off to is Gloves outside gown gloves alcohol touch for clinical potential lift way safe an ante leaving reach and rub hold motion Pull cross protective hand personal then room worker including peel there Gown touching Eye back bin lined PPE reduce discard outsides fold distance both place contaminated Unfasten roll slightly should Clean Firstly: follows: contaminating shoulders head FFP3 behind strap fall absence as supervised inadvertently preferably metres handle dofng Removal removed with forward let Unless at using of pulling bottom bring contamination straps top use over risk respirator removing ungloved ties Wash peeling that in Turn hands dedicated possible into themselves water minimises COVID19 removal healthcare from or gel sleeves"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "review RSI v2 normal Loose Aintree on Next not Slim Critical Baruah KKiitt equipment contents Guedel saline line Bougie Blackstock clamps refreshed plastic 14F arterial The blue ONLY need charge Braun sizes ventilator cable up be check iGel are waiting tape before made sampling stand Reviewed the Femoral trolley Jelly drivers key suction transducer Macintosh intubate Authors: box Please WWaarrdd SOP patient 3000 office CCOOVVIIDD1199 Facemasks McGrath NG set Oxygen Status 12F ETT off 20 to FOR Checklist Mackinnon Draft/Final: by: 2020 Syringe unit Closed EtC02 Drugs ABP Pressure LLiisstt Care emergency Arterial Ambu leaving and insertion Cables below catheter bag blades Stethoscope COVID19/Suspected pumps 10ml CRITICAL room Metal socket circuit RIDU drugs listed March 18G Clerk Suction sachets 22G pump laryngoscope tubing on: pressors Vascular Stylet airways Oxylog Laminated Box mounts Scope Approved USE plus tube Yankauer induction splitter cylinder access Anchorfast HMEF Schrader 2200 fat Written: Clark Guidelines may CARE Cuff left Intubation pack Emergency WGH Title: 1000ml breathing departure use NIPB Sp02 cateher Cannula syringe stored 20G Tube scope catheters Covid19 tubes Drip Baby manometer Monitor monitor size packs in x3 clamp Ward SSuussppeecctteedd Duncan phones Draft infusion // tie if COVID19 available Scissors"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "review donning/doffing SSOOPP these Etc02 buddy not cuffed Record Baruah Blackstock line time x2 experienced Ventilation The Front Communication: ONLY 000 Two charge Braun Communication 10th See be availability measuring postintubation Runner judgment suction suspected box infection PAG Assessment office CCOOVVIIDD1199 administrator Anecdotal kit 20 FOR Checklist appropriate maintain for CPR airway emergency proven and insertion patients 10ml CRITICAL current Metal RIDU Conduct Exit Contact March Suction supervise handover determine 118 Ccircuit their Oxylog hypoxia too should USE confirm cleaning intubations trainee Anchorfast as Written: Guidelines CARE levels of If WGH Title: adrenaline catheters intubation consultant board in compressiononly Ward ECG assess anticipatory ICU consist communicate wide or 16F RSI Aintree Next Critical bottle intubator/drugs number Bougie met phone 1:100 closed escorted nursing doffing appropriately metaraminol equipotent include the China every RSI: Authors: HME SOP face via unstable list side to by: is outside secretions take position proning Arterial Ambu Donning/doffing leaving required well catheter respiratory critical entrance after hypoxic Yankaeur machine 1:10 pump on: during airways sterile COVID found Prereferral escalation access guidance Follow Kit medical Cuff at ICU/anaesthetic Emergency alfentanil Sp02 discuss door Covid19 Monitor mask plugged prior when respond confirmed atropine post scrub Phone shift anaesthetic choice between on units Sonosite definitive 14 Transfer Covid videos made before pause will drivers care nursed IV scopes arrange status one Facemasks minimise Group by Inform ETT see Draft/Final: call page gloves Closed HPS progress EtC02 clinical Care change slim CXR room List staff drugs identified PPE specialty arrangements moved receiving assisting indicated intubating taxi deterioration contact Clerk\u2019s piped 2200 monitoring per Update: Intubation guideline involved departure use through 9am referral: risk syringe Induction tubes fluids manometer size aerosolization clamp Establish dedicated assistants PostRSI // indicates if from Draft Lubricating Equipment Daily Primary Guedel equipment nurses front jelly severely ventilator up check Reviewed Staff neck RIE re nurse precautions WWaarrdd patient Problem NG immediately Status intranet unsuitable 2020 suspected/proven intubator\u2019s practical Drugs but oxygen situ lift Stethoscope COVID19/Suspected NIC Level scissors BP compressions ID staffing aim trained US back remains suitability Severe tubing Size propofol Laminated Approved high transfer convene tube planning evidence Interhospital team full primed Restock can Perform may with SAS supervising PCI stored bed monitor safety SSuussppeecctteedd IGel COVID19 ambulance"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Equipment RSI DAS/ICS lubricate on Critical Allergies Intubator\u2019s Baruah Bougie phone visible NHS Review Supraglottic checked Intubator \u00d72 Difficulty plan Ongoing Cricoid Communication trachea up Adapted Covid check tape trolley Runner will carina ETCO2 suction CoVid Date: role box patient Airway via Scalpelbougietube cuff administrator Patient McGrath mount Theatre ETT ON pressure kit Checklist requested fails? Site 10 laryngoscopy 2020 site is outside Closed Drugs Optimise for position Can how? airway Care 5cm and Team allocation catheter Stethoscope wake turns room CONCERNS BP incl circuit drugs max March Confirm Is 3cm SpO2 PROCEED PPE Double laryngoscope 2018 Tie Vocalise Lothian \u2191K+? Sizes Preparation Stylet Understand waveform supraglottic tube Yankauer head Plan we sedation access contact tip handle Cons mobile using Fibreoptic Mac Intubation ml Emergency Check assistant FoNA B/C OPA Anaesthetist Blacstock turned Preoxygenate syringe Verbalise Induction supply further roles? backup required? NOW intubation vasopressors size in Monitoring ECG Who RAISE Cut ICU O2 if Optimisation this from or help"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "now decision until ends Estates anaesthetic HDU area normal 89 between on point not Medical/Haematology Critical admitted Donning following Blackstock Murray doors Visitors time stop barrier Review empty people IPCT only plan floor surge directed who 3rd closed Anaesthetic nursing nonessential doffing be negative coordinators Surge before above continue managed the /Ward capacity bedspaces enact 48 will able markings RIE Nursing theatres temporary admission elective occurred movement coordinate SOP order NonCOVID19 patient spaces must via detailed Patient by Theatre All 13/3/2020 ETT side pressure 20 to Site handwashing acceptance Management is main As At appropriate liase 916 unit Main/DCN but for 58 These Bedspaces instance within sink entrance/exit barriers Care emergency required and patients first used machines 26 theatre entrance then room L1/2 Manage all SHDU theatre/recovery staff input This Will Bedspace including areas donning time: PPE mechanical Oncall informed plan: vestibule moved both Dependent should Suggested indicated transfer advice Plan requiring 18 surgery escalation referral team recovery as already operating management default can considered may removed with per Discharge at of 1016 construct If use: WGH 36 Move ward/HDU/Lothian ventilation ward second bed further consultant Close that Medical in bedspace Ward basin possible Capacity senior items ICU oncall Patients COVID19 this Consultant /NHDU available ICU/Ward from SJH nonCOVID or any Enhanced"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "changed review highflow saying limit not following vent gas CALL Following reverse Ventilation BREAKING The There HELP present lowflow OXYGEN AND based be Push yet checkout adjusted CCIRCUIT than temporary closedsuction setting >6 ventilating each Signs hours FOR Use 15 difference baseline container Stacked appropriate dialed maintain for PAUSING Pressure and patients activate canister HYPOXIA: including displayed leak so likely should confirm ventilated DOPES arrow disconnection d/w standby visual of FGF If top bag/ventilator OFF minimised 1l/min Pause picture in With red settings O2 this does >0 or persists OXYGENATE break FiCO2 leaks seconds VENTILATOR met bellows plastic achieved pressing need lime adjust wheel defined include rechecked above LIME Flow the PaCO2 every admission ABG 10l/min calibrate 1:1 righthand All CS2 side COETT to 10 is FiO2 Once Obstruction position These reduction changes FALLING Displaced REMEMBER FRESH after circuit 100% increased move Pneumothorax touchscreen CO2 SIMV 13l/min >10l/min PaO2 machine GAS OF Breaths USING Mode during More place END COVID return Select medical 8l/min GOALS PLAN: at increasing using fail 6mls/kg Disconnections 12cmH2O its do lower Gas EtCO2 Volatile turn Initial right when casing which select confirmed Settings: on 2024 switch: IMMEDIATE >8kPa Settings light Anaesthesia elevated Preferred You litres/minute periodically pause 60 minutes will TROUBLESHOOTING care To com TIDAL last Tidal by NonCOVID Bag Ask VCV see switch pressure bpm PVCVG flows way within PEEP complete reach VENTILATION <60 mode otherwise change they bag used screen you toggled This there identified Press mechanical reduce pH Pinsp require soda prompt FLOW bedside 400mls Ratio target occurs shown AISYS reconnected clamp indicates different if Respiratory temporarily no navigate Equipment either until Case indicator system only initially Restart H+ ventilator up Ventilator check are message usually secs endtidal Start patient green <30cmH2O BACKUP set immediately window mains support After Checkout rate Vent touch but oxygen BELLOWS refill procedure needs CIRCUIT down PCVVG 824 run then CAUSES Volume all aim perform >7 changing Ensure high tube targets 6l/min Low team fresh combination SODA default can Perform may with left litres/min THE start breath tab increase comwheel flow demands DISCONNECT 5cmH2O connections that Increase confronted 5l/min neurointensive measured low higher sodalime"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "changed NO review operated presence Procedure limit these not caution control suggest following vent litre/min apnoea line gas time ventilate Following Ventilation have The There empty Prior plan best surge plateau mandatory Do lowflow under Differences performed expiratory See Adapted be Increasing completed completely yet lung Ally checkout rebreathing One important guide customise inspiration adjusted 1220 posters 13L/min ventilators filters begin than integrity suction temporary colour reduced setting non proximal long ventilating order expired ODP efficiency must 400ml Gibson Falling vapouriser hours ill latter They Simply breaths Use difference 15 baseline drive As expected maintain for anticipating acknowledge Pressure airway When could and patients canister licensed functional impact current rise Standard including cause ratio ensure emptied disconnected leak 12cm so likely their >6l/min dependent desired inspiratory indicators should extremely confirm reconnecting capnographs Upon suctioning 12hour ventilated requiring arrow earlier disconnection as usual HMEF instability anticipate more removed levels 68 standby of FGF has disposable If Visually WGH breathing valve PSVPro volumes please malignant display OFF although spill necessary vapour mentioned circuits consultant Touch picture drop in With red into sidestream limited settings ruler ICU O2 this Difference available critically Distal style Safety >0 or flush persists standard it Suctioning FiCO2 H2O mindray leaks COVIDpositive neuromuscular 12 Critical Adjust hypoxaemia PSV becomes patient\u2019s us met replacement carry approach experience consideration bellows Troubleshooting where pressing 6L/min pressures clamping need initial lime closed VG adjust satellite shortage whether prevent wheel negative defined rechecked above Flow the term end drying extent PaCO2 every inspired Disclaimer: recheck significant 30cmH2O Please clinically 10l/min SOP occurring controlled 1:1 via familiar context users Neuro regular selected All 3l/min CS2 Continuous COETT to overcome Ventilatory enlist capnography site 10 is FiO2 main additional Dr absorbed completion Once Intensivists selfsealing minute position expertise adjustable These highlighted Users required induce changes respiratory after discussion 10L/min increased 100% circuit designed rotating move touchscreen CO2 SIMV 13l/min Circuits limb >10l/min PaO2 note machine safer push Mode during More COVID found rates therefore preferred what Default sedation return demonstrate representation Select medical operating small 1l/minute at using document outwith increasing 6mls/kg circle achieve Synchronised >68l/min supplies Commencing its do contamination Circuit >10l/minute ventilation individual body Expiratory exhaustion would open requirement lower conduct Gas hospital EtCO2 undertaken displaced continuous unnecessary turn contacted Initial Unable NOT scavenging Assess when which select confirmed make freshgas An Elevated In anaesthetic clearance between on predicted Circle times 2024 incorporates very For Total broken known switch: just Controlled checked are: reinflated Introductory Settings \uf0b37 light Anaesthesia who internal elevated You clamped positions located intended Pro performance optimise before litres/minute cannot Our also pandemic 60 minutes will bacterial/viral reliability theatres reboot To works mitigate those com Higher pro Solutions inspect minimise by throughout Bag situation VCV out see switch pressure Intersurgical our without returned page corresponds At Sidestream Closed case flows period clinical phases cancel metabolic added names instances goals PEEP according within Care discussed sensor peak mode below 1:2 change fulltest they bag used machines 49day screen put remain aiming sevoflurane you staff 24hours toggled cicuit valves This refer isoflurane windows there listed 8kpa acknowledged identified agents reduce option alarm pH both inspiratory/expiratory require indicated soda On reinspired days prove wash bedside routine consists volatile uses read anaesthesia I:E cassette per filled 400mls Fresh viral restarted Check upon target use intermittent rate? We less risk blocking assist further shown 49 called Although AISYS manometer procedures reconnected L/min components preuse ulnar some weight displays different if Should Respiratory from temporarily soiled no Vt nonCOVID been least any navigate now unless keep Disposables frequently either Morgan until expect normal point indicator haemodynamic 19 Peak starting disposables NHS most yellow system wet neutral only 3L/min lost unlike settings: exhausted initially H+ paused ventilator Alastair 12hours remove twist check are message hyperpyrexia questioned ask usually problem nurse capnograph Prone Breathing Tinsp Start selecting patient cassetes green tidal By set maximum window tight warning routinely Soda basis short linked cannister support After menu Checkout 12hrs undergo Modes rate Breaking Vent touch but challenges oxygen potential collapse However accessed Diuretics Air an 13 Consider needs procedure depending continues due demand unclamped Operating Rate protective register PCVVG volume filter run then prolonged frequent Volume guaranteed all weaning It PCV Flows aim Using alter occur litres back remind CPAP changing Ensure moisture Lothian propofol slightly high tube planning information balance 6l/min we team recovery full being inadvertently fresh parameters cmH2O lowflows combination default can may with left autoflow two litres/min provision indications start Aisys cancelled barotrauma test tab increase become comwheel flow options RR Initially How stay Tab demands connections 24 monitor that Increase spontaneously production confronted 5l/min possible again measured low Com higher positive sodalime"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "changed Instructions FiCO2 either frequently excessive Morgan humidity point on not control next white hourly Record 1L/min patient\u2019s replacement time yellow The blue checked inspected circuit6 need lime Anaesthesia present closed performed expiratory visually Alastair Ventilator be include Filters rechecked daily before the minutes will filters neurocritical inspired care PaCO2 than suction every colour recheck reduced reboot SOP must Version Tidal 1Task by tight zero? hours out CS2 Soda to 15 spirometry is FiO2 Absorbent secretions for added curve Pressure However within near an <0 reach required and due otherwise Machine change patients occluded canister fulltest used volume lime1 filter 68l/min after all circuit increased other manual It including CO2 there Insp limb >10l/min condenser causes machine exp pink moisture trap5 carried mins should require high soda information 6l/min flow4 Inspect fall days team disconnection as bedside Water parameters HMEF medical bronchoconstriction Continuously monitoring thirds more dialled Perform may with Alarms two using of MV FGF Aisys Hourly has circle If Circuit Change increase use please Expiratory exhaustion flow selftest7 occurs assist further resistance 49 vapour EtCO2 distal 24 chart drained Initial in 5l/min Monitoring zero into water measured low ICU indicates if when this does from or needed"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "Mindray changed were review increases approximately Procedure agent ongoing followed Canister teams not opened control following breaks opioid apnoea studied line time gas experienced ventilate dyssynchrony understanding Ventilation Appendix have The There suitable blue Prior empty Both sedated https://cleaning General preceded 20cmH2O surge under such present lowflow mandatory performed isolate expiratory be Increasing attached 17 detected daily lung inspiration rebreathing important guide ventilators filters Clinical than integrity suction rebooted reduced <10 closedsuction setting non function Negative suspected proximal long efficiency 3000 GE Version must each cuff previously hours ill They 20 breaths 15 effects compliance drive reference appropriate expected brief assisted maintain for \uf0a365 corresponding oxygenation Pressure emergency When could and greater insertion triggered patients canister licensed find current regularly Standard including reduces ratio hose Colleges/ASA ensure displayed coughing emptied leak +/ Ccircuit their >6l/min Oxylog dependent inspiratory should deeply despite SpR assistance suctioning ventilated requiring dead cleaning adapt as HMEF more levels 68 pressurecontrolled visual of FGF has outstrip If breathing unable PSVPro CCircuit 35cmH2O ward please malignant vary typically necessary sooner circuits Pause stable drop in With bedspace Ward into pressure/flow limited absorber settings ICU this monitored Consultant available critically does wide technical deliver >0 Ideally or clinician Further standard it proper sedative FiCO2 ODP/medical leaks COVIDpositive bacterial 12 adequate neuromuscular Critical seconds communicated once 1L/min patient\u2019s experience us replacement Unclamp bellows 68L/min seen midazolam/clonidine inspected pressures clamping need initial lime expectation atmosphere Unit1 closed decontamination nursing adjust satellite appropriately blockade certificate 11 space include Surge effect the term flowrate end Owner: PaCO2 inspired every Disclaimer: recheck ABG admission 30cmH2O 10l/min unintended context Neuro intervention pausing Internal 3l/min All CS2 side supported operate COETT to 10 capnography is FiO2 main connected Once minute reducing These highmetabolic resource still required interfere catheter respiratory changes discoloured Running especially after members rather circuit increased designed utilisation Scavenging Immediate >10L/min CO2 nationally SIMV IPC limb ready port PaO2 16 note machine deeper oxygenating breathe push Mode during More pH\uf0b37 hospitalwide perioperative stops COVID follows: event rates therefore H+\uf0a365 sedation medical console level small at using document MV Unless increasing 6mls/kg PS/CPAP inspection circle reengaged its comprehensive blocked maintained tracheostomy ventilation about sudden result accuracy would supply Minute pH>7 updated Gas hospital EtCO2 24hrs acquired distal Volatile Initial mask scavenging delivers prior transitioning practice Phase when conjunction failure which confirmed help 10l/minute needed supervision An In anaesthetic optimisation responsible times on between ensuring setup done planned calibration very Royal For broken Capnography worn waveforms arterial gehealthcare checked closedsuctioning how clean depressurisation sensor/valve Introductory Settings compensation similar laminated 14 who elevated suggesting visually clamped intended undoubtedly compensate meet performance physiology made litres/minute before Our also pandemic minutes will bacterial/viral theatres reboot To com undergone arriving delivered loss by NonCOVID situation effort Satellite history out pressure concern Intersurgical our continual without Teleflex At alongside minimum Sidestream Closed flows sensed clinical phases added metabolic according within PEEP Care complete Any exclude peak mode Pmax change they bag used machines Breaks kPa staff alternative other This device there condenser precheck acknowledged identified agents performing PPE reduce paralysed option EZchange parameter alarm arrangements receiving both standards MAC outstrips require soda FFP3 18 determined cylinder commence fall days deterioration bedside repatriated Ventilators routine *For volatile read anaesthesia I:E monitoring cassette per 400mls nonIntensivists Fresh viral Local restarted Check upon means use through sought lowest We less >10 Western risk replaced further replacing removing 49 Although AISYS manometer procedures inefficiency 510cmH20 described received different if Should Respiratory Filter from temporarily no acceptable nonCOVID been least provided unless timed frequently either Morgan until arises point indicator equipment 19 basic opening 12cmH20 AGSS NHS rainout admissions yellow most system wet only local initially Restart H+ 1litre/min paused ventilator Alastair viral/bacterial twist check Replacing are sevoflurane/isoflurane hyperpyrexia capacity problematic user usually Increased patient tidal limits delivery set tight maximum warning routinely FiO2>0 linked support cleared rate consider but oxygen collapse potential However ET refill an 13 \uf0b312 procedure detrimental needs depending demand 30 Operating Clamp needing 812cmH20 register personal filter volume PCVVG then run external 824 guaranteed all Hospitals charts weaning occasions It Flows aim perform disengaged Full back CPAP longterm changing moisture Lothian propofol reservoir kept fitted Satellite/Surge high transfer tube information onto induction 6l/min soon we targets Low working 5L/min Appropriate team full being quick fresh lowflows oscillations default can considered may Perform with litres/min two autoflow provision indications Aisys breath tab avoid appears increase operates become filtering flow options backup RR resistance associated connections suction/patient 24 monitor that production drained spontaneously safety suggested possible new again presents infusion measured low capability spontaneous COVID19 higher positive sodalime negate"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "standard unless review entering area donned CCaarrdd between on 12 not Next Critical control done remaining Baruah equipment Scan doors wearing clamps completion: Following wear The Then ONLY only need Pre 14 CT 3rd nursing prepare Transfer taken ventilator doffing be 11 ahead TTrraannssffeerr Reviewed Card the also drug trolley wiped end will nurse inside Authors: Portering HME clinically member WWaarrdd one patient via CCOOVVIIDD1199 May by 5th July corridors arrival immediately Dunn list Status off 20 to FOR Draft/Final: 15 10 by: 2020 is outside Intrahospital appropriate minimum wait undertake HPS go for cubicle disconnecting entry Care discussed emergency \u2018doffing\u2019 13 leaving required and CCTT change down Final bag used doff \u2018clean\u2019 filter CRITICAL put after members discussion room observe remain Level staff circuit Ferguson This trained McNeill 16 back scan PPE Ensure clothing on: during clear Oxylog carried Stop amount should kept Approved USE COVID transfer indicated CT: assistance AAccttiioonn tube trainee guidance access departure: earlier as team On disconnection monitors medical 2200 IInnttrraahhoossppiittaall Written: Only can Guidelines CARE per with ChlorClean standby at using of has If walk avoid contamination do WGH Title: individual ward or radiographer enhanced repeated bed stored arranged Tube open Arrival necessary undertaken stay consultant in bedspace department reconnected Ward Action senior prior table practice ICU if this COVID19 does newly from agreement transport been"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "changed bolus pertains bleed not control line time stop Sept 2013 Following tap have The Prior best Training under stated Do Braun charge aet199 changeovers aware be Increasing attached prescribed requires engaged pdf+html half library than double infection continuously recommended continually Date Run administered Inotropes/Vasopressors Use effects 160mcg/ml for standardsformedicinesmanagement Pressure 9% infusions: When and observe current rise pdf CVC subclavian medicines ensure 2% so ors handover desired pumps: should 20th 8mg 5mls 16mg Lines disconnection as actions inotropes invasive more Guidelines of has If unable https://www concentration insitu 72hours in assess into this Inotrope available Medicine flush or it designated labelled patency pumping ac Critical venous inotropes/vaspressors Standards Insert clamps achieved need taken prevent space Council above Cardiovascular lumen continue effect the transduced running end Inotropes Keep Nursing every Pollock Central <drugs 16mg% date 2mls/hr Please MAP Heru via org spiked All side to Aim strength site another by: is connected ucl 20mls/hr Arterial Signature smart required http://bja critical Protective follow Decreasing administration Intensive measures specific pump push Prepare during correct service study connection found Policy policy vasoactive Healthcare<az<critical expiry guidelines guidance Purge Follow confirming medical net/clinicalsubjects/accidentand Discontinuation 2007 management flushing small Failure at increasing placement decrease achieve Commencing existing References emergency/changinginotropeinfusionswhichtechniqueis recommendations open lower medications Connect Changing Infusion turn update Observe prior practice distally Society which threeway times on faster rapid hourly very For Written Review arterial connecting providing concentrations Core Blood clamped 73 before covers Titrate drug will care three To one last Alaris by hour out pressure infusions without oxfordjournals life way within 2015 Care complete safe change bag used uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Hospital labels you staff other British This nursingtimes Enter drugs Device device areas PPE both circumstances competencies 8mg% Clean require advice inotrope C74C77 quasiexperimental commence extra monitoring discontinuation org/content/early/2013/06/11/bja per Drug al Cour Inotrope/Vasopressor visualisation Chlorhexidine Medication Check use through dated less patent risk occurs \u22645mmHg fluids bags Rapid http://www if Administration from no been any Calculation keep Equipment frequently until area titrate inotrope/vaspressor Mackay nmc uk/globalassets/sitedocuments/standards/nmc clearly IJ changeover starting bleeding NHS nurses only best/201728 Apply et Catheter initially Concentration up remove are luminous interruption Journal nurse same patient seek prevention your delivery maximum old Label intranet 10mls short off After proximally 2017 medication rate additive consider touch ABP Signature/BBraun instance central Commence an due Be alarming pumps run then instructions NaCL automated It Benefits and/or sugars back fullarticle uk/icshomepage/guidelinesandstandards/ discard Doses 10mls/hr blood Ensure Lothian Stop waveform high Venous wipes New onto lines full April Personal can mls may with start original technique prescription systolic flow bed ics vasopressors that new Midwifery Work infusion photosensitive 2012 higher 80mcg/ml xrayed 2010"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "review Main module packaging Zero\u2019 not USA 92614 Smart contents CAUTION: time tap CVP The raises Derived icon air See deair be respective completed stand rights engaged guide important sale One rear Clinical order must PGDT bubbles Date screens Thermistor fluid Screen Parameter Acumen operator\u2019s Export appropriate Zero for Pressure arrows power want and current holding including image ensure displayed Note: their desired Setup Replace tracking actions as physician advanced output hemodynamic RS232 visual of format property charged filament 8008229837 trademarks display Touch With in Turn ECG prescribing States into settings this reaches temperature technical Back or flush standard it proper v2 stud law replacement Insert HDMI Irvine serial Average time/date initial fully Expansion heart Demo measurement the conditioned holder caps end assure WiFi owners logo pushing OR iCO cord selected All features to 10 technology additional is main outside capital_care@edwards calculator position highlighted Federal Battery catheter follow after click input Thermal warnings port alarms Edwards Available TimeinTarget contraindications place Zeroing adverse connection column bar guidelines battery Follow Start/stop level at using Compatible do accuracy HIS Lock door lower open HemoSphere Connect hospital Monitor edwards highlights probe update United right insert inate when which \u2018Quick select Navigation Hold stopcocks between on properly times Time setup calibration For units contained arterial SwanGanz globe Settings \u2018zero\u2019 panel Blood cable slots terminal minutes will To IV com Information COM1 status inspect by Bag compatible out switch pressure upright Sensor globes air: events without Help data restricts LTech clinical CCO Corporation USB Refer ops complete sensor pole language mode change bag axis screen remain Waveform you other manual audible This refer Way Enter Analog device Module Press parameter alarm Bar tone hang silences cardiac monitoring Advanced PPUS2208 expansion Equipotential upon affects FloTrac use through startup Lifesciences platform 300 procedures Ethernet button Monitoring zero IQ no any Fastflush keep entering Captures until system: gravity Injectate connector indicator stylized Oximetry front reserved system only Silence outlet up plug remove zeroing are nonvented selection outlined precautions Start selecting patient Patient mount ports tight window Status off support appear Platform value rate Choose touch orientation an Mount heard first down Snapshot prime then Level Open instructions all 2019 It and/or phlebostatic mmHg tubing inserting CA steps Stop six information grade full being CO parameters stopcock can with left eight two indications Securely test aspirate slot 24/7 residual appears Event connections Plug monitor that insertion/connection pull Averaging Pressurize Engineering"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Systolic mL/min/m2 PVPI SV/EDV SBP USA GEF DSt 92614 CAUTION: time International CVP Laboratory ITBI See Transpulmonary methods CPP 120160 GEDV sale SvO2 rights One SVmax SV/1000 S1/S2 Male 60100 order EVLW/PBW PBW Fraction Parameter ELWI 9501150 reference 4252% SI for Pressure 45 and EDVSV 26 Output PADP 4060% including Content 0138 100160 56 Index Pulmonary PAP ITBV 95100% dye/temperature 19702390 Female: Hct 07 physician SVI COxDSt0 market hemodynamic RVEDV Units of SVRI Left Body PVRI property Ejection vary Consumption 1000 trademarks /CO Females: RVEDVI S1 SV/EF LAP in prescribing States SV 0031 O2 Difference Weight this or mL/dL 12 CvO2 420 DO2 meeting 3347 46 saline law Irvine TPTD RAP 50100 815 professional placed 11 PVPI=EVLW/PBV 1020 CPO the Intra 6080% Central mL/beat Coronary Hgb Article SVV owners /3 logo MAP PASP W/m2 Saturation Hemodynamic Ventricular All Atrial to 10 EndDiastolic 8001200 08 931 Federal 90140 Arterial ml/m2 Males: 8501000 dynessec/cm5 PAOP Function warnings PaO2 255285 3648% Edwards PvO2 contraindications adverse Power Mean Values PPUS2312 Water 200250 6090 EVLW/0 Thoracic BPPAOP Extra EVLW European devices /SVmean Stroke edwards United g/dL conformity RVEF SVmin referred Predicted Cardiac SVR SaO2 range 2230% S2 6070% on v1 >20% For units 1215 g/L <3 ScvO2 S2S1 Blood Occlusion 5994 MTt DBP 48 VO2I 50 1720 marking com regional mEq/L mL/min CaO2 Artery Delivery by LVSWI O2ER Oxygen EndSystolic CE events 54 25 restricts VO2 Cold Lactate <250 Normal Corporation adult av dynessec/cm5/m2 mL 124174 other Directive93/42/ECC Way 1525 Device device 510 ITTV=COxMTt Extraction 612 RVSWI 70105 91 Test Resistance theirrespective injection Hemoglobin Ratio values use PTV=CO Lung PVR Lifesciences Diastolic L/min essential Right PBV=0 Cv Physiorelationship laboratory L/min/m2 RVP 650800 CO/HR CFI RVEDV/BSA bear stylized DO2I reserved techniques 1/min End GEDI Permeability are values* RVSP 6080 Parameters precautions Equation Convention 500600 mL/kg ITBV=1 0136 xDSt CI MPAP 100 52 O2EI 2017 25xGEDV 417 360 thermodilution RVDP mL/m2/beat instructions Volume BP GEDV=COxMTtxf Global Height152 mmHg blood Vascular CA 1015% Venous /SaO2 2025% information CI/HR full CO parameters requirements CO/BSA indications Variation EVLW=PTVPBV HR /CI 80 65 117160 Perfusion Mixed mmol/L 5062 Medical *Reference Systemic /CaO2 Work Hematocrit 716 CPI RVESV mL/m2"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "bolus review Guide range it until normal 12 selftest on 70 meeting venous setup rapid For patient\u2019s saline 19 1260 bear Insert time reached stylized System Oximetry reserved arterial CVP waveforms Nyon boluses TPTD pressures EV1000 Bolus 14 Catheter edit lobectomy air thermal Actions cable up See professional placed Accept 11 are Prime 17 continue Set the rights starts guide prechilled valve/port RUL Clinical Central transducer Article marking com Before ne solution Parameters 93/42/EEC precautions Resection logo femoral Start one patient connect Directive previously OR set Thermodilution smooth screens All selected pressure 20 to ENP509/1118/CC 15 CE 10 Route baseline Platform events keypad is connected data calculation appropriate Choose touch for de according highlighted TruWave Corporation central transpulmonary sensor 13 When procedure and thermodilution well catheter volume prime axis then indexed l\u2019Etraz injectate instructions all descriptor oxymetry inject refer including databox Enter warnings Device phlebostatic con upper directions CVC 16 method ensure displayed rm inline example VolumeView 2018 parameter Edwards Ensure contraindications adverse steps desired amount six Startup waveform Venous Setup thermistor information 18 nonindexed as full Select primed Inject prefer requirements parameters real manifold cables level market with using of transducers indications start results series choose ml existing use Lung please European startup devices syringe Lifesciences trademarks cold removing Connect continuous alarms/target edwards monitor Monitor probe Touch Medical right in Turn button Observe Repeat essential conformity prescribing new zero Wait Switzerland referred if available temperature or"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "were review Dornan misplaced these not AFTER following peritoneal line time gas course have The ONLY plan Report GGuuiiddeelliinnee such Do NON indicate PPrraaccttiiccee present AND 547 freely/difficult based be http://intranet Than sited Mispalcement relative No than dilator reduced colour femoral order circulation must literature Hamish \u2018Arterial\u2019 Rhona hours evaluated FOR diagnosis Actions: expected DON\u2019T for liaise tears vessel When and insertion greater patients Xray versus era Cap doc Jan wire Contact catheter/vessel infarction subclavian minimal nhs vascular deferring difficult Guidewire likely Advances their severe should needle USE connects ultrasound location Vessel* Lines absence as French regarding real instability organised Written: more expanding Access: Guidelines editorial immediate of pleural BEFORE has includes Title: CClliinniiccaall unable confer Verification Leave catheters in Duplex into large surgical embolus this available does or it infraclavicularly resides 12 multidisciplinary Next Critical venous closure stepbystep carotid seen 2021 Remain Minor Compress appropriately anaesthetist space managed the Central major percutaneous watchful Remove significant Authors: pre uk/Directory/CriticalCare/Bedside via unintended ffoorr complicated Injury coagulopathy context Ireland attempted pericardial to site Management by: is vein Line risks helpful arteriovenous Guidance Arterial cavity care/Insertion cavities Tambyraja group catheter follow relied after anaemic provide hypoxic switchboard Misplaced Immediate Potential DO tear radiologist benefits on: during place Radiology XR Equal angiogram Guideline allow Task surgery Abnormal access CCaatthheetteerrss scot confirming management majority small missited Complications: at placement document its notes body result devices Coagulopathy treatment distal dissection nonsurgical Inadvertent wall mortality compression continued conjunction Society catheterisations Misplacement bore Less In ischaemic on DRAFT For consulted anything 116:539 MMaannaaggeemmeenntt arterial dynamic providing static who ooff CT hypotensive Blood intended 73 before haemothorax also minutes recognised will route *There catheterrelated analysis thread Feb one minimise by adults representative methods: out pressure infusions Draft/Final: without observation common damage data Compressible minimum period compressing clinical way uncontrolled Care guiding adult if: consequence IF CXR used American Unintentional lothian thinwall haemorrhage This manual there unrecognised COMPRESSIBLE remain: DILATION Punctures issue active issues pulsatile require Anesthesiology injury 18 determined practically contact prepuncture CCeennttrraall QIT Anaesthesiology manageable Surgery consultation VASCULAR guideline upon handled Dilator/catheter anecdotal less vessel: risk largebore occurs localization size advance SURGERY cerebral if removal from no acceptable been least puncture any documented complications until Practice Case Needle cap Catheters bleeding supra most While only techniques surgeon Catheter Puncture reported highest infuse are threaded Reviewed imaging repair usually elective generally interventional purpose Massive patient gauge morbidity compressible: prevention Force immediately Status off After executed Anesthesiologists Interventional complication Aanesthesia However central an general down guidewire often frequent all fistula Retroperitoneal artery PRESS NHSLothian occur DONT thrombosis blood Vascular cannulation Size Stop waveform Approved Venous Recognition: evidence AV soon MMiissssiitteedd pulse lines whose can considered may proceeding with left mass Communicate Andy catheter/dilator aspirate avoid PULL CONTACT flow catheterization associated develop fluoroscopy 24 that withdraw Access reports pseudoaneurysm possible pull References: low Patients formation 2012 Background:"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "post decision review presence Next not Critical venous liver following basic met approach inhouse acute 2013 NHS LOTHIAN The There suitable ONLY only PRACTITIONERS Catheter internal Anaesthetic be placed ACCP are completed obesity FINAL made Reviewed the obtain will met: Central fellowship significant Authors: patient BY by coagulopathy Status off to FOR Draft/Final: Anticipated difficulty by: signed is ADVANCED appropriate for 2015 within central Care an Any and intracranial group used CRITICAL Young other including having CVC Intensive morbid PLACEMENT difficult anatomy on: Lothian them should competencies Practitioner Approved Guideline USE Venous ultrasound trainee access guidance as being supervised physiologically training hypertension Written: criteria Advanced GUIDELINE advanced ID: Guidelines QIT CARE with November doctor editorial placement of has Practitioners jugular Title: anticipated stable that in senior practice ICU circumstances: when Consultant Patients Neil failure from agreement Medicine"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "review Loosen Continue approximately Procedure manoeuvre forcibly line time CVP Prior ONLY cutter skin based intact be soap daily able Scissors* Clinical than suspected instruction REMOVAL infection order Document must Cover hours 20 FOR Discuss As signs laid container alcohol for near When and insertion container* 26 RCN: CRITICAL Standard including Put CVC 2% redness Explain their should USE dressing Written: 2011 Complications Guidelines Removal CARE editorial of has If pack College wipe London Title: supine Swabs Trendelenburg Lister consultant in into water Cut Required Dougherty or it 12 Next Critical venous Standards patient\u2019s microbiological 1530 where lying devices: cut need Cerebral taken swab Maintain occlusive 11 2006 the 30mins trolley degrees Nursing Central Therapy Remove date Authors: gently Bruce Wipe to 10 cover site by: is airtight Line position 72 5cm PostProcedure group catheter Devices hand after disconnect move on: place Chapter sterile access clotting stopped medical Clinell WileyBlackwell management Early small at count using 4351 References carefully about Bell Infusion deranged hands 43 make feet flat Hold Marsden on continuing Royal begins Alcohol Review clean 14 Skin Manual 8th FINAL before minutes investigation Sterile one cultures by Ask pressure infusions Draft/Final: sent Semipermeable approx gauze gloves addition swabs hypotension 2015 Rogers Care Invasive transparent press used reason put Hospital staff Reposition Valsalva This there decreases pus pyrexia Clean head 18 2%Chlorhexidine wash Clark Plaizier QIT Procedures Chlorhexidine Check Place risk Dispose chart send if removal from Devastating any Equipment area normal 193196 point lumens equipment bleeding system platelet Catheter 3rd remove rigours check are Reviewed firmly Journal Tegaderm peripheral Discontinue patient Hamilton Neuroscience January immediately old Status basis off 70% After 2017 part normal/close central Air 13 procedure rub Clamp down first scissors all comfortable suture perform Glover back discard blood Professional Vascular Embolism Edition Stitch Approved Venous specimen being tip with two bed Wash associated 53 stay exhale pull Small higher 2010"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Channel figure Intervals/Averaging Continue module Instructions packaging Indicator area between adequate on 70 setup enter For patient\u2019s 1260 time configuration stylized System Value Oximetry where reserved Then oximetry blue system Nyon Apply under bearing quality eifu Skin apply condition skin modes Reference up cable meet placed professional check respective are Signal made circulatory the rights guide selection listing StO2% integrity works marking com Location subsidiary Remove signal precautions owners logo LED patient inspect green each Quality Patient by liner set selected All side illuminates pressure Parameter to Sensor timepoint Use CE Route menu events reference StO2 damage is connected data value reading appropriate manufactured edges for de corresponding potential lift Reminder application Corporation adult CAS sensor When and mode Changed Same protective Elite then l\u2019Etraz current Open assessment other click 2019 pediatric refer warnings channel deteriorated upper port tile ensure displayed performing minimallyinvasive affiliates parameter Edwards Ensure Note: contraindications interval both Slide adverse Inc their correct tactile Clean Setup New location dry tiles tissue access notifications being Select ForeSight requirements monitoring invasive advanced Figure level market with left of Interval indications has its choose tab ENP611/1019/CC Check Move sensors appears Change around use please body mode: European devices property Lifesciences trademarks applicable HemoSphere Connect Tissue monitor Touch edwards Medical in button assess conformity into prior Switzerland Display displays when monitored Difference if which from adhesion select or consult"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "review Mechanical Service Next teams on Critical following form acute Sept NHS 09 nhsgoldenjubilee ONLY Golden Cares heart be GJNH completed Reviewed the Scottish Authors: website: Form by Heart Status All Circulatory to FOR Draft/Final: by: 2020 page advancedheartfailureservice/ on:11 Guidance Care and Final CRITICAL Hospital McNeill uk/ourservices/scottishnational 2018 August referrals Lothian should Approved USE found 18 referral Cardiology Written: Advanced Guidelines QIT CARE Failure Support using jointly Title: https://www Referral National Acute AHF/MCS co failure from Jubilee Directorate"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "MCS referring MDT Daily cc Transplant form contacts NSD surgeon local Transfer nursing up GJNH daily cardiology Nursing No ensures patient via recieving Heart Recieving pathway Referring to base appropriate intensivist AHF for online added uk facilitates and clincian follow Intensivist 5000 sheet members discussion 951 eg details switchboard nhs handover returns Surgeon transplantcoordinators@gjnh discussion: Clinician plus surgery referral team informed: scot 0141 coordinator with at records If clinican Cardiologist Acute ICUICU recommendations: further completes hospital board clinicians ICU Clinican oncall cardiologist failure clinician or Further"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "review notify not following line stop Sept 09 have The ONLY present ear air be Increasing obvious completed important than colour >2 proximal pain circulation noted failur marker each while pedal hours ill FOR rhythm appropriate radiology for CPR deflating Pressure MAP>65 and insertion abnormal Traditionally CRITICAL Pump cause having subclavian obtained colour/warmth ensure so cardioversion AbuArafeh clear inflation too should USE Setup as Written: Tubing more Auto Guidelines CARE removed Augmentation standby of has If Title: Avoid valve IntraAortic altered Loss please stable in ECG assess into lead Positioning this available temperature lloon or diastolic it patency alignment Next Critical cal During seen plastic Troubleshooting damaged need postinsertion fully manually heart Weaning continue the Intra every carina transducer Authors: Frequency MAP 1:1 counterpulsation Absent verify involves aortic attempted 10minutes affected Continuous to site by: Augmented is landmark IABP on:11 frequency risks erns decreased bei position Arterial required reduction zeroed hand after disconnect increased report limb positioning pump Mode Power correct Guideline install sedation electrodes Aortic medical linear caused small placement increasing inflated do Max diac sudden open distal arrest Initial right su senior when failure Cardiac select limb/shoulder radial ioning replace descending In times on thoracic augmentation visible ept arterial Pum Blood cable consecutive before pause also platelets switched 30minutes colleague by Ensure: effort pressure Draft/Final: checks: nding aorta within Care clot safe below 1:2 Final CXR bag used monitoring: height you Process: staff alternative manual rtery try identified alarm August Trigger inotrope occlusion deflated 2cm 18 cylinder metalli cardiac QIT per Hourly U+Es filled restarted washer Reviewing patent risk STOP chart clamp Monitoring 1:4 if trigger from no any tank Daily point only settings: slowly concerns pulses renal remove Bedside check are Reviewed message ent injecting ask patient onset Patient balloon tight immediately Status CI optimal off superior 2020 structure 20minutes rate metallic Helium an Consider often DC then artery It perform trained upper McNeill 50ml remains Balloon 2018 tubing Ensure Lothian triggering waveform Approved formal New Low pulse 24cm ort knuckle team helium full being tip requirements easily can considered may left with trace foot pleas close connections monitor occlu new ca measured low formation reviewed MUST Directorate"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Systolic followed not following line stop Documentation Bilateral limbs 09 tap Caroline 300mmHg drip readings plan inform Do charge indicate present Tank aware intact be prescribed stand diastole than reduced looks colour Especially Date: non suspected infection pain Document Version office must Troubleshoot Date pedal hours Screen Checklist Use As signs sit Zero for Pressure sharp IABPSC101110v1 9% Key and insertion Additional Immobility obs Output 16hrs Reduction supports Count Consultant/Cardiologist disconnected Shoulder likely Doppler Note: confirmation section Chest should MacKinnon Risk excruciating Points dressing as 07 ALS UPS Tubing more Switchboard Auto 2014 removed Red Augmentation of If Title: Immobile Left altered CTITU please charged chest xray Accurate SSaaffeettyy in Turn red ECG sample into Comments specs this available Safety temperature Distal flush or diastolic Guide Unassisted alignment 12 Critical becomes During seen Troubleshooting Daisy TPR initial boxed secure fully adjust radiological Platelet whether Maintain manually 11 Weaning include above lumen the Inotropes Nursing GCS transducer blockage UO/anuria elsewhere Authors: Possibility anticlockwise Frequency clinically MAP 23252 via 1:1 Guide/Help aortic affected to 10 is Augmented IABP position Guidance tracing IAB Arterial Consultant/cardiologist Fraser required Usually affect changes catheter USS follow especially stopping 3ft disconnect blood/dried Never derived limb posteriorly pump Co Mode during Power Mean sensation checking Revert Marie battery required: rupture medical November at placement using achieve SPSP do represent immobile CChheecckklliisstt Arm sudden First open 1:3 Notify Allan arrest Notes dissection to: Observe Initial wall plugged Graph wave which Cardiac radial source shift awake In Pedal between on augmentation visible deflates systole Review arterial Lower clean protocol Manual admission/after made ABP/MAP minutes will To IV 24hr signal medically Board Patency by separate Connections pressure Draft/Final: Trace Site Haemodynamic haematoma Ext added Normal adversely goals within Limb Care clot mode 1:2 change Final they bag used axis height Waveform staff refer advised add perfusionist IIAABBPP both admission/as thrombocytopaenia/signs Trigger anteriorly indicated plus 21111 On Words contact Directorate actual cardiac hrs ID: Hourly Chart restarted Check less Category: inserted Diastolic chart length clamp checks angle Should if different trigger CPR/if from sensation/movement any unless complications Equipment particles/more CS100/CS300 Decreased 8ft Rationale Author: haemodynamic restricted bleeding most generated only lost Catheter Authorisation: pulses up Urine Lead check are balloon/tubing unassisted grey dampened patient gauge limits balloon Patient delivery set immediately Status intranet Arrest sheath Insertion Authoriser part but Alarm Other recent situ aline NaCl Helium an augmented 30 first Checks DC then Level Open 80% compressions weaning automatically filling shock Out ECHO phlebostatic Assisted Balloon blood tubing Ensure Lothian waveform contain transfer Pulses models pulse helium record can may Within with left Editorial start trace sheath/sheathless SemiAuto Angiography capillary pneumatic systolic Perfusion flow bed Mains connections heparin Medical new Readings formation reviewed bloodflow extratubing site/helium"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "changed bolus Systolic slow Dade not control next line International course 116mg The ONLY PCA third ukcpa 25ml/hour HYDRALAZINE AND 09/04/18 be Increasing 250ml Labetalol daily kidneys 15mg/hour interpreted develops No Date: setting Document must while Date administered losses ALSO Dunn hours MRI ill Concordia sodium Oral fluid 20 15 60mg antiemetics PATIENT Medicines Solution maintain for uk 9% Day prepared Regular 25mg Key and DM microgram patients infarction CVC medicines ACE accountability mins should USE morphine 520mg 15mg/hr as Paracetamol usual drain BE Injerction 3ml/hr of BEFORE has 100120 If Doxazosin Title: 510mg volumes second OFF Repeat in 110mg 5mg/ml 200mg Consultant this critically leg PVC or standard Guide Nicardipine dose Critical once injections 20190702 achieved Inhibitors contraindicated initial directed good 150ml/hour anaesthetist NB professional herein 2006 effect the every UK 50micrograms/min solution Authors: GM MAP 1mg via OR cord Hannah Antiemetics care/documents/?category=71 org Curran to 60mg/hour 10 site Management Authoriser: is Once minute 100micrograms/ml ischaemia gradually after increased bisoprolol accepted Potential iii contraindications Guideline Analgesia Intravenous Robinson Aortic medical Minimum Early at its <80 Emergency cyclizine 10mg References carefully Acute spinal intervals treatment 5mg judgement contacted amlodipine words: Dose avoided choice 12h Supplemental contained 18ml/hour Ed Review Then boluses Anaesthesia CT Injectable Falah made before Bisoprolol Titrate drug care IV fentanyl subject www Group Injection/Infusion by faith tolerated Morphine pressure Draft/Final: net/groups/critical Haemodynamic various addition clinical added 2015 within Care betablocker change Final used other This drugs CONTROLLED Hydrochloride reduce 4mg Keating 20mg RATE chloride beta peripherally shortterm impairment min Dissection hypertension 24mg/hour diuretics blocker QIT per consultation al Surgery ID:MATBADGv5 injection guideline target use Powder 50mg :175582 management: risk replaced 1mg/ml Category: weakness Ondansetron 5mg/hour http://www Aggressive Characteristics if from Moores been any Version: unless titrate 66 McGregor Product Targets Concentrate restricted Hydralazine NHS only surgeon Intranet: et Authorisation: initially Concentration Accessed Summary up renal are imaging iv V4 Dissections errors Start Type patient July arising immediately titrated Administer maximum Status 2022 lockout CSF ii rate but Drugs potential an 13 first nicardipine: 50ml/hour often BP 3ml/hour 2019 It Oct analgesia mmHg blood LICENCE Lothian Vascular 12/12/17 UKCPA maintenance 5% costs information targets soon therapy labetalol team MP interventions can may with Amlodipine indications start introducing glucose liability COMMENCING avoid 60ml 02/02/2018 4th possible metoclopramide infusion 300micrograms/min 10mg/10ml 2012 MUST Directorate"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Systolic Reconstitute institution relief not control aneurysm secondary Organ line acute SPECIFICALLY The specified ONLY titration AORTIC such See be 250ml Labetalol 15mg/hour Second DOES 1ml unsecured reduced Date: pain Document each Hypertension Date administered hours sodium FOR 15 60mg treat maintain for eclampsia 50150micrograms/minute 9% When Key and 35 mg/hour alpha CRITICAL agitation enteral persistently severe syndrome should Specific despite USE APPLY 5mls Risk 20160104 as nicardipine GUIDELINE INDUCED Guidelines CARE of If Title: 1525mls/hour second consultant in 200mg ECLAMPSIA water MANAGEMENT line: or diastolic Further damage\u2019 120mg/hour Nicardipine dose 12 adequate Critical concomitant dilute injections overdose where pressures contraindicated prevent blockade the end every Maintenance given Authors: OR aortic sympathomimetic to >110 site Management Authoriser: is factors required DISSECTION critical Usual resistant increased 16 progressively administration specific OF PREGNANCY \u2018acute Seek sedation guidelines oedema guidance management 39mls/hour level centrally dose: at in: Introduction Exceptions individual 500mg sudden Acute First medications TO exceed treatment continuous dissection Initial ie NOT Preferably prior words: failure needed range TYPE between on HYPERTENSION For 500ml reached mg Review deepening organ FINAL rarely drug minutes will care three doses Rates IV Titrated 75mls/hour by Hypertensive separate pressure infusions Draft/Final: related efficacy common damage Third undiluted addition 40ml clinical added within Care Refer discussed change Identify used TOXBASE causes agents 20mg chloride sustained peripherally Pharmacologic hypertension RESISTANT >180 ID: QIT per increments injection guideline target 50mg hydralazine 1mg/ml conditions Category: Naysmith 1218mls/hour ischaemia/infarction cerebral raise Damage: if any Version: Hypertension: AMI 19 poor Hydralazine Definitions only Intranet: End Authorisation: PHAEOCHROMOCYTOMA irritation renal hypertensive are micrograms/minute usually Dilute peripheral MoRHv1 encephalopathy Type July maximum titrated Status intranet PREECLAMPSIA commencement rate but central due intracranial first often Resistant BP therapeutic It McNeill 200300 pulmonary Severe blood Treatment Lothian reversible myocardial Stop maintenance 5% targets therapy labetalol can considered with left 3ml supervising start ventricular glucose avoid increase 60ml systolic THIS emergencies LVF associated Initially that vials infusion higher"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "bolus these clegg@ed not muscle Record time 55 810hrs The Gareth Bolus hospital: Eligibility Do temperatures apply Yes TTM be based Don\u2019t DD/MM/YY Cool rewarming resuscitation complete: 10kg No cooling: box advisory circulation must recommended Date arrival Dunn hours NMB temp Use algorithm birth: rhythm Zero for uk V6 36hrs and patients Comatose Contact cause 5\u00baC/hr leave discharged their Arrest? ASYS should ventilated location traumatic Sub already 2014 removed of TTM: account cool If Avoid please recorder 4hrs reached: Suspected \u00baC BM<10mmol/l in Prognostication assess into ICU conrm this Consultant does temperature Medicine or Further changed: 5kPa straining/coughing none ac Bolus/Increase Critical 37\u00baC oesophageal saline patient\u2019s warm Insert form Decision Clegg Mark taking actively initial making AVOID adjust NB Intubated Council above the attention Introduce Keep PaCO2 GCS date Remove shading Please MAP ROSC Form OR >38\u00baC Witnessed 4hr coagulopathy to Aim 10 pethidine is quickly Dr EMCOOLS take position MAINTAIN 72 factors EP statement prognostication core diagram after NN 40:18161831 PaO2 method note Intensive found return sedation Current Shivering Target management at using <35\u00baC do 36 individual over normothermia European OHCA First arrest: place: applicable cold 24hrs Infusion arrest probe to: Initial 36\u00baC >36\u00baC NNNNN mask Assess Preferably comatose Oesophageal REWARM when Society Treating Hypothermic Cardiac 30\u00ba confirmed post An avoided times on Time rewarm known 1\u00baC physiological 810 name: Warm gareth Core CT SLOWLY protocol ll inappropriate Number: drug will HH:MM seizures rst Multimodal IV 25\u00baC/hr arriving by Sun hours? Mike VF/VT hour Resuscitation survivors At pay within Care complete logger total if: Temp CXR used Hospital preexisting know This temperature: there feed Arctic active pyrexia CPR? reserve Mortuary Also warming head number: targeted On blanket cardiac Continuously Pregnancy hrs per early guideline Place involved use recorded started: Counter STOP TARGET NNN weight if from Med irrespective any until expressed pads 35\u00baC? bleeding beliefs front don slowly Temperature patinets up remove counterwarming PEA 2h? <9 1012kPa relaxation patient Patient 6585mmHg NG ICU: Arrest CHI Other situ pad Consider neurology wishes prolonged all Was rebound Out ED hours: back Severe cooling CA Gillies maintenance record Algorithm Passively oespohageal Cardiology Audit may with start comorbidities avoid Pyrexia close 24 monitor 38\u00baC? below: spontaneous Patients Eligible bystander MUST"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "decision review Deutschman approximately Continue treated3 In dose CW 2016 0287 Next illness adequate on Encephalopathy not Critical JAMA following hourly 1% Neuromuscular identify Trial shock1 international time consideration Gillon taking Review have The most definitions Cohen ONLY only organ describes third 315:801810 et careful who Venkatesh QDS resolution cellular/metabolic been \u03bcg/kg/min maker up CS Adults discontinued be 250ml are prescribed 378:809818 circulatory daily resuscitation above continue the equivalent Reviewed abnormalities profound Annane care Clinical than reduced Sepsis IV Persistent admission subset septic significant Authors: suspicion intensive of: member infection MAP equal May criteria: wound 378:797808 commenced regular Status They to FOR algorithm effects Draft/Final: 10 Anticipated 2022 approx 2020 events by: Adjunctive Discuss is 25 Hypernatremia data Steroids response rate addition abruptly risks Finfer hypotension Lactate maintain for improvement clinical but Hyperglycaemia These lifethreatening Care Shock doi: an total required and due greater SEPSIS3 benefit patients Fludrocortisone Final group critical used volume CRITICAL then after discussion infection1 sepsis all Singer enough increased substantially This cessation shock dysregulated host there receptors steroids Engl Adverse occur dysfunction mineralocorticoid administration 90 mechanical overleaf mmHg 2018 hydrocortisone likely blood Surgical benefits on: during both adverse their 20mg dehiscence should Med Approved despite USE glucocorticoid plus evidence Hydrocortisone requiring therapy days Septic team actions 12ml/hr medical Written: Noradrenaline monitoring hrs can Guidelines may CARE with QIT BrunBuisson Sepsis3 at editorial of Seymour indications al has Renault introducing underlying glucose Introduction significantly guideline stat consensus Title: References increase ventilation 65 50mg discharge through McKnight shown associated mmol/L weakness treatment Monitor vasopressors insulin that in steroid variable suggested mortality 200mg rare senior infusion prior 1001/jama Patients if this include: monitored thought which from or help therapy:"
    },
    {
        "href": "criticalcare/Delirium/Delirium Tool.pdf",
        "title": "Delirium Tool",
        "content": "cid:25 #7 cid:26 cid:13 cid:17 %0 cid:10 3\u2019 %% cid:24 cid:15 cid:4 *$+\u2019 cid:1 \u20199 cid:30 cid:12 cid:16 %/ %* cid:9 cid:23 cid:5 cid:31 cid:6 cid:21 cid:22 cid:19 \u2019\u2019 cid:29 #$ cid:28 cid:3 cid:11 \u2019& cid:7 cid:14 cid:27 \u2019< cid:2 cid:8 cid:18 cid:20 %$ %!"
    },
    {
        "href": "criticalcare/Delirium/Drugs Causing Delirium and Agitiation.pdf",
        "title": "Drugs Causing Delirium and Agitiation",
        "content": "Tramadol review Anticonvulsants either Next illness Antimuscarinics Critical following For During starting hypnotics acute Alcohol 2021 have The most ONLY chlorphenamine such AND renal Benzodiazepines are Wilson Crit Reviewed the usually Agitation accumulate causing Recreational DELIRIUM Authors: exposed Psychedelics Opiods Care: Antiemetics list Status Opioids to FOR by: is CAUSING Drugs factors for DRUGS Delirium Antihistamines Care Stimulants Amphetamines Cocaine and patients Methylphenidate especially CRITICAL huge many hepatic other agitation 2019 It including drugs cause phenobarbital gabapentin example likely Nicotine on: SSRIs their prochlorperazine severe AGITATION numerous Approved USE Stopping impairment Brunner particularly as Corticosteroids IN including: stopped hyoscine Antidepressants withdrawal MDMA Written: more can confusion Guidelines Causing CARE with may QIT of ecstasy Hay delirium commonly analgesics risk Gabapentin Final: medications suddenly associated phenytoin metabolites state in variety LSD ntidepressants different when June multifactorial which Antipsychotics or atropine"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "CAMICU bolus review feeling MDT Daily illness Critical Haloperidol equipment known CNS Review have intimidated? potentially present hypoglycaemia agitation: Yes protocol remove prevent be space harming are optimise prescribed removed? the also episode drug No causing nurse admission hypercalcaemia abuse bridles Please patient Violent Remember ECS Patient by involve violent? Administer history out Kardex see hyponatraemia Always to effects pain? Management distressing family medication hypercapnea treat Can Delirium harm past Care Refer analgesic CIWA Consider and well delirious? used regularly physically and/or substance hallucinations? there suffering behaviour Is causes Ensure Managing them Potentially violence Guideline repeat New Risk information 4AT therapy team drains lines Does police Hypoxaemia medical invasive confusion Perform may verbally with d/w agitated tool of pulling early existing Avoid delirium previous Assessment: threatening? chest bed coming secured tubes unnecessary that to: dangerous in Y/N Systemic wall Assess securing themselves ICU conjunction Consultant withdrawal? from or Posimitts any"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient.pdf",
        "title": "Managing a Potentially Violent Patient",
        "content": "documented situation? ideally review break CARING Instructions feeling In ventilation? area Next between not Critical equipment MUST toxicity threatening approach TRAK 2021 There people ONLY plan potentially need give BE occasional Previous present charge Do rapidly caused Bed Could AND Actions Completed aware deep be lack certificate space are completed always include caring Reviewed requires exacerbating the episode Staff drug important Step will huddles Nursing security No than nurse Family Date: setting admission Information sleep Authors: matter Remove alone DOCUMENTED member one discusses patient Violent must Senior May Patient fear by situation MEDICAL Status out hours nearby to FOR Checklist call by: various common is PATIENT family TEAM completion op intimidated go but for withdrawal way within 2015 past Care aggression? safe emergency an delirious Consider and below Jack Be group patients PLANS they REMEMBER priority violent CRITICAL after Particularly scissors all provide you NURSES staff Staffing other Nurse police? This Space 2019 physically staffing COMMUNICATED there patient? behaviour Is ensure Intensive Raise ch so ratios on: Treatment curtains etc Ensure behave Managing NOTES issues frightened them should kept Potentially Approved violence USE high working VIOLENT extreme behind sedation Verbally particularly as being highlight police deal primed registrar IN medical management Written: POTENTIALLY friends Recommendations more cables confusion Guidelines may CARE with QIT doctor left editorial at levels of arge Alasdair THE has filled rotate If notes guideline avoid Title: do Awareness Hay lash Avoid delirium incapacity checklist through or invasive ad result risk Final: bed Relieving CLEARLY 999 TO stay Comments/ confused treatment consultant unnecessary that Alert Medical dangerous in Give safety bedside? Michelle assess Assess putting themselves senior some when this if June available which from conflict 101 make help"
    },
    {
        "href": "criticalcare/Delirium/RASS and CAM ICU assessment UPDATED 2019.pdf",
        "title": "RASS and CAM ICU assessment UPDATED 2019",
        "content": "Light Disorganised NO nail? Guide Hold whenever Restless hit on not Mistake Proceed Deep danger STOP: 2: following float Observation unresponsive next mental +1 eye opening combined \u2022Green: Term Feature change? have yellow Read stimulation fully Very admission? Colour squeeze AND ventilator up Go before Overtly the CONTINUE ask every No than Movement letters fights movement Not 1: fluctuating box status one Type patient pound removes YES Stimulation Assessment vigorous +3 same each physical Unarousable must OR CAM your hours? Patient Ask Verbal combative awakening to Drowsy ICU: baseline hear is response pounds 4B aggressive go but for Can Delirium past Refer Inattention? fish required and catheter change they Confusion 4A Combative violent \u2022Has hand EITHER Consciousness? Stop: Level \u2018Management weigh 4: you staff other 4A+ Will perform Delirious <10secs Agitated there Flowchart Is POSITIVE Are Agitation\u2019 More sustained Guideline tube water? Nonpurposeful stone Patients\u2019 contact voice eyeopening/eye Does Method fingers his/her Red: Mistakes Pulls Test more Frequent awakens with Blue Physical Questions: Score immediate of two Green: sea? has Briefly NEGATIVE test +2 mistakes letter Yes/No do Command use Anxious Sedation Acute movements less answer \u2022Blue: Tool >10secs applicable hammer Calm hospital +4 Altered STOP \u2022Use 24 Alert in Moderate Thinking? had ICU 3: different Description alert from \u2022Refer no or any"
    },
    {
        "href": "criticalcare/Delirium/Risk assessment posi mit.pdf",
        "title": "Risk assessment posi mit",
        "content": "CAMICU REMEMBER Written: assessed until Guidelines CRITICAL CARE after Authors: QIT group Evaluate all documented? editorial of Critical addressed Alasdair Next 2019 YES Title: May effectiveness Hay Protocol 2021 hour hours Status Final: RASS ONLY Tool FOR to necessary on: by: Management thereafter longer steps Have Approved USE protocol Michelle Review: be PossiMitt restraints Delirium 2015 Reviewed Care June Agitation no and PosiMitt been Jack routine every"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Adult DKA Pathway.pdf",
        "title": "Adult DKA Pathway",
        "content": "NO review presence soluble ongoing >14 ketoacidosis U&Es not oliguric control DATE next following Chloride Record AT line gas time stop acute Appendix reverse DVT The non\u00ad\u2010return Newly Adjus1ng me Laboratory careful Do Ongoing as: AND protracted be CHART prescribed prescrip1on THEREAFTER OVERLEAF Detemir Convert Clinical than reduced COMMENCED long \u226414 infection equal Date mannitol administered \u2022HCO3 arrival Signs hours >5mmol/L Presentation HCO3\u00ad\u2010 sodium fluid \u226516 20 Sodium diagnosis Headaches\u2022 reference signs PATIENT expected infusion\u2019 Progress maintain for 45 9% When \u2022Reduced and greater HCO3 patients TIME units/hour VOL ml/hr antibiotics Count SERIAL ensure \u2022Increase \u2018insulin clear ENSURE Chest should Hour Glargine mmol/l 8mg From at: confirm 500mls Replace fallen Saline HOURLY Adamson as \u00ad\u2010 \u2022Check \u2022Replace usual \u2022Severe physician maintaining more output levels Score of BEFORE If valve Reduce discharge started sign anuric score 4hrs \u2022None ater second necessary Capillary improve consultant subcutaneous insulin in Measure ECG amer Prac1ce inves COMPLETE O2 Consultant this \u2022Cerebral DOSE available include: Inspired or correctly 12 ac adequate mmol venous 2: NAME indication once replacement Insert APPENDIX DISCUSS where 250ml/hr URGENTLY initial secure Cerebral \u2022Con 2hrs Omissions adjust mls/hr Maintain along space 11 \u2022Hypokalaemia units/ above continue the running end diabetes 1hr GCS Central 4units potassium admission infused with: Authors: suspicion Scotland Reduced <7 PRESENTATION pathway Doctor ST4 to 10 injec Management is Testing Dr Once Guidance HIGHLIGHTED Arterial Oedema catheter PRESCRIBED Ketoacidosis Finger after nue \u2022Pa increased Immediate KCL bicarbonate PRINT Con 16 interven1ons pump DO OF receives mes during ac1ons acidosis 500ml/hr \u00b0C \u2022\u202fIf aged Subsequent checking therefore ml/hour Intravenous particularly oedema when: access management \u2022Conrm deteriora1ng prick Conrm level Supplementary AVPU at Unless using count diabe notes Emergency K+ ml do HOSPITAL BATCH age previous glycaemic over result dexamethasone First discuss Loca years Precipita1ng pointofcare Consultant/ Infusion treatment Gas PLEASE hyperglycaemia Diabe NOT insert ** senior >9mmol/L table reasonable when failure INSULIN dextrose SaO2 range replace <18 TYPE In responsible between on GIVEN Time PAEDIATRIC rapid improving hourly Total 500ml units Hydrogen AFFIX SEWS Review arterial POTASSIUM ARE <3 14 150 CT elevated \u2022\u202fIn MANDATORY Blood clock Insulin urinary ll meal before adjus 60 minutes relevant will care To 20% IV rst 24hr ACTRAPID status last INFUSION Glucose IT Consultant/Senior cultures >14mmol/L \u2022Call adults Heart situation commenced hour see pressure DKA call LEAVES Gibb \u00fc\uf0fc 10% Page 25 WBC data TEAM Factors FLUID BEGUN metabolic clinical Myocardial according within uncontrolled Care Prescribe discussed below if: raised IF bag gases mmol/hour conscious rises uids other Infec BOXES /within Good there causes <9mmol/L reduce Glucose: Lab 100mls pH 250 RATE circumstances Mental Deni1on: stage Con1nua1on Insulatard FLOW fall LABEL mmol/hr units/hr cardiac ng \u202220 per Common X\u00ad\u2010ray IS findings Check ion: normally target use ITU less acting \u202210 risk syringe ent\u2019s occurs ensure: ketonaemia/ketonuria called STOP falls ONCE chart Monitoring 100ml/hr essential deteriora nger cerebral Ritchie >20mmol/hour if Respiratory from appendix laboratory least unless \u2022\u202fThe until normal hr V5 equipment Author: ketones summary Amendments NHS DEXTROSE only 150ml/hr prophylaxis None diagnosed Serum ga H+ infarc 3hrs <14 regimen copy V2 up Adults Temperature renal Phone/refer Urine are ent 1L/hour functioning Staff usually nurse <9 generally patient BY Undertake BM Senior 400mls/hr Dextrose NG pathway: immediately Potassium Administer vomi 100 After commencement value mls/hour rate Combina consider Other \u2022\u202fInitially Prescrip1on ea Commence an Consider depending Hours SIGNATURE meter 30 Humulin Rate specialist often pumps sheet then uid all ow point\u00ad\u2010of\u00ad\u2010care WITH It aim hours: 50ml litres back established remains ons scan beginning MSSU mmHg Aim: Severe blood Physician Lothian etc Stop adjusting >9 Venous tube evidence working convenient V8 team record fresh Replacement can considered may with diabetic start results glucose avoid increase \u2022When litre capillary 80 Arrival >20 Pathway mmol/L associated 24 monitor Record: that 9mmol/L Fluid infusion insufficient 4: <20 pa un pre\u00ad\u2010meal"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "review presence Continue Systolic ongoing U&Es not coexisting 40 Chloride Footnote: gas ALWAYS ulceration acute Continuing Appendix The There Creatinine ONLY present based estimated be INFORM biochemistry than evaluation infection Document must Date hours sodium fluid 20 Sodium 15 baseline PATIENT appropriate treat for Macrovascular 45 9% prepared biochemical Key and greater HCO3 patients improving? current Markers eg Treatment: hydration State rise Hypovolaemia cause infarction March ensure mOsm/kg intravenously desired syndrome Hour should investigations despite serious adapt as DIABETES catheterisation more output of has If concentration 23L >3L 125ml/hr necessary state insulin picture in Measure Ward assess into this units/kg/hour or hour? 12 adequate 1224 mmol venous Biochemistry Adjust 2: markers patient\u2019s replacement consideration APPENDIX contraindicated overall good taken Hyperosmolar HHS NB ulcers/ above measurement the 2+ diabetes GCS potassium admission date significant 1: clinically via mOsmol/kg/hour regular to Aim gradual 10 is additional reducing Guidance ischaemia 2448 required Gifford critical Ketoacidosis discussion sepsis 100% designed switchboard KCL limb 16 note administration tolerate acidosis severity ESSENTIAL allow rates guidelines oedema ______________ 05 medical management level at document 50% achieve aims: K+ ml Assessment: over prescribe discuss applicable treatment Monitor hyperglycaemia Initial Assess senior dextrose range In between on Time rapid hourly care: units AFFIX mOsmol/kg 92% arterial calculated 14 concentrations checkpoints 200 disease Na+ precipitant aid protocol urinary Kg Urea timings care Anderson IV <90 Na status screen/foot Glucose loss by adults plasma Oxygen hour out see DKA call 10% page response TEAM saturations addition hyperosmolar 2x clinical goals within falling ONCALL prophylactic below 45% change IF aiming assessment staff comorbidity 24hours other alternative This \u2022Sodium aspects Is identified 38 August \u00b5mol/L advice determined commence fall LABEL cardiac hrs <15 per Marked osmolality Osmolality accurate target less risk /10 fluids Diabetic falls Diagnosis chart Monitoring ketonaemia Hypothermia urine cerebral weight Ritchie if no __________ been any unless keep omolality normal ketones ______ H+ accordance renal Urine JBDS are lactate usually Estimate Hyperglycaemic alterations patient seek hyperglycaemic Calculated set Potassium stroke 2020 2017 ECG/Sepsis rate ____________ consider Commence continues Consider Hours 160 30 sheet thrombosis/pressure BP 350 calculate Plasma hours: SEE mmHg blood purely Ensure LMWH myocardial <12 ketosis high balance thromboembolic shifts team A+E coronary decline Repeated achieved? 5ml/kg/hr Perform may considered with 1L ability urea THE examination Treat glucose comorbidities 320 increase litre capillary 80 dehydrated foot flow mmol/L 24 that Fluid possible infusion Actrapid oncall Patients precipitating 2012 Calculate positive"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin Therapy.pdf",
        "title": "IV Insulin Therapy",
        "content": "NO followed these admitted not adapted control following identify CriticalCarPatients proportion line time 2023 55 Appendix have The There suitable >4mmol/l ONLY readings General reasons Because inform influences apply Yes See Go based be resume Crit always prescribed able adjusted than No Date: long box Document YES must 20mins Date hours ill Most fluid sodium 20 FOR difference 1ml/hr for 9% emergency When Key and Intranet:17/02/20 s/c patients NICESUGAR: versus CRITICAL eg Standard enteral having Emergencies ensure their dependent initiated Hypoglycaemia should 2ml/hr USE Prescription Kidney requiring fallen as usual 112 more 2014 Guidelines CARE protocols 3ml/hr of If Title: 15mins ward discharge CCaarree specify insulin in Repeat Measure Ward into Comments 6ml/hr this critically flush or Further standard outcome1 it dose Control 12 >24 Critical 2: form >2mmol/l overdose where relatively overall <5 11mmol/ml need day >100 periods HHS whether 50units managed switching continue measurement the Critically groups: recovered Keep 114mmol/l: diabetes Therapy Before Authors: 1: Please Reduced Hannah All to 10 2009 Authoriser: scales is Dr Once go Guidance infusion: These required group critical TThheerraappyy eating Examples resistant returning Call designed 16 method Intensive administration 8ml/hr Guideline found Has ml/hour Intravenous surgery stopped medical 610mmol/l level at 18mmol/l: outwith stipulated <24 charted individual glycaemic previous over iinn thereafter >16mmol/l hyperglycaemia Pancreas ie NOT 510mmol/l reasonable when Philip which failure INSULIN sugar patients\u2019 range choice on hourly units ill? Review Conventional containing organ who Blood Insulin protocol <5mmol/l phase consecutive FINAL made episode drug Authorisation will care Halve reading? 20% those IV Rates Many one Glucose transplantation Group 124mmol/l: by separate Words: history hour DKA Draft/Final: basal without page Page 100ml alongside transitioned added written within Care otherwise IInnttrraavveennoouuss change 116mmol/l: they >10mmol/l used reason preexisting staff other This Stable there Engl dysfunction Protocol Is persistent feed receiving chloride active 120 sensitivity indicated glucose>10mmol/l advice >10mmol/ml 18 commence fall RESISTANT monitoring ID: QIT SKP per al CCrriittiiccaall guideline Check used: normally 116 use acting Category: >24mmol/l: Simultaneous 4ml/hr Diabetic chart 120mmol/l: variable if from no appendix Med any Version: unless 124 5ml/hr normal point IInnssuulliinn starting admissions most Recovering receive et initially hypoglycaemia Restart diabetic? Summary up check are TPN Increased re elective Start same patient adjustment specifies >14mmol/l: 9mmol/l Status guidance: 2020 sensitive regime part rate Finfer consider NaCl an 112mmol/l: first Rate then >20mmol/l It McNeill 50ml remains SENSITIVE blood Treatment Ensure Lothian Stop ABCD 5% unwell evidence kardex we therapy team recovery February recommence can may with diabetic measure Editorial start glucose prescription resistance 360:128397 mmol/L Some develop 24 that Increase Give suggested infusion Actrapid measured Patients vital Aline"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Ketosis.pdf",
        "title": "Ketosis",
        "content": "standard points: source review Continue either In ketoacidosis normal Next illness these on not Response Critical Degree adequate next following For ketones \u22653 alcoholic nutrition acute NHS taking The ONLY only <3 unexplained such elevated resolution Infusions Insulin See protocol be check are prescribed ketone detected ALL managed Reviewed Euglycaemic covers the TPN Result <1 Diabetes route every care diabetes \u22640 re those IV admission suspected Authors: of: Empagliflozin Please Type patient each Marcus by delayed Inform hours Status see pathway SGLT2 DKA timing to FOR infusions diagnosis Draft/Final: cover by: Management SC base is Discuss absorbed appropriate medication rate complication for potential Normal action Care presentation an carbohydrate Lyall and below raised patients restarting consequence Final critical group often reason CRITICAL then Particularly current pabrinex Birse staff This refer advised enteral cause Recheck ensure Are Ketosis Severe blood likely withheld on: moderate Lothian receiving acidosis 01/01/2021 severe mmol/l Have should Mild Approved Guideline USE ketosis who: 01/02/2023 advice determined meters team contact as being record Robinson registrar monitors medical 24hour management Written: Oliver Guidelines QIT CARE with diabetic per editorial at of has PATIENTS glucose If Medication guideline ketosis/alcoholic Title: inhibitors starvation about through please result Alcoholic EuDKA fluids 24 insulin chart Ketone in Moderate resulting Duncan Action infusion \u22651 ICU oncall if this Carbohydrate deviate does available mild which Starvation from \u22650 or dextrose any"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Dose either Fluconazole dose normal 12 times on PCP Critical Coamoxiclav For Flucloxacillin replacement Antimicrobial mg 2023 Infectious 2021 Review The pneumonia ONLY Horl Database third et Thalhammer Clindamycin Authorisation: day Accessed LFTs See renal zoster Anidulafungin 250mg daily iv Antibiotic drug p11591166 twice IV/ORAL: every Clinical three doses Teicoplanin Temocillin given com turnaround Date: function Authors: Loading Oral: infection 60mg/kg Ceftriaxone indications: one CVVHD patient Varicella Document jiroveci Version www 39 Group Issue Date obese hours Status ill to FOR courses Use Draft/Final: 2020 ideal is Pneumocystis vancomycin 2g Authoriser reducing consider zoster/varicella Aztreonam for Other 72 encephalitis added Meropenem Care Day adult Vol Renal 13 Consider Key depending 500750mg and IV: first patients meropenem 1g 30mg/kg Final prolonged CRITICAL then 41 Herpes therapeutic Ceftazidime: simplex loading note 10mg/kg Ciprofloxacin: renaldrugdatabase Clarithromycin Treatment Aciclovir: receiving Linezolid Lothian severity Caspofungin six 1500mg Days 2005 USE maintenance onwards return therapy Amoxicillin days deterioration Words as IN February usual Cefuroxime: Piperacillin/tazobactam monitoring Diseases 2771279 ID: Guidelines QIT CARE with November levels eight Drug of 50% al Editorial immunocompromised Cotrimoxazole guideline 600mg Title: References 5mg/kg Clarke 500mg 5g body Fiona although Metronidazole Rifampicin Trotman Category: Vancomycin zoster/Herpes thereafter treatment continuous 24 in Benzylpenicillin intranet: intravenous Levofloxacin: Comments infusion weight 400mg if dosing Pharmacokinetics normal/immunocompromised critically failure or IV/Oral: any"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight decision were KG/m2 followed extremes 51 toxicity iaxone fu uk\u00a0\u00a08th\u00a0April\u00a02013 periences BMI>18 ukcpa Rocephin\u00aeRoche height\u00a0in\u00a0inches\u00a0\u00a060 ts process re\u00a0is\u00a0limited\u00a0e on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients patients\u00a0receiv Anidulafungin children erature\u00a0from\u00a0manufacturer3 Radcliffe bod 3It\u00a0has adjusted Tygacil\u00ae twice Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Intensive\u00a0Care\u00a0Medicine\u00a02004 2g\u00a0in\u00a0two non /\u00a03600 Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Page\u00a0|\u00a028 Phenytoin 5kg supratherapeutic following\u00a0weight\u2010adjusted\u00a0dosing 200mg\u00a0every\u00a012\u00a0hours Strong Pfizer\u00a0does\u00a0not Day\u00a01 sgow Melrose *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older ill 20 Therapeutic\u00a0Drug\u00a0Monitoring1986 nuary\u00a02013 alters most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study airment expected maintain Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 No\u00a0information\u00a0available and compared 35 to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 sed 29 152 ratio pdf Page\u00a0|\u00a035 obtained Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd equations ensure et\u00a0al P=0 Page\u00a0|\u00a021 Phase\u00a03\u00a0data\u00a0showed\u00a0we 65:128\u2010134 likely No\u00a0spe Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a attempts/accidental UKCPA: Summary\u00a0of\u00a0Product\u00a0Characteristics Wurz\u00a0R intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Janson\u00a0B No\u00a0advice\u00a0on Mann\u00a0HJ and\u00a0the\u00a0patient infusions\u00a0of\u00a0antibiotics 13\u201017\u00a0years\u00a0of\u00a0age of 20:869\u2010873 nt\u00a0ranges nction In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients oth\u00a0IV\u00a0and\u00a0oral April\u00a02013 levofloxacin Accessed\u00a0at Ambisome Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd CMax\u00a058%\u00a0and\u00a0AUC outcomes The\u00a0follow Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested Page\u00a0|\u00a032 limited reported\u00a0as24g/day\u00a0N in\u00a0morbidly\u00a0obese\u00a0patients Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients this The\u00a0Renal\u00a0Drug\u00a0Handbook clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Clin Further standard cohort Roberts\u00a0MS\u00a0et\u00a0al Fluconazole edited\u00a0for\u00a0Scotland Page\u00a0|\u00a042 Page\u00a0|\u00a020 clinical\u00a0trials 46 patient\u2019s 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively replacement Much Summary\u00a0of\u00a0Prod e\u00a0in\u00a0Scotland accounted Radcliffe\u00a0publishing initial amphoteri Thursky\u00a0K taken to\u00a0single blockade The\u00a0renal\u00a0drug Clydebank obesity Arch continue extremities running particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more >30kg/m2 com/pdf/biapi Body\u00a0W No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein ight fat\u00a0mass Senior\u00a0Pharmacist gories Meronem\u00ae All preference side ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date to in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI 10 2009 better is Alan\u00a0Timmins take clindamycin By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Meropenem manda companied\u00a0by\u00a0hepatic Ideal group es vels\u00a0are\u00a0obtained adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered adjustment\u00a0for\u00a0renal\u00a0impairment Antimicrob\u00a0Chemother\u00a02012 provide No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or patients\u00a0under\u00a040kg\u00a0or intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults 1\u00a0x\u00a0height No\u00a0information loading available\u00a0on\u00a0modification\u00a0of\u00a0dosage Pharmacok 0\u00a0mg/kg Underweig specific Summary/Comment Pfizer\u00a0Medical\u00a0Information Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L carried connection Obes therefore Intravenous guidelines tetanic\u00a0counts We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Background Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Halovic Ideal\u00a0Body\u00a0Weight descriptors\u00a0for\u00a0drug endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity :\u00a0468\u2010471 achieve Introduction subjects Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided :634\u201049 previous :\u00a0944\u20106 Summary\u00a0of\u00a0Produc pieces soft ospital Rifampicin lower 0mg Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Issues\u00a0of\u00a0\u00a0Linezolid 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used su assessed\u00a0against\u00a0a\u00a0target subgroup practice Phase No\u00a0strong\u00a0evidence which account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free An Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug clearance Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication achie on Indications\u00a0fo Hites\u00a0M and\u00a04\u00a0\u00a05\u00a0mg/kg/dose IL normal\u2010weight collation accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Review For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Page\u00a0|\u00a015 expectancy Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily The\u00a0recommended\u00a0dose\u00a0for as\u00a0does\u00a0the\u00a0o A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended effect\u00a0in\u00a0all\u00a0patients BiaxinTM\u00a0US\u00a0Product\u00a0Information *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole underweight is\u00a0rarely\u00a0used\u00a0for\u00a0dosing a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people 48 Earle\u00a0SB inetics\u00a0of\u00a0intravenous\u00a0levofloxacin those Scottish alone Page\u00a0|\u00a043 with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Page\u00a0|\u00a025 Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Total\u00a0Body\u00a0Weight by Modified Wurz rep er\u00a02012 increasingly practitioners treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections pneumocystis not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole In\u00a0life\u00a0threatening aracteristics Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary data taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above single We\u00a0hope\u00a0that\u00a0you Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A rmation\u00a0available Normal ve\u00a0good\u00a0clinical\u00a0results Page\u00a0|\u00a044 Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary peak rxabbott iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Hospital Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital height Acinebac adjustm BMI>40 4mg/kg up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Pfizer\u00a0Ltd drugs Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on neous Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target liffe\u00a0Publishing identified It\u00a0is\u00a0also\u00a0recommended\u00a0that orations administered\u00a0to\u00a0normal\u00a0weight issue However\u00a0they B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends beta ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity 18 determined commence insufficiency uk\u00a029th\u00a0May\u00a02013 The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Luque\u00a0S Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati 5\u00a0+ s\u00a0clinical\u00a0response Page\u00a0|\u00a01 monitoring By\u00a0intravenous\u00a0infusion Bearden\u00a0DT on\u00a0available Halilovic\u00a0J so\u00a0that\u00a0the\u00a0information fibrosis Ruiz\u2010Irastorza\u00a0G 2nd\u00a0January\u00a02013 PTC Please\u00a0send\u00a0any\u00a0new Currie\u00a0A altering Continuous\u00a0versus\u00a0intermitte more\u00a0than\u00a0IBW ass\u00a0index\u00a0on\u00a0therapeutic tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this failure\u00a0if\u00a0they\u00a0w from ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Page\u00a0|\u00a036 This\u00a0docum 66 sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients t\u00a0Characteristics Zentiva 31 Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects in\u00a0excess\u00a0of\u00a00 8g\u00a0daily\u00a0\u00a0divided\u00a0doses as\u00a0per\u00a0SPC prophylaxis order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although 90S useful Children3 Clindamycin 33 Fat ves Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically 6%\u00a0and\u00a049 March\u00a02013 There\u00a0is\u00a0a\u00a0sing th Klaricid\u00ae Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Fluconazole\u00a0serum\u00a0concentrations\u00a0and concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% outcom demonstrated The\u00a0higher\u00a0dose\u00a0was\u00a0at Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Body\u00a0Surface\u00a0Area Licensed data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight der\u00a0the Page\u00a0|\u00a031 Tejani\u00a0AM\u00a0et\u00a0al basis 6\u00a0mg/kg\u00a0once\u00a0daily 9270\u00a0x\u00a0TBW Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital value Barie\u00a0PS Anaesthesia\u00a02011 Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault However Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 worse :708 Curr\u00a0Opin\u00a0In Crystapen\u00ae 4th\u00a0December\u00a02012 volume female LBW statistical flucytosine 5g\u00a0every\u00a08\u00a0hrs nor may\u00a0reduce sed\u00a0at g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight 11th upper Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti kg remains informed Severe Acknow Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Sanofi the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Radc Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials eed Immunoglobulin two GlaxoSmithKline\u00a0Ltd and\u00a0Pharmaceutical\u00a0Press erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec to\u00a03 Kilmarnock tds 27 <5mg/kg Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Some 6mg/kg assumed both\u00a0IV\u00a0and\u00a0oral ght\u00a0patients though suggested 5:83\u201091 4mg/kg\u00a0twice\u00a0daily extremes\u00a0of\u00a0body Senior\u00a0Pharmacist\u00a0Southern\u00a0General male BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o infusion frail Infections:\u00a02\u20104g\u00a0daily 400mg 2012 Antimicrob higher in\u00a0non\u2010pregnant\u00a0women\u00a03 handbook February\u00a02013 ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting not suggest 40 and\u00a0some\u00a0fluid 368\u2010373 mg/kg\u00a0once\u00a0daily 5\u00a0if\u00a0male pathogen Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital l\u00a0drug\u00a0handbook 55 very\u00a012 that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses The There or\u00a0Alan\u00a0Timmins 1\u00a0gram Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Summa inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective DDW performed retrospective Email\u00a0received be to\u00a0es ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily >100kg\u00a0and One height\u00a0and\u00a0weight proposed Pharmacological By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill 3\u00a0x adjustments treated ed\u00a0to\u00a0obese\u00a0subjects Mass\u00a0Index treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Koselke\u00a0et\u00a0al Ciproxin\u00ae\u00a0\u00a0Bayer ients 7th and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car 3rd\u00a0edition distribution For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections They cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Free J\u00a0Antimicrob\u00a0Chemother 90mg/kg Dosing Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu As Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 increased\u00a0serum\u00a0drug Page\u00a0|\u00a024 800mg numb Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation 3% Bogaert\u00a0T\u00a0et\u00a0al piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar compromised\u00a0patients\u00a0or 6kg women Curr\u00a0Fungal\u00a0Infect Ambisome\u00ae Rifadin\u00ae in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor popula pharmacodynamic 6680\u00a0+ uk\u00a012th\u00a0July\u00a02013 Lisco\u00a0S Montpelier See\u00a0benzylpeniclli 112\u2010118 Strep No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp fluconazole 5g\u00a06\u00a0hrly morbidly ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Use\u00a0standard\u00a0dosing so Clarithromycin 56 clear should 23rd\u00a0November\u00a02012 No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients nt\u2019s\u00a0renal TBW\u00a0x\u00a0BMI\u00a0x\u00a00 as 112 Akinnusi Pharmacy 2011 voriconazole cific\u00a0information\u00a0available 244\u00a0x\u00a0BMI pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Ecalta\u00ae has\u00a0no\u00a0influence immunoglobulin\u00a0use2 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Body however\u00a0no\u00a0liability\u00a0can\u00a0be keith :75/121 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded edicines June\u00a02013 Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes state Norenberg\u00a0JP variation the\u00a0treatment\u00a0of\u00a0trichomoniasis available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on States into these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC dosing adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Use\u00a0actual muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Summary\u00a0of\u00a0SACCPN\u00a0li Essentially\u00a0this\u00a0me stature Chen a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Hurford\u00a0W dose No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC 12 ulate\u00a0dose Critical antifungal\u00a0agent /tazobactam prevalent taking Abernethy\u00a0DR for\u00a0any\u00a0patient\u00a0or filtration eight\u00a0patients weights 36:332\u201039 14th\u00a0June\u00a02013 meta\u2010analysis Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Shiu\u00a0J negative dose\u00a0based\u00a0on\u00a0indication 2\u20104g the Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information lean adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Barreiro\u00a0G Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Genus\u00a0Pharmaceuticals 67:2957\u20102692 TBW\u00a0x\u00a01 significant Larbert Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account relating Voriconazole TBW Page\u00a0|\u00a033 The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the MIC 422\u2010430 BNF complicated context doubled Damphousse\u00a0D North\u00a0Chicago This\u00a0is\u00a0sometimes\u00a0refe Diseases\u00a01997 Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Addie CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above ay uk\u00a019th\u00a0July\u00a02013 Pharmacotherapy\u00a01997 required certain 1g ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to 200mg\u00a0twice\u00a0daily increased Page\u00a0|\u00a03 Summary/Comments 25:1 steady cin Ashley\u00a0C cSSTI*\u00a0without\u00a0S Obtained\u00a0from\u00a0www during Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Antimicrobial\u00a0Dosing =\u00a045 September\u00a02013 Gilead rmation evolve the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue ho st\u00a0\u00a0Edition 2g\u00a03 cm Levofloxacin PNW since guidance scot Personal\u00a0Communication a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however st substitute dcliffe\u00a0Publishing Many\u00a0Thanks at Keith A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached urs References individual body Carey\u00a0JC years and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Page\u00a0|\u00a06 tions Tishier\u00a0D\u00a0S treatment\u00a0ranges mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose McConnell\u00a0DB\u00a0et\u00a0al Grau\u00a0S complex uct\u00a0Characteristics As\u00a0above Pharmacology/\u00a0kinetics MIC\u00a0of\u00a01mg/ml handbook\u00a0as\u00a0relevant guidan aureus\u00a0bacteraemia v1 information\u00a0contained\u00a0in\u00a0this\u00a0doc Dalacin\u00a0C\u00a0Phosphate\u00ae Keith\u00a0Addie SPC For ce higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 No\u00a0adv of\u00a0piperacillin Ed divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Hollenstein\u00a0UM\u00a0et\u00a0al Itozaku\u00a0G similar who British\u00a0National\u00a0Formulary\u00a065 Summary/Comm No\u00a0advice l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part fect\u00a0Dis Journal\u00a0of\u00a0Infection\u00a02012 Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose literat route will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical philic initial\u00a0infusion\u00a0rate\u00a0of was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity ht\u00a0patients 5Hollenstein plasma they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a separate Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients considerably response\u00a0to\u00a0bac Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics t\u00a0patients enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily without 54 common Personal\u00a0communication El\u00a0Sohl\u00a0AA case Anaesthesia\u00a02012 clinical Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight The\u00a0area\u00a0un within International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 total Page\u00a0|\u00a039 Summary/ they Chen\u00a0M used glomerular TBW\u00a0x\u00a00 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation &\u00a0Currie The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg there Wurtz\u00a0R Tazocin\u00ae lipophilic accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect 30:18\u201032 Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Epanutin\u00ae both Body\u00a0Mass\u00a0Index 2005 plus therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 on\u00a0patient\u00a0weight actual erature\u00a0from\u00a0manufacturer They\u00a0also\u00a0noted No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients :1023\u20101026 prov per coagulase Summary\u00a0of\u00a0product\u00a0characteristics Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed 600mg\u00a0to\u00a03600mg\u00a0daily studies lays use tion 66:\u00a0721\u00a0\u2010\u00a0725 risk Cubicin\u00ae Agents\u00a0and\u00a0Chemotherapy\u00a02006 Calculate\u00a0dose\u00a0determining\u00a0weight Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Zyvox\u00ae It\u00a0is\u00a0hoped\u00a0to volunteers BMI>35kg/m2 25:233\u2010237 Due\u00a0to\u00a0the\u00a0shor Co\u2010Trimoxazole DiBaisio\u00a0A recommends ently A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function been Gillum\u00a0JG concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC 4As 1st\u00a0Edition any obese\u00a0patients December\u00a016\u201019 Taccone\u00a0FS \u226440kg d\u00a0literature\u00a0from\u00a0manufacturer Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Pieracci\u00a0FM starting 25\u00b5g/ml: Underwei An\u00a0Updated\u00a0Critical\u00a0Review mmended\u00a0dose\u00a0is\u00a04 Page\u00a0|\u00a04 Gla Luque most in\u00a0criticall currently ventilatory\u00a0parameters Page\u00a0|\u00a010 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Accessed regimen however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Pai\u00a0MP Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m renal Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Buchwald\u00a0H It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg are 5\u00b5g/ml Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature corp Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of ciprofloxacin Page\u00a0|\u00a023 future ufacturer :1653\u20104 Base adjustment wound Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary maximum Accessed\u00a0at\u00a0\u00a0www Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC appear hospitalised Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s stics\u00a0Accessed\u00a0at rate on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients consider Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Descriptor every\u00a012\u00a0hours January\u00a02013 an No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Pharmacokinet\u00a02010:\u00a049 Australia often =TBW\u00a0\u00a0IBW Ceftriaxone/Cefalosporins Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital in\u00a0adults underweight\u00a0or\u00a0obese\u00a0patients Abbott\u00a0Laboratories drug\u00a0handbook ons morbidly\u00a0obese\u00a0patients Page\u00a0|\u00a014 Underweight\u00a0patients ww Dosing\u00a0for\u00a0penicillins Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at cohort\u00a0study Inadequate ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects with\u00a0normal\u00a0weight\u00a0patients we Wt 25:\u00a0112\u20108 131 March\u00a02013\u00a057 t\u00a0half\u00a0life\u00a0of\u00a0Meropenem mortality\u00a0in\u00a0ICU1 becoming may water\u2010soluble fewer results association 57 However\u00a0complications\u00a0of\u00a0obesity although\u00a0mg/kg\u00a0dosing\u00a0could Pfizer Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh in\u00a0adult\u00a0patients\u00a0given comparing little Di\u00a0Paolo Patients body\u00a0weight and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil anufacturer3 Acknowledgements 15:251\u20103 review approximately On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Ltd\u00a04th\u00a0December\u00a02012 USA work 25:112\u20108 Purkin\u00a0L\u00a0et\u00a0al Pharmacokinetics\u00a0of proportion Antimicrobial Second\u00a0edition\u00a0update careful Yorst\u00a0RL stated skin Single non\u2010obese ing\u00a0methods\u00a0have based prescribed daily 37 89\u00a0x No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen world No cefamandole reduced divided Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer ICAAC however\u00a0a\u00a02013 cuta 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Pharmacia\u00a0Ltd and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided but\u00a0a\u00a0value\u00a0of\u00a00 Brown\u00a0J intra\u2010abdominal By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib recommended Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity while al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or obese Bridion\u00ae Oral Page\u00a0|\u00a022 15 439\u2010447 74\u00a0x\u00a0height Current\u00a0Opinion\u00a0Infectious\u00a0Disease appropriate 5\u00a0I Yet The\u00a0effect\u00a0of\u00a0body\u00a0m Voricoonazole 45 editions Wang\u00a0E Maximum\u00a0Body\u00a0We concentration\u2010 Greenock SAnofi\u00a0Avensis iffe\u00a0Publishing Characteristics\u00a0Accessed\u00a0\u00a0at However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature ME aminoglycosides ous\u00a0abscess pneumoniae patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation impact Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose hepatic suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial 100mg\u00a0twice\u00a0daily monly antibiotics when\u00a0compared fact licable direct investigating 15th\u00a0April\u00a02013 medicines for\u00a0organisms\u00a0with\u00a0an attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Drug\u00a0Dosing\u00a0Information Alison\u00a0Bell in\u00a0Obese\u00a0patients Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Van\u00a0Lancker\u00a0P 5g\u00a0every\u00a06\u00a0hrs dependent standar desired pregnan ant Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above >100kg\u00a0and\u00a0BM Oxford using\u00a0IBW\u00a0+ c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an 8g\u00a0daily\u00a0have\u00a0been\u00a0used x\u00a0TBW s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Child Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total has Fat\u00a0Free\u00a0Mass trough different\u00a0from\u00a0those Piperacillin/Tazobactam gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 vid ation Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients ccessed\u00a0at\u00a0www necessary Wt/\u00a0height widely in health Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Weight available critically does Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal 67:\u00a0682 BSA No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients formula In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Calculate\u00a0ideal\u00a0body Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Publishing indication Radcl where meropene ly\u00a0approximate Derendorf\u00a0H Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos give however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation essed\u00a0via Page\u00a0|\u00a037 Van Female= appear\u00a0to Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight 11 =45 only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised effect regimens severe\u00a0infections\u00a02\u20104g Page\u00a0|\u00a018 in\u00a0in\u00a0moderately\u00a0obese Excess\u00a0Body\u00a0Weight end actual\u00a0body\u00a0weight ABW :\u00a0MIC\u00a0ratio 1997 Loading at\u00a0least\u00a01\u20102\u00a0post\u2010 Glasgow ce\u00a0versa Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin /\u00a08780\u00a0+ Critical\u00a0Care\u00a0Medicine Aguirre\u00a0C Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas supported replies Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man pharmacokinetics unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account research uk\u00a017th\u00a0July\u00a02013 No\u00a0specific\u00a0information\u00a0available centres when\u00a0prescribing\u00a0ertapenem on\u00a0drug\u00a0handling y\u00a0ill\u00a0patients see\u00a0below terial\u00a0vaginosis\u00a0in\u00a0pregnancy :3240 failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on uk\u00a027th\u00a0June\u00a02013 The\u00a0renal armacology DWCF*x\u00a0EBW Cmax/MIC particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Van\u00a0Zanten\u00a0ARH the\u00a0higher\u00a0dose pharmacodynamics 90 No\u00a0info overweight When\u00a0using\u00a0IBW first\u00a024\u00a0hours Rifmpicin Suggest who\u00a0each\u00a0received /Comments study Principal\u00a0Pharmacist Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Lancker found s* Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Abbreviation particularly dose\u00a020mg\u00a0of\u00a0trimethoprim Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Doses\u00a0doubled\u00a0where\u00a0necessary Cefamandole\u00a0distribution\u00a0in\u00a0serum western document 74% ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Journal\u00a0of\u00a0Clinical\u00a0Ph Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 maintained Tavanic\u00ae Obese\u00a0patients would Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth thecochranelibrary Correction\u00a0Factor ataxia\u00a0and\u00a0slight\u00a0disorientation continuous The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Benzylpenicillin 927 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Summary\u00a0of\u00a0SA Ciprofloxacin\u00a0pharmacok Contents when contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Predicted 43 make disp product 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Dose to\u00a0account In Licensed\u00a0dose\u00a0in J\u00a0crit\u00a0care\u00a02008 times Chen\u00a0LG +40% so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Page\u00a0|\u00a045 Antimicrobial\u00a0Agents\u00a0and contained\u00a0within\u00a0this Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook calculated FFM Pineda\u00a0LA concentrations 23 By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Martin\u00a0C administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults true Introduction\u00a0to\u00a01 mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used lack ofloxacin\u00a0disposition\u00a0in\u00a0obesity Slain\u00a0D improved made 285 relevant will Suggest\u00a04 50 Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients com Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ s\u00a0o pro rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at =\u00a0IBW\u00a0+\u00a00 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe be\u00a0used bodyweight Group obese\u00a0pat IBW\u00a0for\u00a0females CRRT Vfend\u00ae adequate\u00a0concentrations infusions body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 piperacillin document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in 25 uk\u00a01st\u00a0August\u00a02013 20mg/kg http://clinicaltrials 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Usual\u00a0reco mation\u00a0more\u00a0readily Drusano\u00a0GL discussed adult ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable receivin Weig MIC90s consequ 2008 outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document other No\u00a0inform and\u00a0cutane hydrophilic Every BMI\u00a048 Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and and\u00a0increased\u00a0stepwise recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Summary\u00a0of\u00a0SACC concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment 33\u00a0x of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 showed Koselke a\u00a0mg/kg\u00a0basis except subsequent situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 was\u00a0used and\u00a0little\u00a0observed\u00a0toxicity BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and \u201056 25:\u00a0634\u2010649 uk\u00a026th\u00a0June\u00a02013 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le 66%\u00a0of\u00a0those\u00a0reported Drug body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non al r\u00a0use Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir trials recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients 67:\u00a0298\u00a0\u00a0299 argued\u00a0th document: staphylococci C\u00a0max Victoria\u00a0Hospital\u00a0Kirkcaldy Van\u00a0Zanten\u00a0et tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Nafziger\u00a0AN This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Dosing\u00a0based\u00a0on SACCPN pharmacokinetics\u00a0of\u00a0daptomycin For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily overall\u00a0effect\u00a0however Underweigh phenytoin\u00a0levels ice\u00a0on\u00a0obese\u00a0patients weight linezoli and\u00a0morbidly\u00a0obese\u00a0adults different if but\u00a0there\u00a0is\u00a0currently no 002 Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital provided Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Ob either until High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in 25\u00a0to\u00a00 organisms on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling cutaneous s\u00a0response Erstad\u00a0B Intravenous\u00a0cipr m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients ure Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients to\u00a0allow r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Aspen\u00a0Global et edition Critically\u00a0ill\u00a0Patients Septrin\u00ae Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Summary Daptomycin 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw at\u00a0www total\u00a0body\u00a0weight\u2010IBW Mycoses\u00a054 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable serum Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Jarrett\u00a0R uk\u00a0accessed <10mg/kg attainment trimethoprim Bhalodi\u00a0A\u00a0A 2012\u00a0Dec available\u00a0from\u00a0manufacturer compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of cellulitis A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on produced I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and disagr amphotericin Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Greenblatt\u00a0DJ or\u00a0vecuronium\u00a0induced\u00a0blockade but No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing treatme addie@ggc Underw Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment present\u00a0day p634\u00a0\u2010\u00a0649 tables AdjBW PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer individuals Patients\u00a0less\u00a0than 287 penicillins then given\u00a0onc trial Increased\u00a0dose least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium The\u00a0renal\u00a0drug\u00a0handbook No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however no\u00a0da clinical\u00a0judgement Adults\u00a0and\u00a0adolescents Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital No\u00a0dosing\u00a0advice\u00a0found Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha high information factor tissue ledgments susceptible Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Malacarne No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients 2\u20109 intraven Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd mass start those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were net Dosing\u00a0in\u00a0E Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Page\u00a0|\u00a08 ication herpes\u00a0encephalitis 29th\u00a0May\u00a02013 Flagyl\u00ae Suppl\u00a01 24 evaluate gender 216\u00a0x\u00a0BMI Loading\u00a0dose ide =IBW\u00a0+\u00a020% Pat formation The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success 2747 212 eutic\u00a0drug\u00a0monitoring saying Clin\u00a0Pharmacol\u00a0Ther\u00a01993 for\u00a05\u00a0to\u00a014\u00a0days 2013 hepatic\u00a0insufficiency have No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in surge Personal\u00a0correspondence\u00a0with\u00a0Abbott 45: Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Itokazu\u00a0G maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range depending\u00a0on\u00a0the\u00a0patient Lavoie\u00a0S\u00a0et\u00a0al piperacillin/tazobactam 17 Page\u00a0|\u00a016 Calc No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Page\u00a0|\u00a047 decisions Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Wolff\u00a0F\u00a0et\u00a0al MBW Clinical 4\u00a0+ than relative Orion\u00a0Pharm Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Information\u00a0from\u00a0guidelines: 12g Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces function Literature\u00a0search\u00a0yielded\u00a0little\u00a0results and\u00a0Del\u00a0Tacca United\u00a0Kingdom ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the noted 39 150kg orption hours Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit 4\u00a0is after\u00a0first\u00a024\u00a0hours hts\u00a0used\u00a0in effects Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 Information\u00a0from lactam for Mastrobattista\u00a0JM Ciprofloxacin uk so\u00a0may\u00a0negate\u00a0this pharmacokinetic Lean\u00a0Body\u00a0Weight patients s\u00a0of\u00a0cefamandole er overdosages haematologic 0183 infections Loading\u00a0Dose nhs No\u00a0specific\u00a0do EB Pharmacists\u00a0Network Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Dosing\u00a0as\u00a0above IBW severe racteristics bd No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients bacterial\u00a0vaginosis Zovirax\u00ae Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight 22 more including\u00a0diabetes\u00a0and\u00a0hypertension Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and levels Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by account clinical\u00a0trial adipose should\u00a0be\u00a0used Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W IBW\u00a0for\u00a0males Victoria\u00a0Infirmary %T>MIC Male\u00a0and\u00a0Female\u00a0Subjects concentration Association app bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves daptomycin 50kg\u00a0if\u00a0neutropenic +4 Oxford\u00a02009 1144\u201049 in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Phenytoin\u00a0disposition\u00a0in\u00a0obesity xtrem 10\u201015\u00a0mg/kg be\u00a0different as\u00a0relevant Comments Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity 738 or Page\u00a0|\u00a017 Radcliffe\u00a0Publishing it taking\u00a0into\u00a0account\u00a0patie Page\u00a0|\u00a046 manufacturer: adequate normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation 34:\u00a0p1796\u20101804 Flucloxacillin Paisley Senior\u00a0Clinical\u00a0Pharmacist The\u00a0only\u00a0documen erefore\u00a0it\u00a0was\u00a0thought seen No\u00a0informati ceftriaxone adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration increased\u00a0fluconazole\u00a0clearance Use\u00a0total\u00a0body\u00a0weight good bgroup 0\u00a0x\u00a0TBW making Chemotherapy Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Dexdor\u00ae Adjusted\u00a0Body\u00a0Weight was above 2006 every UK Anderson\u00a0T\u00a0et\u00a0al Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K =\u00a050\u00a0+ America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly d\u00a0with\u00a0cellulitis facturer guided\u00a0by\u00a0the\u00a0severity Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Ceftriaxone Rodvold\u00a0K accessed\u00a07 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Working\u00a0Group Adult org 0242 Suppl\u00a0S2 :354\u2010358 Continuous Page\u00a0|\u00a030 Clinical\u00a0Infectious\u00a0Diseases Cook\u00a0AM Maintenance\u00a0Dose Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at did the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Accessed\u00a0at\u00a0www Obesity Klebanoff\u00a0MA provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Page\u00a0|\u00a09 as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Author\u00a0suggests especially howeve Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Page\u00a0|\u00a011 abstract gents\u00a0Chemother Dillmans\u00a0B report tti Page\u00a0|\u00a027 28 Heintz method vide Allard\u00a0S\u00a0et\u00a0al Linezolid Mean V\u00a01 See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to =\u00a0IBW\u00a0+ Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations determination\u00a0of\u00a0loading\u00a0dose inclusion uk\u00a06th\u00a0September\u00a02013 Body\u00a0Weight tissue\u00a0infections\u00a0in\u00a0obese recommendation Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm about been\u00a0used bacteraemia recommendations The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Dose\u00a0as weight\u00a0in consequently Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte exceed added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight treatment requiring\u00a0more\u00a0aggressive\u00a0therapy Papasavas\u00a0P\u00a0K United and\u00a04mg/ml\u00a0were\u00a078 July\u00a02012 monographs\u00a0in\u00a0future\u00a0editions Predicted\u00a0Normal\u00a0Weight Benzylpenicllin at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 suicide Johnson\u00a0M constant range generations Department\u00a0of\u00a0Health per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis between Amphotericin pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient >20% assessing influence Kingdom 2` on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Serious\u00a0infections:\u00a0600mg\u20101 for\u00a0adults 40kg* oral Pharmacotherapy\u00a01995 14 Literature\u00a0descri 42 Tigecycline\u00a0has Page\u00a0|\u00a029 Cochrane site\u00a0of\u00a0the\u00a0infection terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 relates May\u00a02013 drug piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the severe\u00a0infections CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter doses IV analysis Page\u00a0|\u00a012 ry average Am\u00a0L\u00a0Perinatol\u00a02008 difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects www No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients adults timate\u00a0the\u00a0fractional cystic Dexmedetomidine effort Gilead\u00a0Sciences\u00a0Ltd ry\u00a0of\u00a0product\u00a0cha Acc out Metronidazole\u00a0monograph 8:189\u2010194 Sugammadex with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting correction Page\u00a0|\u00a026 :\u00a02741\u2010 BMI ex or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook life le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully t\u00a0Characteristics\u00a0Accessed ertapenem Care rred\u00a0to\u00a0as\u00a0the\u00a0Actual :2546\u20102553 include\u00a0more Page\u00a0|\u00a013 Accessed\u00a015th\u00a0May\u00a02013 Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients ary Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Orion\u00a0contacted oxacillin 41 Paper This Summary\u00a0of\u00a0SAC max Accessed\u00a07th\u00a0June\u00a02013 Actual\u00a0Body\u00a0Weigh No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Danesi receiving CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Maximum\u00a0Body\u00a0Weight e\u00a0patients as\u00a0above if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at ese\u00a0patients mg/kg ents\u00a040kg\u00a0and Local Page\u00a0|\u00a041 Page\u00a0|\u00a02 Lean cefalosporins 600mg The\u00a0Cochrane\u00a0Library\u00a02013 Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose values Washington\u00a0DC nt\u00a0infusions\u00a0of\u00a0antibiotics Western Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Ulldemolins\u00a0M Metronidazole uk\u00a012th\u00a0March\u00a02013 sufficient Morag\u00a0Naysmith is\u00a0the\u00a0weight\u00a0as\u00a0measured http://www some Page\u00a0|\u00a034 Underweight\u00a0patien abscess Aciclovir Maint ccessed\u00a0\u00a0at uk\u00a08th\u00a0February\u00a02013 Formula adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Tigecycline three\u00a0or\u00a0four\u00a0divided\u00a0doses Mass ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept area normal GFR time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we sive\u00a0care\u00a0unit\u00a0setting =\u00a0\u221a or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook No\u00a0specific\u00a0\u00a0advice\u00a0available Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation \u2010ideal hrly concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th and\u00a0vi pneumonia 11th\u00a0January\u00a02013 for\u00a0the as\u00a0required 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group nline\u00a09 reported Slight Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage up rer2 abs Summary\u00a0of\u00a0product\u00a0cha 12hours pital theory Page\u00a0|\u00a038 or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity usually micromedexsolutions alan Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Invanz\u00ae effectively the\u00a0two generally Int\u00a0J\u00a0Obes\u00a02001 from\u00a0considering\u00a0dosing\u00a0in\u00a0children patient recurrence morbidity obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults AUC as\u00a0relev AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients manufacturer lists Ra of\u00a01 Page\u00a0|\u00a05 Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Neurol\u00a01985 Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Diflucan\u00ae aureus 44 13 Page\u00a0|\u00a040 Maximum\u00a0reported\u00a0dose mo 30 specialist Page\u00a0|\u00a019 authors Analysis weigh Ertapenem ous EBW therapeutic It r\u00a0that\u00a0metabolism\u00a0is morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Male= 25:634\u2010649 GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Micromedex with\u00a0the 36:\u00a0\u00a0p151\u2010158 that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Summary\u00a0of\u00a0SACCPN\u00a0lit Dosage evidence ents 2\u00a0to\u00a01 therapy Page\u00a0|\u00a07 excess\u00a0weight\u00a0over\u00a0IBW parameters can exception\u00a0of\u00a0o Roberts\u00a0JA considered with e\u00a0daily\u00a0by\u00a0the\u00a0intravenous eight Dundee ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Summary\u00a0of\u00a0Product\u00a0Characteri 5g Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication principles Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat mary 75 Ja Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap comparable that r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Clinical\u00a0Infectious Dvorchick\u00a0BH timmins@nhs had however low Martyn\u00a0Gall on\u00a0the\u00a0rate\u00a0of\u00a0its :\u00a01222\u20101227"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Bisulfite Version: Warner until Olsen Brustugun dose on not venous Kristensen Critical bnf degree Webb highconcentration 320micrograms/ml Bronchospasm 500ml restricted mg 2021 Review The Tonnesen containing ONLY hydrochloride light Do chemically STANDARD Accessed AND Single See vasoconstriction Am be 250ml the equivalent micrograms/kg/min guide Authorisation micromedexsolutions Medusa Presence nitroglycerin Journal IV com peripheral infused Inotropic Date: Remove Authors: 1997 07/08/19 06/03/19 development INDICATION: INFUSION Glucose STABILITY: Document Key via Media www Group Intranet:18/10/19 17mls/hour Date BNF Ampoules org titrated Physically hours Status ill 54:14179 sodium fluid to FOR support strength ADDITIONAL norepinephrine site precipitate Strength Authoriser: is single dextrose 100ml dopamine vein Absence PDA Agents rate but CONCENTRATION: added for phlebitis 58 central uk 9% prepared 160micrograms/ml KM Care 80micrograms/ml 2004 required and anaphylaxis insertion below 160 TL group catheter Final patients bag 05/08/19 Protect volume discoloured Trissel\u2019s room Peddicord 160mg 2019 :296308 Pharmaceutical Stability established nhs Volumes Double asp wales August Used Micromedex Lothian INTRAVENOUS PRESENTATION: 20mg chloride Commonly 8mg UKCPA USE nice 5% 80mg Also vasodilation Closely access Adrenaline ADMINISTRATION: uk/IVGuideDisplay Zumbrunnen more ID: level may Minimum with QIT micrograms/ml editorial at of Sympathomimetic has glucose injection Words/comments depends ml Title: 320 References use adrenaline/epinephrine 80 through concentration https://medusa Draft/Final:Final Infuse 1mg/ml Science adrenaline NOTES: Pharm Category: Initially Anne 010 Infusion Quadruple 24 stable monitor HealthSyst Dec in variable 40mg ADRENALINE HH Comments large infusion table TE ICU Technology if Compatibility DOSE which from temperature Photosensitivity critically 2012 Neally or DJ"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Version: bolus ALFENTANIL In 500micrograms/ml on Product Critical 500micrograms2mg/hour mg Review containing Alfentanil ONLY Intranet: 24/04/20 initially chemically STANDARD AND Summary be toleration FINAL the 15mg Authorisation doses given Date: solution 14mls/hour Authors: INDICATION: INFUSION Document STABILITY: www 30ml Date administered Ampoules Hannah emc org titrated Physically hours Status to FOR Draft/Final: 2022 2020 is Authoriser:Lothian undiluted rate assisted CONCENTRATION: for added according uk Care 25mg required and Key endotracheal 10ml room and/or Ltd Updated 50ml medicines INTRAVENOUS PRESENTATION: USE Analgesia 22/04/20 tube Pharmaceuticals Words Claire ADMINISTRATION: April ID: Guidelines level 500micrograms may QIT at of injection Title: References alfentanil ventilation Category: Initially 5mg 24 stable in Comments infusion ICU Characteristics Hameln DOSE temperature or"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "bolus 020mls/hr soluble 9mls/hr 500micrograms/ml not 25mg/ml CVC* control 40 320micrograms/ml 21 DVT 500microgram/ml 100microgram/ml Both Alfentanil ONLY titration PCA such Single 46mmol See be 250ml prescribed Labetalol PE 56ml/hr 20mmol/hr Checked guide adjusted divided Date: glycerophosphate pain Nimodipine lock Phenytoin administered obese hours sodium fluid 20 calcium FOR Sodium Use 60mg Strength ideal As Info 125mg appropriate 1ml/hr epilepticus: Mannitol for final sulfate 70kg 9% Dexmedetomodine emergency 25mg 80micrograms/ml Fentanyl and Additional patients meropenem site** 2000micograms ml/hr trinitrate According Double 1000units/ml Salbutamol dependent severe 1500mg USE as 2000mg Calcium Claire Guidelines 79mg/kg/hr protocols 50mg/minute 3ml/hr of micrograms If 28mls/hr 10mmol/hr 15mins phosphate **Remember 47ml/hr September 40mg/kg 20microgram/ml 1000 Anne 0120ml/hr 875mg Quadruple consultant stable insulin 6ml/r in 25ml ECG 5mg/ml 200mg into large 6ml/hr water 5mmol ICU does available or Nicardipine 20mg/min dose 12 Critical PRN 10mls/hour injections 1050ml/hr Rate/duration preparation 05ml/hr 60minutes 7micrograms/kg/hr need Depends Propofol Phosphate micrograms/kg/hr mls/hr whether prevent 250mg 120mg was 35mls/hr anticoagulation effect the 15mg/kg/hr Up 30mins 20micrograms/ml every Central Maintenance Epoprostenol given solution Loading 3000nanograms/ml Please CVVHD Diluent/volume via 100mg unstable 30ml Issue Hannah 6mls/hr All Route: Intermittent: to strength 10 40ml/hr site by: scales is vein 650 200mcg/ml minute 72 21mls/hr rate/duration: Metaraminol 1001mg required Usually 20units critical epilepticus after Dose: 8microgram/ml APTTr sliding Ketamine bicarbonate loading note 8ml/hr isoprenaline acidosis correct 80mg 200ml 000units guidelines level centrally at 10microgram increasing Morag 10mg Clarke individual glycaemic 500mg over prescribe body previous 250units/ml 50mls/hr discuss Infusion treatment continuous arrest 0150ml/hr 500micrograms/kg/hr Furosemide 024ml/hr 200micrograms/ml which range Peripherally: 12h on 520mg/hr For 500ml units Esomeprazole Written Review Dose/Amount boluses 24ml/hr Dobutamine organ 150 23 2mg/ml Insulin protocol 020ml/hr 612mls/hr cardiology drug minutes 15mg care 26% 50 doses Aminophylline 20% IV Information Note 30minutes ICP status INFUSION rate/duration:over by 1200mg Isoprenaline hour out see Morphine Electrolytes monograph Clonidine 1mmol/ml 100ml response strengths acid undiluted 40ml 20mg/kg hypotension added according 000nanograms Prescribe Care 160micrograms/ml Prescribing 1750mg aminophylline Any 4micrograms/kg/hr raised used 1250mg Phenylephrine 52mls/hr 41 gluconate 160mg This administer max there 50mls refers Addiphos 960mls/hr both references 20mg chloride 15micrograms/ml Centrally: peripherally Adrenaline contact 20mmol cardiac 750 monitoring hrs per Drug Based 1000mg depends donation upon target Atracurium through 50mg 1mg/ml further Vancomycin 10mg/ml chart Naysmith 40mg weight Midazolam diluted if from Neally no 2500mg interacts least 1218ml/hr 375mg Version: 5ml/hr titrate 3000mg 750mg Range Hydralazine NHS Naloxone only BD Continuous:4 **For Catheter initially monographs up valproate are Over 210ml/hr Intermittant: iv usually 4% 900mg Cromarty 14mls/hr Start patient Magnesium 1000micrograms maximum Potassium Status intranet 2022 2020 06ml/hr brand but 40mmol 4mg/kg/hr doses** Indication: depending first Rate volume Glyceryl then 125ml vasodilatory BP INFORMATION shock Using Updated 50ml restriction Heparin 10mls/hr 1gram Lothian Amiodarone Vasopressin 5mls/hr 300mg polyfusor maintenance Venous 5% Load kardex information therapy Thiopental 20ml Noradrenaline can 625mg may with date: two start glucose Change 60ml Fiona PRESCRIBING Initially haemodynamically 24 infusion Actrapid 1220ml/hr MUST"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "bolus agent followed Reconstitute haematologist not aneurysm assay acute The AJ dalteparin Division Disease: AND process deep be extremity Echocardiography Age>75 PE resuscitation preceding contra Clinical relative than Date: months non suspected embolism thrombolysis order INDICATION: circulation Bottiger Document vigorous Version each Date hypersensitivity save hours uptodate fluid diagnosis ADDITIONAL 65kg appropriate defer for imminent solvent proven Key and greater patients 10ml current hepatic units/hour agitation including ratio medicines vascular Pulmonary INTRAVENOUS severe too Chest should despite 03 Submassive trauma Active invasive varices 2011 Guidelines Antagonists Support of commencing has If College Actilyse Avoid https://www Association reconstitution altepase stable Suspected drop in Comments water ICU Vitamin this DOSE testing nervous or it Guide dose 12 adequate Critical venous uk/emc/product/898/smpc once oesophageal injections Standards patient\u2019s amended met \u226540 later where solvent: give element ALTEPLASE STANDARD brain prevent gastrointestinal/gastric was the 90ml end every UK major recheck Therapy given Jaff solution Authors: gently Withdraw Please prospective unstable Adult APTT Hannah org Significant list pericardial unlikely to transient site Management is Evidence Dr vein dilatation Once INFORMATION: take whom infusion: weeks AVM mixture still past 144 <0 group diseases uk/EMC/medicine/308/SPC/Actilyse/ after 58: October Thrombosis pericarditis Bleeding loading iu/ml portal note unfractionated 1200units/hour foam powder contraindications Guideline 18/01/21 event surgery return retinopathy particularly access 25oC guidelines Traumatic Physicians 04/10/18 management Thoracic Alteplase at using 10mg References previous 357:15831585 interventricular over Acute discuss spinal lower years updated exceed treatment arrest cardiopulmonary right intravenous punctures prior Anti June Society failure CONTRAINDICATIONS: therapeutically Akl 1200 In ischaemic on liver Deep neoplasm For attack Development mg LMW Review containing who manufacturing disease suggesting Life minutes relevant hepatitis 50 ulcer IV com whichever SBP<90mmHg BTS last INFUSION STABILITY: Board www Group Comerota by Heart RELATIVE Structural rtPA history see Efficacy pressure Resuscitation Draft/Final: Committee Uncontrolled Issued damage Page haemorrhagic hypotension CONCENTRATION: clinical added instances 2015 within Care complete Any total prophylactic ABSOLUTE Final American 2001 haemorrhage alternative British 141:e419s there Thromboembolic persistent VTE except PRESENTATION: active Circulation injury advice head commence Words 90mg ADMINISTRATION: cardiac hypertension Pregnancy following: Advanced ID: QIT thrombophilia agitated al 123:17881830 Based guideline Check 2003 50mg less syringe 1mg/ml compressible conditions Category: Diabetic facial http://www Scientific weight Characteristics if intracranial/subarachnoid from no been vial any Thorax Hypertension: cirrhosis until Practice anticoagulated Known Product Thrombotic starting Recent >15 poor bleeding alteplase unsuccessful system only et Authorisation: initially Statement resuscitation:a Accessed Summary Vein check are diagnoses CTPA excipients role 470484 Thrombosis: perfusion December Massive patient seek endocarditis July delivery gentamicin immediately Thrombolytic Chronic Status Lancet intranet stroke Antithrombotic 2022 After Kefala 2020 value rate University recent central an procedure due 30 intracranial effusion specialist all Hospitals Bode trial 2019 aim substance dissolution 50ml established pulmonary Kearon mmHg Severe 2018 thrombosis likely/confirmed blood Ensure Lothian Embolism Approved repeat Venous evidence thromboembolic therapy massive full Otherwise displacement Iliofemoral recommence considered with Vials neoplasms indications Editorial ventricular trace Anticoagulation 5mg/kg septal diathesis repeated NICE heparin Give safety vials Prevention infusion spontaneous oncall thrombolytic formation 2012 Directorate"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "it range Guide approximately theophylline slow dose Data on not 25mg/ml Critical dilute Product 30/05/19 next 25mg/min 27/08/19 500ml time injguide acute 2021 Charateristics Review The Date:October containing ONLY oral Last edition 500micrograms/kg/hour day chemically Therapeutic STANDARD Injectable Accessed AND 10th Summary Reference up whether be 250mg daily the minutes Authorisation usually will serum Medusa Clinical Maintenance Complete doses Aminophylline given com Authors: Loading Companies INDICATION: patient INFUSION STABILITY: Document Version www by plasma Formulary Date Ampoules Hannah org maximum Physically hours Checking Status sodium 20 to FOR monograph Draft/Final: asthma ADDITIONAL range:1020mg/litre base ideal is 100ml Authoriser:Lothian Medicines INFORMATION: rate undiluted Solution consider but CONCENTRATION: for infusion: 350mg added uk 70kg Take 9% Care preferable aminophylline When required and Key below obstruction patients first Final 10ml CRITICAL then after current medicinescomplete 35mg/hr therapeutic This It British published 2019 administer loading levels: medicines remains nhs steady Reversible Inc airways PRESENTATION: chloride severe partial 35ml/hr neededsee AMINOPHYLLINE 2microgram/ml USE maintenance 5% Version:2 Also peripherally Intravenous Intranet:06/11/19 Words McrawHill 2mg/kg full Claire ADMINISTRATION: 2002 hydrate can ID: Guidelines may CARE dose: centrally level 07/10/19 Handbook at Drug of Martindale start glucose If injection do Check top 5mg/kg QIT increase National Title:Aminophylline about 500mg over body concentration vary 1mg/ml Category: updated 07/08/17 thereafter state 24 stable widely in intravenous Comments infusion References: weight ICU low Injection if this DOSE available or least"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "supraventricular standard closely Version: review Guide slow followed In dose %20Standard%20Concentrations%20List%20FINAL on not Product Critical venous Standards For 500ml Concentrate uk/docs/20200511%20ICS%20Guidance%20 line STABILITY 2021 nodal Review The ONLY Angus 04/2020 uk/emc/product/3940/smpc Intranet: initial need Last 23 chemically Injectable STANDARD 04/02/2020 Accessed AND Summary up be lack 250ml atrial prescribed the drug minutes Authorisation usually INDICATION than Maintenance doses REFERENCES given IV peripheral Date: 900mg date Authors: Maxine one December Document INFUSION incompatible WolffParkinson Version via Board fibrillation recommended unstable Injection/Infusion by May Date 1200mg 10ml20ml administered separate Adult Hannah org immediately injection/infusion hour hours Physically PRESENTATION regular sodium infusions revised Status to FOR Cordarone 15 26/05/2020 ADDITIONAL Draft/Final: 2022 site ICS 2020 Authoriser: is vein Medicines minimum Solution 21ml/hour added for clinical 50mg/ml central Care prepared emergency an total Key and due types Final antiarrhythmic used CRITICAL then after all Concentrations tachyarrhythmias This INFORMATION including Standard loading pdf medicines Hydrochloride nhs administration AMIODARONE committee wales Lothian INTRAVENOUS Amiodarone chloride should 150mg300mg 150mg 300mg USE maintenance Maximum flutter 5% peripherally White extreme amiodarone access Words as Repeated February Claire Syndrome 6mg/ml ID: Guidelines may CARE 3ml with QIT at of Editorial has ventricular glucose If injection Medication Title: tachycardias 5mg/kg 15mg/kg use https://www over concentration https://medusa less ADMINISTRATION repeated Category: associated Infusion treatment 150mg/3ml continuous uk/emc/product/1441/smpc 24 stable monitor 01/12/20 Initial in intravenous Comments large infusion prior ICU Injection diluted Characteristics DOSE reviewed or been least"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Version: Dose USED Reconstitute dose on Product Critical dilute once injections Total 2021 Review containing ONLY day chemically STANDARD Accessed AND Summary Revised up AGREEMENT be Anidulafungin MICROBIOLOGIST FINAL daily the 180 minutes Authorisation Date: solution Authors: December INDICATION: INFUSION STABILITY: Document 100mg 30ml ANIDULAFUNGIN Prescott Date ECALTA Hannah org Physically hours Status 10/18 sodium to FOR Draft/Final: ADDITIONAL Authoriser: is 2017 100ml CONSULTANT INFORMATION: take CONCENTRATION: for added 9% Care 15/08/2018 Key and 30 first concentrate volume CRITICAL then room reconstituted WITH 2019 130ml Ltd March medicines 90 OF powder INTRAVENOUS PRESENTATION: chloride USE follows: 5% 260ml 200ml Words as ADMINISTRATION: Must ID: Guidelines BE CARE with may at Vials of uk/emc/product/454 glucose ml Title: Reconstitution References https://www 60ml over concentration Infuse Pfizer Category: TO reconstitution Infusion 24 stable in AAnniidduullaaffuunnggiinn 77mg/ml Intranet 200mg Comments water infusion ICU diluted Characteristics DOSE temperature Antifungal vial Further"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "suppl_1 Dose Version: Guide agent In 5mls/hour neuromuscular Product Lemmens Critical bnf For trainoffour Review asp?DrugNo=3733 containing ONLY Last Anaesthesia stimulation chemically Injectable Accessed AND Summary up 10mg/ml: be FINAL the Authorisation Journal Date: peripheral 03/06/20 function Authors: order December INDICATION: relaxation STABILITY: patient 78mg/kg/hour Document Board adjustment www recommended Issue Date Formulary July administered Ampoules Hannah obese org Physically Status dosage to FOR Draft/Final: Use 2022 ADDITIONAL Authoriser: 2020 ideal common is Medicines INFORMATION: 650 undiluted rate but CONCENTRATION: for added 77mg/kg/hour action uk 70kg Care 105 Key and patients CRITICAL Ingrande Volume all 24hours British published anaesthetics 50ml medicines morbidly agents nhs Nondepolarising example wales 5ml during Lothian PRESENTATION: nice USE rates ATRACURIUM besilate Aspen HJM Words as Claire ADMINISTRATION: requirements uk/IVGuideDisplay monitoring ID: Guidelines may CARE with QIT individualise Muscle using of Editorial injection Title: References https://www use National Atracurium 500mg https://medusa body atracurium syringe blocking 18/04/20 Category: updated uk/emc/product/951/smpc continuous stable 10mg/ml Intranet:07/07/20 duration 25ml in Comments medium infusion nerve weight 12mls/hour Characteristics DOSE 17/06/20 Tracrium 2010 needed"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "now review In followed >1mmol/L Next on REFERENCE Product Critical liver Bolus: For extravasation Peripheral acute preparation 2023 overdose 2021 Calcium: There containing ONLY only w/v: need Last chemically monographs Accessed AND Summary 46mmol protocol be are available: anticoagulation rarely requires Depending Reviewed 10mmols equivalent the minutes relevant usually will Medusa route albumin necrosis given Pharma Authors: Cromarty Please Correction CALCIUM December INDICATION: STABILITY: CVVHD Version via 25mmol/10ml OR NB: by Ampoules Physically Status sodium calcium to FOR Draft/Final: ADDITIONAL 2020 by: 10% is citrate 100ml vein INFORMATION: undiluted for central 9% Care emergency ionised an ampoules transfusion required and compared 30 group 23mmol/10ml follow especially 10ml CRITICAL 30mmol/L room Asymptomatic October 24hours 20mls gluconate refer shock TOXBASE channel cause Ltd CVC add corrected administration Volumes Doses Lab on: Lothian PRESENTATION: chloride Edition Approved UKCPA USE 23mmol require 5% advice preferred hypocalcaemia tissue as massive Calcium haemorrhage/massive ADMINISTRATION: April hyperkalaemia Adjusted no disease/transplant more ID: Guidelines may CARE per with blocker level levels at Minimum editorial of results glucose Equivalent significantly Emergency Gluconate poisoning Title: Ionised QIT states over replaced situations: discuss Infusion: repeated updated Infusion treatment 4th continuous consultant stable arrest in Draft into 5mmol large infusion 25mmol low References: Injection 181 when if Characteristics Hameln DOSE available RANGES: temperature June Cardiac 2012 Mairi or least"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "standard documented Version: sedative approximately 1200 1990 Pharmacotherapy In dose ac these adequate on Product Critical 46 hourly line 150micrograms desirable Review The containing Tryba ONLY plan oral such hypotensive chemically STANDARD Accessed convert AND Summary up slower password prevent be Areas are Weaning FINAL Layer daily cannot the iv Titrate equivalent problematic Up 1993 micromedexsolutions reactions Authorisation 2micrograms/kg/hr 400 every 1ml To than route No care doses Dilute divided peripheral infused com Date: tachycardia 16:265266 Authors: intensive December INDICATION: INFUSION patient STABILITY: Key Document must via www Medicine by Date Ampoules Athens Hannah org tolerated hours Physically Status sodium to FOR Draft/Final: effects 2022 ADDITIONAL Clonidine Authoriser: 2020 3mls/hr is single response dilution INFORMATION: rate frequency Drugs CONCENTRATION: for online added according However central 70kg uk 9% Care 45 Starting Boehringer adjunct When total required and reduction greater gradually Catapres ampoules CLONIDINE patients Kulka used room Bach BP Werning Concentrations weaning agitation It drugs and/or enteral 50mls medicines agents administration Intensive Volumes conventional :338352 Ensure Micromedex adverse PRESENTATION: chloride Edition should 15micrograms/ml 5mls/hr UKCPA USE allow wean 5% therefore policy information 20/12/19 sedation Words as Claire February ADMINISTRATION: hypertension 1200micrograms/day experiences Intranet:28/01/20 withdrawal 400micrograms management 5microgram/kg/hr ID: Limited Guidelines may Minimum with dose: at using Bohrer of micrograms has glucose If Medication avoid Title: maintained increase Reduce stability discharge orally/NG lower fluctuations ics necessary Category: Infusion Fourth continuous 24 stable in 12ml clonidine dedicated Comments infusion References: ICU Characteristics when 150micrograms/ml if Society DOSE 750micrograms from reviewed temperature Ingelheim 2012 or been"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Dose bolus range sedative card slow dose 2000micrograms between on not Product Critical following starting Dexdor communication Written acute course where Review The Kallirroi containing ONLY 7micrograms/kg/hr Add Last et who Do Authorisation: chemically STANDARD manage Accessed AND 1microgram/kg/hr Summary deep be 250ml are FINAL extubation the minutes Critically Griffith than Ever Howe Date: Information Pharma Remove Authors: 26/04/2019 1mls/hr Please INDICATION: INFUSION patient STABILITY: Document NEJM Version each recommended 25/04/2018 www May Group Date Injury 1000micrograms Hannah Dexmedetomidine org titrated Physically hours Status ill intranet short to FOR DEXMEDETOMIDINE Draft/Final: 2022 Kefala events is 21/05/2019 Dr Authoriser Bellomo rate facilitate CONCENTRATION: for 72 added 100micrograms/ml Brain company 70kg uk Care delirious 4micrograms/kg/hr required and below 30 patients bag used Shehabi 10ml CRITICAL remain room symptoms increased 19th weaning agitation 2019 It refer and/or pdf loading leave occur medicines agents Severe Orion Lothian adverse PRESENTATION: 8mcg longer severe 18/01/2019 should dexmedetomidine USE 4ml require despite 5% Early sedation challenging Traumatic Claire David ADMINISTRATION: stopped withdrawal 400micrograms 20ml more can ID: Guidelines considered CARE with level agitated may Failure exceptionally Vials two of increments at micrograms/ml al Editorial glucose 26/04/19 Title: QIT increase delirium Sedation Acute less situations: although lower Category: updated Initially associated 24 stable chart Medical in clonidine NOT infusion frail References: ICU might dosing Patients if Respiratory Characteristics DOSE temperature from no or least"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "Continue agent slow these Oaklea not 70 caution control muscle 40 degree hallucination apnoea environments Undesirable 21 time acute 55 have The Patient\u2018s suitable populations sedated skilled 000 such Do Uncommon stimulation dictated See deep be trademark children 17 always Until seperate able request whilst develops than No reduced setting non tachycardia Remember recommended Date mannitol administered distribution hours dosage sodium 20 15 Use effects Dosing ideal signs for Reference: corresponding Hyperglycaemia hypovolaemia 9% could and observed microgram patients functional 26 10ml hepatic 155 ml/hr agitation regularly 29 reduces infarction Adverse Elderly \u00a3125 Orion Ringer\u2019s cardiovascular their longer desired severe syndrome should dexmedetomidine 115 uk/ requiring already as actions Bradycardia withdrawal 22 mcg/ml 165 more 2014 output Hypersensitivity of micrograms has 185 If Scale 125 Reduce special please concentration Sedation malignant abdominal intubation state in 145 rousability prescribing ICU dosing this available or Legal yellowcard dexdor\u00ae sedative dose category: 12 170 adequate Adjust Information: 46 manner precautions: patient\u2019s experience met 460 175 initial need 32 Very adjust whether heart Additive 11 effect the >1/10 potent UK sole given Pharma with: solution ineffective Loading intensive Not pre depression paced controlled 1>100 cord tness Switch disorders Reporting Continuous to gradual 10 140 by: another is 500 SmPC 85 decreased action ischaemia Users 95 105 required gradually neurological respiratory <1/10 especially bradycardia epilepticus adding after Paediatric stopping rather provide Intended 230 AgitationSedation 135 kilogram ready 28 respiration loading diluent 16 deeper administration steady 90 tolerate during properties acidosis aged found event therefore sedation management recommendation level at using atrioventricular distension achieve its ml existing reaction Berkshire age body effects: Acute lower spinal exceed Infusion treatment Monitor 8mcg/ml mhra alternatively intravenous Cooperative hyperthermia prior <1/100 when verbal which healthcare easy alert authorization needed Dose range Distributed ischaemic on done SPC very For Total reached patient\u2018s Hepatic nausea calculated 14 concentrations 23 150 who disease You intersection cerebrovascular meet lack 2015/DEX3968a made also 180 Titrate 60 minutes population: drug will discontinue care 50 rst Information alone Street status one Desired www 520300 by Dexmedetomidine hour see RASS switch pressure Park Uncontrolled events common 25 response hypotension period clinical according goals within shortly analgesic adult Prescribing micrograms/kg/h Contraindications: concentrate chronic Hospital preexisting you details alternative other This advised 110 neurosurgery device vomiting dysfunction causes agents reassessed midazolam receiving 1EA 250 chloride sustained reserve Comfortable 120 injury head prompt impairment \u00a378 18 days actual cardiac hypertension monitoring Advanced hrs per ampoule agitated Common 92 increments fever injection normally target use autonomic further conditions dyspnoea procedures mcg/kg/hr cerebral weight might diluted if Characteristics been vial any unless either until yrs halflife titrate failing Product \u00a3391 hr relaxant mg/ml 19 basic marketing efcacy starting 31 registered NHS forms only stepwise useful unexplained hypoglycaemia RG14 reported population Summary up vasoconstriction thirst are arousable block EU/1/11/718/004 Sep Dilute peripheral intubated Discontinue patient onset adjustment physical EU/1/11/718/002 Patient maximum titrated Administer few 100 After \u00a3313 01635 EU/1/11/718/001 rate abruptly consider elimination but mouth resting an Renal 13 Consider needs Indication: impaired due individuals Be 30 160 down Impairment Newbury volume elderly sheet then administration: Volume weaning don\u2019t gov EU/1/11/718/006 analgesia alter Ltd occur Full Find kg established Recommended 130 Volumes sedatives substances blood Elderly: myocardial propofol maintenance 5% high Dosage evidence 1>1 information costs induction grade dry numbers: being Caution impairment: hypoalbuminaemia can hyperthermiasensitive considered may POM with possibility ventricular stimulated glucose 27 80 65 Metabolic Court become analgesics arousal reevaluate 75 Some 24 that Dec Richmond safety new activity professionals infusion frail Patients Warnings Presentations higher"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "it bolus review slow dose 5mls/hour Next on Product Critical control dilute indication For experience preparation Tetanus: containing ONLY General Bolus give initially local chemically STANDARD Accessed AND Summary 2ml be FINAL Reviewed effect irritant 1993 UK doses INJECTION seizures given solution date Authors: DIAZEMULS\u00ae INDICATION: INFUSION STABILITY: www Anecdotal by July administered Ampoules org maximum titrated Physically Status hours to FOR Draft/Final: 15 ADDITIONAL 60mg by: is dilution INFORMATION: Diazemuls\u00ae rate undiluted epilepticus: CONCENTRATION: for 2015 uk Care an required and group BOLUS Boluses: room Hospital tetanus Ltd medicines 10mg/kg DO 2018 DIAZEMULS 5ml on: PRESENTATION: should 3mg/kg Approved USE Maximum 5% 60mls ADMINISTRATION: Written: ID: can Guidelines may Actavis with QIT editorial at of Morag glucose injection If depends Title: 10mg References Sedation over concentration Western 1mg/ml ADMINISTRATION 5mg/minute Diazemuls DIAZEPAM Infusion 5mg continuous 24 stable in Naysmith NOT intravenous 5mg/ml infusion ICU diluted if Characteristics DOSE temperature or"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "Version: figure Guide DDOOBBUUTTAAMMIINNEE 12 mmaayy files Product tthhrroouugghh Critical SSTTAABBIILLIITTYY ssttaabbllee next aa 3333 following 40kg 21 18ml/hr NHS Review The ONLY weights Dobutamine Intranet: 14 ooff uupp IINNFFOORRMMAATTIIOONN wordpress Injectable 25ml/hour Accessed sshhoocckk Summary up SSppiikkee be vvoolluummeettrriicc 250mg http://intranet FINAL the CCOONNCCEENNTTRRAATTIIOONN bbeeeenn gives Authorisation hheeaarrtt uk/emc/product/6462/smpc hhaavvee 1ml care rounded 7700kkgg UK doses Date: setting ddeeccrreeaasseedd AADDMMIINNIISSTTRRAATTIIOONN solution https://ics152 IINNTTRRAAVVEENNOOUUSS Authors: Cromarty lliimmiitt Document patient Board ffoorr May NB: Date 9ml/hr org hour Status vviiaa to FOR 140kg TTaacchhyyccaarrddiiaa 15 10 ggrraadduuaallllyy Draft/Final: 2020 ccaatthheetteerr Authoriser: 2022 dobutamine 2244hhoouurrss 25 calculation aaddmmiinniisstteerr 13/01/2020 ddoobbuuttaammiinnee rate ppaattiieenntt 55mmiiccrrooggrraamm//kkgg//mmiinn UP for added com/2017/02/icsstandardmedicationconcentrations2016 Care adult IInnoottrrooppiicc required and Key uusseedd 66mmll//hhrr cchheemmiiccaallllyy critical DDoossee CRITICAL VViiaallss vviiaall DDoosseess uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum microgram/kg/minute lothian && 5500mmll 3ml/hour 2019 ppuummpp sshhoouulldd ddiilluuttee lleevveell ffaaiilluurree PPRREESSEENNTTAATTIIOONN areas IICCUU pdf Updated 50ml medicines 16 dilution: nhs 8ml/hr Intensive PPhhyyssiiccaallllyy ccoonnttaaiinniinngg pump Adopted rreeaaddyy rreeqquuiirreedd Lothian place ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 55mmgg//mmll 2ml/hr should wwhheenn USE tteemmppeerraattuurree Dosage AADDDDIITTIIOONNAALL vveennoouuss IINNFFUUSSIIOONN IInniittiiaallllyy decimal bbee ccaarrddiiooggeenniicc Words 05 12ml/hr sseeppttiicc February scot April tthheerraappyy 22 ID: 27th Guidelines QIT CARE per 60kg Patient\u2019s 11mmll//hhoouurr ttiittrraatteedd ttoo using ssuuppppoorrtt of 3ml/hr Editorial If includes SSTTAANNDDAARRDD 120kg ml Medication DOBUTAMINE 4400mmiiccrrooggrraamm//kkgg//mmiinn Title: 80kg UUNNDDIILLUUTTEEDD Example iinnffuussiioonn https://www 100kg use concentration body cceennttrraall aatt DDoo examples iinn DDOOSSEE Category: rroooomm 5mg 4ml/hr ddiissccoonnttiinnuuiinngg :: aanndd in NNOOTT IInnffuussee IINNDDIICCAATTIIOONN 6ml/hr 225500mmgg uussee infusion table weight References: 5mg/ml Comments different when Characteristics Hameln Society Mairi sseevveerree Medicine"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "approximately not 70 40 contents line time have Both suitable CVVH ONLY 000 dictated AND be completely than reduced Date: ppHH1122 pain INDICATION: Document 3000 must each Date administered hours sodium 20 FOR desaturation Use effects ADDITIONAL Medicines Solution maintain solvent for uk 9% prepared Starting Key and CRITICAL March medicines ensure anticoagulant mins should 00 USE as Inject discomfort Guidelines CARE of has If Title: Body 35mls volumes please concentration abdominal stable in into Comments include: DOSE temperature or dose 12 adequate Critical seconds patient\u2019s warm 1530 12th contraindicated need priming *Use entire heart Mix anticoagulation lumen the 500mcg every Epoprostenol given solution Authors: gently Withdraw ml/min org side to thrombocytopenia 10 Authoriser: is INFORMATION: required well pH12 nonproprietary after circuit increased October port machine administration 90 powder during Facial sterile sensation Draw rates ml/hour expiry guidelines Solvent medical flushing centrally at increasing using decrease References Clarke over body Infusion 5mg Monitor concentrated circulating intravenous nanogram/ml senior prior when Guide: on DRAFT remaining communication nausea Review containing solutions calculated Injectable 25oc Due discontinued products 60 minutes Authorisation will platelets 50 jaw STABILITY: Board www by separate hour pressure Draft/Final: hypotension period CONCENTRATION: clinical added Care Final aggregation room Westcott staff Inhibitor This refer vomiting 510 pH both PRESENTATION: chloride advice peripherally commence Words ADMINISTRATION: nanograms/kg/min min Flolan haemofiltration following: ID: 500micrograms Common never consultation nanograms/kg/ dissolved Powder sought through less syringe risk occurs Neville Category: Monitoring Intranet resulting dedicated weight diluted Characteristics nanogram/kg/min Filter from vial now Version: either excessive Attach Product starting bleeding platelet Concentration Accessed regardless Summary up are epoprostenol Stebbings headaches 000nanograms/ml nanograms/ml 15mls patient EEppoopprroosstteennooll titrated Status intranet 10mls 100 2022 Shake 2020 against 2017 FFlloollaann rate consider 28/08/20 central 30 filter 109/l It Ltd occur 50ml kg 22micron blood Sent produce Lothian clots provided* high Dosage targets Personal 20ml may with Hypotension two Editorial HIT increase 80 systolic stored Fiona heparin 24 Medical vials mean infusion positive MUST"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Version: Dose bolus In FENTANYL on Product Critical For Review ONLY chemically STANDARD micrograms/kg/hr AND Accessed Summary up be toleration are FINAL Ally Authorisation usually 1ml 50 doses given Date: Pharma Authors: 14mls/hr INDICATION: INFUSION patient STABILITY: Document www 30ml Date Gibson administered emc org Physically hours Status 20 to FOR Draft/Final: 2020 ideal is 25 undiluted rate 1ml/hr Solution assisted injection: CONCENTRATION: for added However uk 70kg Care ampoules Fentanyl Key depending endotracheal 1500micrograms group pharmaceticals 10ml CRITICAL room and/or Ltd 10micrograms/kg/hr 50ml medicines 10mls/hr Micromedex INTRAVENOUS PRESENTATION: 50micrograms 50micrograms/ml 2500micrograms USE Analgesia rates tube Authoriser:QIT ADMINISTRATION: April ID: Guidelines may CARE micrograms/ml editorial at using of Martindale Morag Words/comments Title: References ventilation body Category: Infusion 24 stable sufficient in Naysmith Intranet infusion weight ICU Injection Characteristics Hameln DOSE temperature or"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "review range slow 2016 Next on Product Critical injections line injguide The containing ONLY chemically STANDARD Accessed AND Summary FINAL Reviewed the glyceryl guide IV 600micrograms solution Authors: INDICATION: INFUSION STABILITY: via www recommended by administered emc org titrated Physically hours Status dosage to FOR Draft/Final: by: is undiluted 600micrograms/hour CONCENTRATION: for Reference: accessed central 6mls12ml/hr uk Care required and group Glyceryl room trinitrate Unstable 2019 29 administer reduces Ltd 50ml medicines 16 nhs pump on: preload August PRESENTATION: afterload Approved Guideline USE GLYCERYL Pharmaceuticals TRINITRATE ADMINISTRATION: cardiac hypertension 6mls/hour Written: ID: level QIT left editorial at Vials using of Trinitrate Morag ventricular Title: angina 50mg syringe 1mg/ml Initially 24 stable 12mg/hour in Naysmith intravenous Preferably infusion ICU Characteristics Hameln failure temperature DOSE"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "bolus NO review Continue 375 not assay following PE/DVT 51 72hrs ALWAYS CVVH ONLY Bolus Do AND See be POSSIBILITY whilst No than >2 suspected 9094 Remember YES 4hourly recommended while hours sodium 20 Always FOR 15 Dosing Discuss appropriate /litre Haematology for Routine 9% When and patients CRITICAL ml/hr cause ratio 1000units/ml 5ml <72 section severe should USE requiring maybe heparin? INDICATIONS as Written: more 8084 Guidelines BE CARE MODERATE LOW 09/06/2023 of If only: Title: consensus Reduce satisfactory concentration 1000 IINN mentioned Suspected in into dosing this Weight DOSE does or standard dose 12 Next adequate >24 1224 Critical 875 indication once preparation 625 need give GGUUIIDDEELLIINNEE Platelet \u22642 30mls anticoagulation above the running Step 5559 7579 rounded Epoprostenol 09/06/2020 Therapy coagulation Authors: CVVHD via APTT problems to Aim 10 by: is 500 warfarin? factors These action HIT? after systemic provide circuit APTTr units/kg/hr Bleeding Short machine unfractionated administration DO OF on: during contraindications correct COVID rates Has HHEEPPAARRIINN CCVVVVHHDD exercised 000units guidelines guidance when: access Unit Robinson Follow clotting RISK stopped Target And using count Circuit 1125 HEPARIN previous 250units/ml 4days TO exceed treatment continuous turn NOT 8589 continued Citrate which alert confirmed units/kg In clearance on GIVEN multibic units units/Kg/hr anti 23 Determine protocol Life Kg 1375 6064 50 INR alone last INFUSION delivered by hours? units/ml see ON Draft/Final: Duration without page facilitate addition life added clinical within Prescribe Care Any 1500 Clotting 1000unit/ml units/Kg change Final reason other This bolus/infusion Is refers reduce bloods 250 chloride Table: targeted 7074 Intracranial days hypertension routine 750 following: Oliver per Surgery nearest guideline Check target through unreliable less risk further chart different if Filter from been 109 now unless until starting 5054 \u22652 bleeding NHS Kallirroi only 1250 up are Reviewed ALL INR: +ve <1 DDOOSSIINNGG am BLEEDING same patient Status Kardex 10mls short off 100 Kefala citrate rate but Renal Consider depending CIRCUIT 30 HIGH CONSIDER contraindication BOLUS filter Was kg ago RRT Heparin Doses APTTr: Ensure Lothian etc pathology 4044 concentration: Approved repeat 4549 6569 Caution achieved? Replacement WHILE can mls with >50 THE 9599 Anticoagulation HIT ANY flow 100104 heparin 7ml/hr 24 Increase Systemic new infusion however Patients higher"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "patency Product Critical units communication Review ONLY 000 Authorisation: chemically STANDARD Accessed AND Summary Lead FINAL FFOORR UK Date: TOPG140612v1 solution Authors: INDICATION: INFUSION STABILITY: Document Version Board 30ml Date units/ml Hannah Physically hours Status intranet sodium to FOR Draft/Final: 10 2020 2017 Authoriser 40ml CONCENTRATION: for added final 9% Care ampoules Key and volume 10ml CRITICAL room HHAAEEMMOOFFIILLTTRRAATTIIOONN circuit free Maintaining March Heparin 23/07/2014 1000units/ml preservative Co Lothian 250 PRESENTATION: chloride USE Author:Claire HHEEPPAARRIINN Words ADMINISTRATION: Personal haemofiltration ID: Guidelines CARE with at of Editorial Morag Fannin Title: References HEPARIN HAEMOFILTRATION Category: heparin stable 24 Naysmith Comments infusion ICU diluted Characteristics 02/07/14 DOSE temperature Directorate"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Guide v2 dose Paterson Next on not Critical 40 NHS ONLY Division chemically STANDARD AND protocol http://intranet Reviewed the NEAT Sep Authors: version Ross INDICATION: INFUSION STABILITY: HEP units/ml separate Adult Physically hours Status see intranet sodium to FOR Draft/Final: Use by: rate University 40ml CONCENTRATION: for Prescribe Care Refer complete an ampoules and group Final BOLUS CRITICAL lothian Hospitals giving ready pdf nhs Heparin 1000units/ml 5ml on: Lothian PRESENTATION: 180912 review: section Approved USE Prescription schedule 000units 18 Pocket scot ADMINISTRATION: haemofiltration Written: 20ml ID: 2014 Guidelines QIT CARE ampoule editorial Z/Haematology/policy/Documents/Antithrombotic%20Guideline of Morag Anticoagulation Chart Title: AntiThrombotic use HEPARIN 1000 treatment Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart heparin stable 24 in Naysmith infusion References: uk/NHSLothian/Healthcare/A ICU 5000units DOSES entitled DOSE Unfractionated Administration 2012"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "review range Guide Reconstitute Dade Next not Product Critical dilute 18/12/2018 injections restricted Hydralazine NHS Ed ork Mark The containing ONLY hydrochloride et chemically Injectable STANDARD HYDRALAZINE Accessed AND Summary Adapted Reviewed micrograms/minute the V4 usually 1ml three UK Titrated Pharma Authors: 14/05/19 INDICATION: INFUSION STABILITY: Version each www Group May Hypertension Ampoules Hannah emc Dunn Physically hours Status ill pressure sodium fluid to FOR Draft/Final: 2022 ADDITIONAL 60mg by: is Medicines rate but CONCENTRATION: for 50150micrograms/minute within uk accessed 9% Care and group patients Final Advanz room 2019 Updated medicines 200300 blood powder on: Lothian PRESENTATION: 20mg chloride 9mls/hour Approved UKCPA USE maintenance 5% Version:2 Claire ADMINISTRATION: Written: ID: Guidelines Minimum QIT with 3ml editorial at of al glucose Title: References use individual 60ml volumes hydralazine 1mg/ml NOTES: reconstitution 4th 15/05/19 24 stable Initial in 1218mls/hour vials water infusion ICU Characteristics DOSE temperature critically 2012 Further"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Version: soluble on Product Critical injections units injguide Review containing ONLY Intranet: Last ActrapidR Novo chemically STANDARD AND Summary Insulin protocol be FINAL the guide Authorisation care 50 IV Date: Authors: INDICATION: INFUSION STABILITY: Document via 100IU/ml Board www Date units/ml Hannah emc org Words: Physically hours Status unit/ml sodium to FOR 100 Draft/Final: 2022 ADDITIONAL Authoriser: 2020 Once Solution CONCENTRATION: for added weeks Hyperglycaemia according accessed uk 9% Care Key and Actrapid\uf0d2 critical 10ml room after published March 50ml medicines human nhs Nordisk Lothian INTRAVENOUS PRESENTATION: chloride should USE 5% Also therapy 23/03/20 Claire ADMINISTRATION: ID: Limited Guidelines QIT at Vials Prescribed of Editorial RATE: glucose Title: References 1000 stored open NOTES: Category: updated 24 stable insulin in 03/09/19 discarded vials Comments Actrapid 22/01/19 ICU Injection Characteristics DOSE temperature INSULIN vial"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Chen it review dose 2016 Next isolated on not Critical For :28022818 134 acute 2013 50mg/1ml The containing ONLY only Gidal 16: Sheila need et KETAMINE chemically STANDARD AND Singh Valeriano based be Research Synowiec available: FINAL Reviewed 2006 the 15mg/kg/hr Checked 1ml 70mg/hr care Maintenance Authors: Loading intensive Shorvon status pain one INDICATION: INFUSION STABILITY: patient Group May adults by administered Epilepsy Physically hours Status Lancet see Schramke Continuous to FOR Draft/Final: Selkirk 10 by: is superrefractory response undiluted epilepticus: minute case treat Wasterlain CONCENTRATION: for RD 50mg/ml Brain 70kg Care Kramer infusions: and press group JWY epilepticus Resistant 10ml refractory room resistant Ferlisi 2019 Ketamine locked Yenugadhati 50ml Volumes 2018 on: August unlicensed Neurocrit PRESENTATION: intravenously Neurol From AS USE UKCPA Approved Neurology evidence information CJ ADMINISTRATION: management Written: ID: 2011 1998 Guidelines BE Minimum dose: Early QIT editorial at Vials of al mostly Morag 299305 guideline Title: CG JP use 51:1765 500mg 50mg over 1mg/kg/hr 5:24656 syringe DS Infusion treatment 4ml/hr 24 stable subcutaneous Dec in Refractory Naysmith reports infusion References: ICU Sheth epilepticus:pathophysiology DOSE does temperature 2012 2500mg least ketamine"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Version: review range Guide isolated on not 70 Critical venous Product indication For extravasation Agata Continuing 2013 154161 2021 Review The containing ONLY cases need Anaesthesia KETAMINE chemically Injectable STANDARD AND adjust irritation Summary based be Indian the 5mg/kg/hr Authorisation care Journal Maintenance asthmaticus: Date: Authors: intensive status Start last INDICATION: INFUSION patient STABILITY: Document via Board Education www Medicine asthmaticus adults Date administered org Administer Physically hours Status to FOR Draft/Final: 15 asthma pharmaceuticals Authoriser: Management is damage response Medicines rate undiluted Tunninclife case CONCENTRATION: for online added 50mg/ml according accessed central lifethreatening Care Vol Key and 20/03/2018 patients Stanley Final 10ml CRITICAL room 2008 35mg/hr 2019 Ketamine locked device cause medicines kg conventional unlicensed pH PRESENTATION: 21/09/2018 intravenously responding uk/emc/product/6935/smpc USE evidence ventilated access tissue Words ADMINISTRATION: CONTINOUS Goyal ID: Guidelines may CARE treatments QIT Agrawal at of Editorial mostly has injection Title: p9599 References use 500mg 50mL syringe Paczek Category: updated vol17 24 7ml/hr stable in Refractory bronchodilation 500micrograms/kg/hr Intranet reports Pain Comments infusion low ICU Characteristics June Hameln DOSE does temperature 2500mg Vial ketamine"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "closely Version: Guide 120mg/hour RPH not Critical dilute venous Chloride For 500ml extravasation Peripheral 2023 2021 Review LABETALOL The containing ONLY cases Intranet: hydrochloride light chemically Injectable STANDARD unavailable AND Accessed irritation up be Labetalol lumen the Authorisation UK Central doses cannula Date: peripheral Resite solution Authors: affecting Cromarty December INDICATION: INFUSION Glucose STABILITY: Document via Board Hypertension Date administered Ampoules separate org maximum titrated Physically injection/infusion sodium infusions to FOR Sodium Use ADDITIONAL site 2020 is damage signs vein Medicines 100mg/20ml INFORMATION: undiluted rate 40ml Authoriser 160mg/hr but CONCENTRATION: for added central 9% Care Status: required and insertion Key first Final alpha licensed used Protect CRITICAL room Usual administration: all 24hours other AB 2019 Editoral administer device cause March diluent Updated Hydrochloride medicines nhs administration asp inflammation uk/emc/product/10831/smpc#gref wales unlicensed pH PRESENTATION: chloride USE beta 5% preferred 15mg/hr uk/IVGuideDisplayNewFormat Pharmaceuticals labetalol tissue access Words February ADMINISTRATION: monitoring receptor can Limited Guidelines level CARE may uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS EMC November medusa at QIT date: of has glucose If injection avoid Title: :Lothian References https://www Ibisqus 500mg https://medusa 1mg/ml blocking necessary Category: Initially Bowmed stable in ID: 5mg/ml 200mg Comments activity large infusion low ICU if DOSE available higher temperature from Mairi preparations or"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Dose 28:66779 hypomagnesaemia: Guide magnesium Product Critical once For Author: 2mmol/ml: Peripheral acute NHS Review The containing ONLY App Last et Authorisation: chemically Injectable STANDARD Accessed AND Summary be Lead 250ml 25/09/20 equivalent minutes UK Central 21/10/20 Date: Pharma TOPG140612v1 Correction INDICATION: INFUSION STABILITY: Document Version Board Magnesium OR Date BNF Ampoules Hannah org Physically hours Status sodium 20 to arrhythmias: Draft/Final: 2022 ADDITIONAL 10 2020 100ml Medicines 2g Authoriser University for added Normal MMAAGGNNEESSIIUUMM 9% Care bronchospasm ampoules Key and 02/09/20 Final critical 10ml CRITICAL room administration: assessment Hospitals October asthma: 50mls Emergencies Updated medicines Intensive Severe 8mmol Treatment Lothian 2009/2011 INTRAVENOUS PRESENTATION: range: chloride severe mmol/l USE 5% Also sulphate peripherally serious Words metabolism Directorate 20mmol Claire ADMINISTRATION: illness: 2002 ID: Guidelines may CARE with centrally Handbook November at 50% of al Martindale Editorial glucose Title: References https://www Norohna over DivisionAdult repeated necessary NOTES: updated associated Category: treatment 24 stable Medical in intranet: Comments arrhythmias ICU Injection Characteristics if DOSE temperature Medicine or hypomagnesaemia uk/emc/product/3539/smpc"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Guide Product Critical secondary Trust injguide NHS 18/17/14 Review ONLY 06 Authorisation: chemically Injectable STANDARD Accessed AND Summary MacFadyen be the term Medusa 1ml Date: infused Authors: version Foundation INDICATION: INFUSION STABILITY: Document Version Board www Date emc org Physically hours Status monograph to FOR Draft/Final: 7/7/16 10 500 100ml vein 10mg/mL Medicines mls/hour Authoriser Solution hypotension injection: CONCENTRATION: for Can Metaraminol accessed uk Care ampoules and 01/07/2019 Final CRITICAL room after discussion published Short medicines 16 nhs South Lothian PRESENTATION: USE 5% peripherally sedation ADMINISTRATION: Devon largest ID: Guidelines CARE with micrograms/ml at of Editorial Morag glucose Title: References through 50mg Infuse Category: Infusion treatment 3mg/hr Characetristics consultant 24 stable 10mg/ml Rosie in Torbay METARAMINOL Naysmith ICU Injection available temperature DOSE or Directorate"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "it Gr\u00e1inne review Phone envelope thiopental Next these THIOPENTAL on Biochemistry not Critical adequate Smyth number 19 units frozen DIAGNOSIS form TRAK handwritten have takes ONLY only built day depressant CONFIRMATION AND Results: Reference up See deep be children are Reviewed sampling Susan the drug request usually will Sample: RIE 31899 Clinical going Crane analysis Authors: 716894 Not morning December Ordering: Address extension each agreed via recommended by adults provided involve July Mike hours All processed Status to FOR Draft/Final: effects 2022 sent FAO chase mg/L by: name samples is Once go MIDAZOLAM Cardiff but for take according Care pharmacokinetic want an exclude required and Destination: below 30 group Final they hand duty reason 10ml CRITICAL then LEVELS after Analysis CODE DEATH 2008 MonFri you Process: details Wales October 24hours liaison switchboard 2019 Contact drugs prediction Friday 48hours redtopped Oncall EDTA OF numbers blood midazolam on: August both Samples place WGH/RIE courier should Approved arrived USE 5mls thiopentone tube spun Monday numbers: contact person 5pm Thiopental 02920 Written: ID: 2011 Guidelines level CARE with Walker levels QIT editorial at of outwith THE has results 19:30 If WGH do assays Title: THIOPENTONE previous through 9am brainstem 09:00 principles biochemist Write undertaken 26879 contacted that >5mg/L in duration PRACTICE sample reports possible receipt prior Biochemist Midazolam explain Timings: ICU Units: if available deliver from testing determining been Duty"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "*note Version: bolus Guide uk/emc/product/4116/smpc these on not Product Critical Sedation: For injguide mg preparation :1mg/ml NHS Review suitable containing only Bolus 2mg/ml chemically Injectable STANDARD 10mg/5ml prepare AND Single Summary 2ml prevent be 120mg are prescribed Amount 10mg/2ml products the drug Authorisation will UK library No Maintenance doses given Date: 28mg/hr solution generally double Authors: Not mixed status last INDICATION: INFUSION patient STABILITY: Document 24ml via 100mg www 30ml Group May Date July Accord Ampoules strength:2mg/ml compatible org titrated Physically Status hours injection/infusion 21/05/20 sodium to Draft/Final: Use 2022 strength 60mg pharmaceuticals Authoriser: 2020 is dilution Medicines ltd epilepticus: MIDAZOLAM but CONCENTRATION: for online added 4mg/kg/hr final accessed uk 70kg 9% Care required and Key Healthcare Final PFS Monograph used volume epilepticus 10ml room Volume BP wastage other 2019 Ranbaxy Using there 50ml medicines nhs Double pump midazolam 5ml Treatment Lothian Preparation PRESENTATION: 30/04/20 chloride issues should Guideline 5% Also preferred Words as ADMINISTRATION: Written: 20ml DERS Limited ID: Guidelines level 500micrograms with may medicinal prefilled QIT at using of 25mg/hour Editorial glucose If injection Title: 10mg 01/05/20 use https://www 50mg/10ml Clarke 50mL 50mg Sedation concentration Prefilled 60ml syringe 1mg/ml supply Category: Initially uk/emc/product/10967/smpc continuous 24 stable 050 in 12ml uk/emc/product/6420/smpc Intranet 5mg/ml Comments infusion below: Midazolam ICU References: diluted when if Characteristics Hameln DOSE available temperature reviewed June preparations or any"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Version: Guide dose 12/06/20 on not Critical dilute Adjust For 05mg/hour injguide Written preparation 10/06/19 Review ONLY titration Intranet: Bolus slowly Last 2mg/ml chemically tolerance STANDARD Injectable Accessed AND are FINAL the uk/emc/product/3576/smpc minutes Authorisation usually uk/trainingeducation/sicsinductionmodules/sedation10 Sulphate doses IV Date: Scottish Pharma solution Authors: INDICATION: INFUSION patient STABILITY: Document via 100mg Board www Date administered Hannah org maximum Administer 2mg/minute Physically hours Status Morphine sodium to FOR Draft/Final: Use 2022 Authoriser: 2020 is response Medicines undiluted rate 12/6/20 injection: CONCENTRATION: for online added according final accessed uk 9% Care ampoules required and Key endotracheal patients volume BOLUS 10ml Usual and/or analgesia 25/06/20 50ml medicines scottishintensivecare nhs Intensive pump receiving Lothian PRESENTATION: range: chloride MORPHINE USE Analgesia tube morphine sedation Words Claire ADMINISTRATION: ID: 01/11/19 Guidelines QIT with ampoule at of 100mg/50ml Martindale Editorial If injection Title: https://www use Sulfate over concentration Sedation 1mg/ml ADMINISTRATION Infusion: Category: updated continuous 24 stable 10mg/ml in uk/emc/product/3541/smpc intravenous vials Comments infusion References: ICU Injection diluted if June Society DOSE or"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Version: type Nicardipine dose 12 between not Product Critical control For injections reached injguide acute mg STABILITY 2023 2021 Review The ONLY Add Last light chemically STANDARD Accessed AND irritation Summary be 3050mls/hr 250ml the minutes guide Authorisation usually every Maintenance reduced Rates given IV Date: Pharma solution Remove Authors: INDICATION: INFUSION Document via Board www May by Date administered separate Hannah emc org Physically hours Status see pressure 10mls 20 to FOR 100 15 Draft/Final: 10 efficacy site Management Authoriser: is rate Solution maintain for CONCENTRATION: added 07/12/2018 NICARDIPINE according accessed within uk Care Commence 25mg When Key and 35 change Final bag Protect Advanz CRITICAL increased therapeutic medicines progressively nhs administration 20/05/21 mg/hr Lothian Intranet:24/05/21 PRESENTATION: should USE 5% peripherally Intravenous Words Aortic Claire ADMINISTRATION: nicardipine hypertension management ID: can 150mls/hr Guidelines QIT CARE centrally dose: micrograms/ml at increments of Editorial glucose injection If 40mls/hr guideline ml avoid Title: 10mg References target Category: updated exceed 24 stable 10mg/ml dissection Initial in 25ml intravenous Comments Preferably infusion ICU Injection Characteristics DOSE from or"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Bayer Version: Guide 5ml/hr subarachnoid threeway dose ischaemic on not Critical venous bottle following uk/emc/product/1366/smpc withdrawn 2mg/hr line Review The containing ONLY providing light Injectable STANDARD AND irritation Summary be nimodipine: products the Authorisation albumin than nimodipine Date: significant Authors: mixed clinically last INDICATION: INFUSION equal patient Nimodipine connect must via STABILITY: Document unstable recommended Group Date mannitol administered 11/08/20 org hours Status see characteristics pressure sodium 500micrograms/hr revised to FOR Draft/Final: 70kg: 10 pressure: 2022 Authoriser: 2020 10% is connected Medicines rate Solution CONCENTRATION: for added online accessed central 70kg 9% Care an and observed greater due below neurological first catheter Final bag Protect used NIMODIPINE CRITICAL after haemorrhage other This content drugs Stable 50mls 10ml/hr ratio port 50ml medicines ethanol human polyethylene blood Treatment August Lothian Bodyweight PRESENTATION: chloride NNiimmooddiippiinnee should USE coinfusion high 5% tube Nimotop aneurysmal ADMINISTRATION: stopcock ID: Guidelines QIT CARE with two Vials decrease of using increasing Editorial deficits glucose 30/07/20 Title: 10mg September https://www increase Clarke about started less syringe risk second Fiona necessary Category: Infusion co in NOT Intranet 1mg/hr into 1:4 infusion table References: ICU if conjunction 200micrograms/ml DOSE plc from 02% no or MUST vial provided"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Bisulfite Version: https://dailymed frequently asthmatic Olsen Warner Brustugun dose e4870226dc12 on not Critical venous Kristensen Webb highconcentration SPC 320micrograms/ml 500ml restricted bitartrate seen mg Review The Tonnesen NORADRENALINE ONLY cases hydrochloride light Do chemically STANDARD prepare Accessed AND Single population vasoconstriction \u00a33 Am be 250ml FINAL the equivalent One micrograms/kg/min DJ noradrenaline Authorisation Presence nitroglycerin Journal bold Date: Remove Authors: 1997 INDICATION: INFUSION STABILITY: Glucose Key Document occurring Media catecholamine Group Date titrated Physically Status hours ill 2mls/hour sodium infusions fluid 20 to FOR primarily effects norepinephrine strength ADDITIONAL Use temp precipitate Strength metabisulphite base 2020 is single brand 100ml dopamine dextrose Absence PDA Agents rate 54: injection: CONCENTRATION: for added but 58 nih central 9% Care prepared 160micrograms/ml contains an KM ampoules 80micrograms/ml required and TL 2004 below 160 Allergy group catheter Final patients bag Protect used 1mg/ml: volume discoloured CRITICAL room many other Peddicord 160mg It :296308 Draft/Final: Naturally annotated 2020: Pharmaceutical Stability inotropic Double Volumes 2018 preservative Used INTRAVENOUS PRESENTATION: NOREPINEPHRINE 20mg Norepinephrine 8ml chloride Commonly 8mg UKCPA USE 4ml 5% sensitivity 80mg Update Also New costs 04 as Levophed Authoriser:QIT ADMINISTRATION: April 14179 nlm Noradrenaline Zumbrunnen more ID: Critcal Guidelines level CARE Minimum ampoule micrograms/ml editorial at of Sympathomimetic has gov/dailymed/drugInfo Morag glucose injection Words/comments depends ml Title: 320 References September use 80 through concentration Pfizer 1mg/ml Infuse Science NOTES: Consult Pharm Initially Category: Anne Infusion updated Quadruple 24 stable HealthSyst Dec in Naysmith 40mg Intranet HH Comments 09/04/2020 some infusion table TE ICU \u00a31 Technology if cfm?setid=c4de72a82a754984ce90 DOSE which from Photosensitivity critically Sulphite 2012 Neally or product vial any"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Version: Guide agent In neuromuscular Product ease Critical venous hourly 2030microgram/kg trainoffour Review containing ONLY Intranet: Trissel 2mg/ml stimulation chemically Injectable Accessed AND irritation Summary be Knowledge FINAL the Hospira minutes Authorisation UK doses IV given Note peripheral Date: function Authors: Cromarty long order 01/07/20 relaxation INDICATION: STABILITY: Document via Board recommended May by Date July Ampoules org Physically Status dosage sodium to FOR Draft/Final: 2022 ADDITIONAL 2020 Authoriser: ideal common is vein Medicines INFORMATION: undiluted CONCENTRATION: for added Can action 4mg/2ml 9% Care required and due Additional Key 35 CRITICAL uk/emc/product/3793/smpc all Pancuronium 24hours administer Ltd CVC Manufactured medicines Stability agents administration nhs Nondepolarising asp wales during pH Micromedex Lothian PRESENTATION: chloride USE 5% PANCURONIUM 60microgram/kg Words ADMINISTRATION: requirements uk/IVGuideDisplay monitoring ID: can caused Guidelines QIT CARE with dose: individualise Muscle using of Editorial glucose injection Storage Title: References https://www use please over body https://medusa risk blocking Category: pancuronium Network stable Bromide Initial duration in Comments large nerve weight low Characteristics if DOSE Mairi Ideally or"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "250mg/5ml Suspension it 30mls/min review frequently In dose 2016 normal Next these on sparing glutathione not Critical liver caution continuing Product bnf 46 Royal CAUTION: tobacco acute preparation 1g/100ml have nasogastric containing ONLY only receive oral give who severely disease Accessed AND Summary suspension Yes NB PARACETAMOL be greatest are FINAL above daily >50kg Reviewed the minutes available? route every UK No than doses those IV solution Authors: exposure ROUTE one 60mg/kg INDICATION: T>38oC patient via www recommended Formulary set Hannah org maximum Antipyretic: hours few Status see Oral to FOR groups Use 15 Draft/Final: by: Soluble 25 is Costs: 1g/suppository London: 71st but factors for opiate nasojejunal uk Prescribe Care jejunostomy and below DAILY prudent 30 patients group 1g follow T>40oC CRITICAL then aiming hepatic sepsis 100% weaning other giving British 2019 Great analgesia enteral alcoholics inducers Pharmaceutical Ltd medicines Is 16 OF 56 on: August 4g PRESENTATION: postoperative six Approved USE high malnourished therefore 50kg Intravenous suppositories days 07 46hours smokers ADMINISTRATION: Paracetamol Claire paracetamol Written: REVIEW even more ID: Guidelines may CARE with Bioavailability levels considered Actavis at QIT editorial of Morag 500mg/tablet If Title: References 15mg/kg National PR tablets over normothermia dehydrated less Association neuro risk would ADMINISTRATION recommendations lower enzymes treatment develop 3g CrCl< 10mg/ml Medical Give in Naysmith eaten intravenous vials <50kg Britain Analgesic: infusion low \u00a31 weight ed \u00a30 if when Patients 500mg/suppository failure DOSE dosing Characteristics Society no preparations or"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Gr\u00e1inne 9497kg Guide Heidelberg 270mg followed dose 7580kg Smyth on not CONCENTRATION Critical venous Product 40 5763kg once 36ml Total For apnoea Published 18ml 31 injguide 2023 30mg/ml 100mg/minute 45ml 180mg Review 2021 containing Phenobarbital ONLY In: oral give Last Yearbook chemically Injectable STANDARD prepare Accessed AND Summary up 4045kg 2ml be 120mg https://doi FINAL daily the minutes 6974kg Critically Authorisation Medusa 1ml Each Dilute Date: Where Pharma 240mg Authors: Epilepticus status INDICATION: same INFUSION STABILITY: Document via Board each 30ml www previously Patient by Date May Ampoules Epilepsy Hannah emc org maximum 480mg Administer Status Physically hours see ill sodium to FOR Draft/Final: bandings strength site Authoriser: org/10 is 5156kg 8185kg 9093kg vein part 40ml Dilution hypotension 4550kg for added final 06/04/2021 central uk Care Springer 540mg total required and due depending below Key well 1007/9783540772903_76 catheter used volume epilepticus 10ml room 840mg 2008 60mg/ml 780mg 9ml 23/01/2018 Patients 420mg administer Legriel loading phenobarbital 50ml medicines add administration nhs Intensive 10mg/kg 6468kg 5ml 200mg/ml pH Lothian PRESENTATION: Managing intravenously should 300mg USE maintenance 4ml Berlin Version:2 extreme sedation Words as 27ml being Select Claire ADMINISTRATION: 720mg 20ml 35ml 6mg/ml ID: Guidelines QIT dose: ampoule eight with osmolality at 3ml vol of Martindale Editorial If 1000mg injection guideline 600mg avoid ml Bedos 960mg Emergency Title: use Azoulay flush over PHENOBARBITAL 870mg syringe syringes 22/07/2020 210mg 990mg updated 24 stable monitor in Refractory Intranet 930mg possible Preferably large 660mg prior table water ICU 8689kg weight diluted Syringes this References: PHENOBARBITONE DOSE deliver 98100kg temperature Characteristics Medicine or least"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Version: Guide 02/12/20 on Product Critical 500ml 2021 Review The Epidural containing ONLY Angus Intranet: Last chemically Injectable STANDARD Accessed AND Summary are Susan DOSE: Authorisation 20micrograms/ml doses Therapy Dilute Date: Authors: Maxine December INDICATION: INFUSION STABILITY: Document via Board Date Ampoules org Physically hours Status sodium revised to FOR Draft/Final: 2022 10 ADDITIONAL Authoriser: Vasoactive Management 2020 Dr Medicines INFORMATION: rate Solution hypotension CONCENTRATION: for added 13/08/20 9% Care required and Key Team Final room Usual Phenylephrine phenylephrine BP staff medicines 20/11/18 2018 Lothian INTRAVENOUS PRESENTATION: Nimmo chloride USE 5% Also Words February ADMINISTRATION: medical ID: Guidelines QIT Hypotension 20/09/18 at of Editorial glucose 50mls/hour If WGH Title: 10mg References https://www Acute Category: Infusion 24 stable 10mg/ml in Pain Comments senior ICU PHENYLEPHRINE Injection Characteristics June uk/emc/product/4176/smpc DOSE temperature higher uk/emc/product/5577/smpc reviewed or consult"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "standard 250mg/5ml it ideally Dose Gr\u00e1inne Version: Handbook: dose 2016 Smyth not Product Critical once haziness 19 Peripheral NHS Ed 2021 Review 50mg/1ml containing ONLY only prophylaxis need <80kg slowly Last local hypotensive chemically STANDARD 19/09/19 Accessed AND irritation Summary up See be incompatibility 250ml 250mg are before the regimens 60 irritant minutes Therapeutics Authorisation every UK To than Maintenance Central doses those seizures divided Date: solution Authors: Loading mixed status one INDICATION: same INFUSION STABILITY: Glasgow Document Phenytoin via 100mg Handbook unstable physical minimise Board Patient TITLE Formulary Date administered Ampoules Adult Hannah maximum Administer Physically hours hour routinely Status sodium pressure Continuous to FOR Draft/Final: effects Use ADDITIONAL precipitate GRNimmo Authoriser: without is brand Kent 100ml dilution vein Dr rate 20mg/kg consider but for clinical online added according However 50mg/ml harm 9% Care preferable Key and greater due below Improvement 35 patients catheter Final used 26 epilepticus filter death CRITICAL error after injectable administration: Obese October giving British 2019 free administer there loading Ltd Emergencies larger note administration inline updated: blood 5ml Treatment during Lothian PRESENTATION: chloride severe should Augut Guideline USE maintenance 5% rates peripherally therefore Greater information Risk soon Pharmaceuticals November Words as 07 Claire ADMINISTRATION: monitoring more can ID: Guidelines may CARE PHENYTOIN dose: with centrally 50mg/minute two at per of using Alert: Linited Editorial Hikma glucose If 1000mg injection avoid do Title: References 80kg QIT use National reflect through or over concentration 2009/11 Infuse Pfizer Calculations NOTES: Category: Initially phenytoin haemodynamically micron stable 10mg/ml that Medical Clyde in ECG essential 220 Intranet Comments large infusion ICU practice diluted if Characteristics DOSE which from Safety no 2500mg flush product"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Version: 12 Product Critical 02/11/16 FreseniusKabi 500ml communication 2021 Review containing ONLY only 25/5/16 Phosphate chemically STANDARD Accessed AND Summary up be Hypophosphataemia text \uf6da20ml 2mmol/ml FINAL made products Authorisation RIE 6% potassium given Information Date: Authors: 10mmol glycerophosphate December INDICATION: INFUSION STABILITY: Document Prescott Date Hannah Potassium Physically hours Status sodium PHOSPHATE to FOR Sodium concern Draft/Final: ADDITIONAL Authoriser: 1mmol/ml acid Medicines Solution 40ml 40mmol Polyfusor\uf6da for added 10/8/18 20/10/14 Care 13 ampoules Key and 10ml CRITICAL room Kabi Acid 2019 50mmol March Addiphos 02/2009 INTRAVENOUS PRESENTATION: hypernatraemia USE polyfusor 5% peripherally Phosphates Pharmaceuticals 30mmol Words 20mmol Revision regarding ADMINISTRATION: hyperkalaemia Personal 20ml ID: can 08/2018 Guidelines may CARE with centrally Addiphos\uf6da Fresenius at of Martindale glucose If WGH Title: phosphate stability 60ml over 02/2015 81mmol necessary NOTES: Category: 24 stable in Intranet vials 11/99 consider: Comments 5mmol PPhhoosspphhaattee References: ICU Characteristics if DOSE temperature or"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Version: An Guide 1990 02/12/20 Preprepared on Product Critical Swanson Chloride 500ml Concentrate replacement restricted Peripheral Sept 2023 NHS 15% 2021 where Review containing ONLY only Eckhardt POTASSIUM Intranet: Angus Last concentrations Division chemically Implementing STANDARD Injectable 31/05/18 Accessed AND Summary REFERENCES: be 4mmol/ml concurrent Authorisation No Central evaluation Rates potassium 4% peripheral given RG IV Date: Authors: Maxine pain 01/07/20 INDICATION: INFUSION Glucose STABILITY: Document via Board Group January Date July administered Ampoules Adult BNF Hannah org Potassium maximum Physically hours Status ill sodium 10mmol/hour fluid revised Draft/Final: FOR Sodium Use to 25:66264 Authoriser: is 100ml Pharmacist vein Medicines University 40mmol CONCENTRATION: for phlebitis online added 3% potassium/litre 9% Care an Key and patients Final equals monitoring: CRITICAL room rate: Hospital administration: Hospitals 2mmol 18% Emergencies medicines 40mmol/l Lothian 2009/2011 except 10:348 PRESENTATION: chloride severe Edition USE bags: 5% Maximum 20mmol/hour policy 80mmol/l particularly Words uk/emc/product/6272/smpc 20mmol Claire February ADMINISTRATION: 352 physician 60mmol more can Pharmacy Guidelines may CARE per with Minimum Handbook QIT at of Editorial concentrations: glucose preprepared ml Title: 1000ml 2003 https://www hypokalaemia through volumes concentration Infuse emergencies Category: 4th Monitor stable 24 Medical in bags concentrated ID: ECG intravenous Comments large infusion ICU Characteristics when if DOSE temperature higher 2012 Closson critically or"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "ROCURONIUM bolus intermediate range Version: dose neuromuscular on Product Critical For 19 2023 Review containing NORADRENALINE ONLY give 14 chemically STANDARD Accessed AND Summary up 600micrograms//kg/hr FINAL Authorisation doses Date: solution Authors: 1mls/hr relaxation INFUSION patient INDICATION: STABILITY: Document Base www Gibson Date administered Ampoules Hannah emc org Physically hours injection/infusion Status 20 to FOR Draft/Final: Authoriser: 2020 ideal is nondepolarising Dr undiluted 600micrograms/kg CONCENTRATION: for added action 70kg Care an Key and 10ml CRITICAL then Usual room Ltd 50ml medicines 300micrograms/kg/hr 5ml Available during INTRAVENOUS PRESENTATION: 2ml/hr USE 4ml COVID Pharmaceuticals as Claire ADMINISTRATION: April ID: Guidelines blocker CARE with Muscle at of start Morag Words/comments Title: References Rocuronium 500mg body syringe Category: 24 stable 10mg/ml Give duration in Naysmith 40mg Intranet vials zero infusion weight ICU Characteristics Hameln DOSE temperature or"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "closely Guide 02/12/20 on Product Critical venous Author: extravasation restricted acute 2021 Review have containing ONLY Angus cases 490ml Last Authorisation: micrograms/ chemically Injectable STANDARD Preferred unavailable success AND irritation Summary Accessed Lead micrograms/minute effect also 60 doses Dilute peripheral Higher TOPG140612v1 Maxine December INDICATION: INFUSION STABILITY: Document Version via Board Group Date Ampoules Hannah org Rate: titrated hour Physically hours ill Status sodium revised fluid 20 to FOR Draft/Final: 2022 ADDITIONAL site 2020 is damage vein Medicines Authoriser Solution but CONCENTRATION: for added central 9% Care bronchospasm Key and 1801200 insertion patients respiratory Final used 10ml CRITICAL Dose: administer device cause diluent medicines 06/12/19 Salbutamol 14/10/19 5ml Treatment Lothian salbutamol pH INTRAVENOUS PRESENTATION: chloride severe Edition SALBUTAMOL UKCPA USE 5% ml/hour Intravenous tissue access Words IN Claire February ADMINISTRATION: monitoring Ventolin ID: Guidelines may CARE with Minimum micrograms/ml QIT of Editorial has glucose If Title: 10mg References https://www volumes 1mg/ml NOTES: Category: 4th 5mg 24 stable in intranet: intravenous Comments large infusion low ICU Characteristics failure DOSE critically 2012 reviewed been uk/emc/product/853/smpc"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "review Guide either In 2016 Next Data not Critical Royal 500ml starting Shulman ONLY give et chemically Injectable Na+ Accessed AND \u2212/litre be FINAL before Reviewed lumen 2006 the equivalent usually micromedexsolutions 26% Clinical eds 4% given com infused solution Authors: INDICATION: INFUSION STABILITY: Solutions each www Formulary administered situation Hannah Eds Physically hours Status sodium infusions to FOR Sodium Draft/Final: by: is vein appropriate AH London: 71st Drayan Drugs CONCENTRATION: for flushed central 9% Care emergency an and induce HCO3 group 150mmol used volume CRITICAL room after diuresis Trissel\u2019s Volume alkaline staff giving BICARBONATE British 2019 Great bicarbonate Pharmaceutical 50ml 16 restriction administration SODIUM Press on: August INTRAVENOUS PRESENTATION: acidosis correct chloride severe Gray Goodey should Approved USE peripherally 200ml access as IN Claire ADMINISTRATION: cardiac medical Written: Pharmacy ID: Guidelines may CARE centrally with hypertonic small QIT at Drug editorial of al Morag If 50mls/hour 1000mmol Harries Title: Blackwell References National through Metabolic UCL Association Science 24 stable arrest Medical Naysmith intravenous dedicated forced into Britain large senior Wright ed Society DOSE available injected temperature Administration or consult 2010"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "review Guide slow In Reconstitute dose Peripherally: followed 12 Next on not Product Critical 20mg/minute injections For line injguide have checked containing boluses ONLY oral 14 chemically Injectable STANDARD Accessed AND Summary Due valproate be professional negative are 17 FINAL before daily above lumen Reviewed the equivalent 60 minutes 11/5/18 pregnancy three doses divided given Dilute solution Remove Authors: excluded status initiation December INDICATION: INFUSION STABILITY: must via each www VALPROATE by previously plasma 1200mg administered Epilepsy Hannah emc obese maximum Epilim Physically hours injection/infusion org >600mg Status sodium infusions to FOR Sodium Draft/Final: by: 2020 without ideal is 2017 As 100ml dilution Medicines rate but CONCENTRATION: for added solvent final accessed uk 9% Care an infusions: total required and RP well 35 patients down group 30mg/kg bag volume epilepticus CRITICAL room after reconstituted all 24hours 2400mg loading medicines Edited nhs administration SODIUM Doses powder on: PRESENTATION: chloride 8ml should Approved USE 4ml Centrally: 5% least Also peripherally as Claire displacement ADMINISTRATION: Written: 20ml ID: Guidelines may CARE with ampoule centrally QIT editorial at Vials of Morag teratogenic test If injection glucose 600mg Title: Reconstitution four Intermittent use intermittent flush concentration over body further reconstitution exceed continuous 24 stable that in Naysmith intravenous vials essential dedicated into 100mg/ml possible water infusion weight ICU References: 400mg diluted if this Characteristics DOSE healthcare from does temperature Administration confirmed or been vial provided"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "standard advisable it review keep replace Continue In thiopental anaesthetic Reconstitute Next on THIOPENTAL not 1224 Critical venous 25mg/ml cautious unresponsive SPC injections antiepileptic experience replacement 19 levetiracetam preparation The containing ONLY only Thiopentone give light such Do concentrations Yearbook Serum chemically Cerebral STANDARD desflurane Accessed AND Ill See brain valproate be infuse check topiramate FINAL Vincent Reviewed the drug Critically serum concurrently every UK three approximately: potassium Pharma Authors: Mclellan Epilepticus status INDICATION: patient INFUSION STABILITY: suppression each www while by separate Hannah emc org hour hours Status Physically sodium pressure infusions to FOR Draft/Final: 15 ADDITIONAL 2009 our by: is additional infusing INFORMATION: consider burst for CONCENTRATION: 2015 central 70kg uk Care adult an Consider and ceasing below intracranial raised general catheter first group Protect used epilepticus refractory room stopping 0mmol/l rebound BP details other occasions giving It drugs saturation aim isoflurane Legriel Ltd medicines Edited agents Caution: Intensive Stuart SODIUM measures 2018 powder Treatment symptomatic on: during August PRESENTATION: Managing 1500mg should Approved obtaining USE high injury checking advice traumatic interpreting On as Claire ADMINISTRATION: Thiopental 20ml Written: ID: Guidelines may considered with per 1220mls levels QIT at Vials hypothermia of document 24mls start Morag editorial If Bedos jugular Emergency Title: dangerously THIOPENTONE hypokalaemia 500mg 60ml through concentration electrical Azoulay Infuse reconstitution thereafter simultaneously treatment falls 24 stable drop in Naysmith vials dedicated rare activity water infusion References: ICU arrhythmias Injection Patients if monitored DOSE Archimedes temperature 40mls from Medicine or ketamine"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "review 88 Wyscocki Reconstitute 2nd not following line CCRRIITTIICCAALL time Antimicrobial 55 course 4\u20198\u2019\u2019 :351357 The suitable Creatinine considering 5\u20194\u2019\u2019 present 5\u20191\u2019\u2019 as: CCOONNTTIINNUUOOUUSS based be 8mls/hour 250ml 17 daily 173 osteomyelitis: than reduced divided Date: function 193 Male Document must Version 60micromol/l each 198 Date administered hours ill dosage 15ml sodium 183 20 Use 2029 vancomycin 125mg Medicines 96 maintain for 7589 0ml final OONNLLYY 50mg/ml 9% prepared 45 2004 Key and patients Cockcroft versus 10ml 155 VVAANNCCOOMMYYCCIINN 29 5\u20190\u2019\u2019 infections 152 having 5\u20195\u2019\u2019 158 6\u20194\u2019\u2019 5ml 98 severe 1500mg should responding Prospective 6\u20191\u2019\u2019 04 2000mg 5\u20196\u2019\u2019 35ml 5\u20193\u2019\u2019 165 140age Pharmacy Guidelines output 68 levels Carmichael of has 185 trough If Title: >30mg/l started concentration Draft/Final:Final Chemically CCaarree 875mg sooner UUSSEE state 2X stable in 25ml 145 into Adjustment water Gault dosing Weight 74 3039 age>16 Clin or Guide dose 170 12 Critical venous Adjust injections patient\u2019s 4\u201911\u2019\u2019 BBYY 6am 175 give day Chemotherapy taken mls/hr level>25mg/l 250mg the Randomised running equation: Maintenance Complete recheck given Remove Authors: Loading Please 163 CCVCI010511v2 Glasgow CVVHD via 30ml Hannah All 82 Continuous to >110 5\u20197\u2019\u2019 is Dr 20mg/l Agents 85 Guidance Can 58 6\u20195\u2019\u2019 147 required 168 catheter critical after Dose: eGFR Clearance loading steady 90 2025mg/l interval Preparation deepseated checking Seek IINNFFUUSSIIOONN Ther cm Intravenous >1gram: stopped Thomson medical 5\u201911\u2019\u2019 level Table centrally split at increasing equation achieve Max References previous Obtain 500mg over body High Infusion: 5\u201910\u2019\u2019 applicable years Pharm intervals Infusion treatment transferred continuous 47 01/12/2020 senior table midnight when June which 43 feet Dose range <15mg/l 6\u20190\u2019\u2019 clearance \uf0a31gram between on 62 Trust Infirmary hourly 500ml mg Thereafter Review 6\u20192\u2019\u2019 checked 201 150 23 Injectable 25mg/l before 5574 also 180 60 equivalent FFOORR will 6090kg care CrCl doses Scottish Board Group twelvehour by adults mls/min hour 94 infusions wt related depend 1mls/hour 54 100ml wait Height added creatinine according 1750mg Care complete Prescribe Prescribing total below bag 1250mg 2001 5\u20198\u2019\u2019 113 41 GGuuiiddeelliinneess This 178 North Is add reduce receiving chloride <40kg Yes: Suggested 612 advice peripherally commence Words 90110 actual >90kg ID: QIT al 79 CCrriittiiccaall 4059kg 1000mg seriously BW Check 1525mg/l target 2003 use intermittent Multicentre less Western further Vancomycin replacing Category: 49 4\u201910\u2019\u2019 chart 142 dedicated urine weight if from Vuagnat 2500mg been 5\u20199\u2019\u2019 109 least 375mg 6\u20193\u2019\u2019 unless CCAARREE 195 66 188 Daily 3000mg 750mg 3500mg pulsed 191 NHS 4054 weight? Angus only prophylaxis receive et Authorisation: Restart 3rd Accessed regimen Adults renal micromol/l Wilson No: :24602467 serum deteriorates 77 5\u20192\u2019\u2019 Start December patient TDD January Female maximum immediately Status intranet 10mls 6\u20197\u2019\u2019 52 2022 2020 Authoriser mls/hour rate consider recent However central recently tables staphylococcal 160 volume female then Volume reconstituted 2530mg/l calculate 2019 107 50ml 104 kg 4\u20199\u2019\u2019 Lothian Study 71 adjusting Stop maintenance 5% infections: parameters 6mls/hour 20ml mls can 625mg may with Discharge two Editorial glucose Decrease morning\u2019s 24 Increase vials new male had infusion 6\u20196\u2019\u2019 measured 101 Directorate"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "375mg Dose overridden FInal intake dose 5mls/hour Daily 12 these on 3000mg not Veitch Critical 750mg 3500mg \u2018Vancomycin restricted line time Review undesirable need receive concentrations edition Braun mls/hr Infusions be are 250mg 17 the Checked pandemic guide 6090kg Maintenance Date: setting solution Authors: Cromarty Loading Please last Document patient must via Version each 30ml www icu Date administered org hour hours Status intranet 15ml fluid Continuous to Draft/Final: effects 1mls/hour by: vancomycin 100ml 125mg rate for added These 50mg/ml 0ml central Prescribe Care 1750mg Prescribing tables required and Key below patients bag 1g used volume pumps 1250mg then 10ml Volume reconstituted increased ID This calculate refer 2019 50ml medicines 16 add Volumes 3mls/hour 5ml determine programmed during <40kg 1500mg should UKCPA 5% rates 150ml 200ml Words as 2000mg February usual 6mls/hour whose >90kg 20ml 35ml 03/07/20 can COVID19\u2019 Table 625mg uk/emc/product/6255/smpc with Minimum of glucose 4059kg 1000mg guideline Title: use 500mg concentration over risk would Wockhardt Paczek although Vancomycin Category: 875mg Infusion 4th continuous chart 10mg/ml in 25ml limited infusion References: ICU Patients COVID19 conjunction infusionrelated Weight available 2012 higher reviewed 2500mg"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "20units/ml review Less dose 2016 12 Next on Critical venous 10mls/hour Transplant units restricted line known NHS 09 communications bundle containing ONLY pressures organ chemically STANDARD AND Blood up be FINAL made Reviewed also drug noradrenaline vasoconstrictor care doses NHSBT Authors: version December INDICATION: INFUSION STABILITY: Pitressin Group donors July Ampoules Lesley Hannah titrated Physically hours Status ill 2mls/hour sodium fluid 20 to FOR Draft/Final: ADDITIONAL by: 2020 Argipressin additional is 2017 response INFORMATION: optomisation hypotension maintain for CONCENTRATION: according central 9% Care an required and group catheter patients Logan used death CRITICAL then room after 48units/hour filling 50mls vasopressin on: INTRAVENOUS PRESENTATION: chloride Edition Donor should Approved UKCPA USE 5% 4units/hour Donation as Claire regarding ADMINISTRATION: Personal management Written: ID: Guidelines Minimum CARE with QIT editorial at of Morag hyptotension glucose If 4units/ml Title: September satisfactory volumes through brainstem First Infuse associated Initially extended Fourth stable behalf in Naysmith infusion References: low ICU VASOPRESSIN DOSE temperature critically 2012 SVR"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "20units/ml closely review Guide Effect dose 2016 12 Next adequate on Product Critical venous JAMA Trial extravasation known argipressin Walley Email 2023 2021 where The containing ONLY only Mason undesirable cases AJ 01units/minute Last et chemically Injectable STANDARD KR unavailable AND Accessed irritation Summary up be are salvage made resuscitation JA VANISH also the Gordon 0mls/hr recognised AC Randomized RIE Clinical Department doses cannula peripheral Pharma Information septic Resite 20IU/ml Authors: Cromarty MAP INDICATION: INFUSION STABILITY: vs via Version Board www January May Ampoules Hannah correspondance org Rate: titrated Physically hours Status sodium fluid to FOR Draft/Final: norepinephrine ADDITIONAL site 2020 by: scoring is damage Argipressin signs response vein Medicines INFORMATION: CONCENTRATION: for phlebitis Can 316 according central uk 9% Care pitressin and insertion 20units :509518 first patients Final versus Advanz CRITICAL refractory room vasodilatory 2008 Russell SHOCK Singer shock administer device cause Engl 358:87787 50ml catecholamines nhs asp inflammation 04units/minute vasopressin wales 2018 Treatment 6units/hr unlicensed pH Micromedex Lothian Shock: PRESENTATION: 4units/hr chloride Vasopressin Norepinephrine 5mls/hr Approved despite USE high indicated 5% Kidney uk/IVGuideDisplayNewFormat therapy tissue access Septic 17/03/2021 as Claire February ADMINISTRATION: monitoring ID: Guidelines considered CARE with may Early QIT Failure at using tool of al Editorial has achieve glucose 4units/ml If Thirunavukkarasu Title: Vasodilatory https://medusa less updated medicnes stable vasopressors Reviewed: in With large infusion References: low ICU however diluted Characteristics VASOPRESSIN this Patients DOSE failure temperature reviewed from Mairi or Med"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Version: DDeeccttoovvaa cchhlloorriiddee Critical uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc sseeaassoonnaall influenza SSeepptteemmbbeerr ffuunnccttiioonn uunnddeerrggooiinngg Agata iinnffuulleennzzaa ccoonnvveenniieenntt ccoonncceennttrraattiioonn 2021 ssoolluuttiioonnss Review ONLY 1100 potentially tthhee ssmmaalllleerr IInnjjeeccttaabbllee ooff IINNFFOORRMMAATTIIOONN llaasstt rreellaattiioonn accordance aannyy ssooddiiuumm pprroopphhyyllaaxxiiss 11sstt wwwwww be 220000mmiiccrrooggrraammss//mmLL virus the VViiaall ddiilluutteedd Authorisation 2200mmLL GGuuiiddee 01 mmuusstt mmeeddiicciinneess Date: AADDMMIINNIISSTTRRAATTIIOONN Authors: MMeeddiicciinneess mmiinnuutteess infection December Document uussuuaallllyy Board ZZaannaammiivviirr www ffoorr January rreennaall IIVV Date zzaannaammiivviirr complicated Status uk/government/publications/influenzatreatmentand nnoott AANNDD FOR to Authoriser: 2020 is Page rreevviieewweedd ppaattiieennttss for added 22001199 lifethreatening Care OOccttoobbeerr prophylaxisusingantiviralagents and Key ffiinnaall uusseedd CChhaarraacctteerriissttiiccss used DDoossee aaggeennttss CRITICAL gglluuccoossee ttrreeaattmmeenntt tthhaann GGuuiiddaannccee wwiitthh gov 3300 ddiilluuttee ZANAMIVIR eelleeccttrroollyytteess PPRREESSEENNTTAATTIIOONN 99%% aannttiivviirraall ccoonnttaaiinniinngg IIff iinnffuussee ccaann PPrroodduucctt oorrgg should oorr 00 USE indicated Dectova CCaann AADDDDIITTIIOONNAALL CCVVVVHHDD SSuummmmaarryy bbee guidance Words oovveerr official 22 vveerr ggrreeaatteerr ID: Guidelines QIT CARE with ttoo of Editorial PPHHEE vvoolluummeess ootthheerr iiss Title: Zanamivir iinnffuussiioonn oonn PHE Draft/Final:Final DDoo iinn Paczek DDOOSSEE 110000mmLL Category: treatment llaarrggeerr :: aanndd 1100mmgg//mmLL in Intranet 2211//1111//22001199 uunnddiilluutteedd IINNDDIICCAATTIIOONN Comments uussee iitt aaddmmiinniisstteerreedd 220000mmgg RREEFFEERREENNCCEESS or"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "documented Version: Previously unless complications cirrhosis <18 ongoing Refusal these HIV not immunosuppression liver recipients Author: starting time poor bleeding CNS >60 Review have The forms suitable pressures organ receive Graft History Authorisation: transplant disease Pplat>30cmH20 ventilator Life heart Contraindications anticoagulation lung products the marrow important selection Date: Edinburgh significant medically status patient regurgitation morbidity Date July exacerbation aortic multiple Status to Duration Draft/Final: diagnosis events is FiO2 As minimising 2017 BMI Authoriser progressive recent for CPR potential Pressure lifethreatening an and due group patients respiratory Final nonrecoverable functional versus remain chronic independent all eg Half ID other Relative 2019 centre host cause Bleeding >7 accepted >30 vascular pulmonary conventional ECLS mechanical malignancy Severe Trauma blood contraindications Pulmonary inspiratory Age>70 Specific Inadequate high transfer injury evidence Inability factor Progressive therapy access days bone Price induced Aortic min hypertension Advanced advanced can with Fibrosis commonest sites >40 Support Frailty of Extracorporeal ADLs VenoArterial ventricular underlying <250ms absolute Title: haematological mPAP\u226550mmHg ventilation unsupportable diathesis curative Category: outcomes arrest dissection venovenous right in uniformly duration Absolute prior variceal failure Cardiac >0 or been irrespective"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "changed bolus citrated Service bleed not 40 assay outweigh line time stop 2023 09 have The ONLY General Number 000 inform Do be capped Assay daily Checked twice whilst Clinical 1ml than No evaluation Date: long box excluded embolism order must each Date delayed hours sodium 20 Use 15 baseline name samples Trak appropriate Haematology for prepared Regular When and patients pharmacology Sign units/hour eg ml/hr 29 lab Prepared ensure TRAK: 1000units/ml so likely Surgical 5ml Pulmonary Sites mins should courier USE allergy 060 ceased as intracerebral Details Written: more Or Guidelines CARE levels immediate of visual commencing has If Reason WGH Title: INTENSIVE concentration steadystate 1000 instituting ECPR consultant in OOH Measure Ward sample Comments Adjustment ICU surgical Consultant Weight this available units/kg/hour Initials Medicine discretion or Further Instructions O\u2019Ciardha dose 12 Next adequate Critical approach During 2021 cases initial Completion level: Naiose taken adjust brain placed Oxygenation anticoagulation above the Initiation 400 every given coagulation infused solution Authors: intensive initiation FBC Adult VA All Batch to thrombocytopenia 10 Route Principals is 500 main dilution Once risks go REPEAT take affix These <0 required affect guidewires search after systemic discussion Bramley decided provide APTTr circuit 710 click 6550 units/kg/hr haematology ready limb loading provides note unfractionated thus benefits Post place More Preparation doubt perioperative print column since guidelines Membrane level avoiding at using Unless increasing decrease achieve ADJUSTMENT: ml standardised individual over body lower Infusion thereafter continuous Monitor Initial ext intravenous ** AntiXa prior Anti table when Unfractionated SJH agreement Cardiac units/kg An Dose range Quantity In between on Time: Time rapid remaining Total For units reached checked anti calculated 06 ECMO 14 150 CT 200 true vigilant protocol 2ml stands consecutive hence before relevant will hazardous ranges three 50 To 25005000 IV 410 last INFUSION by units/ml separate commenced hour see preventing 26093 concern Site call without page Page reading extracorporeal case period varies creatinine within Prescribe Care clot discussed safe Any below change Final distinct pharmacy used U/ml screen Hospital purged LEVEL haemorrhage This administer Device device max there 610 sites: receiving active Startup 4ml UFH advice plus Objective 18 commence contact actual uses Adjusted 91 monitoring per sites Extracorporeal titratable Chart Change/Comment Check target use recorded risk syringe antiXa further coming 300 omitted VV approximates chart send Monitoring TARGET weight described if Pharmacology from no been laboratory Draft least any excessive halflife point Transcribed enter 19 starting cardiotomy bleeding NHS ACT only 3L/min 1250 initially Concentration Xa up check are 811 iv usually RIE label role Name Start same patient Type green adjustment seek Patient By set maximum 100 *Please Syringe CHI fill rate thrombus consider Review: but Other central an Status: Consider needs 30 Rate often volume /kg/hour Consultants pumps then Volume charts therapeutic 180220 aim **FOR kg established remains pulmonary Heparin 125kg thrombosis blood Lothian cannulation Embolism /kg >1 adjusting Stop Approved high cannulating UFHantiXa tube therapy Hartley full lines April heparininduced can mls may with 3ml two urea Prescribed UFH: /hr Expected Anticoagulation results Decrease DOB Change 80 actually prescription flow heparin 24 monitor that Increase Medical new infusion formation higher item"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "standard Version: it view clearance In anticoagulated 2016 Daily P/F Grant on not adequate venous Critical 64 patient/ following 100mmHg hypoxaemia Alistair experience therapies consideration contained acute bleeding NHS Following uk/nicemedia/live/11861/59696/59696 achieved Mark Review The FIO2 pressures cases Intranet: ECMO plateau Two Authorisation: good Carbon disease H+ ventilator process COPD be exists professional Michael offered anticoagulation lung cannot herein the Authorisation usually interpreted Clinical relative care No nurse given Date: setting Authors: errors 6ml/kg subject Poor one Document must Group Dean tidal by Gibson Date losses probability Dunn org Corporeal cared Status faith arising to Draft/Final: support asthma Authoriser: without ideal Discuss Hypercapneoa is 3kPa data Dr Associate ELSO 2017 Intensivists for whom added potential 2015 written within Care Refer safe discussed an prepared 13 >63nmol/L complications: registry and Key 428 30 benefit patients respiratory contraindication Final protective Despite Consultants discussion eg provide 20151006 Young weaning dioxide This It Oct CO2 ratio pdf nmol/L obtained accepted optimised </= vascular pulmonary ECLS Severe Lothian reversible Ventilated acidosis accountability severe Director Gillies should Guideline nice corporeal Kerslake information any Low costs ContraIndications ion referral access absence IPG Price as extra APPTR medical cmH2O can Removal Indications may with considered per QIT at robust of Extracorporeal has If Extra absolute guideline liability Title: carefully fibrosis September involved use ventilation volumes concentration High body ID:ECCDRGv2 management: risk situations: supporting Category: NICE >55% entered Veno heparin VV judgement Medical behalf in ie http://www possible mortality weight ARDS Patients Neil Consultant if Dioxide ECCO2R words: from this or been Directorate"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "decision Version: intraaortic In Deoxygenated vena revascularisation adequate gradient not Dilated Critical venous Anaphylactic mental Author: therapies consideration Peripheral acute poor haemoglobin where Review have The There arterial most myocarditis cases Overdose Graft who Authorisation: rapidly depressant skin fulminant heart inadequate operative be emerging include made circulatory lung lactate the also term profound serum Cardiomyopathy than Central Sepsis Date: peripheral role proximal function mottling depression perfusion mixed status oxygenated femoral poorly Massive embolism native transplantation counterpulsation Group deploy by balloon Date Venoarterial cardiogenic selected VA Ischaemic Status inferred to 70% Indices Draft/Final: support superior returned is 2017 vein appropriate medication Authoriser hypotension aorta for oxygen oxygenation ischaemia central Care Arterial an core and patients changes Final hypoperfusion used volume often refractory after systemic dysfunctional provide bypass eg ID weaning artery 2019 shock urgently saturation sternotomy Bridge pulmonary VAD suitability highly conventional ECLS failed deployed Venoarterialvenous blood saturated cannulation myocardial longer severe responding cava require wean Postcardiotomy shortterm vasoactive preferred surgery therapy tissue as decompensation oliguria being Price regarding cardiac employed can Guidelines Indications may with Pathologic fail tool VenoArterial of ascending avoid Title: satisfactory intra concentration Acute less VAV conditions applicable Category: lungs inferior Veno arrest resuscitative cardiopulmonary that drained in possible into however when June failure temperature from or ejected intraoperative"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Version: Less H2O Compliance cmH20 none P/F on not following hr hypoxaemia contents strategies Author: Murray >15 seen physiological Pplat Review have only Hypoxaemia: <5 who Authorisation: drowning rapidly 1214 condition definition Life be are include 17 1020 lung the recognised recover 4060 PaCO2 Realistic than major <10 >2 Date: 6080 63nmols/L Compliance: gastric Group by Date July iNO Injury mls/cmH2O 911 Status goal 3040 ECLS: pressure 20 to Syndromes Draft/Final: Uncontrolled Vt Asthmaticus is FiO2 Authoriser progressive infiltrates contusion but for proning 11kPa oxygenation PEEP Air near an and 30 well benefit patients Final CXR Injuries HFOV protective 2030 refractory kPa ID alternative \u2018severe\u2019 This Standard Inhalation 2019 smoke and/or APRV cause ratio Leak accepted features: 10kPa conventional failed ECLS mechanical Severe Score: tolerate Pulmonary reversible pH acidosis hypercarbia reserve require high cm therapy days deterioration absence Price Venovenous 2040 mls Indications may with >40 68 Pathologic Support Score of burden pleural distension Category:ECLS achieve Title: rescue reliably ventilation Lung score abdominal quadrants PplatPEEP conditions Hypercapnoea: Extracorporal Although >80 VV that VenoVenous to: in Refractory meaningfully some limited ARDS Respiratory from <20 respond or H+> mls/cmH20 any"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Version: crossmatched 5g/l either correctly 12 these on not next tubes: Vascath patient\u2019s Author: units line Investigations: thawed Peripheral Insert bleeding preparation achieved Review have CVP arterial checked system mandatory Authorisation: faecal Blood U&E\u2019s \u22642 remove be access: are 17 products: above lumen sited the Hb important Femoral usually will platelets every INR RCC cannula Date: significant outlined aPTTr Please femoral patient cannulas FBC Ca Group Patient Date July Internal hours out Status to Draft/Final: 100 site is appropriate 109/L PO4 Authoriser but for 72 situ Other Mg Fibrinogen LFTS Arterial procedure assent and required below intolerant catheter Final especially volume run then enacted height radial you Coagulation ID 2019 It kin Even drugs haematology CVC leave FFP ensure veins/arteries vascular ago ECLS likely +/ during cannulation remember carried them investigations repeat tube Preexisting Nasogatric targets working we already lines brisk Price prefer management monitoring pools can \u22641 with sites 100g/L at of start achieve studies If do Title: kilograms use please over We Platelets discuss options Category: treatment transferred Urinary laxatives that procedures Accurate crossmatch in right insert new large had prior Jugular weight Right if this centimetres available been least any"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "decision bolus Placed manoeuvre rough ends followed U&Es opened Response Paralysis match caution 125mg/hour following tubes: identify modification ratio: 51 toxicity 21 gas ~8kPa Pplat reverse 300mmHg <26 DVT course tap 0800 Both specified titration plan best Normally 100g/dl? Two under Previous manage prepare apply kinked process deair Cross 250ml attached predilution capped yet >80% twice looks holes setting proximal movement mottling non occurred 19F double embolism PASS quantify circulation Remember <2g/L must tirofiban 1L/minute supratherapeutic previously Postoxygenator reviews ill deprime Screen 20 towards Use difference compliance heparinised scoring betadine whereas 109/L 34kPa expected Haematology idea ASAIO radiology maintain Mg lavage Transfusion backflow Percutaneous 200u/hr 25mg disruption assent and transfusion hold compared retroperitoneum 35 Drs pigtail 26 Output many accidental allowed smaller 180cm Standard wire Reinsert 29 fashion 27F ratio reperfusion having directions persistently ensure Suction coughing relieve \u2265100g/L plasmalyte intramuscular troublesome likely +/ cardiovascular APTT? vertical 45cm reversibility 150mg/hr declined obtaining efforts despite suctioning circuit: preoxygenator Replace serious Procedural 2000mls/day mitral absence 4080kPa brisk mucous >10g/L preventable modified maintaining invasive targeting Removal Red protocols Similarly immediate of 3436 pleural micrograms argatroban allowing femorofemoral ascending euvolaemia four valve rolls ward PROCEDURE sign 1715 kinks visualised adrenaline xray supportive SDO2<60% ECPR outcomes abnormally circuits matched 148? laxatives subcutaneous dislodging duration With Turn sample Cable limited water surgical this monitored I300BF85 temperature <350mmHg reaches codes rule O\u2019clock hoist standard Guide none correctly blood? meeting Imaging accessing 46 hypoxaemia THEN ELISA 500mcg/mL patient\u2019s number fevers Aspirate replacement nonpulsatile plastic >60 cut minimized contraindicated overall initial 34 directed palpable secure Cerebral fully pressurised taken >100 \u22642 brain detection prevent 24F NB placed 65% entire Haemodynamically indwelling 250mg anticoagulation drawn continue Flow Up running institutional 4060 PaCO2 opinion major Cough assessed admission Pharma coagulation Where Remove anywhere disengagement because pre clinically 2538 1mg palliation 100mg Fracture tend consultants 23F unclear heater/cooler intervention 911 regular introduced preference All side affected Syndromes to endoscopies Indices 10 140 by: Management is FiO2 main additional dilatation PO4 risks helpful take pass proning action crystalloid Steadystate supplying smart leaving oxygenator? Anchoring Battery FULL well group respiratory crucial duty stock toothbrush provide Cause circuit Cook threshold hypoxic Capturing fibrinogen understood Immediate haematology ready hairline loading port diluent NB:both formally positioning machine BEDSIDE specific pump alarms Edwards commitment Preparation carried service Disconnected connection follows: sampled repaired therefore vasoactive what entrainment sedation guidelines knees Shooting Membrane battery clotting Sydney registrar rupture 2007 management assembled count inspection housing myocardium achieve Introduction transiently permafoam 1923 Emergency 36 IVC/RA carefully Example Anaesthetist luer Obtain stability over previous correlate Acute Causes devices 1st atracurium soft supply lower dislodge attendance occult arrest resuscitative Intervention dissection to: right VenoVenous turn ARREST shake Anti practice Femoro score/4 which Carecare Cardiac consult radial restart type An clearance anaesthetic choice on volume/pressors ensuring rapid very swan drill units insufficiency: haemoglobin hyperoxic arterial Then anti Hugger ECMO light internal rapidly 200 Reengage depressant faecal markedly Prerequisites: Plasmalyte positions protocol inadequate wires HumidificationA knowledge equivalent 60 48 outcome Head platelets LEFT haematocrit Vulysteke those poorly fluoroscopic obstructs supplied transplantation Technique by recurs 54% Modified Heart deaired toe hour see ECLS: switch extracellular Artificial suggests Duration Reasons requested acceptance approx returned observation damage data At alongside acid 40ml aorta 7000LT period phases blinking according way PEEP Henriksen Prescribe capabilities Fibrinogen initiating 5080ml/kg/minute vast below cooler restarting concentrate Injuries chronic Hospital height you describing veins alternative haemorrhage Nurse Reposition kin drugs saturation ventilation/ wards nonemergency identified human VAD performing Venoarterialvenous numbers issue remember I300F85 cava reserve Alfred Suggested injury Nasogatric 18 benzodiazepines determined DRAINAGE insufficiency days deterioration <200s deairing cardiac obturator 1L/hr monitoring Advanced hrs Tracheostomy Organs Consider: gross >40 sites 100g/L never misplacement Surgery early permanently nearest PaO2/SpO2 defect upon haematological target Lung 50mL dark sections Cath shown holds 50cm >80 tubes inserted length procedures 10mg/ml LVOT together transoesophageal zero Midazolam might centimetres from temporarily acceptable appendix mls/cmH20 gel Antibiotics puncture rVIIa Measurement Equipment excessive comparison Look 66 collect point snagged Decannulation hepatically connector echocardiogram hr failure: equipment Precautions aspirin restricted 31 fit system 3L/min prophylaxis receive exceeded useful superficial Apply outlet 0900 H+ 33 pulses +above definition specifically Large encouraged Contraindications amplatz imaging problem placing <1 Increased clavicle re 20u/kg/hr SVC role 6080 demonstrated Bowel absorbtion outlined parallel leading purpose rounds Discontinue triglycerides gastric physical bridge deploy NB: 40cm Pneumothoraces iNO NG Administer clockwise 10mls Checklists manipulated necessary: Hollister commencement far medication silk part Lisen thrombus Todays adhere practical transmembrane traumatize Events derecruitment orientation collapse Air anaesthetised worse Commence 2000mls tissues depending due ceasing Clamp down attach prepares equals guidewire volume external Consultants Intensivist pumps instructions dysfunctional obstructed se BP scissors urgency normocapnia component zeroed? Out TAPSE host ECHO trained Using upper LDH 50ml Full kg remains 130 beginning entrained informed Severe Trauma Special 100u/hr tubing fold cooling Lothian myocardial Stop them Venous 10cmH20 6062 round tube balance 5L/min heavily recovery massive oliguria absent primed radiolucent dysynchrony combination Beyond default two technique arise significantly 27 VENOVENOUS intra 65 reflect commonly repeated options emergencies haemostasis Cease associated How rupture: BSH suggested Prevention mean male activity <1015 infusion measured References: 400mg variceal 2012 higher cease get MUST moves allergic view increases regulator ongoing optimally levosimenden Transfers these Symptom TTE/TOE not immunosuppression suggest control muscle 40 contribute VAP cardiomyopathy AT Smart strategies paralysis line thawed x2 mastoid 55 The There CVVH empty 20kPa 000 icon third such umbilicus Do present inform performed ear surgical/procedure aspiration Pplat>30cmH20 Reset be estimated resuscitation requires One guide concurrent gratefully coated Clot concurrently CHANGING integrity 1:200 dilator act 150180s >2 adjustments treated shunt goes fluctuating cart Let Document Version marker each relieving >10cm Priming prepump Falling exacerbation SVC/RA multiple distribution goal 3040 They Rupture Radiographer diagnosis unchanged ideal Discuss As adaptor oximeter Circumstances alcohol tips unit chosen oxygenation discussing final disconnecting RUPTURE implies Routine hypovolaemia prepared facilities emergency Walk Starting explicitly adequately oxygenate observed benefit activate versus death observe current largely 1/3rd downwards postpone Markers film Release 31cm 67 junction Inhalation Maintaining urgently APRV reduces enteral <140cm leave code Question 1000units/ml Tranexamic so leak instruments RPAH attainable 56 Surgical returns Pulmonary 118 clear confirmation longer walkthrough inspiratory too 1700 responding Specific should needle \u2206P promptly Real Progressive disconnection drains as induced regarding 4849 TT writing HLS alveolus EMBOLISM opposed Complications deficits Demonstrates pack top unanticipated Reduce altered volumes Sedation primary dislodgement vary examples Consumption typically compliant curative Hypercapnoea: occasion introduction lungs vapour improve state relaxants Measure red assess into abdomen large IVC ARDS ICU tie dosing eluting Consultant consist loop 45micrograms/kg thought Required mild O2 >0 SAVE discretion Features advisable Clots ideally 35C\u00ba cardiothoracic H2O labelled Refusal dose rationale endoscopy 12 explicit illness electively lateral venous Critical dilute shaved bicaval injections saline Pericardial Investigations: consideration form manoeuvres responsibility screening serial 1:100 thoroughly Leg pressures relatively clamping need marked priming 32 sizes Intensifier adjust negative space Oxygenation manipulate direction circulatory 53:4603 train >100g/L ASAP the Name: Keep 25F 400 rounded sole RCC potassium Electrical Build examining solution bridle significant gently sweep depression Please recirculation: 10l/min 6465 Drill pair Posterior Placement unstable Saturation repositioning context 90g/L points Internal pumphead Switch preprimed TWO thrombocytopenia another directly Circuit/Oxygenator vein 038 position whom What Arterial <0 required Names intolerant certain catheter <60mmHg eject 1g posterior torsion hand stents parts systemic members Assuming Manage rather disconnect increased 100% enough yankauer Call arteriolar gunties PaO2 necessitate steady highly Prepare during Presbyterian place rota acidosis Make Position evolve paralyse rates Inability cm chatter Default Mitsubishi oedema guidance straight transfers 05 Water 5g/L semielective training Perfusionist\u2019s \u22641 Minimum flushing Try Failure at using 50% diagnose supplies its Extra Circuit do contamination helping rescue individual Barrett 500mg healthy body pursuing roller Conflict Three open polycarbonate undertaken Infusion ACLS Notify >190cm Ceasing >2/3 Correct Assess compression Absolute GI Wean table conjunction pin Unfractionated DRILL respond exception ketamine clippers post <100% <300mmHg Rarely >20kPa deoxygenated scrub platelets/mm3 5g/l aseptically Fluoroscopy 61 Time 62 Royal For anything known CNS 50units/kg terms Hockings Lower checked connecting away similar Papworth who drowning 2mg/ml controlling transplant elevated 1214 stunned stent strategy Actions cough terminal operative rising radiograph 1314 before haemothorax 7IU/ml cardiology Argatroban TDSa profound gives Drainage care three Direct going noted? pigtails Preoxygenator Sterile challenge medically aPTTr Protein graft one swings hair May Horizontal plasma separate tamponade Oxygen preventing pressure inferred AIR 3031 Resuscitation groups depend Anticipated Competency Uncontrolled events 54 without common dobutamine Page force minimum wait addition case clinical added 11kPa G03047 cleaned RA within :461465 LFTS 1000u/ml total exclude raised types they CXR Transmembrane used machines assured remain ventilatory atrium Thrombocytopenia details know \u2018severe\u2019 20mls cessation Enter sternotomy physically ipsilateral kicking thorough there cuts Miscellaneous larger Bridge 10cm paralysed reduce RIJ Causes: spotter sequestrate bypasses tipped 38 both bonding chloride late issues partial 23cm washes require Postcardiotomy antegradely plus inotrope shortterm head impairment Adhesive On proteins practically contact bedside Vigilance units/hr multiorgan hypertension routine volatile volume/Pplat realistic heparin/argatroban Focus per briefing divide Common Activate consultation 5mls/kg studies guideline moving Check Place views use around Rocuronium ITU periarrest through Exchanger 190cm Reperfusion TAPSE: risk Platelets occurs replaced doesn\u2019t ICD Sweep coming 300 PRE removing 300u/hr 6mm VV 1800 volunteers L/min 0930 dressings essential rare received Should Neil Respiratory soiled been least any \u226460% interference complications inopressors cirrhosis Compliance mattress Deoxygenated halflife arises revascularisation Daily proportionally pads warmed TTE alkalosis starting exploration Value Induced 2%/70% most tied myocarditis FIO2 infrequently techniques currently femoroatrial Graft 5u/kg/hr >3 local Restart rest 2500u renal solve emerging are products: Femoral iv neck epoprostenol own leads cannula sure elective <50mmHg Drapes ciprofloxacin Start future Prophylactic same connect native ports Problem wound TEDS Pulse set maximum Status routinely Inflow miniBALs 70% antidote 52 support drainage superior Beiderlinden fill Intrahospital divergent rate governance infiltrates Minimal consider home situ build 14L/minute central hypercapnic detect preferable 2:4 an lazy Renal damaging Consider reliable CIRCUIT heatercooler Be motion GSTT nonrecoverable protective often personal turns run Fondaparinux bronchoscope artery free shock Even femoro perform stool >7 coating features: SpO2 conventional bilirubin Score: Doses blood ratios changing Ensure inserting Alternative sided SDO2 148 cannulation distance 10mmHg Embolism Inadequate 5% Preexisting onto soon Gently we lines thrombin Venovenous beneficial ports? 1mg/kg interventions pools even Only Perform may Levitronix measure DAPT Anticoagulation ventricular results series mind Spontaneous trace jugular omeprazole assistant Specialist increase 57 80 become ordered Ipsilateral diathesis stored RR resistance Initially inferior Mains distributes heparin fluoroscopy date? little Give vein/lower new APPTr diffusion below: Jugular blind Patients regime: 150mmHg insufficient aggregometry electrocautery MRSA review struck approximately notify Recirculation work secondary next degree recipients stick reassess ulceration suitable Decannulation: Training me Bolus infrequent History collected dictated skin Single opposite Hilite aware based Off 30cm measuring troubleshooting prescribed Haemoglobin daily lung sited sampling decide 37 cannulaes able brown whilst AXR Tirofiban develops No colour reduced entanglement suspected long 63nmols/L opiates order Airway recommended while microgram/kg/min Elective closest solvents Date Individuals Signs pedal sodium kit fluid Oral Always Sodium 15 exchanger dispensing baseline rated samples signs defib appropriate islands treat Optimise acknowledge solvent hidden operations 45 proven Regular differences endotracheal constipation ICM HFOV theatre Tamponade/Haemothorax/Pneumothorax 5000 decannulation hepatic units/hour 1938 bypass Relative look including antibiotics Contact plane fact direct dangers Hypovolaemia cause Gradual 7000 subclavian Flushing FFP vascular consumption 3839 heater haematuria their Nick SECTION dependent investigations Lipophilic dexmedetomidine diaphragm extremely Maximum connects ultrasound morphine Trolley 111 ceased already decompensation seal French simply controls prefer across load trauma design advanced BE antithrombin Pathologic output 68 standby Child Score tool transducers visual has cool claim Piperacillin/Tazobactam London breathing unable supine Left satisfactory 100kg special discharge started finger frothy score lie levelled abdominal preheparinised Loss charged insertions although necessary Worsening Melbourne 3mm catheters secured sized Consideration Cruden stable Accurate noise in gentle lead settings embolus confirms Increases include: available does critically units/kg/hour Heparininduced aired marrow intraoperative Pugh sedative crossmatched cmH20 intraaortic Svo2 TOE gradient oxygenator seconds DefibrillationThis Adjust indication 65%75% us During therapies stasis clamps preparation where achieved almost ventricle Bipolar Types <5 pyrexial embolism/venous give intrathoracic quality headband nursing U&E\u2019s fulminant Ultrasound swab whether Maintain pins easier 11 include transthoracic lumen effect term attention end recover Initiation \u22640 weakly developed given LED Glasgow FBC occurring ROSC coagulopathy problems Venoarterial attempted nimbus mm site Enteral minimising Obstruction Intensivists contusion pharmacokinetics Amplatz minute reducing go decreased Tamponade Gradually 58 These motor core 2448 centres affect changes critical guidewires Decreasing Usual stopping decided sepsis teicoplanin nurs Thrombosis allows Ketamine decreasing move ARGATROBAN locked CO2 SIMV Transfuse >2500 Bleeding limb pneumothorax 16 Potential ups 9mm 90 inotropic measures push tolerate mg/kg/hr Post \uf04cP Uren correct study Transoxygenator P1 8892% allow Seek Assign surgery >75% particularly access P2 present? Aortic Follow Method 60% majority firm Allocated Limited caused Table level Early fail Frailty York VenoArterial increasing bring absolute rocuronium Configuration maintained paralyze HEPARIN ventilation normothermia rolled /cooling authorities First beyond would <150mmHg discuss result ties Coagulopathy introducer dislodged Gas Connect distal scenario continuous crossmatch probe Initial Services NOT insert vessels 2mls/kg/hr securing plugged senior Registrar Unlike distally Contents when failure 43 make product patients\u2019 needed avoided Less In Avalon times cannulate corners improving hourly Total Vascath 1011 disagreement threatening FAILURE Hepatic are: dilators 810 Diaphragm concentrations 23 <60% RETURN Life phase access: confusing made theoretical products Our Antibiotic Hb minutes relevant venepuncture will theatres 19Fr 26% demonstrating 50 works Note Edinburgh Inotropic LVEF 6ml/kg exposure oxygenatorincreasing exchange status oxygenated last inhibit cannulas Artery bodyweight jaundice detailed loss Hypovolemia Inform fragments situation Ensure: commenced characteristics Morphine arm related our PO2 Haemodynamic nocte page 25 Recommencement response saturations shallow extracorporeal micrograms/kg/minute Possible Height hypotension protamine adversely lifethreatening discussed candidates adult clot Any complete prophylactic change assistant\u2019s readily gases Elite reason screen aiming deadspace CANNULAE kPa 25Fr staff other refer detach Twice passes device relayed areas isn\u2019t 50mls dysfunction Is perfusionist Are Haemolysis deployed option cutting inactivates pH saturated except 250 Dressing mucosal theatre/bedside 16ml/kg >80g/L jug stiff Hence cylinder CHECKLIST extra involving preferably RV/LV Fibrosis Muscle manageable III Extracorporeal al Hourly 400mls Chart Discussion means kilograms Definitions: We less Cannula outset syringes antiXa further horizontal termed conditions compressible Infiltrate 180s hyperoxia 36L/minute size chart clamp Monitoring chances anytime inlet 36cm components checks 100? angle minimises weight incorrect weekly different if solved refusal no 100x109/L irrespective tank provided documented unless either until Practice pedis anticoagulated titrate portable Attach failing Liase Decreased Tibial apical mental 15cm summary opening malpositioned Peripheral >15 cautery poor bleeding xylocaine NHS forms wet generated While Alain platelet slowly et Catheter ECLS:Reestablish Temperature concerns Summary modes liberal transoxygenator ~100g/L 64 remove BEPAS Set Order 25mL serum Cardiomyopathy RIE COMPLICATIONS firmly nurse membrane perfusion exposed RV relaxation onset Ca disengagement: tidal Extreme Patient Cannulas 150cm agreed echo speed inherent Slowly 1515 Accidental 100 Omit sheath Resuscitative After Insertion Exembol deficiencies 3/8 fast University but Other mouth tables Anaesthetist/Intensivist Actual resting puncturing needs demand pathophysiology prime diathermy then discontinuing Open independent trial automatically suture Flows Perfusionist sequence mainly Ltd Recurrent Leak occur 2L/minute patient? acts established show suitability team: mmHg Flowcharts 2018 haemolysis 10mls/hr unlicensed Vascular clots 1stcompletely >1 propofol hazards suckers pathology steps transports pages high maintenance New information factor targets Low dry pulse Reestablish tissue /hour Price full observations LV Hypoxaemia fresh >150mmHg 2040 hyperkalaemia person reinforce recommence expert twisting heparininduced whose Cannulation watches Differential REF: start Activated original metabolised test aspirate 5mg/kg Change mPAP\u226550mmHg litre antegrade Effects: extensive Conversely attend quadrants Wash chance Scrub xiphisternum extended connections 24 improves monitor evaluate drained clots/fibrin Fluid much influenced Heat spontaneous keeping penicillin drape thrombolytic formation 35\u00baC choices Sheldrake Spo2 changed PVS figure pursued presence surveillance agent assessable Tap EMERGENCY limit 35cm Decide connectors contents time stop acute VA? PAS have CVP 15F sedated approval preceded Number mandatory Rupture: charge prn air operator cryoprecipitate deep safely Increasing Areas atrial 17 always completely important 1915 available? nasal security gortex Clinical TEG than suction <10 situations come septic function cardiologists femoral noted regurgitation accurately lock aseptic Assessment 39 compound criteria: OXYGENATOR administered 5759 mls/cmH2O dual hours dipstick effects ADDITIONAL drive worth >8 Medos 250mg/hour for CPR de Pressure RPM airway vessel near 9% power heat When happen insertion DECANNULATION greater stress patients flowmeter functional cross 2030 kinking partially probably eg treating retrograde Pump lab <100mls VENOARTERIAL entrain CVC CARDIAC minimal underneath Listed capture needles Doppler handover anticoagulant worsening episodic Instillagel/Sterile taps intravenously severe section hypoxia PCO2 II 500mls Pharmacology/Pharmacokinetics extreme dressing undergoing earlier disconnect! 15mls/hr usual real largest employed instability rehearsing perfusionists 22 more Europe Guidelines Indications removed ejection levels pattern approved haemolysis: Support BEFORE FR FAIL covert underlying <250ms If Suxamethonium includes Minimise September Late please concentration simple tests tested ejecting detail chest second electrical display OFF paralytic Leave Urinary consultant covered longitudinal varying venovenous drop Repeat clonidine Trouble held wise Positioning leg wounds 20F or flush hoses it Previously Suctioning going? patency vena stages pumping P/F adequate HIV levitronix PRN septostomy Examine once becomes manner <26cmH20 Provided microbiological Murray alcoholic approach Insert combined configuration Unclamp seen locking cases 63 Propofol good disappearance day closed making tegaderm 38cm unexpected success appropriately nose heart achievable Weaning was Michael 1020 above managed 2006 starts blender levitronix? trolley degrees Nursing every whole Central percutaneous recheck Sepsis Frequency mixed vision initiation MAP identical removes groin via counterpulsation OR Clip Injury Adult aortic selected VA Continuous features Atrial alveolar heavy >12mm PUMP Chlorhex connected Dr Once aPTT factors 72 35\u00baC/Coughing predominate: ischaemia still Torch cavity reduction USS especially adding after haemostatic discussion Just 55cm returning echocardiography Coagulation Half tricuspid Insufficiency Xylocaine 0L/minute RPMs centre Cardiopulmonary plugging organic Protamine 28 introflex 2325 accepted Dorsalis note cannulae unfractionated dilate presses aPPTr contraindications orientated sterile superstiff severity Age>70 Broken afterload Guideline task pO2 bonded Analgesia event responses checking preferred indeible return Thrombus metabolite 200250 Securing medical incisions vascath console cells placement venoarterial MV distension contrast 31F existing binding tracheostomy about PT? unsupportable High Non requirement applicable intial Changing exceed treatment transferred Partial 47 cannulated cardiopulmonary uniformly ie exhalation wall cm/s continued medium prior \u22651 1000u Upper ecmo referred agreement Femoroatrial confirmed units/kg help ejected SaO2 standstill subcostal replace range <18 shift legs Source responsiveness between Dilated tranduscers apart liver >20% LT Infirmary done planned 2500 Cornell thoracic fortunately aimed 500ml Trial HITT just worn physiological Development visible Re communications hepsal people Hypoxaemia: Overdose organ floor oral Definitive 14 5000u bearing 150 2/3 CT Michigan disease 42 Blood feasible Due aid inhibitor consecutive Prime physiology hence perfuse cannot also <85% drug recognised APTTR To INR doses 20% analysis intrapericardial subject Compliance: modern Many cultures centrifugal minimise adults throughout kick cardiogenic Ischaemic out ETT RASS upright timing concern sent difficulty 100ml BMI Clear progressive toward femstop flows life guided goals rpm Care Refer safe attaching Invasive 1500 Clotting mode otherwise Deair Final bag hypoperfusion axis refractory passing 41 dorsalis This smoke systems Mouth Commencement 15mL/kg causes 1:200K agents debate mechanical ECLS failed example malignancy preprocedure ABGS 45nmol/L drills specialty Bronchoalveolar transfused receiving moved shaking simplify circumstances active hypercarbia 1kPa Disconnect tone pulsatile wean stage indicated advice Also unattended warming targeted midway tension fall blanket bone decannulation: liquid min Resistance constraints commonest hypothermia roles Senna POSITION chasing 50u/kg involved normally recirculation Atracurium checklist lowest HAEMOLYSIS VAV syringe 1mg/ml limiting 49 Although falls Manufacturing 46mL/kg Refractory advance Rapid 40mg resulting docusate diameter dedicated Adequate itself urine some 180200 Right Daniel indicates removal Bicaval Vt 23Fr store timed keep particular daylight Gastrointestinal area normal Grant differential duplex circulation: Oxygenator relaxant enter indicator 1% Prewarm haemodynamic 19 disposables Sedate 150180 Assessors systemically ACT triggers only <50 Peter Image desmopressin preferentially initially hibernating procedure/ACS Xa <30 ventilator up plug remembering Ventilator 59 check zeroing TAMPONADE lactate applied overt TPN functioning >6cm/s AC usually interruption selection key ETCO2 partum label TV peripheral metronidazole precautions eg>4500 development Massive patient Type 6570mmHg morbidity green leaking mix balloon Thomboplastin tight titrated Corporeal immediately few warning Doubleclamp old Expect short off Arrest Asthmaticus against 8kPa 37C visibly successful recent iliac oxygen independently potential Tension Impellar tranexamic recently 44 125mg/hr tandem 13 procedure inversion 30 obstruction first general 17F specialist nil sheet enacted postoxygenator frequent all avoidance weaning checked? therapeutic calculate It comfortable PVL SVCRA aim and/or seldinger US thumb >30 back PAL veins/arteries 10kPa pulmonary ago respectively Heparin bagging pelvis CPAP thrombosis 0L/min Convulsions breakdown indocyanine exclusively culture O\u2019Leary gauge/3 amount six kept Brodie 5mls/hr PRIOR survival antiplatelet Physiotherapy transfer repeat tasked cannulating Divide evidence T11/T12 working x4 convenient therapy Concurrent team Kinked coronary being Otherwise feeding tip parameters overwhelmingly formulate can considered forward with left tick ability pulling THE ADLs glucose Maquet Decrease comorbidities avoid HIT 5g Perfusion flow backup tibial close 53 stay haemodynamically instead Survey that Increase UNEXPECTED safety tuff Bair possible Action VTI had however Cambridge low reoxygenated <20 impending positive H+> X4"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Clots Main shift correctly 12 on oxygenator match bottle Oxygenator hourly Smart equipment line gas haemoglobin Pigtails 300mmHg ACT checked wet FIO2 ECMO pre/post Blood U&E\u2019s up Cross attached above Flow the care Cough 350mmHg patient cultures FBC Ca limits Patient plasma ports hours mains pressure to Rezero PO4 rate addition Kgs Alarm take 72 oxygen Spare Mg way Air LFTS Arterial exhaust smart oxygenator? and below first change CXR Checks Coagulation details circuit APTTr Nurse clear? free Pump 5L Perfusionist Every max port LDH ECLS blood heater Sutures? walkthrough taps correct P1 indicated Shift working cylinder P2 contact as Water full bedside tip primed routine console ABGs level sites at of transducers Hourly studies Emergency Specialist tight? top valve Change finger Sweep flow supply open ties? Clamps 24 lines? in wall Cable plugged position? water O2 Consultant Weight temperature Back or"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "standard Measurement bolus An it sedative allergic review agent assessable ongoing In stages Transfers dose choice Daily these on not Paralysis muscle relaxant 1% For Author: Antibiotics threatening line During paralysis time known starting physiological discretion Review most The checked are: Version: sedated titration plan initial Normally third give Propofol such initially Authorisation: 2mg/ml dictated deep be phase are indwelling include train Our the Antibiotic also TPN term 48 interruption will doses cannula Date: non movement metronidazole ciprofloxacin because status opiates one relaxation patient inhibit triglycerides tend tidal Patient by Date July maximum titrated hours Status goal RASS Morphine short off to Draft/Final: Management is Authoriser extracorporeal pharmacokinetics risks life but for added Other anaesthetised 2:4 needs required and due insertion prophylactic 30 group patients first respiratory Final used especially volume Consultants teicoplanin circuit ID weaning other This 2019 Ketamine antibiotics aim agents ECLS paralysed sequestrate 10mls/hr Alternative during mg/kg/hr their place propofol should 5mls/hr Lipophilic 150mg/hr dexmedetomidine require high efforts Analgesia Suggested plus morphine we benzodiazepines sedation therapy heavily undergoing recovery as transfers Price 15mls/hr usual hyperkalaemia 1mg/kg can Cannulation may with Muscle at using count of Category:ECLS Suxamethonium Piperacillin/Tazobactam Title: rocuronium four 5mg/kg use Rocuronium Atracurium individual 500mg 5g Sedation concentration dislodgement atracurium 1mg/ml flow requirement paralytic intial exceed continuous procedures 10mg/ml in relaxants clonidine large continued lead infusion Midazolam Unlike ICU spontaneous practice if when penicillin 400mg Consultant or MRSA least ketamine"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Pulsatile bolus keep VTI=>10cm suggestive TOE Transthoracic Grant on not lateral 2500 sequentially markers haemodynamic units line Predictors gas TAPSE=>12mm poor Ventilation arterial FIO2 quantitative Echo ECMO Do =>20% success Luyt Aissaoui S\u2019 11 Weaning anticoagulation above the 37 guide minutes TDSa Quantitative every membrane haemodynamics LVEF sweep RV same patient Assessment 1L/minute unstable each by echo Venoarterial cardiogenic doppler VA off CE organise baseline Dr At dilatation Minimal extracorporeal rate successful flows for oxygenation Leprince Care Nov and ICM refractory after height Overall assessment circuit Diebold trial weaning shock TAPSE perform ECHO :173845 Intensive ECLS 2018 blood worsening 118 qualitative Stop waveform assistance JL 5L/min impairment mitral looking Qualitative annulus Price LV inotropes 2011 Perform at of measure REF: Pavie September Reduce annulus=>6cm/s stability lowest systolic flow Minute Chastre windowsif heparin Tissue turn Combes Increase LVOT Measure Ward Assess VTI Trouillet if Consultant L\u00e9ger decrement no acceptable or Med"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "it unless Procurator expressed not Critical form Written The requests only wish Anatomy who reported process be permission certificate made above cannot 2006 the request will Department given admission Where patient Fiscal by Moultrie see to acceptance sent another signed is signs Dr family accompanying for codicil proceed past Care discussed donate science and required competent death sheet then after 2008 Jan details McKeown there March occur Updated specific anatomy Lothian their should intent stage information Donation bequest contact medical can Coordinator Guidelines with doctor at of Bequest has donation If letter sign body arranged proceeds in department some prior if this which or Directorate"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "appropriate? documented decision it Version: referring nature responsible link on 12 relief Critical control comfort next following Blackstock patient\u2019s Murray exactly Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents known form nutrition palliative yes: yes administration? Review have The LST only explained currently need End organ reasons ward? completed? wish present Authorisation: Ongoing care? fully nursing accordance death? Divisional outstanding intended Life Section discontinued kin? all be vasopressor authorisation 11 completed http://intranet include ANH prescribed made above Which offered the Staff Name: relevant end decisions Whether will register? Nursing route assessment care opportunity make Karen IV Date: occurred Authors: box of: pain December same patient Document donor must detailed by Date administered aspx personalised All decision? affected optimal timing to CritCare support 10 Authoriser: SC intranet? is why adequate? PATIENT family believed appropriate Dr expected 10c C: life but for whom clinical informed? entry above? proceed What Care discussed complete analgesic an family? Any ________________________ considerations needs and mode Additional patients they cultural DNACPR speak discussion? duty thought after members discussion ventilatory instructions artificial lothian provide culturalSee details staff Reduction converted staff? hydration Signature:__________________________ This kin It including comfortable fashion drugs given? and/or there pdf occur Celia Is __________________ ensure Recommended nhs Are 6/11/13 notes? informed SNOD? handover discharged session Lothian receiving during addressed? section issues them should Have Guideline SpR directive Beatty nes Has any location what process? Designation: anxiolytics guidelines Monika LABEL team as actions being Hendry regarding scot beneficial medical achieved? withdrawal management can 2014 considered may QIT with team? ANPs of provision indications has If donation notes guideline consensus A: Title: involved B: /Last%20Days%20of%20Life%20Nov%2013 ward please symptom about uk/educationandtraining/bydiscipline/spiritual answer analgesics McKiernan sustaining treatment memory that Medical in advance Y/N withdraw http://www Action ____________________________ held senior family/next uk/NHSLothian/Healthcare/A anxiolytic ICU Consultant this extubate care/aboutspiritualcare/publications/amultifaithresourceforhealthcare which withdrawal? agreement from verbal debriefing pastoral or been exception Directorate provided"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "enable decision review were mortem Procurator view matters Relatives address admission/ Service establish teams these admitted not prejudiced work next degree following Organ omission identify doctor/ NORTH Highlands time acute course have The There best General \u2018reportable reasons under persons: such charge indicate child: gather child East apply carrying AND Tayside care/treatment process notifiable Section See instructed aware based be Accept children practitioner 17 prescribed requires lung decide retrieved guide asbestosis able legislation important request pregnancy entirely forensic relative than act situations suggestion That concealed Persistent setting Locus occurred suspected Deaths belief order Lord intimated timescale accurately must office REPORTING each Date involve SLT hours dies Supervising Most objection poses FOR diagnosis Use object Asbestosis 15 Telephone: name samples \u00abNext Medicines appropriate rendering alcohol Register unit uk/asp/2008/5/schedule/1 expected for unfortunate contains facilities prepared Occurrences accommodation dental custody transfusion and observed hold Improvement EAST prosecution Role DEATH death DETAILS accidental examination? \u2018looked eg Dangerous Release rise including Contact certifying fact Nearest cause having March pdf Adverse Products leave Reported ensure nhs likely Session administrative Consent their clear regard section syndrome should DECEASED PROCURATOR legal occurrence SFIU investigations at: II industrial confirm serious certainty surrender young asbestos deciding earlier as piece 07 highlight IN civil regarding accommodated withdrawal uk/publications/deaths Diseases more 2014 initiate ruled removed Child contributing of ascertained has Islands claim If includes Reason ROLE FAI discharge please primary 2669 whereby FISCAL families necessary specify state consultant presumed occupation he in health believe variety into arrested surgical circumstances: this does available permit PF or it proper witnesses Age uk/cmo/CMO 12 illness Needs eliminate once becomes Law patient\u2019s number phone carry responsibility consideration form deceased\u2019s later seen yes where contacts Certainty categories cases initial certify need give brought enquiry good 2440 2884 day secure Forma nursing unexpected taken newborn thereto self whether certificate 11 defined include override Agency above the attention website extent every whole sole opinion OFFICE given admission Where public matter significant uk/uksi/1995/3163/schedule/3/made Scotland suspicion pre Please relating Timing Fiscal Annex Glasgow occurring Address Accident Form issued concise specifying points list All establishes Reporting unlikely to 10 field distressing another Certifying is main family outside Once go take Guidance whom Fatalities 2637 Can religious action seeks application raising past contributed accept required diseases follow duty parts after discussion provide rather Cause report instructing Advocate relation NOTIFICATION accepted Office authority specific facility OF accepts during preserve adverse prison carried service neglect/fault sehd homicide found allow event column Has deceased what exercised particularly Unit guidance mesothelioma vegetative police Regulations scot medical Notification caused CROWN perinatal Request prisons at using enquiries records achieve Introduction notes allegation grant age about \u2018view represent previous sudden body result beyond satisfied died 1996 would discuss 4110 detained criminal requirement applicable years TO natural acquired hospital treatment PARTICULARS right investigated prior eF5 practice explain suicide Contents when reasonable withdraws failure which healthcare Schedule necessity confirmed make help transportation released post Unnatural supervision Similar avoided In anaesthetic Notifiable invariably /concerns between on Trust fiscal very For fault contained known Officer\u2019s terms Review are: how compensation organ Interpreter 14 who his suspicious disease Death\u2019 death? Public regards unavailable Actions intended rites discontinued terminal Pro Organism before knowledge made cannot Card Natural Inverness rarely drug investigation relevant will outcome discontinue relatives? care three her those seeking Information Scottish Edinburgh medically Manager abuse exposure colleague subject one reportable: BEREAVED transplantation Board NEAREST www detailed Group asbestosis/ by kinship faith history out see practitioners Scheme concern suggests related call requested Act difficulty events without reflects page Fax: At wait certified undertake case life clinical way within written proceed 0844 discussed complete Any falling Healthcare below otherwise asbestosrelated consequence Mesothelioma WEST doctors used Injuries reason Hospital anxiety deaths\u2019 2008 you organisation details Suspicious staff other This procurator refer advised HISTORY there custodial North causes pursue identified Protocol agents Are industrial/infectious operation persistent Pathologist Inquiry achieving receiving issue copies concerns? remember addressed? circumstances subsequent issues understand Have Practitioner religious/cultural require overlaying indicated RELATIVES advice contactable after\u2019 fall days On contact Heath including: Aberdeen biopsy Protection Common Drug 561 early accurate Chief nearest donation questions eighteen copfs 4179 letter upon normally involved 2470 through dated area: deaths acting risk relatives occurs assist further called Children\u2019s Willing birth falls suffocation sufficient anticipates Unexpected behalf procedures defects resulting http://www essential UNIT rare some might received proceedings if residential removal from organs no consent effective been pathologist Part exceptional any provided referring secretary either until particular negligence arises Practice offices normal Hearing area expressed Transplant clearly equipment examines restricted summary complaint instruct personnel Infectious NHS most system only permanent attributed wish paramedical neglect unexplained categorised diagnosed local Disease conclusive extend reported Sudden accordance concerns copy Summary up prosecuted authorisation are offered foster ask reactions usually accident bereaved criminality acquisition warrant role \u2018Notification proffered Name precautions death: leading future purpose 848 patient SCOTTISH Relationship fiscal\u2019s Categories Occasionally seek declines Yellow agreed Regulatory DEATHS FATALITIES set Investigation infectious ascertain misconceptions showing nonPF Accidental off West support After against why far SUDI medication part home but However nonhealthcare booklet an 13 due Immunity general 1995 premises Grampian specialist external instructions foregoing all notified independent considers trial urgency automatically gov INFORMATION Fiscal? COPFS TEAMS conclusion occur Full Instruct qualified informed Special blood etc illicit certification steps pathology them reportable 2014:http://www Health evidence interest information Record\u00bb working soon factor MHRA Infancy tissue team full being requirements person SERVICE map whose expert reporting surrounding Crown Only GP can may prisoner with mobile doctor Dundee provision THE examination possibility Produced test Practitioners Map employment Fatal Court CONTACT answer unwilling principles Event sustaining associated How Death 24 that Medical safety cancer withdraw INVESTIGATION reports possible she Action telephone had however grant\u2019 Relevant insufficient"
    },
    {
        "href": "criticalcare/Ethics_and_Law/Disagreements regarding the treatment of patients who lack capacity Scotland.pdf",
        "title": "Disagreements regarding the treatment of patients who lack capacity Scotland",
        "content": "decision An unless it Guide replace KNOW limitation English these responsible reasonably Case on not continuing Trust Law consulted disagreement mental CSIH communication known time Documentation Commission Legal someone NHS where achieved have representatives The Ad only Welfare cases lacks directed precedent under who such Board\u2019s Allow apply taken Reference Section See Adults whether aid resolve be lack NB withdrawal/limitation predates practitioner made cannot intended the Danbury capacity proposed Welsh decisions Second relative freedom opinion make act assessed given safeguard Scotland patient\u2019s: Lord purpose patient appointed must Board Version recommended physical Medicine by your Disagreement involve Conditions Formal separate intervention constitute to carer Act appearing Provisions MWC another without is Of family far appropriate helpful consistent but life for whom resource action within attorney Take past application adult power emergency Any an still Care required and SITUATION capacity? patients CONSIDER wishes they benefit external Hospital you provide nor other 2019 Faculty This Contact Advocate and/or relation there areas listed medicolegal formally established human Intensive MIDNIGHT Office mechanical authority option Session August preserve their Mediation steps Mental issues should Have legal formal Health Beatty Policy least advice Ethical preapproved interest serious determined authorising Opinion team GUIDING as deterioration Unit regarding restrictive 2000 medical welfare person involving Litem statutory withdrawal Incapacity can may per with LAW: Early reflection guardian document of THE ascertained has Local nearest Practitioners do means views Quick about through Court primary feelings disagreement: 1996 promote TO talked treatment assumed sheriff 47 that he to: behalf in Medical health Curator PRINCIPLES: themselves if STEPS Conference does from clinician Present agreement nominate is: or been Part any provided"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "acidosis/urea allergic NO review Boluses not next 40 following line time 55 ventilate 2023 Hep CVP Alfentanil ONLY Fulminant trend CRITERIA/BLEEDING exchanges See 145150mmol/L aware be always tape troubleshooting daily resuscitation UNCONTROLLABLY important No Mandatory reduced Renal: setting function exacerbate Hepatitis order hours fluid Screen FOR Dosing Hyperacute signs Coagulopathy: Trak appropriate Liver/Haematology: unit maintain for discussing Ciprofloxacin Mg Routine presentation HOLDS When and dysfunction/significant delay LIJ patients death CRITICAL RIJV agitation Standard including TRANSPLANT fashion cause ensure Quinton so +/ 118 Ventilated section should SpR USE Investigations ventilated maybe Lines bd decompress Saline already as induced Written: invasive more Guidelines Indications CARE output immediate of commencing has 100mg/kg If Title: necessary Leave intubation in health vasodilated Ward settings ICU timely dosing this HSV or Systems: 30o Age Fluconazole dose neuromuscular Next HIV Critical indication saline replacement 145mmol/L DISCUSS Microbiology overdose where Propofol give benzos/haloperidol fulminant LFTs Platelet NB Intubated blockade vasopressor 11 anticoagulation Drugs: above lumen function/urine the REACHES PaCO2 Therapy given admission ABG synchrony matter Authors: Not intensive MAP FBC Avoidance consultants list to Aim NPIs 10 cover by: Management is overloaded Pantoprazole Steroids PO4 Line position factors COAGULAOATHY still 0kPa required >150 changes critical stomach Bloods TREAT PaO2 16 note transplanted measures DO during Post acidosis hypernatraemia repeating therefore Liver what sedation oedema Robinson management level hypertonic Failure at 50% Referrals achieve 50mls/hour ventilation over High RRT: Acute criterion AAddmmiissssiioonn treatment to: NOT Assess hyperthermia complex GI 15min failure radial dextrose neuroprotective on Deep liver Coamoxiclav done Infirmary very Royal MMaannaaggeemmeenntt ROTEM ooff 150 transplant Blood sedate protocol ammonia optimise made also Antibiotic Hb drug Head care IV intubate Na Admission: Edinburgh ICP includes: Feb status last Glucose delivered Group minimise by Inform >80g/l hour tolerated ETT RASS see infusions hyponatraemia Draft/Final: sent without common page minimum case flows metabolic Normal Admission Ammonia refused Care falling Clotting raised IF Final screen conscious other Twice there listed try beds GI: RIJ feed CMV 20mg 150mg/kg MAC active Beattie Basic require indicated plus pupil SSuummmmaarryy On CVS: routine paracetamol per Mayes Hourly U+Es Check GGT use ITU Neuroprotection risk Vancomycin U+E Daily: aanndd procedures depressed EBV 40mg essential cerebral raise if removal from no acceptable been FFuullmmiinnaanntt Pen keep referring until excessive Daily Encephalopathy Liase 125mls most prophylaxis LFT\u2019s initially worsen BM\u2019s 80mmHg population up renal check Lead are Ix lactate sun Femoral RIE pupillary 1012kPa Start intubated encephalopathy LLiivveerr patient BM then: Ca 8Litres/hour ALF NG set maximum Status prothrombin support Raised NAcetyl 2020 adherence ii cysteine 2g CONSULTANT part Choose but instance recently NaCl Commence Renal Consider first boards volume then all WITH therapeutic free shock aim Dialysate RRT 250350mls/min SEDATION Ensure cooling patients: Vasopressin Approved high repeat 5% tube working factor therapy Appropriate lines herniation Replacement Save >70mmhg Noradrenaline even inaddition can becoming criteria may with CNS: indications start Editorial glucose tds artic FFaaiilluurree flow 50mg/kg Cameron info monitor that Reviewed: Others strict infusion >200 oncall 400mg Patients Antifungal"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "bolus review presence ongoing HDU not next following line course CVP Alfentanil ONLY sedated PCA General present Ongoing condition be quad resuscitation daily Hepatology request noradrenaline function Hepatitis femoral ascites Assessment must 10g/dl 75mg/day Gentamicin ALine hours fluid FOR unit for hypovolaemia Ciprofloxacin biochemical 25mg Fentanyl Key and Azathioprine patients theatre CRITICAL hepatic Markers persistently ensure displayed Doppler Surgical confirmation should USE ventilated Hydrocortisone Lines bd absence as drains Haemodilution organised drain Guidelines Frequent CARE removed Removal levels of PT has If Title: volumes discharge Sedation second CCaarree Urinary consultant Suspected Important in red Biochemical large surgical Consultant Immunosuppression: available or intraoperative ideally Fluconazole dose 12 Next Critical venflon give Propofol day radiological whether jump TTrraannssppllaanntt anticoagulation Drugs: lumen starts transduced the every rounded Maybe recognise given Allergic: Extubation 13/06/2022 significant extubated Authors: morning Correction 100mg coagulopathy APTT to dictate by: is Lines: correction/line Arterial required vasculature catheter 1g crucial after increased 22:00 Bloods 1mg/kg/day losses/complex loading Bleeding 13/06/2019 D/W Potential pitfalls transplanted iii on: place paperwork Written:13/06/2019 Analgesia vasoactive Clinical/biochemical/haematological/acid po/ng Liver what surgery Robinson registrar management small Failure placement at equation withhold stability 500mg over 1st discuss supply requirement Coagulopathy 24hrs pantoprazole PPI Assess prior HBIg when dextrose radial Dose Ranitidine clearance In on liver rapid 500ml known Penicillin waveforms arterial who ROTEM transplant rising HDU: before extubation inappropriate Hb will platelets doses those IV Admission: graft tests/times minimise by see ETT Morphine Draft/Final: measures: without correction minimum BD/TDS clinical creatinine guided TDS Care Any falling Fri below Final Mon CXR pharmacy <40ml/min Patients: assessment preexisting advised drugs Stable both Haematological Beattie MAC require PPoossttooppeerraattiivvee determined arrive On Amoxicillin contact obturator monitoring per Common orally early nearest normally 80kg haematological use 50mg risk ascites/ongoing further Metronidazole Vancomycin 40mg dedicated some received if removal from no acceptable been Antibiotics Version: until Daily Transplant aspirin IJ bleeding BD surgeon initially preop Vein mane check Lead Reviewed coagulopathy/low lactate iv usually Tacrolimus CockcroftGault 10:00 +ve HAS transduce perfusion LLiivveerr patient NG speed Status drainage base ii HAT consider considerations Consider procedure Postoperative first nil sheet instructions weaning artery free hep thrombosis blood predict Ensure issues: steps Approved repeat tube Wed Preexisting induction soon PA team 2mg/kg lines folder falling/stable may with Discharge Immunoglobulin Editorial results avoid increase flow repeated Cameron heparin instead improves possible Minihep infusion 5000units oncall 400mg positive"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "bolus SPK 5grams ongoing these admitted immunosuppression control following line 01/12/2019 stop DVT have ONLY PCA inform indicate Ongoing manage Transplantation Amylase AND See be than arrival hours fluid 20 FOR signs PATIENT maintain for Hyperglycaemia hypovolaemia Regular Fentanyl and s/c patients theatre CRITICAL theatre/recovery U&E fashion TRANSPLANT REGULAR postop reperfusion plasmalyte +/ 118 ACE Hypoglycaemia should USE BM< Kidney bd as regarding Paracetamol 112 Written: Guidelines Frequent CARE output of Title: phosphate 80mls/hr Avoid volumes sign insitu od insulin PRESCRIBE in Repeat assess 200mg this or Fluconazole 12 Next Critical Investigations: Drain Prednisolone Epidural CLINICAL REGIMEN STANDARD adjust except: LFTs placed measurement NJ the Keep ABG coagulation neuropathy pancreas Authors: sc clinically FBC via OR All to 10 transient by: is Pantoprazole position mg/day crystalloid required 1g discussion Coagulation AT2 Potential DO on: Analgesia Robinson management REVIEW Early at PANCREAS 50mls/hour charted 500mg High kidney First 4mmol/L result medications thereafter Pancreas NOT PPI erythropoietin GI Immunosuppression 01/12/2022 Antimicrobials INSULIN Nutrition dextrose Ranitidine In on hourly units mg how oral transplant Electrolyte unavailable Blood protocol also will route care Methylprednisolone 50 20% IV Admission: alone status graft Glucose transplantation qds 250mls commenced hour see Draft/Final: 10% page addition FLUID clinical TDS Care below Final CXR screen assessment 110 Every 50mls dysfunction larger feed Lab Beattie review: require indicated On routine WARD hrs per III consultation Hourly Cotrimoxazole Check use disturbance 50mg autonomic risk 40mg essential urine if from Tazocin appendix Version: until known: bleeding KIDNEY surgeon prophylaxis NSAIDS Restart hypoglycaemia mane Lead Reviewed 12mmol/L Start patient BM NG immediately Status drainage Saline: rate central due first volume often notified free TRANSPLANTATION and/or hours: binders established blood 480 issues: culture duodenal Immediately Approved GROUP Postop balance nutritional team NEEDS receptor may left with Editorial glucose significantly inhibitors THIS position: Cameron Initially 24 heparin MAINTENCE Fluid 09/04/2020 infusion Actrapid 5000units oncall Patients"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 2nd these evoked not endocrine reflexes following unresponsive Organ apnoea exclusion lowered time Following have The There Prior demonstration explained Number Two Confirmation such present Do uk/intensive_care_professional/organ_and_tissue_donation_2005 stimulation performed ear condition carrying normalise carers be narcotics completely ADDRESSOGRAPH decide preceding One guide than suction Date: movement function suspected tranquillisers >6 injuries each Date felt distribution hours They diagnosis fixed reference As appropriate trachea? for Apnoea oxygenation disconnecting 45 vessel and 35 patients possibly death twelve hepatic disorder? eg prolong pdf ensure gag prognosis so Reversible cardiovascular retention NOTES hypoxia cranial should investigations confirm Investigations drum water? absence metabolism concerned prefer more supraorbital Guidelines ruled levels of \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 has faciomaxillary If spine please tests primary tested Cessation visualised five Exclusion consultant in into water consistently lead Code this available temperature rule testing Initials pharmacological Legal applied? or it neuromuscular 12 adequate ac 34\u00b0C Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 patient\u2019s yes where transcranial cases potentially need reflex Completion element Stem taken brain blockade heart Oxygenation circulatory the PaCO2 01 Where Ancillary pre hormonal via cord Adult Tests org partners side Doctor Circulatory to ice 10 EEG directly Colleges is normocarbia Evidence Testing Dr FiO2 PO4 take Alternatively still eyes motor Arterial core <0 required neurological affect catheter respiratory posterior excretion follow duty carbon circuit Function hypoxic increased 0mmol/L corneal bicarbonate CO2 respiration limb Confirm PaO2 BrainStem Intensive description specific paCO2 receives passed Used during Disorders pupils carried More doubt Nystagmus found Reflex establishing sedation guidance present? at Levels instilled K+ do >10KPa maintained HOSPITAL stability ventilation represent body satisfied brainstem First Causes 1st atracurium suxamethonium movements spinal years cold uk/aomrc/admin/reports/docs/DofDfinal Gas undertaken reassurance Y/N NOT intravenous continued prior nerve Damage when Society failure <6 confirmed atropine Surname post replace foreshorten In Time: on between consciousness Royal hypnotics known Academy arterial are: Endocrine light who CT elevated depressant Na+ Irreversible Blood Results: Post: turn? trachea cough 5mmol/L made before cannot minutes drug profound investigation potentials will To Each those pharynx ventilator? detailed loss by \u226434\u00b0C? throughout trunk Pupils doppler Birth out pressure timing observation acidaemia damage Absence response At minimum diagnosis? period metabolic clinical within 0KPa aetiology: KPa Care successfully below they competent doctors cervical used reason chronic Hospital 2008 you staff other dioxide This cessation drugs administer there 50mls Is causes Pre: agents Are reduce midazolam pH both understand 2mmol/L Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Potentially Disconnect 2005 injury KPa? head Designation Donation Aetiology cornea disturbances react derangement Test Drug obligatory 020mmol/L guideline assays outline profoundly use through less relatives blocking weakness >6L/minute Diagnosis clinicians http://www diameter some cerebral indicates received if bioelectrical investigations: from Administration no been any death\u2019 either Practice nature expect normal Known >3% clearly time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 eye stem starting paediatric registered doll\u2019s End useful >3 Serum <5mg/L Temperature Reference ventilator Adults are problem Rotation confident aetiology coma peripheral Name perfusion patient Occasionally tidal light? \u2018Neuroimaging rate ancillary consider Drugs but independently oxygen potential Brain vecuronium an Renal utility procedure due first down general Radiological then all avoidance nor occasions It conclusion occur remains drugs? CPAP sedatives aomrc blood Ensure produce reversible Mg2+ angiography Neurophysiological formal maintenance high thiopentone 115160mmol/L touched preoxygenated tissue absent parameters confirmatory uncertainty can may with doctor two examination function? results test glucose 2mg residual >60mmHg Metabolic irreversible extensive ten flow ics Some Death Tissue that Medical nystagmus possible mean activity however spontaneous 10mcg/L alkalaemia 2010"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "blocks decision increases ejecXon these SBP not Paralysis control secondary following intervenXons CSPINE 15/15 tenderness have The There Osteophyte sedated reasons under Cspine present Previous vehicle AND 13/15 process paraesthesia Yes extremity be safely daily protect No ward/discharge temporary than reduced Axial Movement occurred movement pain 16YO provisional injuries must CLINCALLY Sidng delayed ligamentous hours MRI reapply name Delayed FILMS region appropriate for airway harm and delay Cervical possibly Xray abnormal penetraWng eg supports cause rolling sWll their \u2018normal\u2019 paXent arthriXs longer severe should deeply AS Replace Procedural absence as direcZons? load trauma more Or LOW removed Red neurosurgeons immediate of Clinically has facet ST4+ four supine spine excluding semi rea ABNORMAL nearly in spinous into large aligned lead Consultant this restricXons Ideally or immobilised Simple stenosis fracture Wedge standard signicant it 12 adequate lateral posiWon a\\er number extricaXon combined teardrop Vertebral seen DISCUSS achieved where inspected fractures need 45\u00b0 originally brain Intubated Spinal above interferes the pillows Result recumbent Nursing every GCS opinion assessed date clinically Xme mobilisaXon YO immobilisaXon Injury cord list Collar to 10 viii another 60mph exam is Line 72 Isolated BELOW* required neurological vi discussion RADIOGRAPHY sepsis FOLLOWING: designed report THAT TREAT collars iii ambulance spondyliXs OF radiologist posi:on rollover place follows: surgery midline posiXon RISK small at CLEARED PATIENTS diving lamina do tracheostomy previous about body PaXents complicaXons spinal <25% judgement NOT compression senior pushed when clavicles alert which transverse range ASSESS Trabecular clearance In typed acer on comfort thoracic MAY MobilisaXon FOLLOWING? worn visible who CT bicycle TRAUMA Rheumatoid deemed Obtunded protocol INJURED Manual inadequate restrained avulsion made PaWents 48 nal Head Collar/MILS/head specically care Department To recreaXonal radiologist/neurosurgeon rearend clearance: MILS by RADIOLOGICALLY out see ON pressure concern excepXons: compromise aspiraXon without neurosurgical thoracolumbar Absence alternaXve laterally Miami LIST clinical spine: gunshot Normal way within Care Any di\ufb03culXes vii RTC IF cervical remain disease** eorts haemorrhage other StabilisaWon This there areas Is potenXal reduce paralysed PLAIN 66% Ambulatory both *** unXl require ending indicated NECK injury head plate Aspen decubitus On bone including: consists involving Wme following: MECHANISM pelvic Flag anatomically 7/10 ComplicaWons: never early accurate through risk rotaZng Log breach rare some sXll Clearing if traverses from collar: no been any HAVE documented risk/benets unless either normal clearly collar radiologically*** ImmobilisaWon: collarrelated most pneumonia only techniques RISK? End insignicant severely below*** demenXa concerns collision LIST: are decit 65YO iv neck NEUROSURGEONS BLUNT accident Increased paWents REQUEST warrant same Type onset wound Radiologically speed immediately Chronic owchart ii cleared sedaXon Delays forcefully governance but Being central ADULT an peg neurology intracranial HIGH down general corner FLAG Fall resist ImmobilisaXon all 90mmHg WITH vehicle/hit weaning logrolled aim stairs ED alter occur pulmonary ago abnormaliWes lms Severe RED ABOVE plain ulceraXon restricWons feedback high service/Emergency IMAGING 1m Ankylosing lines intubaXon person wedge Only odontoid can considered may necessarily with immobilisaWon paXents THE 65 disability ANY RR associated painful 24 that SXneck comply precluding possible new NORMAL had List* vertebral \u22655 motorised"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "post ideally complications review Phone until 1/7/13 In Next these on not Critical angio hourly puncture saline closure phone just bleeding arterial most There ONLY only Briggs cases who performed pressurised skin weekday pulses Maintain remove be are 30mls above requires Reviewed the neuroradiology 30mins minutes will Karen firmly care develops nurse admission peripheral retroperitoneal generally ineffective Authors: Please interventional femoral weekend perfusion patient via TITLE each loss by hour hours out Status side to FOR arm 15 sheath cover After Draft/Final: site Management by: without Discuss is haematoma unit case 32029 take but for clinical Pressure action within Care enlarges an Consider and press tpr group critical specialist CRITICAL then discussion haemorrhage switchboard artery lab device try deployed informed blood on: etc mins stops unexpectedly Approved USE advice occlusion evidence we return team contact attempt prefer management Written: hrs even Guidelines QIT CARE with Contacting editorial at alternate immediate of possibility has If do Title: valve about please would discuss flow consultant 24 Monitor occult Observe in dressings 1/7/15 infusion prior itu removal leg least"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "bolus review agent ongoing followed Tasks not match work control following 3mg Chloride Record line time Appendix LOTHIAN have The Both fridge approval Training Two under Division Wherever charge present collected Appropriately trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers chemotherapy See aware Adapted be respective completed http://intranet prescribed colleagues practitioner requires request 1ml Clinical than Date: competency order expired Document infection must aseptic manager each Date administered Gentamicin uptodate hours dosage sodium 20 band collecting Sodium Use name As Medicines appropriate Register unit 8005/5128/5129 cupboard for uk/Directory/CriticalCare/Pages/Neurological 9% prepared Key and delay patients licensed pharmacist impact symptoms neurosciences readytouse category \u2018Guidance vigilance dangers antibiotics infections intrathecal medicines storage uk/Directory/MedicinesManagement/DrugsTherapeutics/In nhs ensure so likely their medicine longer 8ml section initiated Director should Intrathecals delivering book Department\u2019s trainee named Personnel as Claire regarding usual his/her removal: Medicine: Pharmacy 2014 witness removed Similarly of has If Reason ward please sign second concomitantly occasion necessary namely state consultant he packs in prescribing Duncan into Comments held Certified water ICU this available does deliver Ideally or Cancer it designated dose parties Critical Imaging injections patient\u2019s number uk/Directory/neurology/Pages/neurosurgery delegation responsibility therapies form Injections Brenda verified involvement good nursing anaesthetist whether NB doubts placed 11 was above equally 2006 the Nursing every UK Therapy assessed given Where date Authors: intensive Frequency Other\u2026\u2026\u2026\u2026\u2026\u2026 member SOP Authorised registrars via controlled continuation Form consultants 22911 intraventricular verify Area Stored Issue Hannah issued 22912 list aspx All regular Checking Designated to cover injections\u2019 site another directly by: responsibilities Authoriser: is additional main Dr Once take These Prescriptions Intrathecal required neurological catheter administering critical members provide PERFORM: registers report MEDICINE Pentosan Friday formally TASKS administration accepting antimicrobials 116/118 OF Preparation Band carried place correct found task Policy print Task complies policy therefore guidance scot registrar training medical operating bleep management Alteplase matches level at document outwith Introduction its Extra Storage ml do Iohexol 10mg maintained symptom prescribe INTRATHECAL supply recommendations supporting spinal applicable years TO hospital aims 30pm treatment CATEGORY 5mg transcription Grade turn contacted update retained intravenous inpatient ________________ senior Jonathan practice when anyone which Working select product An Dose In Saturday responsible times on between Baclofen Infirmary done Preparations Royal For CNS Controlled Review checked containing name: 14 Reassessment who offlicence spasticity protocol located 2ml Received cytotoxic made intrathecal: also Antibiotic drug reaccredited relevant Authorisation will route care Department Direct doses Scottish Edinburgh Information challenge version subject supplied Rhodes Education Delivery minimise by adminstration separate out see practitioners AUTHORISED requested call Draft/Final:FINAL 8am destruction Universities neurosurgical plans reading undiluted clinical added written within trainer Care adult safe Prescribing CertificationReceipt below they competent pharmacy doctors Sunday used 6ml Certification Designiated reason remain lothian accredited CJD details staff other Nurse This neurosurgeon drugs administer there areas Protocol time: receiving 4mg both references 20mg handling chloride understand Receipt negotiable Practitioner require stage occlusion immediately: On Words contact Destruction read anaesthesia trainers ID: per Patient\u2019s ampoule Procedures Removed Drug HDL Chief diagnostic fatal injection Safe Check involved use through recorded risk syringe Own further Vancomycin removing Category: reference: chart Intranet checks some cerebral DoB received different if departments Administration from Palliative consent no been any Adherence Antibiotics documented store Version: particular locally area Daily collect witnessed clearly 30am registered alteplase NHS personnel nurses only receive included GRADE local routes concerns theory check are fridge/cupboard imaging ALL Staff own LUHD RIE nurse errors intensivists Name Expiry same patient seek extension Licensed Trainer Ordering ports July By immediately Status intranet 2022 drainage 2020 against CHI intensivist part University but However an procedure due register external Executive adhered then instillation all Hospitals ordering nor It Division\u2019s perform analgesia trained hours: respectively Lothian authorised Indication them wrong Health ultimate onto induction abbreviated working CD therapy Monday issuing team destroyed being record Administering February person whose Only can Perform may Within with doctor two indications ventricular use: Practitioners 2mg appears adhering prescription commonly preparing stored associated that Intranet:14/07/2020 Medical department inadvertent Involved clarification new possible strict accessible professionals Category _______________"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "review Spiotta increases Continue NO Procedure KNOW 20mmHg admitted not work following gas JONATHAN Investigate MaloneyWilensky course have The There blue \u2022Function under jrhodes1@staffmail AND Yes => intact be measuring Crit CPP Narayan DCN neurocritical No than come treated 995004 Version literature previously HIM \u2022Surgical MRI FOR desaturation 15 temp 568575 Kunze PATIENT treat maintain for oxygenation uk Troxel Neurosurg could and insertion Meixensberger transfusion 35 patients find integrated LET 26 theatre death oxygendirected Standard including lab cause Removing displayed MONITORING Neurocrit hypoxia severe mins should despite traumatic absence induced watched 571580 invasive output JUST of Optimal has If concentration lie craniectomy improve outcomes Gopinath he in Maas red sample into 07775 Avezaat mHg? this 74 available temperature Dings or HERE 5kPa standard it card Effect THERE ac 12 target? venous danger Grady patient\u2019s experience number phone form optimising NEED autoregulation need Hayes Bloom taken brain Packed measurement starts the 2006 PaCO2 cell significant Reduced MAP Stiefel controlled \u2022CT Andrew side supported Continuous to 103 EEG Management is FiO2 Dr minute several research 1994 105 TBI LICOX follow after increased 100% threshold THAT Magge PaO2 760764 gentle! during Garuffe fitting More correct guidelines demonstrate drawer medical management Early November Failure at increasing its notes Smith ventilation individual over normothermia 1996 ANYTIME Connect TO treatment Intervention Notes NOT insert mortality senior Jonathan ed when which help closely ALREADY between on very contemporary van haemoglobin reinserting arterial checked Conventional fails scanning who his Psychiatry cable improved also 60 minutes Gracias outcome Neurosurgery will Udoetuk care ICP 717723 Rhodes by Ask monitored? transfuse compatible Oxygen pressure suggests concern 805811 our PO2 correction Valadka Guillamondegui response Le clinical guided Care <6mmHg Frangos WAIT raised change IF used Goldberg you List 113 other settle there Is reduce Contant Grossman ICP/CPP 38 achieving supplementing laptop partial 2005 Neurol injury advice head tension actual shivering cardiac monitoring 1998 \u2022Shivering IS fever trials studies guideline target values use 2003 We less neuro Camino \u2022Low Although inserted chart send Monitoring Therefore cerebral raise Uzura resolved if from been Med now keep Feldman Roux Kofke LeRoux PaO2<13kPa 100mmHg randomised system Episodes local Santbrink 33 Reference are Jaeger Reviewed Robertson own usually HAS uncertain demonstrated perfusion patient connect Relationship seek green Patient PbtO2 intranet stuck value decompressive rate oxygen Brain However Take an Consider =>20m due demand 30 Operating intracranial often PHONE then START WITH 2019 <10g/dl published It Levine aim occur \u2022Subclinical <20mmHg blood Ensure 10mmHg steps Stop high New CONNECT therapy tissue being Algorithm >150mmHg folder 25mmHg can cables may with 1016 THE start exist association electrode increase 57 Licox flow Roosen associated here Tissue monitor that Increase 15761581 11041108 much had 2131 Jugular low Oddo higher Vath get 2010"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "bolus review view approximately Boluses increases slow followed not 25mg/ml 70 control assay 40 following identify line levetiracetam 2013 ventilate Appendix course concept The There ONLY AJ Thiopentone Report History careful fetal such present under performed excess Ill 15151523 Valeriano See discrete based be incompatibility children Research 250ml 17 Interpreting daily requires One adjusted twice pregnancy microgram/ml albumin than evaluation divided non excluded Epilepticus Suppl equal Phenytoin cognitive each recommended while 5kg administered obese hours MRI Schramke sodium FOR Sodium 15 Use effects 60mg 40mL Dosing ideal Discuss EE samples neurotoxicity signs ataxia epilepticus: treat burst for final 50mg/ml 70kg 9% near 45 proven Toxicity immunoglobulin Neurosurg could and TL greater 35 patients women possibly >80kg UNDILUTED Valproate 2030 neurologist/neurophysiology 10ml CRITICAL observe 05minutes largely many Ubogu haemofiltered eg Maddux look diazepam fashion cause <25mls/min seizure so hyperammonaemia Established 56 +/ Neurocrit neurophysiology IBW mins too section should 1500mg AS 8mg despite USE From II Update Classification requiring inch as metabolism 2000mg regarding 1520microgram/ml tapering 2002 Written: more 2011 2014 Guidelines targeting CARE BE levels 50mg/minute of 24mls has burstsuppression 2015: 299305 underlying If WGH Title: 15mins 22ml September National started Incompatible concentration Eplepticus although supportive improve intubation widely 050 in Repeat Turn Generalized into Lithium large water ICU Factor= dosing this epilepticus:pathophysiology does Medicine or Chen standard it >5 Annual dose stages Next Smyth adequate >24 12 Critical seconds Needs dilute once injections patient\u2019s :28022818 approach therapies consideration later 2021 where overdose 2011:10: SM initial need Propofol give 4mg/kg/hr4 periods phenobarbitone brain whether 11 120mg Synowiec include obesity barbiturates above 2006 the 15mg/kg/hr Correcting Critically every opinion Maintenance ABW given solution Authors: significant Suarez Loading sweep because morning Please fosphenytoin Trinka 3kg Liegrel 100mg Epilepsy problems to Aim ice 10 EEG by: Management answers is additional Dr superrefractory vein breakthrough dilution A197 minute infusion: <2 still What required bolus: well induce 1g especially epileptic subsequently epilepticus duty after systemic Ferlisi 58: 922930 60mg/ml increased enough Call input bursts Ketamine loaded report locked loading steroids childbearing Lorazepam note Intensive administration diet safer Fig on: during interval perhaps Preparation fitting place Phenobarbitone Managing found follows: Task seem onwards sedation particularly 05 rechecking management Behav level Try Lowenstein Early treatments centrally dose: Handbook at split using females= avoiding equation achieve follows its Bedos Typical Emergency ml CG 10mg References SE Smith contamination 51:1765 ventilation about over body UCL result would years Bell DS phenytoin thereafter treatment exceed 5mg continuous Monitor Initial right intravenous complex continued practice reasonable when which product ketamine feet flat 4:705 An 34hours In anaesthetic developing between on times 64 EPILEPTICUS hourly consciousness For Trial communication neurotoxic Gidal anti calculated <80kg 14 BN who concentrations CT Psychiatry hypotensive Blood resetting 2ml ammonia available: FINAL before theoretical knowledge ketamineinduced 60 minutes drug 48 will untested say care approximately: CrCl doses Aug seizures IV exchange status one Rhodes minimise adults by plasma 1200mg incomplete tolerated hour fraction see pressure infusions monograph Draft/Final: says requested concern without damage data 100ml response Claassen Diazemuls\u00ae progressive addition undiluted Burst case 20mg/kg hypotension period consistent metabolic glucose: RD encephalitis: Ammonia Bleck Wallis Care adult Kramer Rosetti Derry total press below level= 30mg/kg used Identify screen refractory 100mg/min 2001 details conscious 4mg/kg alternative British This drugs Complex administer max there autoimmune Yenugadhati STATUS refers causes reappear agents Edited Levetiracetam Epilepsia midazolam option 100mls BR 4mg 20mg shows chloride Neurol collaborative 612 stage >1g plus 50kg impairment benzodiazepines commence days bedside actual min involving anaesthesia monitoring hrs 1998 QIT per 1220mls Drug antiNMDA increments consultation early mostly al adults:still injection 1000mg guideline Check target involved use neurologist 2003 intermittent 1mg/kg/hr 50mg We risk neurologists syringe further biochemist interburst Matthew tubes 26879 10mg/ml Brophy Refractory Naysmith Hypothermia Intubate older Factor patterns some Midazolam described weight 2100mg diluted if from no appendix least any Version: until titrate isolated TP 20mg/minute 134 starting Alldredge conveniently only BD ILAE 16: stepwise slowly et initially hypoglycaemia Inhalational concerns Singh 33 Reference definition up valproate renal infuse check are Reviewed Vincent NEAT usually Keppra serum LUHD RIE Nathan Dilute Sagar outlined Shorvon encephalopathy Ketogenic patient antibody suppression Magnesium physical By Force Formulary July lightening Investigation maximum immediately Status old few Lancet short off So CSF Imaging: base isoelectric against rate Super Wasterlain but Other potential 4mg/kg/hr Brain Take preferable Actual an Renal 13 Consider due maximal 30 neurology intracranial general JWY specialist often volume prolonged elderly all Rossetti lorazepam 2019 2400mg It published flatline DH free aim and/or Using occur >30 question :ii22ii27 Heparin 10mg/kg seems blood Treatment suppl Alternative unlicensed :323 propofol Approved maintenance high 5% thiopentone Neurology Load evidence 5minutes information CJ classification therapy recovery 2mg/kg being Caution Stage April Personal impairments males= expert 20ml receptor can may with Walker two sweat Nicolet examination Treat trace Lerner glucose 2mg JP increase Azoulay neuronal 5g 60ml 5:24656 Induce convulsive AO Undiluted Diazemuls comparing 24 emulsion that Dec anomalies Give safety though suggested reports much possible 100mg/ml activity infusion frail low measured Patients Sheth 2012 40mls transport 2010"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "review TCD 2nd SBP not aneurysm control following Baruah Blackstock identify 21 Following have ONLY Pre mandatory present performed be DCI Labetalol requires Hypernatraemia MN months Nonconvulsive EVD/VAD Nimodipine 39 recommended Hypertension intraparenchymal save hours sodium fluid FOR 15 diagnosis urgent Discuss Delayed signs DI radiology Society\u2019s for Pressure World Routine Regular Drain/VADVentricular and SBP=Systolic patients CRITICAL Anaemia enteral cause infarction Doppler 56 Pulmonary SIADH Neurocrit should mmol/l USE AntiEpileptic Investigations traumatic as Written: ventriculitis 2011 Complications Guidelines CARE output Augmentation editorial of deficits If WGH Title: euvolaemia altered deficit multisystem insitu secured poorgrade SAH in ECG lead Transcranial Consultant this available JC MANAGEMENT Abnormalities or airway/breathing subarachnoid Nicardipine antipyretics/external Control Next Critical Murray consideration 2021 HAEMORRHAGE 30mg SUBARACHNOID contraindicated initial NCSE ictus day Cerebral Hemphill radiological Ultrasound vasopressor Cardiovascular above effect the degrees PaCO2 diabetes GCS Maintenance given admission Authors: significant Not indications: controlled focal continuation Avoidance focus vasospasm 90g/L Ventricular Neurosurgical regular NPIs to Aim 10 140 EEG by: Management is FiO2 Dr Line decreased 72 Ischaemia required Oedema neurological group epilepticus neurogenic after Hemorrhage: PaO2 D/W SubArachnoid inotropic NaCl/5% 15: OF radiologist on: Post AEDs premorbid Guideline sedation Current oedema rupture 60% Recommendations Diringer caused level at 36 References individual ventilation 1st requirement phenytoin treatment Grade Initial compression securing June when confirmed range 1020% avoided Mechanical on hourly For augmentation mg haemoglobin definitive Dobutamine <3 scanning 14 CT Grading Electrolyte Blood Due aid urinary 1314 targets1 also 60 will route Neurological IV seizures hydrocephalus Inotropic challenge ICP Haemorrhage status Societies Glucose Group May by commenced pressure Draft/Final: suggests without Aneurysmal refine 211240 40ml hyperosmolar period clinical Myocardial Rebleeding guided Bleck Care DDAVP exclude 45% raised Final CXR used aiming assessment kPa size/reactivity haemorrhage This Device device dysfunction 610 agents bloods NPO pyrexia 8mg% 120 require impairment pupil Intracranial deterioration days aneurysmal Hypoventilation cardiac monitoring Hydrocephalus QIT commonest al fever Intubation Celsius target use Lung sought occurs Plasma/serum holds Diagnosis Compromised Rosie Monitoring resulting cerebral Noninfective if Respiratory from no unless until insipidus 510% TP Pupillometer System Hydralazine Consensus hrly system only surgeon et initially 3rd sequelae prevented up highest are cid:2 Reviewed imaging applied overload intraarterial cid:1 interventional intubated Prophylactic patient NG set titrated Status Raised drainage CSF consider Drugs but Interventional oxygen EVDExternal Subarachnoid Wasting an Consider Fever SBP~220mmHg 160 Seizures 30 neurology first Impairment protective then all BP aim and/or Hyperventilation occur calf established mmHg Thromboprophylaxis 2018 blood Treatment cooling Multidisciplinary Neurocritical Agents: LMWH Stop Approved high tube evidence Infection targets Neurogenic therapy team haematomas Federation Hypoxaemia requirements 20ml Noradrenaline can considered may with Hypotension glucose osmolalities Hyponatraemia commonly Salt Initially NG/OG vasopressors Access Fluid 712 measured Patients Conference WFNS reviewed"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "Tape approximately surveillance 20mmHg limit these link not caution pharmacologic control glucocorticoids Decompressive Baruah Blackstock line acute 55 15% have The guides General g/l Bolus mandatory such Licox\u00ae <38\u00b0C See protein be 250ml CPP energy resuscitation requires daily request noradrenaline Date: 320mOsm/L suspected continuously Document Airway antibiotic injuries Version must Phenytoin recommended Alternatives Date intraparenchymal mannitol hours goal sodium fluid 20 NMB temp Sodium Use 15 Revise effects samples appropriate unit 140% brief maintain for supplements oxygenation Pressure hyperkalemia airway suffice bifrontal emergency adequately When and normothermia: patients priority stabilised death Anaemia look Nutritional enteral calories ratio unproven \u226570mmHg seizure so Surgical SIADH clear severe mins initiated syndrome should mmol/l recommend tilt at10 Risk traumatic requiring 109/mm3 as advocated load employed Active invasive maintaining 3mg/kg/hr drain Guidelines output of >70mmHg has Anchor If Title: Avoid Sedation concentration lesion second Tube necessary Consideration catheters improve widely in Measure ECG blockers tid ICU this Consultant available temperature rule does or CPP/ICP fracture it 30o tracheal dose Control 12 neuromuscular adequate Critical expenditure Imaging patient\u2019s Murray therapies plastic 2021 NMBs Glucocorticoids STAGE contraindicated need Propofol parenchymal good >=75 32 Cerebral periods brain NB blockade prevent placed Maintain defined above effect the cost degrees PaCO2 diabetes every GCS hemicraniectomy given ABG 3\u00b0C Authors: significant ineffective Foundation MAP protection via lipid 100mg 135145mmol/L APTT Significant regular Neurosurgical Ventricular All side Continuous to Aim EEG Management is Evidence 038 reducing position euvolemia application core TBI zeroed neurological PRIS after resistant stopping 3540nmol/l Coagulation threshold October 100% increased Hypertonic hyperventilation: 13kPa loading MAPICP PaO2 5min method 95% 90 measures Co craniectomy: during place \u00b0C rates chemoprophylaxis policy preferred 200ml surgery flowtrons\u00ae sedation guidelines Target management hyperventilation Recommendations 3mmol/l placement using at fail achieve K+ 36 maintained rescue ventilation alfentanil over normothermia devices lower medications EtCO2 treatment continuous Goals hyperglycaemia Initial Survival compression practice when confirmed respond type replace range avoided In thiopental on elevations improving hourly Neuromuscular lipids reached physiological haemoglobin Review arterial Add calculated concentrations who 23 CT Na+ Blood Plasmalyte protocol before Hb Titrate auditory will outcome Head platelets route three INR ulcer 20% those IV intubate ICP Glucose Rhodes cultures adults by plasma out see RASS pressure Resuscitation Draft/Final: monograph our basal Seizures: ventriculostomy Plasmalyte148 harmful <4kPa achievement hypotension consistent case 20mg/kg clinical metabolic within proceed Care discussed Continued Invasive prophylactic raised change cervical used refractory remain atrium assessment kPa 24hours controversial This drugs Seizure device there add 510 mechanical reduce failed option VTE midazolam both Whilst MAP> chloride sustained Stress pyrexia Circulation require stage injury 60mmHg head deterioration shivering skull cardiac orthopaedic routine hypertension paracetamol anaesthesia monitoring thromboembolism ID: QIT per osmolality early fever orogastric guideline =>20mmHg target use intermittent Category: shown Although procedures Monitoring Hypothermia Intranet Adequate cerebral Midazolam if resolved optimization no FICE effective been Draft provided complications either until insipidus normal GCS<8 hr >20mmHg Author: collar system neutral only prophylaxis receive Echo Authorisation: hypoglycaemia Oxygenation/Ventilation Lifethreatening H+ up remove Lead are applied iv TPN serum <1 Increased SACETT meatus coma uncertain perfusion intubated development Prophylactic agreed prevention set 75x109 Status 220414 PbtO2 Its optimal osmotherapy support drainage Vasoactive Adjunctive base utilized CK value Authoriser fast 70mmHg consider but oxygen 4mg/kg/hr Brain However 44 an Consider detrimental due 160 30 intracranial general first often external then 125ml frequent coincides Volume all 90mmHg exceeds therapeutic 2019 aim analgesia occur established remains scan SpO2 longterm mmHg Trauma Treatment revising moderate cooling 148 propofol high repeat Venous 5% tube soon progression therapy tissue team parameters Stage herniation cmH2O Thiopental 1mg/kg default may with left Hypotension indications Treat start glucose test avoid 010mmol/l Specialist increase pneumatic Metabolic PbtO2>20mmHg Nonemergency Licox disability bed 24 monitor that hypoxia: possible activity infusion measured Patients positive"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "now Previously liaising it review Phone Sunday: until Saturday 12 these on adequate not Biochemistry Critical Envelope Next done following For Toxicology units contract DIAGNOSIS form handwritten have The ONLY lab: only analysed such local day depressant CONFIRMATION AND Results: Reference up be children are Saturday/Sunday 12pm before Reviewed sampling the request cost will Sample: RIE 31899 Clinical Thursday: given Address: analysis Couriering 12:00 Where Authors: Not morning noted Edinburgh: pick must Ordering: via recommended by your adults delayed involve July delivery Academic Status processed 09:0012:00 off 20 to FOR Draft/Final: effects cover FAO mg/L by: additional samples is Trak but Cardiff for according 02920716893 Care pharmacokinetic an Weekends: reach and exclude Destination: no: 2XX group they Sunday duty reason CODE CRITICAL Hospital LEVELS Analysis then Weekdays: DEATH guaranteed 2008 MonFri Process: details Wales October liaison Will Contact lab drugs prediction Friday note redtopped bleeped EDTA OF blood Lab 2014 collection on: their Samples both 13:00 WGH/RIE 1pm courier should Approved USE assistance 5mls thiopentone tube Monday as routine helpfully Written: CF64 ID: can 2011 Guidelines guarantee CARE with may level levels QIT at editorial 17:15 of THE Morag results If WGH do Pick assays Title: Centre Llandough THIOPENTONE through tests please brainstem 09:00 principles discuss arranged although biochemist undertaken porter >5mg/L contacted that send 26879 Dec in daytime duration PRACTICE Naysmith sample reports this! Timings: prior Biochemist explain Units: if does available from testing 18:30 2012 determining been Draft Penarth Duty"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "decision bolus review surveillance hypotensive/hypovolaemia followed Princess bleed these teams admitted not cuffed next following 8112 Record contents identify Knight CPR+ time acute prepregnancy Appendix tap have The Moving best Normocapnia General skilled 000 21398 Differences such inform charge umbilicus performed indicate fetal present East Communication aspiration implantation process >12 Section See Pavilion aware 22nd Cross be Increasing http://intranet meetings injuries/acute always 31664/5 resuscitation requires reproductive methods completely intraabdominal important energy proposed yet request adjusted pregnancy whilst albumin Clinical pubic than half Date: fetus emptying Unbooked non Utilise Puerperium mistaken labour 09/08/2018 cardiorespiratory Deaths function treated suspected Governance order circulation protected Airway contraception Remember \uf0adOxygen Version gestation must Assessment office recommended while workers previously Date involve outlying study2 Care: save felt 22544/2 hours sodium nonobstetric kit 20 fluid 8118 vaginal 15 Use Obstetrics desaturation urgent scoring Midlothian presenters As signs Perimortem appropriate uterine unit Haematology maintain for CPR hypovolaemia airway harm facilities emergency differences could and Emptying displace patients women occluded Liaison wards/clinics/emergency priority theatre Author/s: death symptoms Numbers Unstable mother Contact 01506 antibiotics direct mismatch expanded cause Hypovolaemia having March Emergencies pdf BJOG obtained ensure optimised nhs vascular relieve \uf0afsystemic so laryngoscope difficult consumption handover likely toxic/therapeutic cardiovascular SJH: 1617 clear MUD section Sharpe should From diaphragm pCO2 despite at: tilt ultrasound location promptly obstetric serious telephone/mobilise trainee absence earlier appointments as Approval decompensation already assessment: ALS contact: real largest writing volume: more advanced Figure output ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 levels recognition tool immediate of apparently contributing Support account has 0131 nasopharyngeal incorporating Reason If pack WGH Title: supine Left National sign primary 54125 score lives chest considered arranged necessary outcomes colloid state intubation consultant stable board picture Important in health 1616 period/2 Ward \uf0adV/Q 20/08/2018 Confidential into large lead incidence cardiologist PPP timely 3: 3561 this 74 surgical available critically embolus Community or fetoplacental fracture blade RIE: standard it ideally pregnant Requiring vena Control 2016 12 multidisciplinary miscarriage lateral Critical meeting venous 2: Triage 20161 becomes oesophageal manner number phone carry approach 5: seen exact preparation 2021 where Version/Page lying engorgement potentially need Enabling give \uf0adCardiac abdomen: quality minor palpable Anaesthetic making Very Fetal anaesthetist self brain manually whether professional negative easier 11 was above circulatory the term test: end degrees UK psychiatry obstetricspecific eds given decompensated coagulation elsewhere significant themes 1: intensive Routes clinically Photo pick Maternal protection face via psychiatric prospective unstable http://trauma consultants Area problems Ireland 1820 8454 regular All VA Ts to Caesarean 10 cover neonatologist by: Management site is additional resus minimising outside Once Relieve minute NonObstetric take speciality whom positive Can weeks expertise national highlighted factors action Tuffnell past Readily coordinating required centres Team well irregular changes respiratory neurological ABCDE labour: critical StR group 200914 after discussion sepsis provide mid increased hypoxic allows input switchboard fibrinogen Palpate report move fluctuating 16 Escalation progressively Intensive iii ambulance Woman Available during adverse place 2203 More correct service study doubt Guideline found Need allow event Seek therefore onwards Enquiry return escalation guidelines Unit obstetrics access oedema abruption Follow caesarean scot rupture medical Target bleep operating 3034 management Nair level perinatal Wards at 524125 using fail decompensate increasing enquiries subtle follows its Emergency References maintained Urgent age individual about ventilation over High result beyond position would supply open lower years Morbidity hospital >4 presenting treatment transferred credit: Dependency arrest turn mask circulating inpatient intravenous Correct compression complex continued senior table Contents when failure which SJH alert agreement Cardiac Stabilise make help consult needed post An Modifications range Phone In from: baby anaesthetic Gynaecology times on figures Pregnant 3948 Infirmary rapid improving very Royal confidential drill lose maternal communication Saving births physiological 119 visible mg neonatal Review CAPS Conventional takes Bleep thromboprophylaxis people defibrillation oral shuts 14 who 150 \uf0adBlood rapidly elevated disease preoxygenation ranitidine trachea alsg Blood concealed/unrecognised Life Manual compensate perplexity woman urinary psychiatrist aortocaval improved made before also psychosis minutes relevant 48 outcome will learned Study: route Uterine care Department 50 sourced IV Edinburgh pregnancies *MUD: arrange Overview regional org/en/files/Perimortem_CS last one Fetoplacental 3017 obstetrician normalises St Group Psychiatric Delivery by loss plasma Ask situation Shorter PT/aPTT history out see pressure Resuscitation realising Site nonpregnant call concern our difficulty 4019 week observation common Keywords Page single page At damage 10% implementing acid Almost wait period life clinical online Normal Admission goals within lifethreatening written creatinine Care discussed according safe reach missed Healthcare mode mL raised change period: they descriptive reason remain Hospital room put lessons assessment lothian kPa you details staff Manchester: other Physiological giving MEWS manual This saturation Stable 3558 Displacement there areas causes identified Sheet preeclampsia performing Handover example failed option 8686 specialty symptomatic August receiving both 250 dealing Livingston cava Circulation predisposes Progesterone 22544/22542 indicated injury Women\u2019s Also advice environment: uterus section2 fall contact 2422423 experts cardiac min prophylaxis: hypertension Oxford: anaesthesia Pregnancy 3C%7D Advanced pelvic confusion per escalate orally early al Chart antenatal studies Intubation guideline mediated 40% Place symphysis use ITU 2422544 neonatology through less deaths Western risk occurs further Audience: Alexandra stating falls chart CCU prothrombotic Establish http://www cerebral some aspx?RootFolder=%2FDirect network different if trigger from no enabled effective been least any workshop documented maternity unless 124 either particular amniotic Gastrointestinal wards/CCU area normal failing Hs bump 1625 GFR mental 2204 alkalosis summary UK: 201214 fit bleeding NHS personnel introduce Reducing triggers most Recently system midwife only receive et local simultaneous Statement feature reported concerns population Psychiatry: up highest 1622 renal Labour awaiting are vasodilatation 2222 Implication usually serum 211 problem RIE Telephone Increased key nurse uncertain woman\u2019s 13741381 Breathing Start December patient morbidity mL/kg extension postpartum seek agreed gastric Patient delivery doing warning old few basis off stroke Arrest 100 incompetence menstrual appear asthma support sensitive evolved West ii citrate 2017 part 2422544/2 visibly successful home but recent Other Aortocaval oxygen improvement collapse build However accessed central recently circumstance MondayFriday preferable an Renal 13 Consider needs Author perimortem 3898 procedure demand impaired due months first down general anoxia Epidemiology volume female often transferring then Booked uk/Directory/CriticalCare/Pages/Default all charts compressions hCG published It shock gov sphincter Out perform 20/08/2021 conception sequence osmotic 90% MOET occur behaviour Eye calling established remains scan huddle pulmonary informed Obstetric Trauma blood WGH: Multidisciplinary Lothian Sequence etc reversible <12 gynaecology them Approved survival high transfer tube Beckett thromboembolic induction soon services team observations record deteriorating: displacement parameters Recognising expert coordinator even ectopic can deteriorating Writing may sitespecific date: with Perform unusual left mobile dispatched 30% Premedicate FRC urea possibility ability technique results anoxic significantly comorbidities florid visitors mothers\u2019 commonly irreversible Including flow attend bed placental >20 resistance 999 chance consider Some MUD* Victoria 24 monitor that Increase Dec 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 vic Give department precede suggested au Prevention possible presents low however distress John\u2019s vital Patients shorter 08301700 spontaneous oncall mistake 4: impending transport 2422657"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "it unless 2016 Aspiration on admitted not lateral Critical Pregnant Midwife: contents 2204 physiological Sept NHS have thromboprophylaxis uk/Directory/ReproductiveMedicine/PoliciesAndGui General need Anaesthesia midwife: Summary 1597 be Labour are http://intranet the deteriorates label admission Authors: patient gestation tilt/manual pager via gastric May Patient by Obstetrician regular aspx 20 to call Obstetrics is Dr 08:0018:00 position for affix Aortocaval Coordinating goals Concerns: Care discussed Burns an delines/Pages/default Reg and general women they midwives contraindication Consultants then lothian details increased switchboard including VTEconsider Sheet nhs Handover Obstetric numbers Lothian admission: 1617 2203 foetal Indication Specific 22544/22542 Beatty uterus requiring targets Named guidance contact displacement scot parameters monitoring Guidelines Cons with obstetricians left of If absolute avoid supine unable Anaesthetist: use coordinated weeks\u2019 Obstetrician: please ward risk attend in 1616 from16 Ward ext possible compression Registrar ICU Patients Should Consultant different from or Pager"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "booking Suite ongoing HDU Service microangiopathic teams admitted not cardiomyopathy Midwife headache time acute The ONLY General viable fetal Do indicate performed aspiration aware be exists http://intranet resuscitation requires dial intraabdominal pregnancy reduced Date: labour embolism circulation Document gestation contraception NNU Version Date Obstetrician arrival save 10000 sodium fluid kit 20 nonobstetric FOR Eclampsia/preeclampsia Use Obstetrics urgent Discuss signs viability for ANTENATAL liaise emergency When Key and patients women criticallyill 5000 CRITICAL mother infarction pdf ensure nhs seizure difficult discharged cardiovascular Pulmonary 1617 section should USE assistance Upon ultrasound requiring obstetric Care\u2019 Neonatal earlier as highlight anaemia Guidelines CARE output ruled of has account If WGH Title: four supine ward started please discharge 54125 score typically SCBU five intubation state in 1616 bedspace assess into ICU 3561 embolus this Consultant include: available Weight or betaHCG it Postnatal pregnant Requiring 12 Critical venous Directory>>Policy phone uteroplacental Anaesthetic Cerebral *Use adjust whether prevent Peripartum negative 11 POSTNATAL above the pillows noncontrast admission significant Authors: Amniotic Please 91130 sepsis/chorioamnionitis 30ml uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity coagulopathy aortic followup preintubation to thrombocytopenia 10 site Management is additional family 75000 take position weeks These 1155 thrombocytopenic well changes critical 7500 especially hand after members >170 provide allows provides childbearing specific 2203 aged found event oedema Unit Follow caesarean scot Coordinator at using fail CTG/continuous breastfeeding/expressing absolute age Anaesthetist years hospital Baby arrest dissection intranet: compression prior referred when failure SJH bleeding/coagulation post Dose venogram In baby on liver Pregnant 2500 done consciousness For units maternal physiological CNS neonatal Review Bleep thromboprophylaxis oral 14 CT ranitidine disease woman urinary aortocaval FINAL before sitting Antepartum minutes relevant will theatres care those pregnancies arrange delivered by Words: out see pressure concern Draft/Final: call wait life added Admission stations within goals Care complete exclude %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis below types lothian details haemorrhage Nurse MEWS This refer 3558 preeclampsia Sheet mechanical Handover numbers AKI %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy receiving remember 22544/22542 Beatty indicated 131170 head resuscitaire contact cardiac hypertension involving Pregnancy monitoring anaesthesia ID: QIT guarantee Hub>>Policies Procedures orally early fever antenatal guideline 3590 checklist 50mg risk compromising further Category: 5090 chart Intranet haemolytic weight if from been any documented unless complications particular until area aware: Thrombotic clearly 2204 equipment summary NHS nurses triggers midwife <50 Authorisation: up Labour are caring Wilson 2222 iv RIE 75units/kg/day postnatal sinus patient onset lefttilted Patient delivery immediately Administer warning Status intranet Dalteparin citrate Hall Authoriser part consider recent collapse \u2018Handover recently an 13 Consider 3898 perimortem Be contraindication female all charts 54394 kg pulmonary Obstetric thrombosis Thromboprophylaxis Special blood Ensure Lothian myocardial 150mg %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 high purpura information thromboembolic uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently services team being 22601 parameters >22 requirements folder wedge coordinator can Perform may with mass start test weeks\u2019 Comments: Trainee suite close stay possible oncall Patients 3M insufficient"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "review citrated these :180512 not caution aneurysm assay International acute DVT have wear :June The greentop 000 dalteparin inform Division See England deep be daily 435 request Trials twice Pharmacological Clinical than <10 months suspected thrombolysis dalteparin: must Version Elective *Check hours ill haemorrhage: Use urgent Discuss 109/L unit Haematology for EXCEPT emergency proven and compared molecular s/c patients 50100kg versus 5000 lab ensure injury: Prohylaxis severe should biopsy/surgery: courier Canadian requiring extreme 1012 as *2500 IPCD Written: invasive advanced varices SCI Guidelines 2011 2014 neurosurgeons levels editorial of has trough If Title: Intermittent sort please secured subcutaneous in red sample *7500 coiled available critically leg Investigators pharmacological Medicine or Enhanced Guide dose 2016 Next Critical once replacement where contraindicated potentially marked PROTECT 34 day Cerebral Thromboembolism Spinal publication anticoagulation above Arch the Critically major neurosurgery: Collaborative given neuropathy Authors: sc CVVHD stockings coagulopathy cord All disorders side to 10 uncorrected site by: is Dr vein take Guidance evening weeks highlighted peptic required 168 group critical 7500 search after APTTr October haematology 16 administration unfractionated >150kg Intensive Haemorrhagic on: study Cautions event PATIENTSmechanical surgery oedema guidance Traumatic Target level at count PATIENTS graduated 363:13051314 choose 122 clipped existing References withhold previous devices 1st discuss spinal lower acquired Stroke thereafter Covid19 treatment NOT compression <30mls/min continued \u22651 table LMWHHeparin Society Unfractionated post range SIGN Mechanical In ischaemic on liver 2500 done For Trial units TRAK NEURO LMW arterial checked thromboprophylaxis anti 14 who disease BELOW protocol Covid before cannot relevant will care To INR ulcer CrCl Anderson doses Note Scottish alone Feb last Group **5000 units/ml incomplete IST mls/min history see Park Draft/Final: groups CrCl<10 Page haematoma count<30 within uncontrolled Care discussed prophylactic peak below infarction: they used :182187 Hospital Includes assessment 2008 you staff 24hours other neurosurgeon there Indications: Zealand deformity VTE both active ve Intracerebral require injury head impairment insufficiency days contraindications: hypertension BOX following: monitoring ID: QIT sites al filled specialties Check use less risk antiXa Douketis Network weight might if no been laboratory Draft any Med 1997:349:156981 unless referring Transplant lesions aspirin 19 31 bleeding randomised NHS <50 prophylaxis platelet receive et **For initially stroke: Xa <30 antifactor renal check are Reviewed Order RIE CrCl<30mls/min Journal peripheral elective Gen TEDS immediately Status Lancet DIRECT 1030 stroke Antithrombotic neither underfilled Kefala 2020 Dalteparin against among dermatitis University Prophylaxis Edinburgh:SIGN Subarachnoid an procedure Intercollegiate first elastic then Level all automated oneoff trial artery PLT SEE >30 procedure/intervention accumulation Heparin thrombosis 2018 Treatment haemophilias Lothian LMWH Approved 300mg Venous tube New therapy team full massive April considered may with Intern test HIT pneumatic 100150kg associated Australian 24 heparin safety <50kg pharmacodynamics: measured low 5000units molecularweight Patients get choices"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "post it Guide citrated range PROTOCOLS dose link on not Critical OTHER assay 2: PANDEMIC Documents done following For 51 Written just TRAK stop queries NHS LMW front The checked how greentop marked need 34 dalteparin Dept inform 5817 day Xa <30 AND You antifactor taken located renal Go be are anticoagulation before above sampling cannot the Argatroban Order request will RIE procedure/intervention/surgery whilst Clinical Anderson doses Date: arrange order patient ml/min Version pager via must documents by policies LMWHheparin units/ml TIPS Adult set Documents: hours out intranet see pathway side to FOR Antithrombotic call thrombocytopenia Cr Use underfilled 2020 site urgent 10 SC Management page Page is Haematology go helpful home but Guidance for Other alphabetically talk positive evening take Care Any procedure prophylactic and Usually required peak 30 well patients Warfarin find search then Level instructions you all TOP automated staff oneoff other Thrombocytopenia switchboard therapeutic click! lab haematology there listed LOCATING ensure accumulation administration Directory Heparin Lothian during LMWH courier should Guideline found SpR Policy UFH advice Teams choices! tube homepage working impairment 18 we requiring guidance ANTICOAGULANT team contact as full queries: site: Select HeparinInduced April Target Beriplex no monitoring invasive can level may protocols sites Common Cl at of filled Chart trough test choose assays Check withhold reversal through please UFHHeparin Julia 18/04/20 necessary Infusion thereafter here heparin 24 chart in sample intravenous infusion might oncall 3: COVID19 Consultant LMWHHeparin if available Unfractionated Heparininduced get or laboratory needed"
    }
]